nodeId	pmid	pmcid	np	head	base	type	term	coid	section	arg_type
ecd04bee9dceaef7fa4938f22aa7554f	chapter_1	978-1-4987-6285-4	a glycoprotein	glycoprotein	a glycoprotein	product	glycoprotein	COID866322	CHAPTER 1	arg0
93693ceb75f76e4812c310c1bdba7ccc	chapter_1	978-1-4987-6285-4	The glycans attached to a glycoprotein	glycans	The glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 1	arg1
a5e0d84ea0572fbc2fcb951b74e75094	chapter_1	978-1-4987-6285-4	the presence of mannose 6-phosphate on the glycan of a number of lysosomal enzymes	presence	the presence	sugar (subset of carbon source)	glycan	COID626759	CHAPTER 1	arg0
46d774ee1dfba907a2391c8131f82bab	chapter_1	978-1-4987-6285-4	the protein binding to the mannose 6-phosphate receptor on cell plasma membrane for uptake, a step necessary for targeting the enzymes to lysosomes	binding	the protein binding	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 1	arg1
e0e2a67393582b28c29c16fdf0b34b25	chapter_1	978-1-4987-6285-4	The status of molecular folding, glycan composition, and even the composition of minute impurities	status	The status	sugar (subset of carbon source)	glycan	COID626759	CHAPTER 1	arg0
92cfcc4a044c13f8b4fb9ccd7ab2cd15	chapter_1	978-1-4987-6285-4	immunogenicity	immunogenicity	immunogenicity	clinical outcomes	immunogenicity	COID444425	CHAPTER 1	arg1
001e4f2998bbe233e8ac4ff9d2df63c6	chapter_1	978-1-4987-6285-4	the glycan structure	structure	the glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 1	arg0
583572ca99d0191833b545cd05e0f373	chapter_1	978-1-4987-6285-4	its pharmacokinetic behavior	behavior	its pharmacokinetic behavior	clinical outcomes	pharmacokinetic	COID373370	CHAPTER 1	arg1
fe68a05eafa5bcbbb17e043ebc37d00d	chapter_1	978-1-4987-6285-4	time	time	time	process parameters or process control	time	COID742277	CHAPTER 1	arg0
fa766ae504710314d07589a13690813e	chapter_1	978-1-4987-6285-4	Such quality changes	changes	Such quality changes	product quality attributes	quality	COID109463	CHAPTER 1	arg1
823472fee2d65941a0ad9c1598fe7614	chapter_1	978-1-4987-6285-4	the protein's biological activities	activities	the protein's biological activities	clinical outcomes	biological activities	COID518861	CHAPTER 1	arg1
f4190deb966d342568faba04db63131c	chapter_1	978-1-4987-6285-4	Many production cell lines	lines	Many production cell lines	cell line	cell lines	COID702829	CHAPTER 1	arg0
7a668a4de089641a318485f3f959c66b	chapter_1	978-1-4987-6285-4	multiple copies of the product gene	copies	multiple copies	genotype	gene	COID185502	CHAPTER 1	arg1
7f2d096a5b98c355c149ca391e8539cc	chapter_1	978-1-4987-6285-4	its ability to elicit an immunogenic response	ability	its ability to elicit an immunogenic response	clinical outcomes	immunogenic response	COID740397	CHAPTER 1	arg0
e2a8be676154c310cfe870b837ea072f	chapter_1	978-1-4987-6285-4	the quality of a virus intended for use as a vaccine	quality	the quality	product quality attributes	quality	COID109463	CHAPTER 1	arg1
8455c0032864b5f6e686e29f0baea8ed	chapter_1	978-1-4987-6285-4	The lack of an effective and robust in-line device that can concentrate cells and return them to the bioreactor	lack	The lack	vessel or process parameter or production scale	bioreactor	COID345693	CHAPTER 1	arg0
c2f7056dcdbc2ec0d383027717af2248	chapter_1	978-1-4987-6285-4	the slow adoption of the perfusion process	adoption	the slow adoption	process mode	perfusion	COID329168	CHAPTER 1	arg1
818cfadd3912ffe991f81a1957b7002c	chapter_1	978-1-4987-6285-4	the biological activities of the protein	activities	the biological activities	clinical outcomes	biological activities	COID518861	CHAPTER 1	arg1
8635bad8d21bb162ad19923bca4a3a30	chapter_1	978-1-4987-6285-4	The glycan structure of some proteins	structure	The glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 1	arg0
062c8c974dffca282d11f185b766fe4d	chapter_1	978-1-4987-6285-4	the protein's therapeutic efficacy (Panel 1.10)	efficacy	the protein's therapeutic efficacy	clinical outcomes	therapeutic efficacy	COID151356	CHAPTER 1	arg1
e280eac065a7a8f2c777ad87b10863ed	chapter_1	978-1-4987-6285-4	its biosynthesis reactions in the Golgi apparatus	reactions	its biosynthesis reactions	biochemical compound	biosynthesis	COID479844	CHAPTER 1	arg0
30f4ffb543c42d755c675f2e8230fec3	chapter_1	978-1-4987-6285-4	This heterogeneity	heterogeneity	This heterogeneity	clinical outcomes	heterogeneity	COID021590	CHAPTER 1	arg1
2e7882ae22a4796d2ed413c20539d36c	chapter_1	978-1-4987-6285-4	then introduced human glycosylation enzymes	enzymes	then introduced human glycosylation enzymes	glycosylation	glycosylation	COID119643	CHAPTER 1	arg0
76487d0604c672e65b1313ac64115817	chapter_1	978-1-4987-6285-4	the synthesis of proteins with humanized glycans	synthesis	the synthesis	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 1	arg1
e2935c57a7a3c566da1f28763b267c12	chapter_1	978-1-4987-6285-4	Extracellular proteolytic cleavage	cleavage	Extracellular proteolytic cleavage	PTM	proteolytic cleavage	COID789633	CHAPTER 1	arg0
2a09cb23f9f485dafc08244c2b10bc02	chapter_1	978-1-4987-6285-4	degradation of factor VIII	degradation	degradation	degradation	degradation	COID049441	CHAPTER 1	arg1
1f8a6b1a1b66c422970b4f926aee190f	chapter_1	978-1-4987-6285-4	the N-glycans synthesized in insect cells	N-glycans	the N-glycans	sugar (subset of carbon source)	N-glycans	COID216687	CHAPTER 1	arg0
f262b01ee54b6178d60fd9299ebee275	chapter_1	978-1-4987-6285-4	fucose	fucose	fucose	sugar (subset of carbon source)	fucose	COID275575	CHAPTER 1	arg1
66419e29f2179c623926a09957805de5	chapter_1	978-1-4987-6285-4	confining glycan distribution to an acceptable range	distribution	confining glycan distribution	product quality profile	glycan distribution	COID651165	CHAPTER 1	arg0
c0b13679f429165890cc4035297f365f	chapter_1	978-1-4987-6285-4	the quality control of the product	control	the quality control	product quality attributes	quality	COID109463	CHAPTER 1	arg1
0117a9705326860f8938aba721d72346	chapter_1	978-1-4987-6285-4	the protein's biological activity	activity	the protein's biological activity	clinical outcomes	biological activity	COID518861	CHAPTER 1	arg1
0c834bbdee309b4543d71e16ee0ab0e4	chapter_1	978-1-4987-6285-4	the number of impurities carried in culture fluid that must be removed from the final product	number	the number	process condition	impurities	COID901557	CHAPTER 1	arg0
d6bee52789c30e64e185d1f92b7b41f5	chapter_1	978-1-4987-6285-4	a gene therapy product	product	a gene therapy product	genotype	gene	COID185502	CHAPTER 1	arg1
36e222d6dcdb3aa37c1e73a56c351f33	chapter_1	978-1-4987-6285-4	high mannose content	content	high mannose content	sugar (subset of carbon source)	high mannose	COID981337	CHAPTER 1	arg0
c50b306ba1f0dc21cc0908b75e0f1e86	chapter_1	978-1-4987-6285-4	the N-glycans synthesized in insect cells	N-glycans	the N-glycans	sugar (subset of carbon source)	N-glycans	COID216687	CHAPTER 1	arg1
3169b8f1e91f0b65d69262d2aeaa7ad8	chapter_1	978-1-4987-6285-4	fucose	fucose	fucose	sugar (subset of carbon source)	fucose	COID275575	CHAPTER 1	arg0
e4a97ac936d9ca40730a1f240c5e1bcf	chapter_10	978-1-4987-6285-4	the substrate level	level	the substrate level	substrates	substrate	COID265919	CHAPTER 10	arg0
a0d486ef36083d87bf981838808a410c	chapter_10	978-1-4987-6285-4	the conversion yield (i.e., metabolism)	yield	the conversion yield	overall titer or batch yield	yield	COID809703	CHAPTER 10	arg1
80e08ca1a27dbaf02d910015669d90bd	chapter_10	978-1-4987-6285-4	perfusion culture	culture	perfusion culture	process mode	perfusion culture	COID368508	CHAPTER 10	arg0
e651679393ba6de5b3f550c44dfa4c07	chapter_10	978-1-4987-6285-4	Most microfiltration devices used for perfusion culture	devices	Most microfiltration devices	filtration parameters	microfiltration	COID128781	CHAPTER 10	arg1
3b850e775d432c1095d2b471591f6389	chapter_10	978-1-4987-6285-4	the specific substrate consumption rate (q s , Eq	rate	the specific substrate consumption rate	substrates	substrate	COID265919	CHAPTER 10	arg0
a1a819b667ef5cc9cd7a3b6e73fdc363	chapter_10	978-1-4987-6285-4	the cell concentration multiplied by the specific substrate consumption rate (q s , Eq	concentration	the cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 10	arg1
ff1da076951ec2597dbb2f77f2f663ca	chapter_10	978-1-4987-6285-4	the cell concentration	concentration	the cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 10	arg0
1709097587d4278e61e74b8658e8867c	chapter_10	978-1-4987-6285-4	The concentration of the inhibitor (I)	concentration	The concentration	secondary raw materials	inhibitor	COID760391	CHAPTER 10	arg1
ab76e55fed6a74c6e87676850136f593	chapter_10	978-1-4987-6285-4	inhibitor accumulation	accumulation	inhibitor accumulation	secondary raw materials	inhibitor	COID760391	CHAPTER 10	arg0
bc4d2b9cbbd2eda8cc67a3b5f033ede6	chapter_10	978-1-4987-6285-4	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 10	arg1
bbc80f4f587287e4b033af427b243e25	chapter_10	978-1-4987-6285-4	glucose consumption	consumption	glucose consumption	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 10	arg0
7de0d66961dd1c98c9effc8a8c83d80f	chapter_10	978-1-4987-6285-4	lactate production	production	lactate production	by-product or waste	lactate	COID250920	CHAPTER 10	arg1
4755875637d48e528d32b11b82ba37f2	chapter_11	978-1-4987-6285-4	cell concentration (Eq	concentration	cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 11	arg0
7e51d458e1495137b0d987ed16ef3828	chapter_11	978-1-4987-6285-4	The oxygen uptake rate (OUR)	rate	The oxygen uptake rate	biological process	oxygen uptake rate	COID844361	CHAPTER 11	arg1
38a22f318151d8fd6ba036e1ee7adee3	chapter_11	978-1-4987-6285-4	the specific oxygen consumption rate multiplied by cell concentration (Eq	consumption	the specific oxygen consumption rate	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 11	arg1
c907d4e1d56672d50a5cf3356cc0d583	chapter_11	978-1-4987-6285-4	cell metabolism	metabolism	cell metabolism	biological process	metabolism	COID291079	CHAPTER 11	arg0
76798a069824b7477c859781644407f1	chapter_11	978-1-4987-6285-4	carbon dioxide generated by cell metabolism	dioxide	carbon dioxide	gases (subset of secondary raw materials)	carbon dioxide	COID132568	CHAPTER 11	arg1
826c180e2ff9eb0725dbd678b4568b8d	chapter_11	978-1-4987-6285-4	carbon dioxide that is intentionally added to provide the pH buffer (see Chapter 7), thus reducing the oxygen level from the 21% in ambient air	dioxide	carbon dioxide	gases (subset of secondary raw materials)	carbon dioxide	COID132568	CHAPTER 11	arg0
b6791fcc3b3a7c007406790d3c2c8779	chapter_11	978-1-4987-6285-4	the pH buffer	buffer	the pH buffer	bioreactor conditions	pH	COID893209	CHAPTER 11	arg1
9b6a7d0b9bb10ff727060484b1b8d954	chapter_11	978-1-4987-6285-4	Carbon dioxide	dioxide	Carbon dioxide	gases (subset of secondary raw materials)	Carbon dioxide	COID132568	CHAPTER 11	arg0
993b998ec625aaf2c5b81a2e33eadcc5	chapter_11	978-1-4987-6285-4	growth	growth	growth	cell culture parameters	growth	COID203666	CHAPTER 11	arg1
d9f97d6199d0a8a05f87d9c70cf62a2d	chapter_11	978-1-4987-6285-4	oxygen transfer limitations	limitations	oxygen transfer limitations	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 11	arg0
81b19661c972acf9993543926e0f4da0	chapter_11	978-1-4987-6285-4	the widespread application of hollow fiber bioreactors	application	the widespread application	vessel or process parameter or production scale	bioreactors	COID345693	CHAPTER 11	arg1
8add677c7a463735ab0c9f05a7203318	chapter_11	978-1-4987-6285-4	aeration	aeration	aeration	bioreactor conditions	aeration	COID371755	CHAPTER 11	arg0
51b7ed82cea0bca1f20b28083f709cb7	chapter_11	978-1-4987-6285-4	the dissolved oxygen level to change	level	the dissolved oxygen level	bioreactor conditions	dissolved oxygen	COID661988	CHAPTER 11	arg1
00473e726f082e609a28aa3301be942b	chapter_11	978-1-4987-6285-4	an oxygen level of ~30% saturation with ambient air	level	an oxygen level	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 11	arg0
b832c07cef9f071b4f0cfe191c1760d1	chapter_11	978-1-4987-6285-4	optimal growth (Panel 11.9)	growth	optimal growth	cell culture parameters	growth	COID203666	CHAPTER 11	arg1
f3983817ecb5cd6ebf79dae16b8ee57a	chapter_11	978-1-4987-6285-4	cell culture	culture	cell culture	cell culture parameters	cell culture	COID293414	CHAPTER 11	arg1
f5205163357ad41937387c49cac37ed3	chapter_11	978-1-4987-6285-4	A medium stream	stream	A medium stream	media characteristics	medium	COID921897	CHAPTER 11	arg0
748f156718b3fb978248734581e01b0f	chapter_11	978-1-4987-6285-4	oxygen	oxygen	oxygen	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 11	arg1
126dc822582bb44a226bcbb54e554ec9	chapter_11	978-1-4987-6285-4	nutrients	nutrients	nutrients	secondary raw materials	nutrients	COID423902	CHAPTER 11	arg1
1f9490d5c4b7c7ff40b0704554758724	chapter_12	978-1-4987-6285-4	high levels that can affect growth or productivity	levels	high levels	cell culture parameters	growth	COID203666	CHAPTER 12	arg0
5a1a515141c15c4ac6f6b550592bcc32	chapter_12	978-1-4987-6285-4	productivity	productivity	productivity	process condition	productivity	COID731421	CHAPTER 12	arg1
8fb83147d86eff7a3477efd0df5fc0e2	chapter_12	978-1-4987-6285-4	high levels that can affect growth or productivity	levels	high levels	process condition	productivity	COID731421	CHAPTER 12	arg0
9bbdc8c822e066125c65a451a5d0ef4e	chapter_12	978-1-4987-6285-4	growth	growth	growth	cell culture parameters	growth	COID203666	CHAPTER 12	arg1
5a299cd2070cf2493604e2bcf9ce0b39	chapter_12	978-1-4987-6285-4	The physical factors that may affect cell growth, productivity, metabolism, and overall process performance	factors	The physical factors	process condition	productivity	COID731421	CHAPTER 12	arg0
3711df1644a01f5a9997bb9d7be1f0e3	chapter_12	978-1-4987-6285-4	metabolism	metabolism	metabolism	biological process	metabolism	COID291079	CHAPTER 12	arg1
8bae5b4a0840fd4f4caaf30ab9b7d91b	chapter_12	978-1-4987-6285-4	The physical factors that may affect cell growth, productivity, metabolism, and overall process performance	factors	The physical factors	cell culture parameters	cell growth	COID093598	CHAPTER 12	arg0
e5366974c386f603bd3799308bfeca80	chapter_12	978-1-4987-6285-4	The physical factors that may affect cell growth, productivity, metabolism, and overall process performance	factors	The physical factors	biological process	metabolism	COID291079	CHAPTER 12	arg0
77902aad84312ba02cc9d0660beb3f08	chapter_12	978-1-4987-6285-4	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 12	arg1
6ce519bac50da58d652050eb10182e88	chapter_12	978-1-4987-6285-4	the relevant parameters that affect their cell's growth, physiology, and productivity, and focus on keeping those parameters in the acceptable range	parameters	the relevant parameters	process condition	productivity	COID731421	CHAPTER 12	arg0
e434426653f9e4bbb2bbcca19ecd8c7e	chapter_12	978-1-4987-6285-4	their cell's growth	growth	their cell's growth	cell culture parameters	growth	COID203666	CHAPTER 12	arg1
5ba48218c4dd2f11399eea7c00a45f94	chapter_12	978-1-4987-6285-4	the relevant parameters that affect their cell's growth, physiology, and productivity, and focus on keeping those parameters in the acceptable range	parameters	the relevant parameters	cell culture parameters	growth	COID203666	CHAPTER 12	arg0
2f86895b3dffc5e86d9825fd1416387b	chapter_12	978-1-4987-6285-4	the molar fractions of oxygen at the inlet and the outlet ( y O2, in and y O2, out ), respectively	fractions	the molar fractions	gases (subset of secondary raw materials)	O2	COID472476	CHAPTER 12	arg0
1b7cc47d284ab4e84a217c7e97231bc8	chapter_12	978-1-4987-6285-4	the molar flow rate of the oxygen at the inlet and the outlet	rate	the molar flow rate	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 12	arg1
e70d94e7a4966eea8666613ba9807984	chapter_12	978-1-4987-6285-4	a cell culture medium	medium	a cell culture medium	media characteristics	culture medium	COID180560	CHAPTER 12	arg0
f0b172786c87f6b36c0839ca658678a2	chapter_12	978-1-4987-6285-4	about 20-40 mM of sodium bicarbonate	mM	about 20-40 mM	buffer (subset of secondary raw materials)	sodium bicarbonate	COID760948	CHAPTER 12	arg1
103c322496ab4e254a3814e89054004f	chapter_12	978-1-4987-6285-4	a cell culture medium	medium	a cell culture medium	cell culture parameters	cell culture	COID293414	CHAPTER 12	arg0
8e29733c658e5ec250d1307b093c9af9	chapter_12	978-1-4987-6285-4	the cell concentration	concentration	the cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 12	arg0
4287c16fd8d95f6308a9dedbfd1e08bf	chapter_12	978-1-4987-6285-4	the specific oxygen consumption rate multiplied by the cell concentration	rate	the specific oxygen consumption rate	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 12	arg1
393f4f06e88fbe82a52299c1b08d2253	chapter_12	978-1-4987-6285-4	cell concentration	concentration	cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 12	arg0
a5373b891ce48c07b2a963767fc9a66d	chapter_12	978-1-4987-6285-4	The nutrient depletion time	time	The nutrient depletion time	secondary raw materials	nutrient	COID423902	CHAPTER 12	arg1
3dc7bb77dabd9caa267637ec6cf0d165	chapter_12	978-1-4987-6285-4	The nutrient depletion time	time	The nutrient depletion time	process parameters or process control	time	COID742277	CHAPTER 12	arg1
ef5a15a970e168ec60304421c1bd3295	chapter_12	978-1-4987-6285-4	Scale	Scale	Scale	vessel or process parameter or production scale	Scale	COID586187	CHAPTER 12	arg0
a0e8f51da593c42f4d6ca424b696277f	chapter_12	978-1-4987-6285-4	Physical Behavior in Bioreactors	Behavior	Physical Behavior	vessel or process parameter or production scale	Bioreactors	COID345693	CHAPTER 12	arg1
bf54b65a21ddf24148f2c575538d8f59	chapter_12	978-1-4987-6285-4	the amount of time needed for cells to settle in the cell separator	amount	the amount	process parameters or process control	time	COID742277	CHAPTER 12	arg0
99ac157cd4a1c1979f8f70979ebc0385	chapter_12	978-1-4987-6285-4	the scale of operation	scale	the scale	vessel or process parameter or production scale	scale	COID586187	CHAPTER 12	arg1
f75d2ca4751cc25e04171064d145edb3	chapter_12	978-1-4987-6285-4	the frequency of passing through the device per day (thus, the frequency of cells' subjugation to shear stress incurred by pumping and temperature fluctuation)	frequency	the frequency	bioreactor conditions	temperature	COID692615	CHAPTER 12	arg0
499f51c97154e7c58e80f72485922f82	chapter_12	978-1-4987-6285-4	scale	scale	scale	vessel or process parameter or production scale	scale	COID586187	CHAPTER 12	arg0
6525857347dcfc869e778bb68a7751f4	chapter_12	978-1-4987-6285-4	cellular levels of CO 2 and intracellular pH	levels	cellular levels	bioreactor conditions	pH	COID893209	CHAPTER 12	arg1
f8d7dc7f6261a1a519efbf2c2a215d8a	chapter_12	978-1-4987-6285-4	OUR	OUR	OUR	biological process	OUR	COID844361	CHAPTER 12	arg1
22f379669d588cce835c5cdb0143d1fd	chapter_2	978-1-4987-6285-4	glucose metabolism	metabolism	glucose metabolism	biological process	metabolism	COID291079	CHAPTER 2	arg0
440c0029fe0847a362fd1eac2dd4172c	chapter_2	978-1-4987-6285-4	metabolic intermediates derived from glucose metabolism	intermediates	metabolic intermediates	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 2	arg1
9e0226aac998379d3650cfda1267b487	chapter_2	978-1-4987-6285-4	glucose metabolism	metabolism	glucose metabolism	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 2	arg0
472564269d9a008b4a9b581991836676	chapter_2	978-1-4987-6285-4	metabolic intermediates derived from glucose metabolism	intermediates	metabolic intermediates	biological process	metabolism	COID291079	CHAPTER 2	arg1
1879b623fbea8e97cdadab982878fe13	chapter_2	978-1-4987-6285-4	therapeutic recombinant protein production	production	therapeutic recombinant protein production	overall titer or batch yield	recombinant protein production	COID708316	CHAPTER 2	arg0
b9fdeaa3dd18ef999875807ef15b7c83	chapter_2	978-1-4987-6285-4	the two prominent host cell lines used for therapeutic recombinant protein production	lines	the two prominent host cell lines	cell line	host cell lines	COID702829	CHAPTER 2	arg1
4fc9ccf2c80cd5b66952893d19f657c0	chapter_2	978-1-4987-6285-4	CHO cells	cells	CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	CHAPTER 2	arg0
7e5e4601a2a09a23a5222ef3e2a09b1e	chapter_2	978-1-4987-6285-4	an amplified genomic region that encodes for c-Myc gene, an oncogene, and a mutated TP53, a tumor suppressor gene	region	an amplified genomic region	genotype	gene	COID185502	CHAPTER 2	arg1
9203062495d1a12709d57835e096abb4	chapter_2	978-1-4987-6285-4	a preassembled oligoglycan containing three terminal glucose residues	oligoglycan	a preassembled oligoglycan	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 2	arg0
9691e36829c0cecb9f682c0b3f63f9f2	chapter_2	978-1-4987-6285-4	the asparagine ( Figure 2 .9)	asparagine	the asparagine	amino acid (subset of substrates)	asparagine	COID698257	CHAPTER 2	arg1
27feca75d9748619ed0d00172c4c22b6	chapter_2	978-1-4987-6285-4	The antibodies	antibodies	The antibodies	antibody	antibodies	COID278523	CHAPTER 2	arg0
60f3f67b55003b9124ec3a82c0b996b3	chapter_2	978-1-4987-6285-4	a limited period of time after the host's exposure to the antigen	period	a limited period	process parameters or process control	time	COID742277	CHAPTER 2	arg1
141c2fe8df51af2a22a9224d5bf76cb8	chapter_2	978-1-4987-6285-4	CHO	CHO	CHO	chinese hamster ovary (CHO)	CHO	COID806780	CHAPTER 2	arg1
a07ca2bb8ff0139449498948b7c3a587	chapter_2	978-1-4987-6285-4	The product of gene TP53, p53,	product	The product	genotype	gene	COID185502	CHAPTER 2	arg0
0ab946363253c026cc2fa7bf8f946870	chapter_2	978-1-4987-6285-4	external stress signals to cell cycle regulators	signals	external stress signals	biological process	cell cycle	COID780295	CHAPTER 2	arg1
1d5325a0ce8ebb1533535f660dcc3d02	chapter_3_1	978-1-4987-6285-4	culture medium	medium	culture medium	media characteristics	culture medium	COID180560	CHAPTER 3	arg0
ef91ac105cb2d6b400bdc7cf23ec3bfa	chapter_3_1	978-1-4987-6285-4	the glucose concentration used in culture medium	concentration	the glucose concentration	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
6b7535b4e28897d6d43ac37cc2d5a23a	chapter_3_1	978-1-4987-6285-4	glycolysis	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	CHAPTER 3	arg0
bcaed34e6639db11eedd7816821f333f	chapter_3_1	978-1-4987-6285-4	Lactate produced in glycolysis	Lactate	Lactate	by-product or waste	Lactate	COID250920	CHAPTER 3	arg1
5ae0ff557ad04e6d549253010f691856	chapter_3_1	978-1-4987-6285-4	lactate produced in glycolysis	lactate	lactate	by-product or waste	lactate	COID250920	CHAPTER 3	arg1
7c7167dc8f4142dc4263d6841a47de44	chapter_3_1	978-1-4987-6285-4	These four enzymes along with pyruvate dehydrogenase kinase (PDK)	enzymes	These four enzymes	carbon source (subset of secondary raw materials)	pyruvate	COID727438	CHAPTER 3	arg0
949505abb6006f90415cd435204d1530	chapter_3_1	978-1-4987-6285-4	the flux of glucose carbon and its distribution at the pyruvate node	flux	the flux	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
89b3f8f30223f8c20f40c50e429f7c5c	chapter_3_1	978-1-4987-6285-4	the supply of pyruvate for the biosynthesis of many cellular constituents	supply	the supply	biochemical compound	biosynthesis	COID479844	CHAPTER 3	arg1
55acfc1dd4a68bf1dc472fea3bac3fa5	chapter_3_1	978-1-4987-6285-4	the supply of pyruvate for the biosynthesis of many cellular constituents	supply	the supply	carbon source (subset of secondary raw materials)	pyruvate	COID727438	CHAPTER 3	arg1
f67e47183bff9ef8fda8a1529426ec11	chapter_3_1	978-1-4987-6285-4	lactate	lactate	lactate	by-product or waste	lactate	COID250920	CHAPTER 3	arg0
ddbff14b1bcd1edc14888c1aa3843b7e	chapter_3_1	978-1-4987-6285-4	pyruvate converted to lactate	pyruvate	pyruvate	carbon source (subset of secondary raw materials)	pyruvate	COID727438	CHAPTER 3	arg1
4cf4877a484a86d68288055a819268a3	chapter_3_1	978-1-4987-6285-4	the depletion of the non-essential amino acid asparagine in culture medium	depletion	the depletion	amino acid (subset of substrates)	asparagine	COID698257	CHAPTER 3	arg0
70442b860206f170a861f7e5379b4fb2	chapter_3_1	978-1-4987-6285-4	amino acid misincorporation into the product protein	misincorporation	amino acid misincorporation	amino acid (subset of substrates)	amino acid	COID693703	CHAPTER 3	arg1
7c1d1b9d8da6c72b199c07faca63868e	chapter_3_1	978-1-4987-6285-4	glucose converted to lactate	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
4e2f563d1d1df89f60562a4fd921ffb5	chapter_3_1	978-1-4987-6285-4	the pyruvate generated in glycolysis	pyruvate	the pyruvate	carbon source (subset of secondary raw materials)	pyruvate	COID727438	CHAPTER 3	arg1
54cccc97be521e7f0ce8548db332e759	chapter_3_2	978-1-4987-6285-4	CHO cells	cells	CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	CHAPTER 3	arg0
efc8e5d379f4cf9d79df750ef118b443	chapter_3_2	978-1-4987-6285-4	glycoproteins expressed in CHO cells	glycoproteins	glycoproteins	product	glycoproteins	COID866322	CHAPTER 3	arg1
6be7a2e9778aa5f696ec94333ec1b5d6	chapter_3_2	978-1-4987-6285-4	dozen glycosyltransferases	glycosyltransferases	dozen glycosyltransferases	enzyme	glycosyltransferases	COID225633	CHAPTER 3	arg0
e9b590dc96855b0c8aa6d2873ae3601a	chapter_3_2	978-1-4987-6285-4	the glycan heterogeneity in recombinant proteins	heterogeneity	the glycan heterogeneity	product quality attributes	glycan heterogeneity	COID262061	CHAPTER 3	arg1
508a3c3f8dbb3d359bbe172f282e2fa2	chapter_3_2	978-1-4987-6285-4	the transfer of a preassembled oligosaccharide (Glc 3 Man 9 GlcNAc 2 , an oligosaccharide of three glucose, nine mannose, and two N-acetylglucosamine) to the asparagine in a recognition sequence of a nascent protein in the ER lumen (Figure 3 .21)	transfer	the transfer	sugar (subset of carbon source)	N-acetylglucosamine	COID510815	CHAPTER 3	arg0
4c1bdca22ba0f008715b481e485e0d7b	chapter_3_2	978-1-4987-6285-4	N-glycosylation	N-glycosylation	N-glycosylation	glycosylation	N-glycosylation	COID293911	CHAPTER 3	arg1
384f7db3261e5965ff05f386694248c6	chapter_3_2	978-1-4987-6285-4	the transfer of a preassembled oligosaccharide (Glc 3 Man 9 GlcNAc 2 , an oligosaccharide of three glucose, nine mannose, and two N-acetylglucosamine) to the asparagine in a recognition sequence of a nascent protein in the ER lumen (Figure 3 .21)	transfer	the transfer	saccharides (subset of secondary raw materials)	oligosaccharide	COID163264	CHAPTER 3	arg0
ac455e703af00f770df57655724c37c5	chapter_3_2	978-1-4987-6285-4	the transfer of a preassembled oligosaccharide (Glc 3 Man 9 GlcNAc 2 , an oligosaccharide of three glucose, nine mannose, and two N-acetylglucosamine) to the asparagine in a recognition sequence of a nascent protein in the ER lumen (Figure 3 .21)	transfer	the transfer	amino acid (subset of substrates)	asparagine	COID698257	CHAPTER 3	arg0
2f9ce64be2fc3c48293100bc86b59d38	chapter_3_2	978-1-4987-6285-4	the transfer of a preassembled oligosaccharide (Glc 3 Man 9 GlcNAc 2 , an oligosaccharide of three glucose, nine mannose, and two N-acetylglucosamine) to the asparagine in a recognition sequence of a nascent protein in the ER lumen (Figure 3 .21)	transfer	the transfer	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg0
138cd599cb6693c2bc45f828b9e8d81d	chapter_3_2	978-1-4987-6285-4	the transfer of a preassembled oligosaccharide (Glc 3 Man 9 GlcNAc 2 , an oligosaccharide of three glucose, nine mannose, and two N-acetylglucosamine) to the asparagine in a recognition sequence of a nascent protein in the ER lumen (Figure 3 .21)	transfer	the transfer	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg0
5ae73dd2a8f8f82101bce29c468cb879	chapter_3_2	978-1-4987-6285-4	the transfer of a preassembled oligosaccharide (Glc 3 Man 9 GlcNAc 2 , an oligosaccharide of three glucose, nine mannose, and two N-acetylglucosamine) to the asparagine in a recognition sequence of a nascent protein in the ER lumen (Figure 3 .21)	transfer	the transfer	sugar (subset of carbon source)	GlcNAc	COID510815	CHAPTER 3	arg0
7b7349096d544d8cc6f7eb71452508c5	chapter_3_2	978-1-4987-6285-4	variant glycans	glycans	variant glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 3	arg0
b40613a4b9afdc04e1e5a3ddc54b6951	chapter_3_2	978-1-4987-6285-4	recombinant proteins directly caused by variant glycans	proteins	recombinant proteins	recombinant protein	recombinant proteins	COID593158	CHAPTER 3	arg1
a63d6042c2ec74d739e6ab35de8e44bc	chapter_3_2	978-1-4987-6285-4	N-acetylglucosaminyltransferase III (GnT-III)	N-acetylglucosaminyltransferase	N-acetylglucosaminyltransferase III	enzyme	N-acetylglucosaminyltransferase	COID039686	CHAPTER 3	arg0
8b13df1542d4c17c8fee6477a81ff3cc	chapter_3_2	978-1-4987-6285-4	the base mannose (catalyzed by N-acetylglucosaminyltransferase III (GnT-III))	mannose	the base mannose	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg1
63ba51875773c41b19a4c12a33ee114c	chapter_3_2	978-1-4987-6285-4	Human glycans	glycans	Human glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 3	arg0
eedb51fbde9dbccf31872d24bef6840f	chapter_3_2	978-1-4987-6285-4	terminal N-acetylneuraminic acid (NANA)	acid	terminal N-acetylneuraminic acid	amino acid (subset of substrates)	N-acetylneuraminic acid	COID042583	CHAPTER 3	arg1
bc18db361c97304d22777224945e730c	chapter_3_2	978-1-4987-6285-4	the same cell line	line	the same cell line	cell line	cell line	COID702829	CHAPTER 3	arg0
748a87e35a1bc96ca391bbac89d5f448	chapter_3_2	978-1-4987-6285-4	glycoproteins produced by the same cell line	glycoproteins	glycoproteins	product	glycoproteins	COID866322	CHAPTER 3	arg1
65506f5b042f592a064cf06fe056ccac	chapter_3_2	978-1-4987-6285-4	the nucleotide sugars involved in the subsequent reactions, including GDP-mannose and GDP-glucose in the ER.The nucleotide sugars for the extension reactions in the Golgi apparatus are also transported through transporters (Figure 3 .26)	sugars	the nucleotide sugars	sugar (subset of carbon source)	nucleotide sugars	COID937318	CHAPTER 3	arg0
d227a45376c564c4d78c63f36498f57d	chapter_3_2	978-1-4987-6285-4	GDP-glucose	GDP-glucose	GDP-glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
8f5844a1bec57d0eefc6f900f43221da	chapter_3_2	978-1-4987-6285-4	GDP-mannose	GDP-mannose	GDP-mannose	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg1
dd12e032888e6657d370006d92d1a9a5	chapter_3_2	978-1-4987-6285-4	The glycan structure on a glycoprotein	structure	The glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 3	arg0
bf210260db07cf7d5ca41632ae2559c9	chapter_3_2	978-1-4987-6285-4	its half-life	half-life	its half-life	process parameters or process control	half-life	COID125212	CHAPTER 3	arg1
14769aa306400e368d307365bbbdd245	chapter_3_2	978-1-4987-6285-4	recombinant proteins	proteins	recombinant proteins	recombinant protein	recombinant proteins	COID593158	CHAPTER 3	arg0
17a6ec4e0898755a1052be35ea6d1dbb	chapter_3_2	978-1-4987-6285-4	The O-glycans seen in recombinant proteins	O-glycans	The O-glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 3	arg1
5a93455901f827d3b73398d0db5e1e96	chapter_3_2	978-1-4987-6285-4	Glycans on glycoproteins	Glycans	Glycans	sugar (subset of carbon source)	Glycans	COID626759	CHAPTER 3	arg0
865e66010c7bef651a492c1a1f296f41	chapter_3_2	978-1-4987-6285-4	their biological activities	activities	their biological activities	clinical outcomes	biological activities	COID518861	CHAPTER 3	arg1
8cfc9db138d3e53385d75d710f5994da	chapter_3_2	978-1-4987-6285-4	GDP-mannose	GDP-mannose	GDP-mannose	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg0
95706b1c5c8e3820ceeaacdbc92a5105	chapter_3_2	978-1-4987-6285-4	the nucleotide sugars involved in the subsequent reactions, including GDP-mannose and GDP-glucose in the ER.The nucleotide sugars for the extension reactions in the Golgi apparatus are also transported through transporters (Figure 3 .26)	sugars	the nucleotide sugars	sugar (subset of carbon source)	nucleotide sugars	COID937318	CHAPTER 3	arg1
02270120aab1005cf6b7315247fae38b	chapter_3_2	978-1-4987-6285-4	GDP-glucose	GDP-glucose	GDP-glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg0
ec2b46cf0baddbb5d6f14761f33adb6c	chapter_3_2	978-1-4987-6285-4	glycoproteins produced in non-human cells	glycoproteins	glycoproteins	product	glycoproteins	COID866322	CHAPTER 3	arg0
77d1a42051677b361a22917b450b2040	chapter_3_2	978-1-4987-6285-4	some NGNA that is not present in human glycoproteins	NGNA	some NGNA	amino acid (subset of substrates)	NGNA	COID390231	CHAPTER 3	arg1
0cb74284d0b9110bd6f844f345c8abbc	chapter_3_2	978-1-4987-6285-4	the addition of GlcNAc to the base mannose (catalyzed by N-acetylglucosaminyltransferase III (GnT-III))	addition	the addition	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg0
10b029a98512fe50834c18d48b19433a	chapter_3_2	978-1-4987-6285-4	further extension of the glycan	extension	further extension	sugar (subset of carbon source)	glycan	COID626759	CHAPTER 3	arg1
e21fc0342e9f189ff2df96b1db7f3a63	chapter_3_2	978-1-4987-6285-4	the addition of GlcNAc to the base mannose (catalyzed by N-acetylglucosaminyltransferase III (GnT-III))	addition	the addition	sugar (subset of carbon source)	GlcNAc	COID510815	CHAPTER 3	arg0
2a7307a7303a12014f701619d898f78a	chapter_3_2	978-1-4987-6285-4	2 N-acetylglucosamine	N-acetylglucosamine	2 N-acetylglucosamine	sugar (subset of carbon source)	N-acetylglucosamine	COID510815	CHAPTER 3	arg0
9f35ee38521f02c0a35dc3025bae35e6	chapter_3_2	978-1-4987-6285-4	9 mannose extended from 2 N-acetylglucosamine	mannose	9 mannose	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg1
7913bc62a68794a0b32bc7e75b7e909d	chapter_3_1	978-1-4987-6285-4	glucose flux in glycolysis	flux	glucose flux	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
d4fa3f293bfb340c4cdf1da909cf87f9	chapter_3_1	978-1-4987-6285-4	rapid cell growth	growth	rapid cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 3	arg0
4ba55bf02b9b54aa28533118aa23364a	chapter_3_1	978-1-4987-6285-4	pyruvate synthesis from glycolysis	synthesis	pyruvate synthesis	carbon source (subset of secondary raw materials)	pyruvate	COID727438	CHAPTER 3	arg1
498550c5f618ade8da124e78bd822777	chapter_3_1	978-1-4987-6285-4	the importance of cell metabolism in	importance	the importance	biological process	metabolism	COID291079	CHAPTER 3	arg0
45978e4687edb0456100df24203a7e9f	chapter_3_1	978-1-4987-6285-4	productivity	productivity	productivity	process condition	productivity	COID731421	CHAPTER 3	arg1
ac55e7cf3ed619aac6e2ea170809cf98	chapter_3_1	978-1-4987-6285-4	the PPP	PPP	the PPP	metabolic pathways	PPP	COID233901	CHAPTER 3	arg0
56e7b6ff0f72b5fb1fd09ce3332914e9	chapter_3_1	978-1-4987-6285-4	glycerol 3-phosphate	3-phosphate	glycerol 3-phosphate	carbon source (subset of secondary raw materials)	glycerol	COID217249	CHAPTER 3	arg1
738b9304b04c38eda1b7fbdd2d4f8d15	chapter_3_1	978-1-4987-6285-4	a large number of amino acid transporters (Figure 3.17)	number	a large number	amino acid (subset of substrates)	amino acid	COID693703	CHAPTER 3	arg0
b4fa202f3389272ecd7aeb835e225fe9	chapter_3_1	978-1-4987-6285-4	Amino acids	acids	Amino acids	amino acid (subset of substrates)	Amino acids	COID693703	CHAPTER 3	arg1
991e93a379fe4ebbb5ec5ae0ba001b3b	chapter_3_1	978-1-4987-6285-4	pyruvate	pyruvate	pyruvate	carbon source (subset of secondary raw materials)	pyruvate	COID727438	CHAPTER 3	arg0
9a642633d921c4761c6e0a7fd0f5df33	chapter_3_1	978-1-4987-6285-4	ammonium toxicity	toxicity	ammonium toxicity	culture condition	ammonium	COID714150	CHAPTER 3	arg1
ab862a771924fbff9d7de1cd8808d754	chapter_3_1	978-1-4987-6285-4	the growth rate	rate	the growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 3	arg0
db6d114fd35e0c99550c6d7a7dcc78f1	chapter_3_1	978-1-4987-6285-4	These two types of metabolism	types	These two types	biological process	metabolism	COID291079	CHAPTER 3	arg1
84f8cdbf8f6797dc3a8a20ee188ee5ba	chapter_3_1	978-1-4987-6285-4	the composition of the medium	composition	the composition	media characteristics	medium	COID921897	CHAPTER 3	arg0
a8dca36df6855da5b3822bb97529ca3a	chapter_3_1	978-1-4987-6285-4	changing the concentration of one or several amino acids	concentration	the concentration	amino acid (subset of substrates)	amino acids	COID693703	CHAPTER 3	arg0
3d26f52c3151338603b809de68ce4c60	chapter_3_1	978-1-4987-6285-4	the uptake rates of many	rates	the uptake rates	biological process	uptake rates	COID844360	CHAPTER 3	arg1
f4aa9a4676d7e063d4d82d09c703c7e5	chapter_3_1	978-1-4987-6285-4	a low pH (high H + )	pH	a low pH	bioreactor conditions	pH	COID893209	CHAPTER 3	arg0
ba5a9e2107be77a0ddf64552d69cb492	chapter_3_1	978-1-4987-6285-4	lactate import	import	lactate import	by-product or waste	lactate	COID250920	CHAPTER 3	arg1
7c722d1ecb4da6c382a2fbc5ca199451	chapter_3_1	978-1-4987-6285-4	The second segment of the PPP	segment	The second segment	metabolic pathways	PPP	COID233901	CHAPTER 3	arg0
d16fe527c8f310b2048abc5bea7796bb	chapter_3_1	978-1-4987-6285-4	a 2-C aldehyde (CHO -CH 2 -) unit	unit	a 2-C aldehyde (CHO -CH 2 -) unit	chinese hamster ovary (CHO)	CHO	COID806780	CHAPTER 3	arg1
8095f48070f4e762a0487bea655ba2cc	chapter_3_1	978-1-4987-6285-4	pH	pH	pH	bioreactor conditions	pH	COID893209	CHAPTER 3	arg0
eda2a719ed7cb3462260e6b04d0a1b46	chapter_3_1	978-1-4987-6285-4	the flux of lactate through MCT	flux	the flux	by-product or waste	lactate	COID250920	CHAPTER 3	arg1
69fc31e0f76760894709052a02e96ded	chapter_3_1	978-1-4987-6285-4	Most cell lines of bioprocess importance	lines	Most cell lines	cell line	cell lines	COID702829	CHAPTER 3	arg0
61e140c4b461c8a239d00bdd493b2c27	chapter_3_1	978-1-4987-6285-4	altered growth control that allows them to proliferate quickly in culture	control	altered growth control	cell culture parameters	growth	COID203666	CHAPTER 3	arg1
ebe17c64d6350ab7dc237dd88a54bbab	chapter_3_1	978-1-4987-6285-4	Glucose transporters	transporters	Glucose transporters	sugar (subset of carbon source)	Glucose	COID367406	CHAPTER 3	arg0
925d198c327e0606ce7fa8a1fcc8d315	chapter_3_1	978-1-4987-6285-4	the influx of glucose across the cytosolic membrane	influx	the influx	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
96ed10679b63b8f9e322596d9ed38fb9	chapter_3_1	978-1-4987-6285-4	the TCA cycle	cycle	the TCA cycle	acid (subset of secondary raw materials)	TCA	COID780120	CHAPTER 3	arg0
ddf0a8565848cc9e1ff4ebd74acad2eb	chapter_3_1	978-1-4987-6285-4	1 mole of glucose	mole	1 mole	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
0fc0ae4251eb75703aa5c89155294d07	chapter_3_1	978-1-4987-6285-4	The regulation of cellular metabolism	regulation	The regulation	biological process	cellular metabolism	COID903943	CHAPTER 3	arg0
c6206bb81332bed21e4718a7de408abb	chapter_3_1	978-1-4987-6285-4	the control of cell growth	control	the control	cell culture parameters	cell growth	COID093598	CHAPTER 3	arg1
b42f3c0d2918fa7bc68e1bcc7057fdb1	chapter_3_1	978-1-4987-6285-4	metabolism	metabolism	metabolism	biological process	metabolism	COID291079	CHAPTER 3	arg0
d1675b0e86b030de340392106b28d2ca	chapter_3_1	978-1-4987-6285-4	growth control	control	growth control	cell culture parameters	growth	COID203666	CHAPTER 3	arg1
8965102b52f6df53781353c37b019a63	chapter_3_1	978-1-4987-6285-4	1.0 unit pH difference	difference	1.0 unit pH difference	bioreactor conditions	pH	COID893209	CHAPTER 3	arg0
65c7c3208a6eb389627eca5f7c0e1aac	chapter_3_1	978-1-4987-6285-4	a strong driving force for pyruvate transport into the mitochondria	force	a strong driving force	carbon source (subset of secondary raw materials)	pyruvate	COID727438	CHAPTER 3	arg1
60ddfda566b8070014e6c7641a89da21	chapter_3_1	978-1-4987-6285-4	no molecular oxygen	oxygen	no molecular oxygen	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 3	arg0
d85513d9e3458be90e63dd250dbb1655	chapter_3_1	978-1-4987-6285-4	glycolysis	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	CHAPTER 3	arg1
81b08544f3ac920e0264757a3b341c08	chapter_3_1	978-1-4987-6285-4	the TCA cycle	cycle	the TCA cycle	acid (subset of secondary raw materials)	TCA	COID780120	CHAPTER 3	arg1
3a450b5b87bb4ab6e55275c0bbb60680	chapter_3_1	978-1-4987-6285-4	6-C fructose 6-phosphate	6-phosphate	6-C fructose 6-phosphate	carbon source (subset of secondary raw materials)	fructose	COID532749	CHAPTER 3	arg0
1d20c92cf509be4eb7893bce6a3c5070	chapter_3_1	978-1-4987-6285-4	5-C sugars from the first segment of the PPP	sugars	5-C sugars	metabolic pathways	PPP	COID233901	CHAPTER 3	arg1
59139846201e10880db8e3beee7edf04	chapter_3_1	978-1-4987-6285-4	Aerobic glycolysis	glycolysis	Aerobic glycolysis	metabolic pathways	glycolysis	COID345655	CHAPTER 3	arg0
cb453abd650dff208ad9327f8efc4941	chapter_3_1	978-1-4987-6285-4	a significant portion of the total energy of glucose catabolism in proliferating cells	portion	a significant portion	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
f418655db1c2f9e0c69dcfe3664a3a96	chapter_3_2	978-1-4987-6285-4	glycan structure	structure	glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 3	arg0
89d033a188b6c69f60fd635ed02b5617	chapter_3_2	978-1-4987-6285-4	biological activities	activities	biological activities	clinical outcomes	biological activities	COID518861	CHAPTER 3	arg1
76065f5ae1fa7b809236a0750ba31835	chapter_3_2	978-1-4987-6285-4	Even glycans of the same sequence	glycans	Even glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 3	arg0
a69ddfe4fc89ea3008e3b84ca85c7973	chapter_3_2	978-1-4987-6285-4	different linkage bonds (glycosidic bonds) between monosaccharides	bonds	different linkage bonds	sugar (subset of carbon source)	monosaccharides	COID882808	CHAPTER 3	arg1
e8bb499c7c17c856f6ad2c163c3a30ba	chapter_3_2	978-1-4987-6285-4	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	CHAPTER 3	arg0
da61b347fdd3cb2e7759bd8bd286987a	chapter_3_2	978-1-4987-6285-4	IgG activity	activity	IgG activity	antibody	IgG	COID713543	CHAPTER 3	arg1
2bea0f5cdf20eeb4fccafc2710a0b692	chapter_3_2	978-1-4987-6285-4	the central corridor of energy metabolism	corridor	the central corridor	biological process	metabolism	COID291079	CHAPTER 3	arg0
7e3c5d2b4ea47bda0e7fb2976766f610	chapter_3_2	978-1-4987-6285-4	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	CHAPTER 3	arg1
376bc412bc860f0b7a2a4f79adf9156e	chapter_3_2	978-1-4987-6285-4	Etanercept (Embrel, a fusion protein of TNF Î±-Fc for rheumatoid arthritis treatment)	Etanercept	Etanercept	recombinant protein	fusion protein	COID506208	CHAPTER 3	arg0
daec94eacd59df59ca8854c16cce9d64	chapter_3_2	978-1-4987-6285-4	11 O-glycosylation sites	sites	11 O-glycosylation sites	glycosylation	O-glycosylation	COID233146	CHAPTER 3	arg1
0e549fd3c30a37aa86e1a2d26f705282	chapter_3_2	978-1-4987-6285-4	3 N-glycosylation sites	sites	3 N-glycosylation sites	glycosylation	N-glycosylation	COID293911	CHAPTER 3	arg1
b3992a153e610d3ec5f99470dbb71a88	chapter_3_2	978-1-4987-6285-4	Bisection of the glycan on Asn 297	Bisection	Bisection	sugar (subset of carbon source)	glycan	COID626759	CHAPTER 3	arg0
d54ce4866d7a10d028794ca3d175785b	chapter_3_2	978-1-4987-6285-4	ADCC activity	activity	ADCC activity	clinical outcomes	ADCC	COID386333	CHAPTER 3	arg1
f6b3f4e61873a52cd2ba36c6f682f14c	chapter_3_2	978-1-4987-6285-4	complex glycans	glycans	complex glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 3	arg0
07d0c1f2184f750d285b78260f653695	chapter_3_2	978-1-4987-6285-4	sialic acid	acid	sialic acid	sugar (subset of carbon source)	sialic acid	COID148212	CHAPTER 3	arg1
c5b6708d4be87067f684514701910497	chapter_3_2	978-1-4987-6285-4	These glycans	glycans	These glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 3	arg0
9863f79848bf529966ddb844f8a5e896	chapter_3_2	978-1-4987-6285-4	N-glycosylation in the Fc region	N-glycosylation	N-glycosylation	glycosylation	N-glycosylation	COID293911	CHAPTER 3	arg0
f0f4c6701ff9a021fee5876684ca24c0	chapter_3_2	978-1-4987-6285-4	This bisecting GlcNAc	GlcNAc	This bisecting GlcNAc	sugar (subset of carbon source)	GlcNAc	COID510815	CHAPTER 3	arg0
30d555dbc05b0cf1a2e7b7ea312cc07a	chapter_3_2	978-1-4987-6285-4	glycan structure	structure	glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 3	arg1
e591706d60f7e9d1552cbd4accb9eace	chapter_3_2	978-1-4987-6285-4	The OHgroups of serine and threonine	OHgroups	The OHgroups	amino acid (subset of substrates)	threonine	COID905902	CHAPTER 3	arg0
0ee1abf71546ec2be6cf1ac29b6026a9	chapter_3_2	978-1-4987-6285-4	mannose	mannose	mannose	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg1
4b7f096580c76e250aebc46ed0788206	chapter_3_2	978-1-4987-6285-4	N-acetylglucosamine	N-acetylglucosamine	N-acetylglucosamine	sugar (subset of carbon source)	N-acetylglucosamine	COID510815	CHAPTER 3	arg1
f2b424d9a939f749467d8ec53c1ee0ff	chapter_3_2	978-1-4987-6285-4	fucose	fucose	fucose	sugar (subset of carbon source)	fucose	COID275575	CHAPTER 3	arg1
9c2590d15639cc1d89862ba700f3d5f1	chapter_3_2	978-1-4987-6285-4	galactose	galactose	galactose	sugar (subset of carbon source)	galactose	COID770311	CHAPTER 3	arg1
797354884167992bae1b60ec0a5627a0	chapter_3_2	978-1-4987-6285-4	glucose	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg1
c8e85ddd0a670fb958998d4472eb2e5e	chapter_3_2	978-1-4987-6285-4	NANA	NANA	NANA	amino acid (subset of substrates)	NANA	COID042583	CHAPTER 3	arg1
d8cc5803504b166789101ca181c49b89	chapter_3_2	978-1-4987-6285-4	Sometimes the C4 of the mannose at the base	C4	Sometimes the C4	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg0
8f9053392cef94677da2495347e42480	chapter_3_2	978-1-4987-6285-4	a bisecting N-acetylglucosamine	N-acetylglucosamine	a bisecting N-acetylglucosamine	sugar (subset of carbon source)	N-acetylglucosamine	COID510815	CHAPTER 3	arg1
010ed05e31d6beedae96d20e2b6cbbc0	chapter_3_2	978-1-4987-6285-4	IgG molecules	molecules	IgG molecules	antibody	IgG	COID713543	CHAPTER 3	arg0
2ebbac58f11b1a2ba2a009a34526c6b4	chapter_3_2	978-1-4987-6285-4	simpler glycan structure	structure	simpler glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 3	arg1
42e96ba91bc602893217b086b4e661f0	chapter_3_2	978-1-4987-6285-4	glycans on a protein	glycans	glycans	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 3	arg0
967c9f11eba6a8e08653b4668d34de5c	chapter_3_2	978-1-4987-6285-4	the immunogenicity of a human therapeutic	immunogenicity	the immunogenicity	clinical outcomes	immunogenicity	COID444425	CHAPTER 3	arg1
fa75840c5b5796aa3208364a5a255d7e	chapter_3_2	978-1-4987-6285-4	the glycan structure at Asn 297	structure	the glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 3	arg0
97ce6220f1cd188438ff8084af4a3ca7	chapter_3_2	978-1-4987-6285-4	the binding of IgG to the Fc receptor on the effector cells	binding	the binding	antibody	IgG	COID713543	CHAPTER 3	arg1
95cf0c280fc8c01593093c21a7bbd4e8	chapter_3_1	978-1-4987-6285-4	lactate concentration	concentration	lactate concentration	by-product or waste	lactate	COID250920	CHAPTER 3	arg0
c96979ccd94435f6054a196d3ad569a9	chapter_3_1	978-1-4987-6285-4	intracellular and extracellular environments	environments	intracellular and extracellular environments	process parameters or process control	extracellular environments	COID244043	CHAPTER 3	arg1
e5ae2ad6bc17027113af63a90ca70ed1	chapter_4	978-1-4987-6285-4	the final drug product that directly impacts safety and efficacy in patients	product	the final drug product	clinical outcomes	safety	COID635261	CHAPTER 4	arg0
cb11dd10d469da180c96f4e91e7c2898	chapter_4	978-1-4987-6285-4	efficacy	efficacy	efficacy	clinical outcomes	efficacy	COID912630	CHAPTER 4	arg1
66a36c5d171c65649cbc34908e5a3d8d	chapter_4	978-1-4987-6285-4	the final drug product that directly impacts safety and efficacy in patients	product	the final drug product	clinical outcomes	efficacy	COID912630	CHAPTER 4	arg0
84f2a2afa4c6e2c547cb4b9a4c0f265e	chapter_4	978-1-4987-6285-4	safety	safety	safety	clinical outcomes	safety	COID635261	CHAPTER 4	arg1
9a41e3a1e8e2d58ee99596218312c03a	chapter_4	978-1-4987-6285-4	a factor that can potentially affect the CQA host cell protein content	factor	a factor	recombinant protein	host cell protein	COID169903	CHAPTER 4	arg0
7bf77427855d3c335f585f4bad9e1deb	chapter_4	978-1-4987-6285-4	the CQA host cell protein content	content	the CQA host cell protein content	product quality attributes	CQA	COID162607	CHAPTER 4	arg1
29dd38cff7a07e91134c2e687f49d74c	chapter_4	978-1-4987-6285-4	a factor that can potentially affect the CQA host cell protein content	factor	a factor	product quality attributes	CQA	COID162607	CHAPTER 4	arg0
29f5e656e4ae8a6c2e4ac767cb9a07d5	chapter_4	978-1-4987-6285-4	the CQA host cell protein content	content	the CQA host cell protein content	recombinant protein	host cell protein	COID169903	CHAPTER 4	arg1
53cc673e1933eb6b08d8d274a02f13f2	chapter_4	978-1-4987-6285-4	cell culture	culture	cell culture	cell culture parameters	cell culture	COID293414	CHAPTER 4	arg0
3b77154535f2884127796066e3d0a93c	chapter_4	978-1-4987-6285-4	glycoproteins produced in cell culture	glycoproteins	glycoproteins	product	glycoproteins	COID866322	CHAPTER 4	arg1
c9131beae7bf3f0f79974bf402bb6823	chapter_4	978-1-4987-6285-4	attributes that enhance antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC)	attributes	attributes	clinical outcomes	antibody-dependent cellular cytotoxicity	COID386333	CHAPTER 4	arg0
3c7166765b6e8741fd586abe832d80f1	chapter_4	978-1-4987-6285-4	attributes that enhance antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC)	attributes	attributes	clinical outcomes	complement-dependent cytotoxicity	COID455860	CHAPTER 4	arg0
b9cf1f82ae1b8d6094e26733734bda42	chapter_4	978-1-4987-6285-4	attributes that enhance antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC)	attributes	attributes	clinical outcomes	ADCC	COID386333	CHAPTER 4	arg0
65c1dd81246638d8faab0de6951ef128	chapter_4	978-1-4987-6285-4	attributes that enhance antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC)	attributes	attributes	clinical outcomes	CDC	COID455860	CHAPTER 4	arg0
90ed9ac3b86aded367c930f8a6eaeb85	chapter_4	978-1-4987-6285-4	the glycan profile	profile	the glycan profile	product quality attributes	glycan profile	COID521331	CHAPTER 4	arg0
e76c29c6c17495acc8cce384d2058941	chapter_4	978-1-4987-6285-4	the cultural conditions	conditions	the cultural conditions	culture condition	cultural conditions	COID626277	CHAPTER 4	arg1
c0ab751700d280b1fb09ba8356e7dbfd	chapter_4	978-1-4987-6285-4	even the particular cell clone	clone	even the particular cell clone	cell line	particular cell clone	COID964819	CHAPTER 4	arg1
253cbd0fcc151c166e66e4eb9ec45026	chapter_4	978-1-4987-6285-4	the cells' metabolic state	state	the cells' metabolic state	cellular metabolic state	cells' metabolic state	COID934077	CHAPTER 4	arg1
f0363068f5b97fb403d5144d30a60fc7	chapter_4	978-1-4987-6285-4	the host cell line	line	the host cell line	cell line	host cell line	COID702829	CHAPTER 4	arg1
ec45dac8edd01b92bd1cd6b6ae981e63	chapter_4	978-1-4987-6285-4	process parameters	parameters	process parameters	process parameters or process control	process parameters	COID163282	CHAPTER 4	arg0
cf4acad1b76577b159a2673d3d12d3d7	chapter_4	978-1-4987-6285-4	CQAs	CQAs	CQAs	product quality attributes	CQAs	COID162607	CHAPTER 4	arg1
76423fa9b0ecc52b68cba6de8a4e8425	chapter_4	978-1-4987-6285-4	process conditions in different operations of manufacturing	conditions	process conditions	process condition	process conditions	COID106153	CHAPTER 4	arg0
af8f25fb2b0033d8734b0eea2c9b9186	chapter_4	978-1-4987-6285-4	these CQAs	CQAs	these CQAs	product quality attributes	CQAs	COID162607	CHAPTER 4	arg1
af54aec8684b2817bd49ddefed66a662	chapter_4	978-1-4987-6285-4	quality attributes	attributes	quality attributes	product quality attributes	quality	COID109463	CHAPTER 4	arg1
6602e7e854fb8941b333516aea92f9d8	chapter_4	978-1-4987-6285-4	degradation	degradation	degradation	degradation	degradation	COID049441	CHAPTER 4	arg0
29921389e1f751757d147ce6810a34c6	chapter_4	978-1-4987-6285-4	Glycan structure	structure	Glycan structure	sugar (subset of carbon source)	Glycan structure	COID684992	CHAPTER 4	arg1
be5c8972960e25c8db26560d97bb4694	chapter_4	978-1-4987-6285-4	the production bioreactor	bioreactor	the production bioreactor	vessel or process parameter or production scale	bioreactor	COID345693	CHAPTER 4	arg0
365461e85103708744ff2645a49e873a	chapter_4	978-1-4987-6285-4	pyroglutamate	pyroglutamate	pyroglutamate	amino acid (subset of substrates)	pyroglutamate	COID083886	CHAPTER 4	arg1
b172df42baaff88fb6b23d659c97dfce	chapter_4	978-1-4987-6285-4	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	CHAPTER 4	arg1
ced7c1e86385294f60a9254a4f3739dd	chapter_4	978-1-4987-6285-4	deamidation	deamidation	deamidation	PTM	deamidation	COID565107	CHAPTER 4	arg1
61e31b4976cc15761de69e56b63aa48c	chapter_4	978-1-4987-6285-4	C-terminal lysine	lysine	C-terminal lysine	amino acid (subset of substrates)	C-terminal lysine	COID549534	CHAPTER 4	arg1
ea90506f40f44d492ba9fb83a3607770	chapter_4	978-1-4987-6285-4	oxidation	oxidation	oxidation	PTM	oxidation	COID907585	CHAPTER 4	arg1
9f007381f535677055e48225ba406aeb	chapter_4	978-1-4987-6285-4	glycation	glycation	glycation	glycosylation	glycation	COID274291	CHAPTER 4	arg1
fd954036f2729368c59c3b2011b07b9e	chapter_4	978-1-4987-6285-4	the glycan structure	structure	the glycan structure	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 4	arg0
68f3f6c721f51a30e911320ed1d0c18f	chapter_4	978-1-4987-6285-4	its clinical efficacy	efficacy	its clinical efficacy	clinical outcomes	efficacy	COID912630	CHAPTER 4	arg1
71d657cf9ce730eb7130b063bb656092	chapter_4	978-1-4987-6285-4	assurance of quality	assurance	assurance	product quality attributes	quality	COID109463	CHAPTER 4	arg1
d47b57d9b2069c74f0320c790c72d2f8	chapter_4	978-1-4987-6285-4	dissolved oxygen levels	levels	dissolved oxygen levels	bioreactor conditions	dissolved oxygen	COID661988	CHAPTER 4	arg0
598bea64b203480734b5a5f25b309467	chapter_4	978-1-4987-6285-4	temperature	temperature	temperature	bioreactor conditions	temperature	COID692615	CHAPTER 4	arg0
7bbfa88e16746595111cdad702104db8	chapter_4	978-1-4987-6285-4	pH	pH	pH	bioreactor conditions	pH	COID893209	CHAPTER 4	arg0
f27ff822d2ff89c7b9334ab73d31c371	chapter_4	978-1-4987-6285-4	medium age	age	medium age	media characteristics	medium	COID921897	CHAPTER 4	arg0
9009d43e2f22d7789437869f1e1f4bc2	chapter_4	978-1-4987-6285-4	The relative % peak areas of the glycans	areas	The relative % peak areas	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 4	arg0
cfb99bda404c0c78edff97be583b31b4	chapter_4	978-1-4987-6285-4	relative abundance of the various glycan species	abundance	relative abundance	sugar (subset of carbon source)	glycan	COID626759	CHAPTER 4	arg1
d58beb20b8ec6b55b3101ab294d8c9ec	chapter_4	978-1-4987-6285-4	productivity	productivity	productivity	process condition	productivity	COID731421	CHAPTER 4	arg1
e1c8e8df909cb89665bc24593676e019	chapter_4	978-1-4987-6285-4	product quality	quality	product quality	product quality attributes	product quality	COID111751	CHAPTER 4	arg1
17b4bff8e1c5668ca090c85a3fdc5d05	chapter_4	978-1-4987-6285-4	the capacity of CO 2 stripping and oxygen transfer	capacity	the capacity	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 4	arg0
c80c4a0a7963145ab78b01073e7974f6	chapter_4	978-1-4987-6285-4	the manufacturing bioreactor	bioreactor	the manufacturing bioreactor	vessel or process parameter or production scale	bioreactor	COID345693	CHAPTER 4	arg1
1d3dc141ea4c3484a2d3ae95d8a512f4	chapter_5	978-1-4987-6285-4	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 5	arg0
7b56fddf7b0069b83b3b196f40b34b56	chapter_5	978-1-4987-6285-4	the lactate synthesized during cell growth	lactate	the lactate	by-product or waste	lactate	COID250920	CHAPTER 5	arg1
32e0ebce8e2d479de72e6acae67325be	chapter_5	978-1-4987-6285-4	a set of growth factors or cytokines for growth	set	a set	cell culture parameters	growth	COID203666	CHAPTER 5	arg0
52a2ac6ef114e9c57b901ecdcd32265c	chapter_5	978-1-4987-6285-4	most cell lines	lines	most cell lines	cell line	cell lines	COID702829	CHAPTER 5	arg1
224dc5fd81ecc9575146cfd36e3097c4	chapter_5	978-1-4987-6285-4	cell concentration	concentration	cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 5	arg0
7dd86df9b5c010581a45401c9234e90a	chapter_5	978-1-4987-6285-4	the specific growth rate multiplied by cell concentration	rate	the specific growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 5	arg1
5d6c2071a0229501c77ab3ff249b26ea	chapter_5	978-1-4987-6285-4	glycolysis to lactate	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	CHAPTER 5	arg0
6ff2ada4d6240c58628c5432aa7ade8f	chapter_5	978-1-4987-6285-4	most glucose	glucose	most glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 5	arg1
03dc7f4a9f5e600a5962853a65f573ea	chapter_5	978-1-4987-6285-4	the concentrations of glucose and lactate	concentrations	the concentrations	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 5	arg0
213c4ccce5b89b7ffe7468338e649ab3	chapter_5	978-1-4987-6285-4	the specific growth rate	rate	the specific growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 5	arg1
753ccef4971226a478aea350f5ab4978	chapter_5	978-1-4987-6285-4	the concentrations of glucose and lactate	concentrations	the concentrations	by-product or waste	lactate	COID250920	CHAPTER 5	arg0
7579483f4557884fe52fc15143937f33	chapter_5	978-1-4987-6285-4	the concentration of growth factors	concentration	the concentration	cell culture parameters	growth	COID203666	CHAPTER 5	arg0
f489fa4b819883ad71d240149d2b3041	chapter_5	978-1-4987-6285-4	the growth rate	rate	the growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 5	arg1
76e809003003990d4b97cd908beba2c8	chapter_5	978-1-4987-6285-4	glucose	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 5	arg0
ddfed6faea6c6a1ff69cc04f7a3fe9ef	chapter_5	978-1-4987-6285-4	the specific production rate	production	the specific production rate	process parameters or process control	specific production rate	COID014362	CHAPTER 5	arg1
6b0ecbb4df784cdf5f1b9b23933afd9f	chapter_5	978-1-4987-6285-4	lactate	lactate	lactate	by-product or waste	lactate	COID250920	CHAPTER 5	arg0
6d4d8eb09f23709eda48a809e17a2cc2	chapter_5	978-1-4987-6285-4	other amino acids	acids	other amino acids	amino acid (subset of substrates)	amino acids	COID693703	CHAPTER 5	arg0
482e03d0b0576a9611751680e73eebd9	chapter_5	978-1-4987-6285-4	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 5	arg1
1e0b2ad30fcd931403d33a41c7905d44	chapter_5	978-1-4987-6285-4	many other nutrients	nutrients	many other nutrients	secondary raw materials	nutrients	COID423902	CHAPTER 5	arg0
ad42f92f25d681a3942ba6e5e2dae049	chapter_5	978-1-4987-6285-4	glutamine	glutamine	glutamine	amino acid (subset of substrates)	glutamine	COID962935	CHAPTER 5	arg0
cc474d3282062ab3d16cdae83cb50c61	chapter_5	978-1-4987-6285-4	osmolality	osmolality	osmolality	process parameters or process control	osmolality	COID710653	CHAPTER 5	arg0
2010b798777f12d06c845f6f06887a13	chapter_5	978-1-4987-6285-4	nutrient	nutrient	nutrient	secondary raw materials	nutrient	COID423902	CHAPTER 5	arg0
928fcd90fe7bcc720655d1776180db80	chapter_5	978-1-4987-6285-4	Their growth rate	rate	Their growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 5	arg1
55c565a912c227268f64fee78c087057	chapter_5	978-1-4987-6285-4	two factors: a "growth-associated" term, Î±, which describes dependence on the specific growth rate; and a "non-growth associated" term, Î²	factors	two factors	cell culture parameters	growth rate	COID957002	CHAPTER 5	arg0
89e6ccf4b6a7bb39b50fd77bc5601406	chapter_5	978-1-4987-6285-4	The specific productivity	productivity	The specific productivity	process condition	specific productivity	COID731421	CHAPTER 5	arg1
8321209cc39a17bbce9c131be0b1963b	chapter_5	978-1-4987-6285-4	q p	p	q p	flux rate	q p	COID599783	CHAPTER 5	arg1
c49eabf8ea48a7c8f898517dc02f6db5	chapter_5	978-1-4987-6285-4	a "growth-associated" term	term	a "growth-associated" term	cell culture parameters	growth	COID203666	CHAPTER 5	arg0
af7b94c9ccd1f1b25224e9b16dec81fb	chapter_5	978-1-4987-6285-4	a "non-growth associated" term	term	a "non-growth associated" term	cell culture parameters	growth	COID203666	CHAPTER 5	arg0
641ffe4a6e3fcec35e81ff40e6576390	chapter_5	978-1-4987-6285-4	an inorganic nitrogen source	source	an inorganic nitrogen source	secondary raw materials	nitrogen source	COID144540	CHAPTER 5	arg0
c2e3e79e405bb832db124d0a079549de	chapter_5	978-1-4987-6285-4	urea	urea	urea	nitrogen sources (subset of secondary raw materials)	urea	COID337032	CHAPTER 5	arg1
db41c66efa6b8b251d22bba46508dac7	chapter_5	978-1-4987-6285-4	ammonium	ammonium	ammonium	culture condition	ammonium	COID714150	CHAPTER 5	arg1
5f6088bb4e48bc9ed65031322f9bfe78	chapter_5	978-1-4987-6285-4	simple carbon sources	sources	simple carbon sources	carbon source (subset of secondary raw materials)	carbon sources	COID571637	CHAPTER 5	arg1
33123537c648ba90505eee147fc9b06f	chapter_5	978-1-4987-6285-4	the levels of the required growth factors	levels	the levels	cell culture parameters	growth	COID203666	CHAPTER 5	arg0
01696fee1955a770e3b383064e1a4afe	chapter_5	978-1-4987-6285-4	The growth rate	rate	The growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 5	arg1
6a0d2a73ed303aa1b4368f4e9ba28725	chapter_5	978-1-4987-6285-4	the TCA cycle	cycle	the TCA cycle	acid (subset of secondary raw materials)	TCA	COID780120	CHAPTER 5	arg0
c6ea527a61a26b2603116be25dbfae98	chapter_5	978-1-4987-6285-4	glucose	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 5	arg1
a7ab38d0a17a5097f8e16701648008dc	chapter_5	978-1-4987-6285-4	glycolysis	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	CHAPTER 5	arg0
51ed85928d2a2f8c7212964d2b379644	chapter_5	978-1-4987-6285-4	the pentose phosphate pathway	pathway	the pentose phosphate pathway	metabolic pathways	pentose phosphate pathway	COID233901	CHAPTER 5	arg0
0b6f7a90bf38684a09bbced035101c51	chapter_5	978-1-4987-6285-4	specific productivity	productivity	specific productivity	process condition	specific productivity	COID731421	CHAPTER 5	arg1
a83e4b37dcd23ab12112fb16c46f973c	chapter_5	978-1-4987-6285-4	energy metabolism	metabolism	energy metabolism	biological process	metabolism	COID291079	CHAPTER 5	arg0
b14c11abd1c118a25743c5f8e3b65db8	chapter_5	978-1-4987-6285-4	lactate	lactate	lactate	by-product or waste	lactate	COID250920	CHAPTER 5	arg1
598bd59e2689de1ec94166aa60cf8564	chapter_5	978-1-4987-6285-4	two substrates	substrates	two substrates	substrates	substrates	COID265919	CHAPTER 5	arg0
0a897e0a13728ac78ce290630a855182	chapter_5	978-1-4987-6285-4	the growth rate (Eq	rate	the growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 5	arg1
f726d826fadc872ed4cc9fbe6796a590	chapter_5	978-1-4987-6285-4	more than one nutrient	nutrient	more than one nutrient	secondary raw materials	nutrient	COID423902	CHAPTER 5	arg0
427631d10eda93f539b21b510b7fe5e5	chapter_5	978-1-4987-6285-4	the growth	growth	the growth	cell culture parameters	growth	COID203666	CHAPTER 5	arg1
eda3f5ae2668968c95f363ff3937e427	chapter_6	978-1-4987-6285-4	CHO cells	cells	CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	CHAPTER 6	arg0
d78d1cc20b36695761c0cd5ed9d3508f	chapter_6	978-1-4987-6285-4	the glycan synthesized by CHO cells	glycan	the glycan	sugar (subset of carbon source)	glycan	COID626759	CHAPTER 6	arg1
9ef6c1dac70c17b8f44b8aebbb18cd34	chapter_6	978-1-4987-6285-4	DHFR-based gene amplification	amplification	DHFR-based gene amplification	genotype	gene	COID185502	CHAPTER 6	arg0
02b8613ce53e603a5a65d8996f0972a5	chapter_6	978-1-4987-6285-4	the possibility that the resistance arises from the amplification of the endogenous DHFR without concurrent amplification of the GOI	possibility	the possibility that the resistance arises from the amplification of the endogenous DHFR without concurrent amplification of the GOI	enzyme	DHFR	COID400950	CHAPTER 6	arg1
8e902174865bfde286966cf611f2da3c	chapter_6	978-1-4987-6285-4	the transition from the production of lactate to its consumption in the stationary phase of growth	transition	the transition	by-product or waste	lactate	COID250920	CHAPTER 6	arg0
d6703baa39874052be247e6c34f8aa53	chapter_6	978-1-4987-6285-4	growth and production kinetics	kinetics	growth and production kinetics	cell culture parameters	growth	COID203666	CHAPTER 6	arg1
457d2b50b191feeafec238c9f67b3d56	chapter_6	978-1-4987-6285-4	the addition of thymidine, glycine, and hypoxanthine to the medium	addition	the addition	amino acid (subset of substrates)	glycine	COID351597	CHAPTER 6	arg0
c1fafafd0d0a9810fb3287801b34fb53	chapter_6	978-1-4987-6285-4	These DHFR-deficient cells	cells	These DHFR-deficient cells	enzyme	DHFR	COID400950	CHAPTER 6	arg1
bc349a2cc68928d3503768f86f0219d0	chapter_6	978-1-4987-6285-4	the addition of thymidine, glycine, and hypoxanthine to the medium	addition	the addition	media characteristics	medium	COID921897	CHAPTER 6	arg0
1c726fefa4e199320b96e9881a468a2d	chapter_6	978-1-4987-6285-4	A human host cell line	line	A human host cell line	cell line	host cell line	COID702829	CHAPTER 6	arg0
603738b4a4641254908409cbfca726e8	chapter_6	978-1-4987-6285-4	the advantage of synthesizing "human form" glycans and eliminating the problem of non-human host cell protein contamination	advantage	the advantage	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 6	arg1
aa761a80acf27cb831c5a1902f243cf9	chapter_6	978-1-4987-6285-4	an impact on growth and production kinetics	impact	an impact	cell culture parameters	growth	COID203666	CHAPTER 6	arg1
15eddef736a1c940a491dc2d5c0801f8	chapter_6	978-1-4987-6285-4	Cell lines derived from different species or different tissues	lines	Cell lines	cell line	Cell lines	COID702829	CHAPTER 6	arg0
0ee6b11c269463eb15ebcdad826bd3c5	chapter_6	978-1-4987-6285-4	different compositions of glycosyltransferases that catalyze different glycosylation reactions	compositions	different compositions	enzyme	glycosyltransferases	COID225633	CHAPTER 6	arg1
c073909cbdc6e63f19322d84242c572f	chapter_6	978-1-4987-6285-4	different compositions of glycosyltransferases that catalyze different glycosylation reactions	compositions	different compositions	glycosylation	glycosylation	COID119643	CHAPTER 6	arg1
484ebb83432b217a2658d12335309458	chapter_6	978-1-4987-6285-4	an IgG product that mediates ADCC	product	an IgG product	antibody	IgG	COID713543	CHAPTER 6	arg0
21f3e86a0c451acea9b9d55ec858b086	chapter_6	978-1-4987-6285-4	ADCC	ADCC	ADCC	clinical outcomes	ADCC	COID386333	CHAPTER 6	arg1
b9ba3615d887a9970304a14e7029e98a	chapter_6	978-1-4987-6285-4	Incomplete or nonspecific post-translational cleavage of the leader sequence	cleavage	Incomplete or nonspecific post-translational cleavage	PTM	cleavage	COID846179	CHAPTER 6	arg0
ad6af8f322d377cd35041d1a829000e5	chapter_6	978-1-4987-6285-4	heterogeneity	heterogeneity	heterogeneity	clinical outcomes	heterogeneity	COID021590	CHAPTER 6	arg1
5a5d985da31f465ef6a81ffb8f15a148	chapter_6	978-1-4987-6285-4	recombinant protein production	production	recombinant protein production	overall titer or batch yield	recombinant protein production	COID708316	CHAPTER 6	arg0
3a0f81f2e2804ebef9e01171cd5829f9	chapter_6	978-1-4987-6285-4	Many cell lines	lines	Many cell lines	cell line	cell lines	COID702829	CHAPTER 6	arg1
3312f8a0ecc565757e28f529873afb2e	chapter_6	978-1-4987-6285-4	different isoforms with different substrate specificity	isoforms	different isoforms	substrates	substrate	COID265919	CHAPTER 6	arg1
284409570d55537d91506177f5b6b61f	chapter_6	978-1-4987-6285-4	Different host cell lines	lines	Different host cell lines	cell line	host cell lines	COID702829	CHAPTER 6	arg0
53505d0bd36082b8757c238695a5b191	chapter_6	978-1-4987-6285-4	gamma-carboxylation	gamma-carboxylation	gamma-carboxylation	PTM	carboxylation	COID487379	CHAPTER 6	arg1
2ca30cdf3828d053556b1d0a75b486c9	chapter_6	978-1-4987-6285-4	phosphorylation	phosphorylation	phosphorylation	PTM	phosphorylation	COID850093	CHAPTER 6	arg1
fb71b1105b5f0f5d826231ab2cc198ff	chapter_6	978-1-4987-6285-4	the ensuing producing cell line	line	the ensuing producing cell line	cell line	cell line	COID702829	CHAPTER 6	arg0
7dbeda043f19fc1cd8a1d48095c6862a	chapter_6	978-1-4987-6285-4	identical genetic information and local gene expression context	context	identical genetic information and local gene expression context	genotype	gene	COID185502	CHAPTER 6	arg1
1f43a19d629caeda5c5e359dd6837060	chapter_6	978-1-4987-6285-4	the cell line used for the production	line	the cell line	cell line	cell line	COID702829	CHAPTER 6	arg0
ec8480b80c73973832a85d53337afe1f	chapter_6	978-1-4987-6285-4	productivity	productivity	productivity	process condition	productivity	COID731421	CHAPTER 6	arg1
c15c475e5322acc136be4e6350e1efcf	chapter_6	978-1-4987-6285-4	Some glycan structure features	features	Some glycan structure features	sugar (subset of carbon source)	glycan structure	COID684992	CHAPTER 6	arg0
ad56b276db8044f68ad88313215fdbd0	chapter_6	978-1-4987-6285-4	the biological functions of some classes of therapeutic proteins with the same mode of action	functions	the biological functions	process condition	functions	COID532355	CHAPTER 6	arg1
72452fde3cf0291b50dc4bee714381e2	chapter_6	978-1-4987-6285-4	different hyperproducing cell lines	lines	different hyperproducing cell lines	cell line	cell lines	COID702829	CHAPTER 6	arg0
02c208e82d0c4485b83c8d8f87ff9a0e	chapter_6	978-1-4987-6285-4	different changes in their gene expression that make each of them a hyperproducer	changes	different changes	genotype	gene	COID185502	CHAPTER 6	arg1
cc92b103eaa231e37d30f2142ffba662	chapter_6	978-1-4987-6285-4	the advantage of synthesizing "human form" glycans and	advantage	the advantage	sugar (subset of carbon source)	glycans	COID626759	CHAPTER 6	arg0
60aa4c1af23fba9b66f23ee2fe3adced	chapter_6	978-1-4987-6285-4	the problem of non-human host cell protein contamination	problem	the problem	recombinant protein	host cell protein	COID169903	CHAPTER 6	arg1
b8fcc21d2ecc9978ec3a5db91d05060f	chapter_6	978-1-4987-6285-4	M ammalian cell lines	lines	M ammalian cell lines	cell line	cell lines	COID702829	CHAPTER 6	arg0
d1d6ecb229d133fb875aba99cbd4edf5	chapter_6	978-1-4987-6285-4	therapeutic and diagnostic proteins as well as viruses for gene therapy and vaccines	proteins	therapeutic and diagnostic proteins	genotype	gene	COID185502	CHAPTER 6	arg1
5d577007b5bba933255b1df88429a84a	chapter_6	978-1-4987-6285-4	glutamine	glutamine	glutamine	amino acid (subset of substrates)	glutamine	COID962935	CHAPTER 6	arg0
219484048aee6db25f0f9fa94605d272	chapter_6	978-1-4987-6285-4	Most mammalian cell lines	lines	Most mammalian cell lines	cell line	cell lines	COID702829	CHAPTER 6	arg1
104a7dd80fc193f9ab97d50f96480426	chapter_7	978-1-4987-6285-4	many precursors	precursors	many precursors	biochemical compound	precursors	COID871085	CHAPTER 7	arg0
9761bffe2fbad519d75fe1989c51ba39	chapter_7	978-1-4987-6285-4	nucleoside biosynthesis	biosynthesis	nucleoside biosynthesis	biochemical compound	biosynthesis	COID479844	CHAPTER 7	arg1
56bc445976f89af05bcf983fdbb6f414	chapter_7	978-1-4987-6285-4	nucleoside biosynthesis	biosynthesis	nucleoside biosynthesis	nucleotide or nucleoside	nucleoside	COID718935	CHAPTER 7	arg1
d77d7b2933c664da441267fe2330d82b	chapter_7	978-1-4987-6285-4	very large quantities that influences blood pH is lactate	quantities	very large quantities	by-product or waste	lactate	COID250920	CHAPTER 7	arg0
2002a9789a91017374c3328d1d2b6e61	chapter_7	978-1-4987-6285-4	blood pH is lactate	pH	blood pH	bioreactor conditions	pH	COID893209	CHAPTER 7	arg1
c2e0c59d76f27b1ecf3d4a4c4fafdf6b	chapter_7	978-1-4987-6285-4	the most important factor that impacts a cell's growth, metabolism, and other biological activities	factor	the most important factor	biological process	metabolism	COID291079	CHAPTER 7	arg0
7aa107cfbc4d8c91f729348d2bc7909e	chapter_7	978-1-4987-6285-4	other biological activities	activities	other biological activities	clinical outcomes	biological activities	COID518861	CHAPTER 7	arg1
d9f08f9e5d54452f7fb0ab40f2ccf79d	chapter_7	978-1-4987-6285-4	the most important factor that impacts a cell's growth, metabolism, and other biological activities	factor	the most important factor	cell culture parameters	growth	COID203666	CHAPTER 7	arg0
b9bc7db0d1efca245ab9e07ac37a5547	chapter_7	978-1-4987-6285-4	the most important factor that impacts a cell's growth, metabolism, and other biological activities	factor	the most important factor	clinical outcomes	biological activities	COID518861	CHAPTER 7	arg0
d8ba3a02533f69f66ffc3127c4b67d61	chapter_7	978-1-4987-6285-4	metabolism	metabolism	metabolism	biological process	metabolism	COID291079	CHAPTER 7	arg1
be8d92d0a370ce460bf694f766001dd8	chapter_7	978-1-4987-6285-4	a cell's growth	growth	a cell's growth	cell culture parameters	growth	COID203666	CHAPTER 7	arg1
e9a213a8c51186b52f15b70689287033	chapter_7	978-1-4987-6285-4	The platform medium	medium	The platform medium	media characteristics	medium	COID921897	CHAPTER 7	arg0
5aac230b78835d68f688bcbd8cf77dd6	chapter_7	978-1-4987-6285-4	the basis for the fine-tuning of medium composition for a new cell line	basis	the basis	cell line	cell line	COID702829	CHAPTER 7	arg1
4363a99f0b7aad3283c34d5813100bce	chapter_7	978-1-4987-6285-4	A complete cell culture medium	medium	A complete cell culture medium	media characteristics	culture medium	COID180560	CHAPTER 7	arg0
b9c571e50c17273ddffe5f3d25affc2c	chapter_7	978-1-4987-6285-4	two major categories of components: basal medium and growth supplements (Panel 7.4)	categories	two major categories	cell culture parameters	growth	COID203666	CHAPTER 7	arg1
d4ae307208aa89da1131758bf99592cd	chapter_7	978-1-4987-6285-4	two major categories of components: basal medium and growth supplements (Panel 7.4)	categories	two major categories	media characteristics	medium	COID921897	CHAPTER 7	arg1
a9430b9880ab15087e9bcd06f84eacac	chapter_7	978-1-4987-6285-4	A complete cell culture medium	medium	A complete cell culture medium	cell culture parameters	cell culture	COID293414	CHAPTER 7	arg0
35f5eb19e23cd53f11f1b05004bfc49f	chapter_7	978-1-4987-6285-4	aspartate family amino acids that produce lysine, isoleucine, methionine, and threonine	acids	aspartate family amino acids	amino acid (subset of substrates)	amino acids	COID693703	CHAPTER 7	arg0
c333cf76c1c88ddb32242ebe0204de3a	chapter_7	978-1-4987-6285-4	threonine	threonine	threonine	amino acid (subset of substrates)	threonine	COID905902	CHAPTER 7	arg1
3875ba7c4a0ea216add4475f42296e38	chapter_7	978-1-4987-6285-4	growth	growth	growth	cell culture parameters	growth	COID203666	CHAPTER 7	arg0
b146275f684f434ec446457a0b1bbca2	chapter_7	978-1-4987-6285-4	a medium optimized for growth	medium	a medium	media characteristics	medium	COID921897	CHAPTER 7	arg1
ba82c929c3d7d9eef2edbf08c63f0d84	chapter_7	978-1-4987-6285-4	The depletion of essential amino acids	depletion	The depletion	amino acid (subset of substrates)	amino acids	COID693703	CHAPTER 7	arg0
968e5b8f52d029768fb6f900315c0159	chapter_7	978-1-4987-6285-4	an almost immediate retarding effect on cell growth	effect	an almost immediate retarding effect	cell culture parameters	cell growth	COID093598	CHAPTER 7	arg1
4bd34567f45336af14993424370c4645	chapter_7	978-1-4987-6285-4	these pH buffers	buffers	these pH buffers	bioreactor conditions	pH	COID893209	CHAPTER 7	arg0
2790c7e428d4e4e74dc98086b3944b62	chapter_7	978-1-4987-6285-4	cell growth (Panel 7.20)	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 7	arg1
516c8984134deb032475264e48debd76	chapter_7	978-1-4987-6285-4	medium design	design	medium design	media characteristics	medium	COID921897	CHAPTER 7	arg0
92a61b7f1953f419c676fa5f1bfcc85d	chapter_7	978-1-4987-6285-4	cell stability	stability	cell stability	process condition	stability	COID548988	CHAPTER 7	arg1
50565a1a6a4380da96c30f19c00581be	chapter_7	978-1-4987-6285-4	The basal medium	medium	The basal medium	media characteristics	medium	COID921897	CHAPTER 7	arg0
09f551f471e83fe72092bbd5d64ceeeb	chapter_7	978-1-4987-6285-4	energy source	source	energy source	cell nutrient	energy source	COID713213	CHAPTER 7	arg1
4142aa1a20dab4591136e6c1f71f7206	chapter_7	978-1-4987-6285-4	various nutrients	nutrients	various nutrients	secondary raw materials	nutrients	COID423902	CHAPTER 7	arg1
9b48b761c9364c0797d49df61d8335ca	chapter_7	978-1-4987-6285-4	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 7	arg1
b47644c0e6702924499d27810ef06fda	chapter_7	978-1-4987-6285-4	Insulin	Insulin	Insulin	recombinant protein	Insulin	COID453872	CHAPTER 7	arg0
f346085a98aed9881d8634101844abfe	chapter_7	978-1-4987-6285-4	glucose uptake for many cell types	uptake	glucose uptake	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 7	arg1
b79da4ccbfeffb994de85543969c82e4	chapter_7	978-1-4987-6285-4	The arrival of the antibody era in the second half of the 1990s	arrival	The arrival	antibody	antibody	COID278523	CHAPTER 7	arg0
7a962622f0172edc2d211b791775c749	chapter_7	978-1-4987-6285-4	the face of cell culture processes	face	the face	cell culture parameters	cell culture	COID293414	CHAPTER 7	arg1
b1e5d9a33f18aca05759bb399dcdc127	chapter_7	978-1-4987-6285-4	adjustments to the medium's composition	adjustments	adjustments	media characteristics	medium	COID921897	CHAPTER 7	arg0
62bbd8e1bc818e0e8ed7a2784f7ae783	chapter_7	978-1-4987-6285-4	osmolarity	osmolarity	osmolarity	process parameters or process control	osmolarity	COID052118	CHAPTER 7	arg1
319eec0f2b3ec4c7ef8cb3d3ec6e66f8	chapter_7	978-1-4987-6285-4	â¢ Insulin	Insulin	â¢ Insulin	recombinant protein	Insulin	COID453872	CHAPTER 7	arg0
873689a38f698770f8414369d465865b	chapter_7	978-1-4987-6285-4	glucose uptake by adipocytes and other cells	uptake	glucose uptake	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 7	arg1
5ea935f06e12ecf5caf6e4685abd43db	chapter_7	978-1-4987-6285-4	the early period of cell culture enlightenment	period	the early period	cell culture parameters	cell culture	COID293414	CHAPTER 7	arg0
3199a5a726115d7654156d8ff75167ea	chapter_7	978-1-4987-6285-4	clonal growth (Panel 7.10, Figure 7 .1)	growth	clonal growth	cell culture parameters	growth	COID203666	CHAPTER 7	arg1
857e426ec8e3d92dcb5d9c414635ecd8	chapter_7	978-1-4987-6285-4	their deficiency in cell culture	deficiency	their deficiency	cell culture parameters	cell culture	COID293414	CHAPTER 7	arg0
2aa6f67369a98dd3e2dbc763f36897b3	chapter_7	978-1-4987-6285-4	biosynthetic functions (for review see reference 3)	functions	biosynthetic functions	process condition	functions	COID532355	CHAPTER 7	arg1
8c5c35fe6818354baafe255abd2c2b08	chapter_7	978-1-4987-6285-4	energy metabolism	metabolism	energy metabolism	biological process	metabolism	COID291079	CHAPTER 7	arg1
4533a81f33c23053b90bd6423204ef41	chapter_7	978-1-4987-6285-4	insulin	insulin	insulin	recombinant protein	insulin	COID453872	CHAPTER 7	arg0
be71be24f8ede64bbae4f2c73f875d03	chapter_7	978-1-4987-6285-4	The intense emphasis on maximizing the productivity and	emphasis	The intense emphasis	process condition	productivity	COID731421	CHAPTER 7	arg0
8c747f1a7c0dd90fa9ac743071b84fef	chapter_7	978-1-4987-6285-4	product quality	quality	product quality	product quality attributes	product quality	COID111751	CHAPTER 7	arg1
4b74ffe9c1bd88f0b0aa98db182b1fd2	chapter_7	978-1-4987-6285-4	The frequent addition of chemically defined phospholipids, phosphatidyl -choline, -ethanolamine, -inositol, and dipalmitoyl phosphatidic acid to culture medium	addition	The frequent addition	media characteristics	culture medium	COID180560	CHAPTER 7	arg0
5cb0fac6ceb17339df8952a6938d793a	chapter_7	978-1-4987-6285-4	a growth-promoting effect	effect	a growth-promoting effect	cell culture parameters	growth	COID203666	CHAPTER 7	arg1
9b259dc6c751c0446b2408b48284291e	chapter_7	978-1-4987-6285-4	Manganese	Manganese	Manganese	trace metals or minerals (subset of secondary raw materials)	Manganese	COID333220	CHAPTER 7	arg0
060422e2333ef1d4ae9aaa29a1618cb1	chapter_7	978-1-4987-6285-4	the oxidation of H 2 O to O 2 in plants	oxidation	the oxidation	PTM	oxidation	COID907585	CHAPTER 7	arg1
d3600cb142bc10226bc4f3f306e408b1	chapter_7	978-1-4987-6285-4	iron	iron	iron	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	CHAPTER 7	arg0
52246a4e7cb89754337f6acedca5bf97	chapter_7	978-1-4987-6285-4	a redox potential of + 0.2 to + 0.8 V	potential	a redox potential	cellular metabolic state	redox potential	COID680210	CHAPTER 7	arg1
461393600a712c2434d107254adc75d2	chapter_7	978-1-4987-6285-4	copper	copper	copper	trace metals or minerals (subset of secondary raw materials)	copper	COID395059	CHAPTER 7	arg0
5f9b416b363da50b7654594747569510	chapter_7	978-1-4987-6285-4	growth factors	factors	growth factors	cell culture parameters	growth	COID203666	CHAPTER 7	arg0
faa382d7b4924a4b8e4e86312b4237b2	chapter_7	978-1-4987-6285-4	different nutrients	nutrients	different nutrients	secondary raw materials	nutrients	COID423902	CHAPTER 7	arg0
04fa50d80c0bf82793985c9a6ace60b2	chapter_7	978-1-4987-6285-4	Iron	Iron	Iron	trace metals or minerals (subset of secondary raw materials)	Iron	COID094956	CHAPTER 7	arg0
97192c1fd4a56f82d4b6619e24466ba1	chapter_7	978-1-4987-6285-4	the key activity of heme in hemoglobulin, which allows red blood cells, myoglobulin in muscle cells, and cytochromes in virtually every cell to carry oxygen molecules	activity	the key activity	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 7	arg1
81592c1bdc88d12163ebf450ccc2461b	chapter_7	978-1-4987-6285-4	the growth of human diploid fibroblasts	growth	the growth	cell culture parameters	growth	COID203666	CHAPTER 7	arg1
42ae64ef48e5d7dcf646f68d7b14bc43	chapter_8	978-1-4987-6285-4	a lower viability that may influence product quality if the product is degraded or otherwise modified by enzymes released by lysed cells	viability	a lower viability	process parameters or process control	viability	COID222142	CHAPTER 8	arg0
3d21148352447671a128e0ebede541d9	chapter_8	978-1-4987-6285-4	product quality	quality	product quality	product quality attributes	product quality	COID111751	CHAPTER 8	arg1
4d0353a58f002b27ecc8f1de830718fe	chapter_8	978-1-4987-6285-4	cell culture	culture	cell culture	cell culture parameters	cell culture	COID293414	CHAPTER 8	arg0
0eee4f446b5c6693c752bc1e1e3603ad	chapter_8	978-1-4987-6285-4	the prevailing bioreactor used in cell culture	bioreactor	the prevailing bioreactor	vessel or process parameter or production scale	bioreactor	COID345693	CHAPTER 8	arg1
bc34cd17a6dab64b612b7e1ba1f892e8	chapter_8	978-1-4987-6285-4	cells' growth needs	growth	cells' growth	cell culture parameters	growth	COID203666	CHAPTER 8	arg0
08825057d6ac235b7e7dd880d9c82ec1	chapter_8	978-1-4987-6285-4	the culture medium	medium	the culture medium	media characteristics	culture medium	COID180560	CHAPTER 8	arg1
eb197469aab7155d376dd89a6aa051fb	chapter_8	978-1-4987-6285-4	intolerance to high osmolality	intolerance	intolerance	process parameters or process control	osmolality	COID710653	CHAPTER 8	arg0
b3e58a65b03e195b9cff5437607462f1	chapter_9	978-1-4987-6285-4	Cells at these distinct stages with different chemical environments, temperatures, growth rates, and metabolic states,	Cells	Cells	cellular metabolic state	metabolic states	COID934077	CHAPTER 9	arg0
8d73ca578098a7fc50e95583d62a64eb	chapter_9	978-1-4987-6285-4	products with different quality attributes	products	products	product quality attributes	quality	COID109463	CHAPTER 9	arg1
3627ec1b04c239521e8d6f7c1f7e58e4	chapter_9	978-1-4987-6285-4	Cells at these distinct stages with different chemical environments, temperatures, growth rates, and metabolic states,	Cells	Cells	cell culture parameters	growth rates	COID957002	CHAPTER 9	arg0
ecb633a1c156f359b04ffbf33a4963ff	chapter_9	978-1-4987-6285-4	Cells at these distinct stages with different chemical environments, temperatures, growth rates, and metabolic states,	Cells	Cells	bioreactor conditions	temperatures	COID692615	CHAPTER 9	arg0
9f682686af73c2fe425d36824fae9a7c	chapter_9	978-1-4987-6285-4	The high osmolality	osmolality	The high osmolality	process parameters or process control	osmolality	COID710653	CHAPTER 9	arg0
733f727b4e36721d2fc1cb602cb8101f	chapter_9	978-1-4987-6285-4	the eventual loss of viability and productivity of the culture	loss	the eventual loss	process condition	productivity	COID731421	CHAPTER 9	arg1
9579af64e9ccca1c42a685a08036d8fd	chapter_9	978-1-4987-6285-4	the eventual loss of viability and productivity of the culture	loss	the eventual loss	process parameters or process control	viability	COID222142	CHAPTER 9	arg1
1c26610d59c7e21f2abea862e5754ff0	chapter_9	978-1-4987-6285-4	accumulation of metabolites and reactive oxygen species	accumulation	accumulation	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 9	arg0
a1d7f01dd8c408a57eda7e3576c1f148	chapter_9	978-1-4987-6285-4	a fed-batch culture	culture	a fed-batch culture	process mode	fed-batch	COID529446	CHAPTER 9	arg0
fc09611734c1e022600f4aecaad2254a	chapter_9	978-1-4987-6285-4	Product molecules produced at different points of time in a fed-batch culture	molecules	Product molecules	process parameters or process control	time	COID742277	CHAPTER 9	arg1
44c8aa99def7bd8b920149e580a6f06f	chapter_9	978-1-4987-6285-4	a potentially wider range of heterogeneity compared to batch or continuous culture	range	a potentially wider range	clinical outcomes	heterogeneity	COID021590	CHAPTER 9	arg0
92aaf0f3e924bc4ef0df664f69c443cb	chapter_9	978-1-4987-6285-4	batch or continuous culture	culture	batch or continuous culture	process mode	batch	COID285438	CHAPTER 9	arg1
df251bd05a838f64b16e93bdd531146f	chapter_9	978-1-4987-6285-4	lactate production	production	lactate production	by-product or waste	lactate	COID250920	CHAPTER 9	arg0
d277132d968dd48736ffc29f81304920	chapter_9	978-1-4987-6285-4	actions for pH fluctuation	actions	actions	bioreactor conditions	pH	COID893209	CHAPTER 9	arg1
4e693cc098075cefe0baf79fcaf4c91c	chapter_9	978-1-4987-6285-4	Intermittent Feeding H ow the feed medium is delivered to a culture	ow	Intermittent Feeding H ow	media characteristics	medium	COID921897	CHAPTER 9	arg0
878ae90c137b66df3d47906635a5b9de	chapter_9	978-1-4987-6285-4	the performance of a fed-batch process	performance	the performance	process mode	fed-batch	COID529446	CHAPTER 9	arg1
a4b521f986a4870412bae098ebfb8b35	chapter_9	978-1-4987-6285-4	productivity	productivity	productivity	process condition	productivity	COID731421	CHAPTER 9	arg1
9f3076f3ab96f36a0ca7bca93fd83742	chapter_9	978-1-4987-6285-4	viability	viability	viability	process parameters or process control	viability	COID222142	CHAPTER 9	arg1
cbcabe800c00937387d627377a46e3f2	chapter_9	978-1-4987-6285-4	The feed medium	medium	The feed medium	media characteristics	medium	COID921897	CHAPTER 9	arg0
f9c4d6b6a62f309470d0e98fb69e2050	chapter_9	978-1-4987-6285-4	osmolality balance	balance	osmolality balance	process parameters or process control	osmolality	COID710653	CHAPTER 9	arg1
38c681c741454f61048ca4b82278f7bc	chapter_9	978-1-4987-6285-4	pH	pH	pH	bioreactor conditions	pH	COID893209	CHAPTER 9	arg0
59a76429c6c00dd80d9220d18cfe32fd	chapter_9	978-1-4987-6285-4	the amount of nutrient consumed	amount	the amount	secondary raw materials	nutrient	COID423902	CHAPTER 9	arg1
02925a87762d50b2f02f6ecf89e96f10	chapter_9	978-1-4987-6285-4	continuous nutrient feeding	feeding	continuous nutrient feeding	secondary raw materials	nutrient	COID423902	CHAPTER 9	arg0
7f592a3a38be3369f8a1d0c0a7218a18	chapter_9	978-1-4987-6285-4	glucose	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 9	arg1
96c36d1892f29ffa95121820e55b1da0	12950230		the main O-glycans	O-glycans	the main O-glycans	sugar (subset of carbon source)	glycans	COID626759	ABSTRACT	arg0
e879b3dda0e05e01928300c1ca2362f7	12950230		Capillary liquid chromatography MS of released oligosaccharides from CHO-K1-produced MUC1	MS	Capillary liquid chromatography MS	saccharides (subset of secondary raw materials)	oligosaccharides	COID163264	ABSTRACT	arg1
1915a5946b7681bc9fab7eaf49896d92	12950230		Capillary liquid chromatography MS of released oligosaccharides from CHO-K1-produced MUC1	MS	Capillary liquid chromatography MS	chinese hamster ovary (CHO)	CHO-K1	COID324081	ABSTRACT	arg1
b52f3775640c8bd00e1b0535e1cfabb3	15593097		low glutamine/glucose concentrations	concentrations	low glutamine/glucose concentrations	amino acid (subset of substrates)	glutamine	COID962935	ABSTRACT	arg0
6a6e247c230f922503bf3bc7ab71217b	15593097		a dynamic on-line fed-batch strategy based on low glutamine/glucose concentrations and its impact on cellular metabolism and, more importantly, the productivity and N-glycosylation quality of a model recombinant glycoprotein, interferon gamma (IFN-gamma)	strategy	a dynamic on-line fed-batch strategy	process condition	productivity	COID731421	ABSTRACT	arg1
4737d19cb6323ad831d47e90024e7758	15593097		low glutamine/glucose concentrations	concentrations	low glutamine/glucose concentrations	sugar (subset of carbon source)	glucose	COID367406	ABSTRACT	arg0
2fcd45d2697a6b2be1adbe3fd50af522	15593097		a dynamic on-line fed-batch strategy based on low glutamine/glucose concentrations and its impact on cellular metabolism and, more importantly, the productivity and N-glycosylation quality of a model recombinant glycoprotein, interferon gamma (IFN-gamma)	strategy	a dynamic on-line fed-batch strategy	glycosylation	N-glycosylation	COID293911	ABSTRACT	arg1
10ea47cc27ae4d7ef831083f01745bd6	15593097		low culture viability	viability	low culture viability	process parameters or process control	culture viability	COID640988	ABSTRACT	arg0
b5636bca6b7666f7b802a5496ea741fd	15593097		N-glycosylation quality	quality	N-glycosylation quality	product quality attributes	quality	COID109463	ABSTRACT	arg1
02ddb5cb727072be63c220b873314b21	15903239		an almost 10-fold increase in specific productivity	increase	an almost 10-fold increase	process condition	specific productivity	COID731421	ABSTRACT	arg0
d53112c46f4697a0e15cb598e018ca1a	15903239		The dhfr amplified cell line	line	The dhfr amplified cell line	cell line	dhfr amplified cell line	COID749839	ABSTRACT	arg1
31df305f4b8d791751a0b4a600400a39	16609957		remaining synthesis of GDP-fucose via de novo pathway for the CHO line and the elevation of FUT8 expression by the YB2/0 cells	synthesis	remaining synthesis	sugar (subset of carbon source)	GDP-fucose	COID766661	ABSTRACT	arg0
734c0b1e5e6ced9eb5dc9c1e412a5a17	16609957		The increase in fucosylation	increase	The increase	glycosylation	fucosylation	COID810570	ABSTRACT	arg1
a6e54bc563fae99359f7ef91e43baa10	19224598		the variable domains	domains	the variable domains	product attributes	variable domains	COID284730	ABSTRACT	arg0
d9687976b46b71317cd7820e84a2cf13	19224598		Fc glycosylation	glycosylation	Fc glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
6185c4f7c7be0547d8d98020d648a69a	19224598		light chain isotype	isotype	light chain isotype	product attributes	light chain isotype	COID790740	ABSTRACT	arg0
652ad64c29fb4baa1d0106cf3683ef99	19224598		the level of galactosylation and/or non-core-fucosylation	level	the level	glycosylation	non-core-fucosylation	COID101427	ABSTRACT	arg0
6d8e83f89298aa76b21bac8a424c6726	19224598		the 105 different cell lines	lines	the 105 different cell lines	cell line	cell lines	COID702829	ABSTRACT	arg1
d514a73121a1f3be91e15320675f4c4f	19224598		the level of galactosylation and/or non-core-fucosylation	level	the level	glycosylation	galactosylation	COID475750	ABSTRACT	arg0
a823014139c53d97bb6cc43c70914ff1	20589669		Production bioreactor parameters that directly influence antibody charge variants and glycosylation in CHO systems	parameters	Production bioreactor parameters	process parameters or process control	Production bioreactor parameters	COID641378	ABSTRACT	arg0
bb45ab0b514dc3d239007b5524daebed	20589669		antibody charge variants	variants	antibody charge variants	product quality profile	antibody charge variants	COID361180	ABSTRACT	arg1
c86779ab83f0cb8c4d182dc2ef8f3ee0	20589669		glycosylation in CHO systems	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
25fa36ea7a60c8195ed6b57794908f85	20639190		afucosylated N-glycans	N-glycans	afucosylated N-glycans	sugar (subset of carbon source)	afucosylated N-glycans	COID239021	ABSTRACT	arg0
0a102c9b6a950ff6185a739287ee9aff	20639190		dose requirement	requirement	dose requirement	clinical outcomes	dose requirement	COID550661	ABSTRACT	arg1
ea4d42e99b951991c00ebdc8ec287472	22699308		faster clearance rate	rate	faster clearance rate	process parameters or process control	clearance rate	COID187126	ABSTRACT	arg0
1fad2e88b20091c8072109257b12e435	22699308		antibodies bearing the fucosylated complex glycoform	antibodies	antibodies	antibody	antibodies	COID278523	ABSTRACT	arg1
fa2d022dc7ad707e510b8d8a9d29ee1b	22699308		enhanced antibody-dependent cell-mediated cytotoxicity (ADCC)	cytotoxicity	antibody-dependent cell-mediated cytotoxicity	clinical outcomes	antibody-dependent cell-mediated cytotoxicity	COID386333	ABSTRACT	arg0
f5a7fd6b1f665cb75b860eac8ac4fe2f	22699308		antibodies with fucosylated complex or hybrid glycans	antibodies	antibodies	antibody	antibodies	COID278523	ABSTRACT	arg1
f42a78299e7fcd41d862641f5ac9dfde	24166780		superior sialylation	sialylation	superior sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg0
496a7bdde503e3877093150d531c7fd4	24166780		the commercially used EPO-producing CHO clone cultured under the same conditions	clone	the commercially used EPO-producing CHO clone	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg1
5ed39281e511538b5bfb08f6c14200a4	24326352		N-Glycosylation of therapeutic antibodies	N-Glycosylation	N-Glycosylation	glycosylation	N-Glycosylation	COID293911	ABSTRACT	arg0
1d9f442b3349a15ca40b3f172cb43b15	24326352		their stability	stability	their stability	process condition	stability	COID548988	ABSTRACT	arg1
8f73f27ee015cfcbf706a8e25b766aa6	24381145		a high dose of VPA late in the culture	VPA	a high dose of VPA	secondary raw materials	VPA	COID953809	ABSTRACT	arg0
8746304e2b1f04b54c9c8d7c734eb81f	24381145		N-linked glycosylation profiles	N-linked glycosylation profiles	N-linked glycosylation profiles	product attributes	glycosylation profiles	COID103232	ABSTRACT	arg1
4a19ea077b25999b3d16319eebac1fee	24692242		media components	components	media components	media characteristics	media components	COID256991	ABSTRACT	arg0
c859b07d842f7a8e2659ab1ad29b88ad	24692242		recombinant protein quality attributes	attributes	recombinant protein quality attributes	product quality profile	protein quality attributes	COID846170	ABSTRACT	arg1
4c0656de439688e8d996d0447c271393	24692242		bioreactor operation conditions	conditions	bioreactor operation conditions	bioreactor conditions	bioreactor operation conditions	COID538546	ABSTRACT	arg0
772b5307792a7fe537342ca52505ee49	24692242		recombinant protein quality attributes	attributes	recombinant protein quality attributes	recombinant protein	recombinant protein	COID593158	ABSTRACT	arg1
c5da01ed083e5ce5be8e37ae7b3878d0	24692242		different integrated ammonium level during the cell culture process	level	different integrated ammonium level	culture condition	ammonium	COID714150	ABSTRACT	arg0
9201327d02b86ec8c4846bf30d6eeb36	24692242		G1F	G1F	G1F	sugar (subset of carbon source)	G1F	COID847930	ABSTRACT	arg1
3ab25e9b62bbf3bf60f22dc3372ff3f5	24692242		G2F	G2F	G2F	sugar (subset of carbon source)	G2F	COID847130	ABSTRACT	arg1
342e8bc003b9c06726415b190bea39d4	24692242		G0F	G0F	G0F	sugar (subset of carbon source)	G0F	COID847830	ABSTRACT	arg1
07b286e01d25123a6f2a15b3f4356e2e	24728980		galactose	galactose	galactose	sugar (subset of carbon source)	galactose	COID770311	ABSTRACT	arg0
f4dafb4f970198df3de3a95e049799e2	24728980		the relative abundance of FA2G1	abundance	the relative abundance	sugar (subset of carbon source)	FA2G1	COID847899	ABSTRACT	arg1
be3f2b74795af228fc96528b0a38a464	24728980		significant main effects (as well as interaction effects) of media supplementation with manganese, galactose, ammonia	significant main effects	significant main effects (as well as interaction effects) of media supplementation	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	ABSTRACT	arg0
70d1c0ec7b8fd74a1bb7c280c8806155	24728980		certain glycans	glycans	glycans	sugar (subset of carbon source)	glycans	COID626759	ABSTRACT	arg1
aba6305268a352f9a7384c053e40bf2d	24728980		significant main effects (as well as interaction effects) of media supplementation with manganese, galactose, ammonia	significant main effects	significant main effects (as well as interaction effects) of media supplementation	sugar (subset of carbon source)	galactose	COID770311	ABSTRACT	arg0
2c15d7fc703b68db7d8105b86496eff9	24728980		N-linked glycan distribution	distribution	N-linked glycan distribution	product quality profile	N-linked glycan distribution	COID235212	ABSTRACT	arg0
1601cdb6992cbd3b7596882d925a7278	24728980		efficacy	efficacy	efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
82ec0e58e51ca139d06c873c717e61ba	24728980		bioactivity	bioactivity	bioactivity	product quality attributes	bioactivity	COID046028	ABSTRACT	arg1
4075cd50a682f4963e5f1f54106c0a39	24728980		various culture conditions such as bioreactor process variables, media type, and media supplements	conditions	various culture conditions	media characteristics	media	COID913636	ABSTRACT	arg0
b2bc95082d22baac4d9065a0b235cbcf	24728980		the glycan distribution	distribution	the glycan distribution	product quality profile	glycan distribution	COID651165	ABSTRACT	arg1
8b5555e43e60c5d25abf2c505586fbe2	24975601		high mannose glycoforms in particular	glycoforms	high mannose glycoforms	recombinant protein	high mannose glycoforms	COID965734	ABSTRACT	arg0
4146a92de52ac258cc4e28f5c53fe843	24975601		clinical efficacy	efficacy	clinical efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
33b0809fd62838c726f65adee61d08e1	24975601		pharmacokinetics	pharmacokinetics	pharmacokinetics	clinical outcomes	pharmacokinetics	COID373370	ABSTRACT	arg1
1129086991cf00c41948dd1aa3683129	24975601		the genetic engineering of cell lines, addition of inhibitors to key enzymes in the glycosylation pathways, and varying cell culture conditions	engineering	the genetic engineering	genotype	genetic engineering	COID939654	ABSTRACT	arg0
7845915a72f69bb584ef0a38d0de787a	24975601		high mannose glycoforms	glycoforms	high mannose glycoforms	recombinant protein	high mannose glycoforms	COID965734	ABSTRACT	arg1
de3d07c135faa9befbd9856f0c6a0dd1	24975601		the genetic engineering of cell lines, addition of inhibitors to key enzymes in the glycosylation pathways, and varying cell culture conditions	engineering	the genetic engineering	secondary raw materials	inhibitors	COID760391	ABSTRACT	arg0
d4ec20823e82db9f2f5e53e39fc76b3a	25014402		average pH reduction	reduction	average pH reduction	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
1d5d2863da84f327f3ce25cd6d7fcb8e	25014402		glycosylation level during the entire culture time or during a specific time span	level	glycosylation level	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
a32b0d7c43b4a9e77a5156a5bf9afc47	25042542	PMC4282109	the selective inhibitor	inhibitor	the selective inhibitor	secondary raw materials	inhibitor	COID760391	ABSTRACT	arg0
02c94c664c2a124c0d49072eae2cf82e	25042542	PMC4282109	a complete and sustained G0/G1 arrest	arrest	a complete and sustained G0/G1 arrest	cell cycle pathway G0/G1/M/G2	G0/G1 arrest	COID007895	ABSTRACT	arg1
5a30dd0d05204030e82feae8b7f882f7	25619381		Asparagine-linked glycosylation of the constant region of monoclonal antibodies (mAbs)	glycosylation	Asparagine-linked glycosylation	glycosylation	Asparagine-linked glycosylation	COID652506	ABSTRACT	arg0
0a08371a08b242149e04569dfd04f709	25619381		efficacy	efficacy	efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
938681a692ecf3e560d997d3668070b0	25619381		stability	stability	stability	process condition	stability	COID548988	ABSTRACT	arg1
d7d2c5a768ef450abbf1d0bd8e65f6ae	25619381		a manipulable product quality lever	lever	a manipulable product quality lever	product quality attributes	product quality	COID111751	ABSTRACT	arg0
88f967b28b4f907a579e2ce5bfec935b	25619381		monensin	monensin	monensin	NYK	monensin	COID766386	ABSTRACT	arg1
b94c2a52285c74904fb14c40c37844c2	25931375		the galactosylation	galactosylation	the galactosylation	glycosylation	galactosylation	COID475750	ABSTRACT	arg0
d948d0db9d944ca15ef2850a98b99a6f	25931375		sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
5d2921b92cea2e44f1c302b1b4b030f7	25931375		Sialic acid levels of therapeutic glycoprotein	levels	Sialic acid levels	sugar (subset of carbon source)	Sialic acid	COID148212	ABSTRACT	arg0
f350b98cd1fd5ecd6bc0c54a3b4e053e	25931375		plasma half-life	half-life	plasma half-life	process parameters or process control	half-life	COID125212	ABSTRACT	arg1
45cd073f4d659a168a4ffd4e9aa8228c	26222761		an application of these glycosylation precursors for	application	an application	biochemical compound	glycosylation precursors	COID638294	ABSTRACT	arg0
edbdd6594b679d767537f18902c729e6	26222761		N-glycosylation of IgG	N-glycosylation	N-glycosylation	glycosylation	N-glycosylation	COID293911	ABSTRACT	arg1
133836c240ae543ce633a6c02e58a0d3	26910040	PMC4947490	product formation	formation	product formation	flux rate	product formation	COID187355	ABSTRACT	arg0
74ff7a670477bd6c0585d5787e95ee50	26910040	PMC4947490	the relative abundance of high-mannose glycoforms	abundance	the relative abundance	recombinant protein	high-mannose glycoforms	COID965734	ABSTRACT	arg1
d884e8b37485d59706b6262ea41464e9	27131894		Supplementation of various media additives	various media additives	various media additives	media characteristics	media additives	COID816450	ABSTRACT	arg0
73516f92b6a950e56a6eb82e99021b56	27131894		intracellular nucleotides and nucleotide sugars	nucleotides	intracellular nucleotides	sugar (subset of carbon source)	intracellular nucleotides and nucleotide sugars	COID456570	ABSTRACT	arg1
3c331547b53fe0f446126ef08a6b3c11	27131894		elevated UDP-GlcNAc and GDP-Fuc levels	levels	elevated UDP-GlcNAc and GDP-Fuc levels	sugar (subset of carbon source)	GDP-Fuc	COID766661	ABSTRACT	arg0
2241f380aab738aa168c8e1da2dcb72d	27131894		the final glycosylation patterns	patterns	the final glycosylation patterns	product attributes	glycosylation patterns	COID857544	ABSTRACT	arg1
761855fc4e4b53b982ca5f90fe43b666	27131894		elevated UDP-GlcNAc and GDP-Fuc levels	levels	elevated UDP-GlcNAc and GDP-Fuc levels	sugar (subset of carbon source)	UDP-GlcNAc	COID510816	ABSTRACT	arg0
223aa5f8364ee43f180129c88ac1ff3e	27131894		manganese and asparagine supplementation	supplementation	manganese and asparagine supplementation	amino acid (subset of substrates)	asparagine	COID698257	ABSTRACT	arg0
4d20656e87fd202739233c41caa49fea	27131894		the glycan profiles	profiles	the glycan profiles	product quality attributes	glycan profiles	COID521331	ABSTRACT	arg1
979b72e860b367d16dcde13bceabdb58	27131894		manganese and asparagine supplementation	supplementation	manganese and asparagine supplementation	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	ABSTRACT	arg0
cb54fa2845c56fe05737f0e0383f28cf	27273898		glucose and glutamine media concentration	concentration	glucose and glutamine media concentration	amino acid (subset of substrates)	glutamine	COID962935	ABSTRACT	arg0
bef1d75decfd581665b5a6720d2a9c5b	27273898		the relative percentage of various glycans	percentage	the relative percentage	sugar (subset of carbon source)	glycans	COID626759	ABSTRACT	arg1
0e950d48d9f930ca703337bd8fad87ca	27273898		glucose and glutamine media concentration	concentration	glucose and glutamine media concentration	sugar (subset of carbon source)	glucose	COID367406	ABSTRACT	arg0
19aa34e89b760d6eaab92ba18d32f768	27273898		pH	pH	pH	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
b0d57c8b66b62563df646985951ff6e8	27273898		temperature	temperature	temperature	bioreactor conditions	temperature	COID692615	ABSTRACT	arg0
c39e0666f3469348da9974b02fb13a6e	27273898		dissolved oxygen (DO)	oxygen	dissolved oxygen	bioreactor conditions	dissolved oxygen	COID661988	ABSTRACT	arg0
c63141146a60ada7cb5244e7756b3746	27453130		pH control	control	pH control	bioreactor conditions	pH control	COID492476	ABSTRACT	arg0
443a99717e676ce74c034021d93070e6	27453130		cell growth and metabolism	cell	cell growth and metabolism	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
ce672e199cb19dda3c2f3494a830fb37	27453130		cell growth and metabolism	cell	cell growth and metabolism	biological process	metabolism	COID291079	ABSTRACT	arg1
1582d4a6c820d57febbd6f3418273e2d	27943633		Immunoglobin G with Î±-2,6 sialylation	G	Immunoglobin G	glycosylation	Î±-2,6 sialylation	COID995015	ABSTRACT	arg0
fa61fdcb13c0860b5096d1e501691574	27943633		antibody-dependent cellular cytotoxicity	cytotoxicity	antibody-dependent cellular cytotoxicity	clinical outcomes	antibody-dependent cellular cytotoxicity	COID386333	ABSTRACT	arg1
6b08fcb409ea00b9947fd724095a6cd1	27943633		anti-inflammatory efficacy	efficacy	anti-inflammatory efficacy	clinical outcomes	anti-inflammatory efficacy	COID334262	ABSTRACT	arg1
8c1dddb526223f7068c02eb44f5dbff3	27943633		greatly increased Î±-2,6 sialylation level relative to Î±-2,3 sialylation for the Î±-2,3 sialyltransferase knockouts	level	greatly increased Î±-2,6 sialylation level	glycosylation	Î±-2,6 sialylation	COID995015	ABSTRACT	arg0
8b3997580abdbc1ca6714c44e17a406d	27943633		Sialidase treatment	treatment	Sialidase treatment	enzyme	Sialidase	COID070440	ABSTRACT	arg1
ca07ddb1fb8ad5c4d61719ef92fe9100	27943633		Î±-2,3 sialylation for the Î±-2,3 sialyltransferase knockouts	sialylation	Î±-2,3 sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
0255560a47d86df0ef7946d443817916	28409838		different viable cell density and media supplement concentrations	concentrations	different viable cell density and media supplement concentrations	cell culture parameters	viable cell density	COID384695	ABSTRACT	arg0
4cb8d5cd256199d056c66135ac71ce0a	28409838		The possibility to modulate the glycosylation profile	possibility	The possibility to modulate the glycosylation profile	product attributes	glycosylation profile	COID103232	ABSTRACT	arg1
78370ad65778bf2a4d3a67447b9927d7	28409838		different viable cell density and media supplement concentrations	concentrations	different viable cell density and media supplement concentrations	media characteristics	media	COID913636	ABSTRACT	arg0
c1e7db6de7e632cfeaa351f93e298019	28409838		the modulation of glycosylation in a sequential steady state approach in combination with mechanistic model	modulation	the modulation	glycosylation	glycosylation	COID119643	ABSTRACT	arg0
f19283e390806dc671619c7e1823d83a	28409838		continuous processes with desired N-linked glycosylation patterns	processes	continuous processes	product attributes	N-linked glycosylation patterns	COID545748	ABSTRACT	arg1
6bc82a90970fcf68a88db651f354fa15	28409838		accurate control of flow rates, media composition and cell density of a Chinese hamster ovary (CHO) cell perfusion bioreactor	control	accurate control	media characteristics	media composition	COID162890	ABSTRACT	arg0
c9dc01dd8a32acf630aeb2181df58f7f	28409838		the production of a constant glycosylation profile	production	the production	product attributes	glycosylation profile	COID103232	ABSTRACT	arg1
5eae96b4c716310d554b19b3cfd6a159	28409838		accurate control of flow rates, media composition and cell density of a Chinese hamster ovary (CHO) cell perfusion bioreactor	control	accurate control	cell culture parameters	cell density	COID283414	ABSTRACT	arg0
ff98fe38b279cd2790d526bab33749e7	28465212		Glycosylation	Glycosylation	Glycosylation	glycosylation	Glycosylation	COID119643	ABSTRACT	arg0
2e053bb642ff7acd37d71b6eb4d84037	28465212		pharmacokinetics	pharmacokinetics	pharmacokinetics	clinical outcomes	pharmacokinetics	COID373370	ABSTRACT	arg1
8d92ed6806929a16c5748ec85dd2abf5	28465212		raffinose supplementation	supplementation	raffinose supplementation	sugar (subset of carbon source)	raffinose	COID985703	ABSTRACT	arg0
2846eba6bc6fb2a73a85687bdef39b50	28465212		the expression levels of a number of glycosylation related genes	levels	the expression levels	genotype	genes	COID185502	ABSTRACT	arg1
c76e77b4d2d47d98e6c37c6185caace1	29314747		low nutrient concentrations were reached	concentrations	low nutrient concentrations	media parameter or raw material	nutrient concentrations	COID287635	ABSTRACT	arg0
125bfede310a8130ec68d6ac7cb1de61	29314747		a decrease in mAb glycosylation was induced	a decrease	a decrease in mAb glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
02a87959937e58c47d2a68bcc3e6c5af	29457629		one carbohydrate modification	modification	one carbohydrate modification	PTM	carbohydrate modification	COID721251	ABSTRACT	arg0
194e5da1e93b65b9c49c9579c4170678	29457629		other glycan structures	structures	other glycan structures	sugar (subset of carbon source)	glycan structures	COID684992	ABSTRACT	arg1
2e277b9ae905bb52fa9655a411e99197	29673624		a critical protein quality attribute which may affect the efficacy and safety of the molecule	attribute	a critical protein quality attribute	product quality profile	protein quality attribute	COID846170	ABSTRACT	arg0
6af50e5655833cee3be86e4fbc87d4ff	29673624		efficacy	efficacy	efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
306b41f0928c45450f833c3d2d48a1c4	29673624		safety	safety	safety	clinical outcomes	safety	COID635261	ABSTRACT	arg1
65105415151608af96ff790bc98af8a2	29673624		DMJ	DMJ	DMJ	enzyme inhibitor	DMJ	COID109253	ABSTRACT	arg0
f0b190c1e360233d94eb8eb0b5f5909a	29673624		high mannose levels of IgG1 antibodies	levels	high mannose levels	sugar (subset of carbon source)	high mannose	COID981337	ABSTRACT	arg1
805f0bc9a72340e0430e2c37e15dd4b9	29673624		Deoxymannojirimycin (DMJ)	Deoxymannojirimycin	Deoxymannojirimycin	enzyme inhibitor	Deoxymannojirimycin	COID109253	ABSTRACT	arg0
df464f959354aac6e5ad4010330afa29	29673624		mannosidase	mannosidase	mannosidase	enzyme	mannosidase	COID020739	ABSTRACT	arg1
57b755d92a6a93838097199f5753d335	29673624		Deoxymannojirimycin (DMJ)	Deoxymannojirimycin	Deoxymannojirimycin	enzyme inhibitor	DMJ	COID109253	ABSTRACT	arg0
dc2335aa54d9e27a6aeff823c2fd5ac7	29673624		the glycosylation pattern of antibodies	pattern	the glycosylation pattern	product attributes	glycosylation pattern	COID857544	ABSTRACT	arg1
db25c94c12093cbc7b507ad2e9bfcc13	29673624		glycan forms	forms	glycan forms	sugar (subset of carbon source)	glycan forms	COID671420	ABSTRACT	arg1
d8b5912c957aed0c12ef12684bd79399	29719200		the bioreactor scale	scale	the bioreactor scale	vessel or process parameter or production scale	bioreactor scale	COID368907	ABSTRACT	arg0
73d49526e6c15473bfc1e0423ffa1d54	29719200		the intracellular processes	processes	the intracellular processes	process parameters or process control	intracellular processes	COID933982	ABSTRACT	arg1
8e724cf6ffcac306ee4be918a7c20c0c	29851298		The first perfusion harvest slice for both product types	slice	The first perfusion harvest slice	process mode	perfusion	COID329168	ABSTRACT	arg0
163d87bdafc120336184a29c1252955e	29851298		different glycosylation than subsequent harvests	glycosylation	different glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
4903449d0bb1b10179ca6daa21f21176	29851298		Product concentration in fed-batch	concentration	Product concentration	product attributes	Product concentration	COID189862	ABSTRACT	arg0
3604bf6927f2c68500321ed1aa970713	29851298		fed-batch	fed-batch	fed-batch	process mode	fed-batch	COID529446	ABSTRACT	arg1
948bfa29f4f90c515e809e44027842a4	29851298		perfusion	perfusion	perfusion	process mode	perfusion	COID329168	ABSTRACT	arg1
0a27c0ae6ecf8d690e445fdf52ad1bf6	29851298		average productivity in perfusion	productivity	average productivity	process condition	average productivity	COID731421	ABSTRACT	arg0
5c585dc3d6e4050d45de9be085823992	29851298		different glycosylation than subsequent harvests	glycosylation	different glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg0
d5fa0146a3f79d2c51a26398c12922ce	29851298		The first perfusion harvest slice for both product types	slice	The first perfusion harvest slice	process mode	perfusion	COID329168	ABSTRACT	arg1
2c27694c27f83f070d1e866c565c2a64	30088083		pH excursions	excursions	pH excursions	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
b448f19cd4b220b0788d856ba64027dc	30088083		N-linked glycosylation	glycosylation	N-linked glycosylation	glycosylation	N-linked glycosylation	COID005169	ABSTRACT	arg1
2202a6ff79c518cf5703def924e9faf5	30327978		Variations in trace metal availability during production	Variations	Variations	trace metals or minerals (subset of secondary raw materials)	trace metal	COID221517	ABSTRACT	arg0
1f597d413048200a9006a5d502da6435	30327978		glycosylation of recombinant glycoproteins such as monoclonal antibodies	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
9a0d1ad678f4767a562d8cdbad436365	30327978		nickel	nickel	nickel	trace metals or minerals (subset of secondary raw materials)	nickel	COID232036	ABSTRACT	arg0
8c982300a4f8fe79b1546e2f4fee4446	30327978		glycosylation of recombinant IgG expressed in Chinese hamster ovary cells	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
c72ee8eeffe4af526b92591b0d95b95b	30327978		cobalt	cobalt	cobalt	trace metals or minerals (subset of secondary raw materials)	cobalt	COID584412	ABSTRACT	arg0
b80b846b1a4353fa1c1d3d1f0300239f	30552760	PMC6590254	The studied cell culture media additives	additives	The studied cell culture media additives	secondary raw materials	cell culture media additives	COID247877	ABSTRACT	arg0
41dcc58911b077bc74597cd35ed5f0f1	30552760	PMC6590254	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
5a21cd08faa4616c22574624ee0d01ac	30597531		media hold duration (at 37Â°C)	duration	media hold duration	process parameters or process control	media hold duration	COID555925	ABSTRACT	arg0
42ca35126109a0a7ae4da6c65a3cce84	30597531		afucosylation of a mAb produced by a recombinant Chinese Hamster Ovary (CHO) cell line	afucosylation	afucosylation	glycosylation	afucosylation	COID653555	ABSTRACT	arg1
2ecbe855272d3e78a47ae104869a8b04	30597531		pCO 2	pCO 2	pCO 2	process condition	pCO 2	COID255565	ABSTRACT	arg0
1c6165bfceb1623a3a6f161cf20b7f8b	30636290		pHi control	control	pHi control	bioreactor conditions	pHi control	COID698824	ABSTRACT	arg0
3500c722fd567dbe2fe1b9b648458232	30636290		protein glycosylation	glycosylation	protein glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
c1d57d94fd01e4a52b814df89554cf9e	30636290		Acidic Golgi pH	pH	Acidic Golgi pH	bioreactor conditions	Acidic Golgi pH	COID995227	ABSTRACT	arg0
4f0489038ab59a2f85120c92f68f9ce7	30959136		this production protocol	protocol	this production protocol	process parameters or process control	protocol	COID625051	ABSTRACT	arg0
1466c7a774b4d05b00c7d6eec6544318	30959136		a more galactosylated glycan profile than a bioreactor culture initiated at 34 Â°C during growth and downshifted to 30 Â°C during the production phase	profile	a more galactosylated glycan profile	product quality attributes	galactosylated glycan profile	COID142990	ABSTRACT	arg1
77c5b2d6517860338027765de00149fb	31049620	PMC7027499	Sialylation	Sialylation	Sialylation	glycosylation	Sialylation	COID543327	ABSTRACT	arg0
89c230dc9afec41467adfea60b4d04df	31049620	PMC7027499	circulating half-life	half-life	circulating half-life	process parameters or process control	half-life	COID125212	ABSTRACT	arg1
470960d5aa3c6c4628ec37432e8aba2d	31487120	PMC7027499	different media	media	different media	media characteristics	media	COID913636	ABSTRACT	arg0
ba44e253c8dcd269f0e8120938943261	31487120	PMC7027499	aglycosylation	aglycosylation	aglycosylation	product quality attributes	aglycosylation	COID076549	ABSTRACT	arg1
3b9ba35af79b99ec8963c29dd988306e	31487120	PMC7027499	diverse amounts of terminal galactosylation, high mannose glycoforms, and aglycosylation	amounts	diverse amounts	recombinant protein	high mannose glycoforms	COID965734	ABSTRACT	arg1
3a81ec1bb7f0f2ab7f900018b8a0d2df	31487120	PMC7027499	terminal galactosylation	galactosylation	terminal galactosylation	glycosylation	galactosylation	COID475750	ABSTRACT	arg1
45deb6b8bb78eb2687e91f5edde608ba	31544815	PMC6640710	their glycosylation profile	profile	their glycosylation profile	product attributes	glycosylation profile	COID103232	ABSTRACT	arg0
302cd7e9905b7414ac4c50e36fb9ac89	31544815	PMC6640710	The biological activity of therapeutic antibodies	activity	The biological activity	clinical outcomes	biological activity	COID518861	ABSTRACT	arg1
8a2c01db2848b7e06511c108fa8de325	31544815	PMC6640710	the reduction of core fucosylation	reduction	the reduction	glycosylation	core fucosylation	COID663555	ABSTRACT	arg0
163477b2e1d6565618c4effd31e437d5	31544815	PMC6640710	the cytotoxic efficacy of antibodies, which are used, for example, in cancer treatment,	efficacy	the cytotoxic efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
7bafebc3fd17823927e75b75d6578419	31544815	PMC6640710	reducing core fucosylation	reducing	reducing	glycosylation	core fucosylation	COID663555	ABSTRACT	arg0
a65b9c1fd19d9c969e233c3408862b02	31544815	PMC6640710	5-alkynylfucose	5-alkynylfucose	5-alkynylfucose	sugar (subset of carbon source)	5-alkynylfucose	COID256307	ABSTRACT	arg1
9228e0447f47d61431b11f6457bbc049	34289087		pH	pH	pH	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
732af622a0226c2c0bd7370ba7954f64	34289087		product titer	titer	product titer	overall titer or batch yield	product titer	COID382077	ABSTRACT	arg1
b0defaf6814fa3a5259527800a017f3e	34289087		the accumulation of mAb proteins in the endoplasmic reticulum disrupting cellular homeostasis over culture time	accumulation	the accumulation	process parameters or process control	culture time	COID763032	ABSTRACT	arg0
edbfcb7479dccb097ffda865cec7e09c	34289087		a time-dependent variation	variation	a time-dependent variation	process parameters or process control	time	COID742277	ABSTRACT	arg1
70809b8f14c1d4067adb161b9f1357ff	34289087		N-glycosylation	N-glycosylation	N-glycosylation	glycosylation	N-glycosylation	COID293911	ABSTRACT	arg1
c314613973350d2b1fd5e4d29e4bae80	34289087		protein aggregation	aggregation	protein aggregation	product attributes	protein aggregation	COID100331	ABSTRACT	arg1
2e28c4c259622cbbca7cdf252de52a85	34289087		mAb productivity	productivity	mAb productivity	process condition	mAb productivity	COID842515	ABSTRACT	arg1
5371f97f2d8cc0f707629bdd7d49378f	34289087		charge variant profiles	profiles	charge variant profiles	product quality profile	charge variant profiles	COID820771	ABSTRACT	arg1
0d850ccd90de3baf4d97821c0c939f15	34289087		pH set points	points	pH set points	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
b44ae62e75a740b7ccf146be4f63fdfe	34289087		apoptosis	apoptosis	apoptosis	cellular metabolic state	apoptosis	COID850789	ABSTRACT	arg1
4ddba0647d44ab058b77eed33a19679b	34289087		intracellular vesicular trafficking	trafficking	intracellular vesicular trafficking	biological process	intracellular vesicular trafficking	COID573417	ABSTRACT	arg1
c64289f3a594561dcbf179171bdde16d	35023143		a continuous Na-pyruvate feed (2 g/L/day)	feed	a continuous Na-pyruvate feed	carbon source (subset of secondary raw materials)	pyruvate	COID727438	ABSTRACT	arg0
b247b04f7cb1dbdc554206d781892320	35023143		ammonium production	production	ammonium production	culture condition	ammonium	COID714150	ABSTRACT	arg1
73d8fe0fbc322eebf2b90e27bba37c18	35023143		sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
c431b905f96f7cd73733e1d252a81a78	35023143		fucosylation	fucosylation	fucosylation	glycosylation	fucosylation	COID810570	ABSTRACT	arg1
68318c0b81fded10f3c44b0070138c67	35023143		high mannose content	content	high mannose content	sugar (subset of carbon source)	high mannose	COID981337	ABSTRACT	arg1
a66339eb354e548a15a3d426b856ac19	35087805	PMC8786911	two different process conditions	conditions	two different process conditions	process condition	process conditions	COID106153	ABSTRACT	arg0
627e3677b8051d2be0f72c32d5edcea9	35087805	PMC8786911	glycosylation changes in a model mAb grown in a bioreactor	changes	glycosylation changes	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
4cc6530e62623227fb3f902fec1dc9a8	35087805	PMC8786911	different media conditions	conditions	different media conditions	media characteristics	media	COID913636	ABSTRACT	arg0
38e1e001c0847b4eacce5c0ffc473f65	35087805	PMC8786911	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
560701271bd712edc62e9fd178737cd8	37446069		a critical quality attribute potentially affecting CAR-T cell effector function and thus impacting therapy's success	attribute	a critical quality attribute	product quality attributes	critical quality attribute	COID162607	ABSTRACT	arg0
b89d704cbfb2b9be25af28c18d1da930	37446069		glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
170e628b7af070565440083c671de70b	37489835		Golgi acidity	acidity	Golgi acidity	cellular metabolic state	Golgi acidity	COID752340	ABSTRACT	arg0
3eb1d62648be44b292b1399cca48cc3c	37489835		correct localization and function of glycosyltransferases	function	function	enzyme	glycosyltransferases	COID225633	ABSTRACT	arg1
a6f72b39a74d7827e1a53ba3aeec9e06	37489835		correct localization and function of glycosyltransferases	correct localization	correct localization	enzyme	glycosyltransferases	COID225633	ABSTRACT	arg1
045570018d6eaa241033d1a95f6cc7a6	23172735	PMC4226405	siRNA addition	addition	siRNA addition	NYK	siRNA	COID416464	ABSTRACT	arg0
8dec2b7f4af260001a4e1a46d2601efb	23172735	PMC4226405	no deleterious effects on cell growth, final protein titer, or specific productivity	effects	no deleterious effects	process condition	specific productivity	COID731421	ABSTRACT	arg1
aa9c74790f5def635a5587c268320aad	23172735	PMC4226405	no deleterious effects on cell growth, final protein titer, or specific productivity	effects	no deleterious effects	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
9a074bacfea746cd3e641552a84aadb7	23172735	PMC4226405	no deleterious effects on cell growth, final protein titer, or specific productivity	effects	no deleterious effects	overall titer or batch yield	titer	COID732378	ABSTRACT	arg1
3ab5bf49faaa7346f555c6984cc9360d	23172735	PMC4226405	siRNA treatment	treatment	siRNA treatment	NYK	siRNA	COID416464	ABSTRACT	arg0
6790e82d0f66fba8b16ba229067af2f4	23172735	PMC4226405	antibodies produced by cells following siRNA treatment	antibodies	antibodies	antibody	antibodies	COID278523	ABSTRACT	arg1
329a501babb50d1522bd1d71abcf6f29	23172735	PMC4226405	specific characteristics that improve efficacy, potency, and safety	characteristics	specific characteristics	clinical outcomes	potency	COID969445	ABSTRACT	arg0
b5d6d4723d23b3d471ba01b41782a267	23172735	PMC4226405	efficacy	efficacy	efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
b44cd67487f97d73e000a524158251d8	23172735	PMC4226405	specific characteristics that improve efficacy, potency, and safety	characteristics	specific characteristics	clinical outcomes	safety	COID635261	ABSTRACT	arg0
f60fa981f5081a039c8149199f5f2df9	23172735	PMC4226405	specific characteristics that improve efficacy, potency, and safety	characteristics	specific characteristics	clinical outcomes	efficacy	COID912630	ABSTRACT	arg0
2c56c14b2be63df307d517ed81a41eb3	23172735	PMC4226405	potency	potency	potency	clinical outcomes	potency	COID969445	ABSTRACT	arg1
f94fefd64e974ad15d7b316f5bdcbd79	23172735	PMC4226405	safety	safety	safety	clinical outcomes	safety	COID635261	ABSTRACT	arg1
49138884c18364f213a6b29ec84bcc88	23172735	PMC4226405	a potentially novel metabolic engineering tool to improve biopharmaceutical function and quality that can complement existing metabolic engineering methods	tool	a potentially novel metabolic engineering tool	process condition	function	COID532355	ABSTRACT	arg0
097315b10c57d90fd12f6088cc2863ea	23172735	PMC4226405	quality	quality	quality	product quality attributes	quality	COID109463	ABSTRACT	arg1
5fa03277170f8854f46f561822b51fcc	23172735	PMC4226405	a potentially novel metabolic engineering tool to improve biopharmaceutical function and quality that can complement existing metabolic engineering methods	tool	a potentially novel metabolic engineering tool	product quality attributes	quality	COID109463	ABSTRACT	arg0
515c2b94664b3a3abe2acd69b7c031f4	23172735	PMC4226405	biopharmaceutical function	function	biopharmaceutical function	process condition	function	COID532355	ABSTRACT	arg1
2de04068e7cac32e747bb35763385e62	23172735	PMC4226405	potent siRNA duplexes	duplexes	potent siRNA duplexes	NYK	siRNA	COID416464	ABSTRACT	arg0
95778c2e43b1748795048d439135f737	23172735	PMC4226405	fut8	fut8	fut8	enzyme	fut8	COID212341	ABSTRACT	arg1
70c12ea88289a4ced64d43ddd14c4457	23172735	PMC4226405	exogenous addition of siRNA	addition	exogenous addition	NYK	siRNA	COID416464	ABSTRACT	arg0
0947919bbbe83782767764fe62566bad	23172735	PMC4226405	siRNA treated cultures	cultures	siRNA treated cultures	NYK	siRNA treated cultures	COID416464	RESULTS	arg0
9b57ebdf27044e0fabf45e33bd481c3c	23172735	PMC4226405	the antibody produced from siRNA treated cultures	antibody	the antibody	antibody	antibody	COID278523	RESULTS	arg1
9dc236c87512a5d73854bd212b1ec975	23172735	PMC4226405	siRNA treated bioreactor runs	runs	siRNA treated bioreactor runs	NYK	siRNA treated bioreactor	COID416464	RESULTS	arg0
cf3dd525426d6b233ed9b88543945292	23172735	PMC4226405	antibody purified from siRNA treated bioreactor runs	antibody	antibody	antibody	antibody	COID278523	RESULTS	arg1
53b74f7e7f18ffde8fbbb88abed4a327	23172735	PMC4226405	siRNA treated bioreactors	bioreactors	siRNA treated bioreactors	NYK	siRNA treated bioreactors	COID416464	RESULTS	arg0
51aa2e202389ae837e8e1fd436f0aff3	23172735	PMC4226405	antibodies produced from siRNA treated bioreactors	antibodies	antibodies	antibody	antibodies	COID278523	RESULTS	arg1
bdde0a415a0ddee978533a2462b9f5d8	23172735	PMC4226405	siRNA treated runs	runs	siRNA treated runs	NYK	siRNA	COID416464	RESULTS	arg0
6bc57158a3559d80d4efc6402bb9c546	23172735	PMC4226405	antibody produced from siRNA treated runs	antibody	antibody	antibody	antibody	COID278523	RESULTS	arg1
2bb3d224615dfab048ac4577e859851e	23172735	PMC4226405	siRNA treated bioreactors (Figure 6B)	bioreactors	siRNA treated bioreactors	NYK	siRNA treated bioreactors	COID416464	RESULTS	arg0
18412ca8eab763fbcef97cdeaf3ec200	23172735	PMC4226405	antibody generated from siRNA treated bioreactors (Figure 6B)	antibody	antibody	antibody	antibody	COID278523	RESULTS	arg1
b1f63e90b72548f6aec8dcc0a1c1143e	23172735	PMC4226405	control bioreactors	bioreactors	control bioreactors	vessel or process parameter or production scale	bioreactors	COID345693	RESULTS	arg0
36263b9d47cb72fa31ad00ecfa6c1c7c	23172735	PMC4226405	antibody produced from control bioreactors	antibody	antibody	antibody	antibody	COID278523	RESULTS	arg1
80bf61f2313083e2308ba5c61536033c	23172735	PMC4226405	GMDS siRNA	siRNA	GMDS siRNA	NYK	siRNA	COID416464	RESULTS	arg0
5d65a8e067d0fef8c7dcc0e0204acc64	23172735	PMC4226405	silencing of fut8 and gmds expression	silencing	silencing	enzyme	fut8	COID212341	RESULTS	arg1
0cc64514c436940653ae63edfb09b708	23172735	PMC4226405	GMDS siRNA	siRNA	GMDS siRNA	enzyme	GMDS	COID390450	RESULTS	arg0
a4e94ded50233acfe22e418c6aab068d	23172735	PMC4226405	siRNA concentration	concentration	siRNA concentration	NYK	siRNA	COID416464	RESULTS	arg0
1a7cefd73de36c5b3d50f7f1c5c4b7c8	23172735	PMC4226405	antibody titer	titer	antibody titer	overall titer or batch yield	antibody titer	COID307661	RESULTS	arg1
8c5a545bf885cfcb1d769821ad220cca	23172735	PMC4226405	specific productivity	productivity	specific productivity	process condition	specific productivity	COID731421	RESULTS	arg1
0c15b206e4a25fbe71f41eeebe5bcb1f	23172735	PMC4226405	Antibody	Antibody	Antibody	antibody	Antibody	COID278523	RESULTS	arg0
bfe9f8030b7a358fcb939c513b8fa22e	23172735	PMC4226405	glycosylation profile as shown in Figure 4A	profile	glycosylation profile	product attributes	glycosylation profile	COID103232	RESULTS	arg1
8b63b9112e74d3872570247e9ee3a958	23172735	PMC4226405	core afucosylation	afucosylation	core afucosylation	glycosylation	afucosylation	COID653555	RESULTS	arg0
faf907b6b0d74d8fa58f6773fd7d6e2a	23172735	PMC4226405	an antibody	antibody	an antibody	antibody	antibody	COID278523	RESULTS	arg1
18c0c840b75411075fd3ab81cb7cbffb	23172735	PMC4226405	samples from various stages of the antibody purification procedure to demonstrate efficient removal of potential process-related contaminants	samples	samples	antibody	antibody	COID278523	RESULTS	arg0
d8628283bf0c5e02c7189936a0270195	23172735	PMC4226405	siRNA	siRNA	FUT8 and GMD siRNA and transfection lipid concentrations	NYK	siRNA	COID416464	RESULTS	arg1
25f021502adaca02d6d4742af5daa095	23172735	PMC4226405	antibody	antibody	antibody	antibody	antibody	COID278523	RESULTS	arg1
76937be412897cd6d3ad2244da0b70c6	23172735	PMC4226405	growth profiles for all conditions	profiles	growth profiles	cell culture parameters	growth	COID203666	RESULTS	arg0
84a6a84c199901df3df419e5e3f39a9e	23172735	PMC4226405	maximum cell concentration occurring on day 9	concentration	maximum cell concentration	process parameters or process control	cell concentration	COID623648	RESULTS	arg1
11227a14f40e6f512566c08a9bd46fc4	25042542	PMC4282109	The continued need to improve therapeutic recombinant protein productivity	need	The continued need to improve therapeutic recombinant protein productivity	recombinant protein	recombinant protein	COID593158	ABSTRACT	arg0
9f7bfa04414fd06a2b91aa0930c617ca	25042542	PMC4282109	therapeutic recombinant protein productivity	productivity	therapeutic recombinant protein productivity	process condition	productivity	COID731421	ABSTRACT	arg1
70c1cf5b21ef73ed941a98e510310c2b	25042542	PMC4282109	The continued need to improve therapeutic recombinant protein productivity	need	The continued need to improve therapeutic recombinant protein productivity	process condition	productivity	COID731421	ABSTRACT	arg0
f9952213191e120fedf8d8d3a7d40e38	25042542	PMC4282109	therapeutic recombinant protein productivity	productivity	therapeutic recombinant protein productivity	recombinant protein	recombinant protein	COID593158	ABSTRACT	arg1
3fbbabd400b739ab73c300baf2eb6546	25042542	PMC4282109	cell cycle arrest by directly	arrest	cell cycle arrest	biological process	cell cycle	COID780295	ABSTRACT	arg0
960db23fb06240280f51d97792d0d3fb	25042542	PMC4282109	CDK4/6 using selective inhibitor compound	CDK4/6	CDK4/6	secondary raw materials	inhibitor	COID760391	ABSTRACT	arg1
8b109d7a2f0fb965d7916ec9abfa9f1b	25042542	PMC4282109	a selective and complete cell cycle G0/G1 arrest	arrest	a selective and complete cell cycle G0/G1 arrest	cell cycle pathway G0/G1/M/G2	G0/G1 arrest	COID007895	RESULTS	arg0
c7de5a1188fe8a58a01ff40b19b34fc9	25042542	PMC4282109	CDK4/6 functions	functions	CDK4/6 functions	process condition	functions	COID532355	RESULTS	arg1
b6905a1b1e8c3f9fbd98a4c69bb2fa9e	25042542	PMC4282109	a selective and complete cell cycle G0/G1 arrest	arrest	a selective and complete cell cycle G0/G1 arrest	biological process	cell cycle	COID780295	RESULTS	arg0
3e937c33afd111e69057a2ec1e39ff34	25042542	PMC4282109	genes involved in the cell cycle pathway	genes	genes	genotype	genes	COID185502	RESULTS	arg0
4367670b28f3ec321aeb3cfb9ba28cf1	25042542	PMC4282109	the cell cycle pathway	pathway	the cell cycle pathway	biological process	cell cycle	COID780295	RESULTS	arg1
eb8da884c9ff621702640ad47b28b832	25042542	PMC4282109	Genes that are involved in glyco-protein quality control	Genes	Genes	genotype	Genes	COID185502	RESULTS	arg0
105e6031b5c5aefe6b5d171c2ecc71e8	25042542	PMC4282109	glyco-protein quality control	control	glyco-protein quality control	product quality attributes	quality	COID109463	RESULTS	arg1
28ffd7a536eb87209e93dd8dcccedf5e	25042542	PMC4282109	multiple recombinant cell lines which produce mAbs with different glycan profiles	lines	multiple recombinant cell lines	cell line	cell lines	COID702829	RESULTS	arg0
c6468b9bc902032760cca694da69b0be	25042542	PMC4282109	mAbs with different glycan profiles	mAbs	mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg1
cdbf3c0ff14ec42d274dd43146ae0468	25042542	PMC4282109	30 C-temperature shift condition	condition	30 C-temperature shift condition	bioreactor conditions	temperature	COID692615	RESULTS	arg0
9c10972ed5af9172df5a3ca81afb7d5b	25042542	PMC4282109	Antibody produced from 30 C-temperature shift condition	Antibody	Antibody	antibody	Antibody	COID278523	RESULTS	arg1
2808996aa97197a8ef2a7847895490a8	25042542	PMC4282109	modulation of glycosylation pathway genes	modulation	modulation	glycosylation	glycosylation	COID119643	RESULTS	arg0
2580f1ea6eaa044f2f14aca55f88d2e9	25042542	PMC4282109	metabolism homeostasis	homeostasis	metabolism homeostasis	biological process	metabolism	COID291079	RESULTS	arg1
5782bcda6b8d6380c04a400a34eb779a	25042542	PMC4282109	modulation of glycosylation pathway genes	modulation	modulation	genotype	genes	COID185502	RESULTS	arg0
db03f194c7d92ec9803508393b918ba8	25042542	PMC4282109	a program that favors recombinant protein secretion, assembly and glycosylation modification	program	a program	recombinant protein	recombinant protein	COID593158	RESULTS	arg1
10e46dce21c941530f24827612110371	25042542	PMC4282109	a program that favors recombinant protein secretion, assembly and glycosylation modification	program	a program	glycosylation	glycosylation	COID119643	RESULTS	arg1
24f23718a1050767f8dcca22488bebe1	25042542	PMC4282109	the cell cycle pathway	pathway	the cell cycle pathway	biological process	cell cycle	COID780295	RESULTS	arg0
67cecbe3215c57293820f83b4b45d910	25042542	PMC4282109	genes involved in the cell cycle pathway	genes	genes	genotype	genes	COID185502	RESULTS	arg1
4fbacc16c31bcad62ced4189ba5131e6	25042542	PMC4282109	G0/G1 arrest	arrest	G0/G1 arrest	cell cycle pathway G0/G1/M/G2	G0/G1 arrest	COID007895	RESULTS	arg0
28e27d33b0e85401c5ac76d7db5aa325	25042542	PMC4282109	glycan processing	processing	glycan processing	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
6267978d658864447cc7d6f8ac1c5ce1	25042542	PMC4282109	a Complete G0/G1 Arrest	Arrest	a Complete G0/G1 Arrest	cell cycle pathway G0/G1/M/G2	G0/G1 Arrest	COID007895	RESULTS	arg0
e1087085d6caa78c1cade1990c0f7981	25042542	PMC4282109	N-Linked Glycosylation Maturation	Maturation	N-Linked Glycosylation Maturation	glycosylation	N-Linked Glycosylation	COID005169	RESULTS	arg1
bb1c4a47fccbbf145330639e18754237	25042542	PMC4282109	decreasing culture temperature	temperature	decreasing culture temperature	bioreactor conditions	temperature	COID692615	RESULTS	arg0
1c197e0c07d20190513d65b5788ae043	25042542	PMC4282109	qP	qP	qP	flux rate	qP	COID599783	RESULTS	arg1
69e078b9583802314cd4a3f4fd4f62ef	25042542	PMC4282109	nutrient-limitation	nutrient-limitation	nutrient-limitation	secondary raw materials	nutrient	COID423902	RESULTS	arg0
40b66af749d12cdf524fb4d54fd5ae38	25042542	PMC4282109	lower cultivation temperature	temperature	lower cultivation temperature	bioreactor conditions	temperature	COID692615	RESULTS	arg0
5d2131dce0dc7ade26a87c597caa0110	25042542	PMC4282109	mAb assembly	assembly	mAb assembly	monoclonal antibody	mAb	COID242255	RESULTS	arg1
d4426fef01ae9e81727a7742e4d94431	25042542	PMC4282109	the phenotypic changes observed in production reactors and product quality	changes	the phenotypic changes	product quality attributes	product quality	COID111751	RESULTS	arg0
0b935096c81822c90e7a7a7f833f113d	25042542	PMC4282109	changes in gene expression	changes	changes	genotype	gene	COID185502	RESULTS	arg1
523e8dc9939ef6071e0793aa8fe5354c	25042542	PMC4282109	a 30 C-temperature shift (<7 x 107/mL)	shift	a 30 C-temperature shift	bioreactor conditions	temperature	COID692615	RESULTS	arg0
c3e72b107a804595763ac0e3cece374c	25042542	PMC4282109	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
9e007cd4a30c392d59c2dcf04361c8f5	25042542	PMC4282109	CDK4/6 inhibitor	inhibitor	CDK4/6 inhibitor	secondary raw materials	inhibitor	COID760391	RESULTS	arg0
385b1e8668910feced5a604d3a0d2bad	25042542	PMC4282109	fewer changes in the cell cycle pathway	changes	fewer changes	biological process	cell cycle	COID780295	RESULTS	arg0
f70be992007556f85c7e926a17501031	25042542	PMC4282109	temperature shift	shift	temperature shift	bioreactor conditions	temperature	COID692615	RESULTS	arg1
ded53584b61a91426728e6d6b8af3211	25042542	PMC4282109	Use of a small molecule cell cycle inhibitor	Use	Use	biological process	cell cycle	COID780295	TITLE	arg0
f9a18068d5d4a6b0111ddb0e955bb912	25042542	PMC4282109	product quality	quality	product quality	product quality attributes	product quality	COID111751	TITLE	arg1
a82249eff3051ab194f72e77fdb75239	25042542	PMC4282109	Use of a small molecule cell cycle inhibitor	Use	Use	secondary raw materials	inhibitor	COID760391	TITLE	arg0
7d41acfceef7aca05db6a7f14bb3b9bc	25042542	PMC4282109	specific productivity	productivity	specific productivity	process condition	specific productivity	COID731421	TITLE	arg1
5131e6ab46b07935edc5e6b26d7f1f92	25042542	PMC4282109	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	TITLE	arg1
b43321758341dff346823104c07afeac	25641927	PMC4492121	CHO	CHO	CHO	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg0
cf2264bc8c89350a9e7fdb588b1cf852	25641927	PMC4492121	Recombinant glycoproteins produced in Chinese hamster overy (CHO) only	glycoproteins	Recombinant glycoproteins	product	glycoproteins	COID866322	ABSTRACT	arg1
3d571e7aa54d0dcd8b640549d12d11c0	25641927	PMC4492121	Chinese hamster overy (CHO) only	overy	Chinese hamster overy	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg0
48bf61e739c889b9ece1cf5d13db0e5e	25641927	PMC4492121	the enriched ST6GAL1 Clone 27	Clone	the enriched ST6GAL1 Clone 27	enzyme	ST6GAL1	COID749247	ABSTRACT	arg0
5ba2e381c91da6d3a01860faf6e71bca	25641927	PMC4492121	IgG produced by the enriched ST6GAL1 Clone 27	IgG	IgG	antibody	IgG	COID713543	ABSTRACT	arg1
388422cf0b2452b1792e45253f643211	25641927	PMC4492121	this host cell line	line	this host cell line	cell line	host cell line	COID702829	ABSTRACT	arg0
db80725d8a23866ea0a8fba18f2e3fe8	25641927	PMC4492121	The recombinant IgG expressed in this host cell line	IgG	The recombinant IgG	antibody	IgG	COID713543	ABSTRACT	arg1
2cfad538773b59ee1ef59405b0d22cbf	25641927	PMC4492121	The recombinant IgG expressed in this host cell line	IgG	The recombinant IgG	antibody	IgG	COID713543	ABSTRACT	arg0
64c709a110742b5ee0661893d10e05cf	25641927	PMC4492121	alpha2,6-linked SA	SA	alpha2,6-linked SA	sugar (subset of carbon source)	SA	COID148212	ABSTRACT	arg1
374af7fa580d7573c4f37c70b604d283	25641927	PMC4492121	ST6GAL1_OE_32 host cell line	line	ST6GAL1_OE_32 host cell line	cell line	host cell line	COID702829	RESULTS	arg0
fdb0f8d29fb89b08d2d7eb712d57a147	25641927	PMC4492121	The IgG produced in ST6GAL1_OE_32 host cell line	IgG	The IgG	antibody	IgG	COID713543	RESULTS	arg1
c3c4cfd94b04954ad4a21624384f5609	25641927	PMC4492121	both ST6GAL1 stable pools	pools	both ST6GAL1 stable pools	enzyme	ST6GAL1	COID749247	RESULTS	arg0
37b48686cb6a136541359aac7a59b85e	25641927	PMC4492121	the IgG produced in both ST6GAL1 stable pools	IgG	the IgG	antibody	IgG	COID713543	RESULTS	arg1
80bdde85a2c29cc6c8b42d1305e11776	25641927	PMC4492121	IgG produced in ST6GAL1_OE_32 host cell line	IgG	IgG	antibody	IgG	COID713543	RESULTS	arg1
6958329cefb7f4066ebd22a3a414ca04	25641927	PMC4492121	two transfections using ST6GAL1_OE_32 host cell line	transfections	two transfections	cell line	host cell line	COID702829	RESULTS	arg0
252c2f67affddb5344a818cb12a37708	25641927	PMC4492121	the two IgG stable pools derived from two transfections using ST6GAL1_OE_32 host cell line	pools	the two IgG stable pools	antibody	IgG	COID713543	RESULTS	arg1
60218e825bab5bbbd0304fe8d71cd49e	25641927	PMC4492121	Clone 27 St6gal1 OE	OE	Clone 27 St6gal1 OE	enzyme	St6gal1	COID749247	RESULTS	arg0
91ab8878a70e9aa4efd64a79f7d9511a	25641927	PMC4492121	IgG produced by Clone 27 St6gal1 OE and the nontransfected control (Supporting Information Figure 2)	IgG	IgG	antibody	IgG	COID713543	RESULTS	arg1
dac4a498b892bcf727737656b2cd66f9	25641927	PMC4492121	IgG produced in both ST6GAL1 stable pools	IgG	IgG	antibody	IgG	COID713543	RESULTS	arg1
09e37855e838fa58a3ca0a2c0b45388b	25641927	PMC4492121	CHOZN GS host cell line (Figure 9C)	line	CHOZN GS host cell line	cell line	host cell line	COID702829	RESULTS	arg0
4588ab4d4c9e11b2c96695582a234bad	25641927	PMC4492121	the control IgG stable pools derived from CHOZN GS host cell line (Figure 9C)	pools	the control IgG stable pools	antibody	IgG	COID713543	RESULTS	arg1
6e7c22951c0b4ca6ca454d58327598bf	25641927	PMC4492121	St3gal6	St3gal6	St3gal6	enzyme	St3gal6	COID373234	RESULTS	arg0
f5e8d29b2d47d1b191eaaa09cc39db8d	25641927	PMC4492121	sialyltransferase	sialyltransferase	sialyltransferase	enzyme	sialyltransferase	COID191824	RESULTS	arg1
f4811559020b5090f0a6ed3ead42e1c4	25641927	PMC4492121	ST6GAL1_OE_31	ST6GAL1_OE_31	ST6GAL1_OE_31	enzyme	ST6GAL1_OE_31	COID749247	RESULTS	arg0
35fd216199d0b075cb64bfab32e4b227	25641927	PMC4492121	several populations that cannot be confirmed to have alpha2,6-linked sialic acid (Figure 8)	populations	several populations	sugar (subset of carbon source)	sialic acid	COID148212	RESULTS	arg1
c4aed60e796b062a8ff50cae01dd35df	25641927	PMC4492121	higher relative content alpha2,6-linked sialylated glycans	glycans	higher relative content alpha2,6-linked sialylated glycans	sugar (subset of carbon source)	sialylated glycans	COID113402	RESULTS	arg0
21658667d5f0e32f9eef2a811d042842	25641927	PMC4492121	ST6GAL1_OE_31	ST6GAL1_OE_31	ST6GAL1_OE_31	enzyme	ST6GAL1_OE_31	COID749247	RESULTS	arg1
80461fc00b566c99fe2196f82f9beea3	25641927	PMC4492121	Chinese Hamster Ovary (CHO) Host Cell Engineering	Engineering	Chinese Hamster Ovary (CHO) Host Cell Engineering	chinese hamster ovary (CHO)	Chinese Hamster Ovary	COID806780	TITLE	arg0
75c9a66980e89642e121104b020a19de	25641927	PMC4492121	Sialyltransferase Expression	Expression	Sialyltransferase Expression	enzyme	Sialyltransferase	COID191824	TITLE	arg1
04519aec6b77f3f1ec05081cd4a65699	25641927	PMC4492121	Chinese Hamster Ovary (CHO) Host Cell Engineering	Engineering	Chinese Hamster Ovary (CHO) Host Cell Engineering	chinese hamster ovary (CHO)	CHO	COID806780	TITLE	arg0
55cfeb986850434452809ed6281e730c	25875452	PMC4622614	sialyl-transferases	sialyl-transferases	sialyl-transferases	enzyme	sialyl-transferases	COID191824	ABSTRACT	arg0
e839eb8abc5369ed1ec13102e884330b	25875452	PMC4622614	the limited sialylation level in the wild-type IgG1 expressed alone or with GT	level	the limited sialylation level	glycosylation	sialylation	COID543327	ABSTRACT	arg1
8aef5d6c7fcbbaa20b37892489126544	25875452	PMC4622614	the glycan interaction with Fc's amino acid residues	interaction	the glycan interaction	sugar (subset of carbon source)	glycan	COID626759	ABSTRACT	arg0
c1113dffad1ee5324ea02f4afee80a25	25875452	PMC4622614	alpha2,6-sialylated glycans in both antibodies	glycans	alpha2,6-sialylated glycans	sugar (subset of carbon source)	sialylated glycans	COID113402	ABSTRACT	arg0
10828af087478b6cc0019e09960a3e48	25875452	PMC4622614	glycoprofile	glycoprofile	glycoprofile	product attributes	glycoprofile	COID135698	ABSTRACT	arg1
05e12459acdb9394560d3e1a55208369	25875452	PMC4622614	The presence of alpha2,6-sialic acids on the Fc N-glycan	presence	The presence	sugar (subset of carbon source)	N-glycan	COID216687	ABSTRACT	arg0
c3d8a63fb6089cf97feb39677bb26521	25875452	PMC4622614	anti-inflammatory properties	properties	anti-inflammatory properties	product attributes	anti-inflammatory properties	COID592241	ABSTRACT	arg1
daadf1f2bcc9a52cfbdb028e9cd76cfe	25875452	PMC4622614	digestion with the alpha2,3SA-specific sialidase S from Streptococcus pneumoniae or the non-specific sialidase A from Arthrobacter ureafaciens	digestion	digestion	enzyme	sialidase	COID070440	RESULTS	arg0
8cf989a6b6cf00501f10c0294ddfcc76	25875452	PMC4622614	The SA linkage types in the glycans	types	The SA linkage types	sugar (subset of carbon source)	SA	COID148212	RESULTS	arg1
b9a2b582729fd155d1cde1c152086f12	25875452	PMC4622614	co-expression of glycosyltransferases	co-expression	co-expression	enzyme	glycosyltransferases	COID225633	RESULTS	arg0
ac2661e663dc4aadf89e888b12816ef2	25875452	PMC4622614	TZM glycoprofiles	glycoprofiles	TZM glycoprofiles	product attributes	glycoprofiles	COID135698	RESULTS	arg1
9dbcdedc1f17086918c64b3bf2b729b0	26910040	PMC4947490	a cell culture process	process	a cell culture process	cell culture parameters	cell culture	COID293414	ABSTRACT	arg0
eddf4be6be19bfc0658ea66d049b306f	26910040	PMC4947490	a monoclonal antibody (mAb)	antibody	a monoclonal antibody	monoclonal antibody	monoclonal antibody	COID242255	ABSTRACT	arg1
9378f0a12d15299978096d90ad872b6a	26910040	PMC4947490	cell respiration	respiration	cell respiration	metabolic pathways	cell respiration	COID898929	ABSTRACT	arg0
3a85fa22b901c25e4f0bd596e40fecaf	26910040	PMC4947490	the deprivation of tyrosine	deprivation	the deprivation	media parameter or raw material	tyrosine	COID500516	ABSTRACT	arg1
fd039b6039456f9baf7e2af27c2d2ce3	26910040	PMC4947490	mAb	mAb	mAb	monoclonal antibody	mAb	COID242255	ABSTRACT	arg1
7cd686eac6a2fead7c2d720cebae39d8	26910040	PMC4947490	the specific productivity in the qP low experiments	productivity	the specific productivity	process condition	specific productivity	COID731421	RESULTS	arg0
cd6cb675918490988be89604efb671a1	26910040	PMC4947490	a pH-dependent behavior	behavior	a pH-dependent behavior	bioreactor conditions	pH	COID893209	RESULTS	arg1
9878f131fa9baef08fe94743e536084d	26910040	PMC4947490	pH	pH	pH	bioreactor conditions	pH	COID893209	RESULTS	arg0
f1ee293a98fdd5dca4ca88d16fc5a345	26910040	PMC4947490	monoclonal antibody (mAb) glycosylation	glycosylation	monoclonal antibody (mAb) glycosylation	monoclonal antibody	monoclonal antibody	COID242255	RESULTS	arg1
714882c51c1519eb2aea2ea83ba68d92	26910040	PMC4947490	monoclonal antibody (mAb) glycosylation	glycosylation	monoclonal antibody (mAb) glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
eb388d9e4d0cc8410ed3013d1133263b	26910040	PMC4947490	monoclonal antibody (mAb) glycosylation	glycosylation	monoclonal antibody (mAb) glycosylation	monoclonal antibody	mAb	COID242255	RESULTS	arg1
9d80d8df4a1cab4dbaf1f0fc842eb716	26910040	PMC4947490	nutrient limitation	limitation	nutrient limitation	secondary raw materials	nutrient	COID423902	RESULTS	arg0
90c144253f61ca95ac5c74aefe4aa552	26910040	PMC4947490	lactate metabolism	metabolism	lactate metabolism	biological process	metabolism	COID291079	RESULTS	arg1
ce92d6c50301d9af0ce3174681742e71	26910040	PMC4947490	lactate metabolism	metabolism	lactate metabolism	by-product or waste	lactate	COID250920	RESULTS	arg1
8da6465a2a82baaa94943b0c2fbca295	26910040	PMC4947490	product formation in our system of interest	formation	product formation	flux rate	product formation	COID187355	RESULTS	arg0
440f0d0a4be41b74ba70627186f43e41	26910040	PMC4947490	cell respiration	respiration	cell respiration	metabolic pathways	cell respiration	COID898929	RESULTS	arg1
75f4de519ff7170c1ef8693d0cb6fc0e	26910040	PMC4947490	the rate of product formation in our system of interest	rate	the rate	flux rate	product formation	COID187355	RESULTS	arg0
24bd13a77af18dd9b8309c9eeaa08671	26910040	PMC4947490	the differences in qP patterns	differences	the differences	flux rate	qP	COID599783	RESULTS	arg0
7c196f3d4ad8d035a479e608720df67c	26910040	PMC4947490	differences in product quality	differences	differences	product quality attributes	product quality	COID111751	RESULTS	arg1
8818c19efba4e46039f4d6d85b140f72	26910040	PMC4947490	the feeding rate in the cultivations without pH shift	rate	the feeding rate	bioreactor conditions	pH	COID893209	RESULTS	arg0
8f4fb11461dec3aad6880caa5d87d9d2	26910040	PMC4947490	the metabolic shift to lactate consumption	shift	the metabolic shift	by-product or waste	lactate	COID250920	RESULTS	arg1
0cbfd5076e31bc8bf1ba41a99b7fbf7f	26910040	PMC4947490	the cultivations without pH shift	cultivations	the cultivations	bioreactor conditions	pH	COID893209	RESULTS	arg0
586a1af02c4b516c4de2562b9eefff9e	26910040	PMC4947490	several time points of the cultivations	points	several time points	process parameters or process control	time	COID742277	RESULTS	arg0
8de53c6360ab46b38ba70ecdca182fed	26910040	PMC4947490	An important CQA	CQA	An important CQA	product quality attributes	CQA	COID162607	RESULTS	arg1
9c6abbc95b6b5232d0644ce2111b567b	26910040	PMC4947490	product glycosylation	glycosylation	product glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
0eb456e3e02db40363f6f25fd0336ac2	26910040	PMC4947490	The relationship of respiratory activity and specific productivity	relationship	The relationship	process condition	specific productivity	COID731421	RESULTS	arg0
2bedd4dc72f96bc0d8fc23fb35dafe7f	26910040	PMC4947490	a pH-dependent pattern (Fig. 7d)	pattern	a pH-dependent pattern	bioreactor conditions	pH	COID893209	RESULTS	arg1
2d15c45ea171e3921602d8205c11303e	26910040	PMC4947490	high mannose content	content	high mannose content	sugar (subset of carbon source)	high mannose	COID981337	RESULTS	arg0
8f39077c857a398e9eb94aeafc153938	26910040	PMC4947490	specific productivity	productivity	specific productivity	process condition	specific productivity	COID731421	RESULTS	arg1
9688b6b727b0130245000c01e22d87a0	26910040	PMC4947490	the exhaustion of tyrosine	exhaustion	the exhaustion	media parameter or raw material	tyrosine	COID500516	RESULTS	arg0
7139c85de76d64a1579ba923bb83f61e	26910040	PMC4947490	qP	qP	qP	flux rate	qP	COID599783	RESULTS	arg1
fc7d782ed280da4c24ce506020cc937a	26910040	PMC4947490	the high amount of new product molecules at high qP	amount	the high amount	flux rate	qP	COID599783	RESULTS	arg0
3d6f0c3f48730b922732ca3d853a583e	26910040	PMC4947490	the distribution of glycoforms in the respective samples	distribution	the distribution	recombinant protein	glycoforms	COID288767	RESULTS	arg1
bfd53d6609c2c90ddd0ef0d3cee3c204	26910040	PMC4947490	product formation	formation	product formation	flux rate	product formation	COID187355	RESULTS	arg0
1b5f49dacb923cb5afe9c904f4014de5	26910040	PMC4947490	the rate of product formation	rate	the rate	flux rate	product formation	COID187355	RESULTS	arg0
be090f476933876b96d5dfc2c33a6449	26910040	PMC4947490	the increase of qP	increase	the increase	flux rate	qP	COID599783	RESULTS	arg0
e4e5f63f863088b3df63cc34c682fd9b	26910040	PMC4947490	the accumulation of pre-mature glycoforms	accumulation	the accumulation	recombinant protein	glycoforms	COID288767	RESULTS	arg1
104fd7c6428bdd783d53480ca2f6c006	26910040	PMC4947490	the setpoint of the pH shift	setpoint	the setpoint	bioreactor conditions	pH	COID893209	RESULTS	arg0
c9688eb0802cf583bf95627cbb1b328b	26910040	PMC4947490	osmolality profiles	profiles	osmolality profiles	process parameters or process control	osmolality	COID710653	RESULTS	arg1
d9812d8c08d078a986cc54aa274fa00b	26910040	PMC4947490	pH shift	shift	pH shift	bioreactor conditions	pH	COID893209	RESULTS	arg0
a844f605f3cd5c240127b571fff67888	26910040	PMC4947490	the relationship between qO2 and qP	relationship	the relationship	flux rate	qP	COID599783	RESULTS	arg1
db2bd782f8d9b6eba3bdbdabc66d78f1	26910040	PMC4947490	the bolus-fed cultivations	cultivations	the bolus-fed cultivations	process parameters or process control	bolus	COID693522	RESULTS	arg1
b53ac97add3bc5aa50bd13975f10a9af	26910040	PMC4947490	the first decrease in OUR	decrease	the first decrease	biological process	OUR	COID844361	RESULTS	arg0
4da7fef1d20261d02a7053ed84c4f687	26910040	PMC4947490	the cultivations with cell line B (day 7)	cultivations	the cultivations	cell line	cell line	COID702829	RESULTS	arg1
829df049a2fd98095a0735ef009e96ae	26910040	PMC4947490	the cell line A cultures (day 8)	cultures	the cell line A cultures	cell line	cell line	COID702829	RESULTS	arg1
32bf4bed8efefe457ca20f765ce2e6fc	27559765	PMC5098448	Chinese hamster ovary cells	cells	Chinese hamster ovary cells	chinese hamster ovary (CHO)	Chinese hamster ovary cells	COID806780	ABSTRACT	arg0
70c2f1665c4c5a1e4fc03c8b095664c8	27559765	PMC5098448	a recombinant antibody produced in Chinese hamster ovary cells	antibody	a recombinant antibody	antibody	antibody	COID278523	ABSTRACT	arg1
d4c3d0303a5660cabac2c61a98c2ad32	27559765	PMC5098448	the chimeric anti-GD2 antibody	antibody	the chimeric anti-GD2 antibody	antibody	chimeric anti-GD2 antibody	COID593142	ABSTRACT	arg1
8ff4486ac455f48a0ffbddb64da98ca7	27559765	PMC5098448	structural stability	stability	structural stability	process condition	stability	COID548988	ABSTRACT	arg0
d712b355912a4e47a3ed16afaeaa498b	27559765	PMC5098448	individual charge variant fractions by nano differential scanning calorimetry	fractions	individual charge variant fractions	product quality profile	charge variant	COID817650	ABSTRACT	arg1
4ff4e82e95d7ed96bc082d5984f65cdd	27559765	PMC5098448	sialylation content	content	sialylation content	glycosylation	sialylation	COID543327	RESULTS	arg0
47674a242f80672b4eb96eb1512872cb	27559765	PMC5098448	antibody in-vitro efficacy	efficacy	antibody in-vitro efficacy	clinical outcomes	efficacy	COID912630	RESULTS	arg1
a7b63f91f02a9987f7eb09cbe2830a7e	27559765	PMC5098448	antibody in-vitro efficacy	efficacy	antibody in-vitro efficacy	antibody	antibody	COID278523	RESULTS	arg1
902e79ea933d4d1b529d1d126df18ebd	27559765	PMC5098448	temperature	temperature	temperature	bioreactor conditions	temperature	COID692615	RESULTS	arg0
3ea3a240b96909d3707a37464e78c562	27559765	PMC5098448	the microheterogeneity pattern of a protein solution	pattern	the microheterogeneity pattern	clinical outcomes	microheterogeneity	COID021590	RESULTS	arg1
de8a694d5beb70a27d8fbb82e4d2bd2b	27559765	PMC5098448	Oxidation of methionine and tryptophan residues by itself	Oxidation	Oxidation	PTM	Oxidation	COID907585	RESULTS	arg0
c2553cabae21f05b7b9bd5a82b5f5b05	27559765	PMC5098448	the charge heterogeneity of a given sample	heterogeneity	the charge heterogeneity	product quality attributes	charge heterogeneity	COID995406	RESULTS	arg1
98fbf650122ac9b1887ba83dd52daf22	27559765	PMC5098448	the overall deamidation levels in the molecule	levels	the overall deamidation levels	PTM	deamidation	COID565107	RESULTS	arg0
0c1016287721af0de0a832509f445da2	27559765	PMC5098448	the observed microheterogeneity pattern	pattern	the observed microheterogeneity pattern	clinical outcomes	microheterogeneity	COID021590	RESULTS	arg1
8538a37e2b3199fcad6f6204a3bb5ea3	27559765	PMC5098448	the presence of sialic acid	presence	the presence	sugar (subset of carbon source)	sialic acid	COID148212	RESULTS	arg0
60ba6f420775ed793e14aa1c06c52d4c	27559765	PMC5098448	the pI of a monoclonal antibody molecule	pI	the pI	monoclonal antibody	monoclonal antibody	COID242255	RESULTS	arg1
6d51cc49638569e89bc3d0aa9d56a827	27559765	PMC5098448	The fourth group of target glycan structures in this study, the complex type non-galactosylated molecules,	group	The fourth group	sugar (subset of carbon source)	glycan structures	COID684992	RESULTS	arg0
ef2f6e2200bc9d307c19b3ad04569a20	27559765	PMC5098448	the affinity of an antibody molecule toward C1q, the initial component of the complement cascade	affinity	the affinity	antibody	antibody	COID278523	RESULTS	arg1
f22f604d3f23022c5232153a6fbf3fab	27559765	PMC5098448	the performance in CDC assays	performance	the performance	clinical outcomes	CDC	COID455860	RESULTS	arg1
c9abc6af24d605c52ee740b41603f5c6	27559765	PMC5098448	microheterogeneity	microheterogeneity	microheterogeneity	clinical outcomes	microheterogeneity	COID021590	RESULTS	arg0
273dd7c3ece210eb2c8dca84e4b11911	27559765	PMC5098448	effector functions	functions	effector functions	process condition	functions	COID532355	RESULTS	arg1
9260f22c695a5ce76471166d139c7f2a	27559765	PMC5098448	the obtained sialylation profile of the individual isoform fractions	profile	the obtained sialylation profile	glycosylation	sialylation	COID543327	RESULTS	arg0
1044eb86c293b59c5fbef43d232cad9e	27559765	PMC5098448	the ADCC data	data	the ADCC data	clinical outcomes	ADCC	COID386333	RESULTS	arg1
c8d4648c060438941da5e30fed9ef8d8	27752770	PMC5274649	process parameters	parameters	process parameters	process parameters or process control	process parameters	COID163282	ABSTRACT	arg0
9f6676dd2f421981ac7b8769073c7e89	27752770	PMC5274649	amino acid metabolism	metabolism	amino acid metabolism	biological process	metabolism	COID291079	ABSTRACT	arg1
9953bd61ab8d9196cef7638ac95227c0	27752770	PMC5274649	amino acid metabolism	metabolism	amino acid metabolism	amino acid (subset of substrates)	amino acid	COID693703	ABSTRACT	arg1
c5f3514c64649059885433beac755a18	27752770	PMC5274649	specific productivity	productivity	specific productivity	process condition	specific productivity	COID731421	ABSTRACT	arg1
a4da15fb450ea5c45567ce5a6770f095	27752770	PMC5274649	specific cell growth	growth	specific cell growth	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
7dbbd0f2171047b741ec353307f32db7	27752770	PMC5274649	the specific cell line	line	the specific cell line	cell line	cell line	COID702829	RESULTS	arg0
c144e96326c2adb40416b68301eef3e6	27752770	PMC5274649	Literature about the influence of process parameters on mAb glycosylation	Literature	Literature	process parameters or process control	process parameters	COID163282	RESULTS	arg1
3f16865cbca1edfcb648225430f1cde2	27752770	PMC5274649	Literature about the influence of process parameters on mAb glycosylation	Literature	Literature	glycosylation	glycosylation	COID119643	RESULTS	arg1
728a3b7a23a5def7c573b34792434134	27752770	PMC5274649	Literature about the influence of process parameters on mAb glycosylation	Literature	Literature	monoclonal antibody	mAb	COID242255	RESULTS	arg1
6282196233f29f72465bf0dc5534eee1	27752770	PMC5274649	cultivation conditions	conditions	cultivation conditions	media characteristics	cultivation conditions	COID699462	RESULTS	arg0
a2e2aea26af8c57647c5fc3f3b8cb996	27752770	PMC5274649	process conditions	conditions	process conditions	process condition	process conditions	COID106153	RESULTS	arg0
e9ddbeebb20ee8cbd7aaa23f33851afb	27752770	PMC5274649	The average specific IgG production rate q P	rate	The average specific IgG production rate	process parameters or process control	production rate	COID014362	RESULTS	arg1
060098e0e4a29cfa15dfe486e9560cdd	27752770	PMC5274649	The average specific IgG production rate q P	rate	The average specific IgG production rate	antibody	IgG	COID713543	RESULTS	arg1
f6be2b4c756a025aa8686578e1220e5c	27752770	PMC5274649	process parameters	parameters	process parameters	process parameters or process control	process parameters	COID163282	RESULTS	arg0
80c4bab84f0d8ba4681cfa8e62547940	27752770	PMC5274649	mAb glycosylation	glycosylation	mAb glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
d3b40ca9c2ade980e9a7a5035a7291c6	27752770	PMC5274649	mAb glycosylation	glycosylation	mAb glycosylation	monoclonal antibody	mAb	COID242255	RESULTS	arg1
9a3282797286bbf2bd20bd3593b70dd7	27752770	PMC5274649	process conditions (Table 1)	conditions	process conditions	process condition	process conditions	COID106153	RESULTS	arg0
a8f54b19433401fb511de5b079566f6a	27752770	PMC5274649	The average specific lactate production rate q lac	rate	The average specific lactate production rate q lac	process parameters or process control	production rate	COID014362	RESULTS	arg1
df73d708229810d370b658dcf53d3565	27752770	PMC5274649	The average specific lactate production rate q lac	rate	The average specific lactate production rate q lac	by-product or waste	lactate	COID250920	RESULTS	arg1
366ae06599e1ef5f3739e81538557939	27752770	PMC5274649	process pH	pH	process pH	bioreactor conditions	pH	COID893209	RESULTS	arg0
4435ce06ddf99aec215fbe0cfe7420cf	27752770	PMC5274649	product quality data attributed to process pH	data	product quality data	product quality attributes	product quality	COID111751	RESULTS	arg1
543d776ed5f406be120cfc477fe59230	27752770	PMC5274649	Similar to Li et al. low levels of lactate during the lactate consumption phase, present at most processes at pH 7.0 and 6.8,	levels	Similar to Li et al. low levels	by-product or waste	lactate	COID250920	RESULTS	arg0
4e1c9b713da9950688e1d4306e7e6c87	27752770	PMC5274649	the consumption of alanine (data not shown)	consumption	the consumption	amino acid (subset of substrates)	alanine	COID060748	RESULTS	arg1
853753513173e2f23f3706e3b3d7bacf	27752770	PMC5274649	Similar to Li et al. low levels of lactate during the lactate consumption phase, present at most processes at pH 7.0 and 6.8,	levels	Similar to Li et al. low levels	bioreactor conditions	pH	COID893209	RESULTS	arg0
a568fa93d1bcd8cd7f517b2807c83679	27752770	PMC5274649	pH	pH	pH	bioreactor conditions	pH	COID893209	RESULTS	arg0
0fa3f509760c614a6684d884740e5630	27752770	PMC5274649	The mean specific glutamine uptake rate	rate	The mean specific glutamine uptake rate	biological process	uptake rate	COID844360	RESULTS	arg1
f865a7b1bdc1bbfee9f3195bbf7b5830	27752770	PMC5274649	The mean specific glutamine uptake rate	rate	The mean specific glutamine uptake rate	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg1
f2f57cdda0f9a4c45e8dec015d81d62f	27752770	PMC5274649	pCO2	pCO2	pCO2	process condition	pCO2	COID255565	RESULTS	arg0
b3098f6fc88b7b1809e03bb4474bf08e	27752770	PMC5274649	Deamidation	Deamidation	Deamidation	PTM	Deamidation	COID565107	RESULTS	arg0
87056f68875376ee66753ac5e498ce98	27752770	PMC5274649	heterogeneity; affect protein crystallization, stability and efficacy	heterogeneity	heterogeneity	clinical outcomes	heterogeneity	COID021590	RESULTS	arg1
4f8d9152f5b415a7f46c5d5c0a5d06b9	27752770	PMC5274649	glutamine	glutamine	glutamine	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg0
9d4997b6fd5325a62240ec27e01249a0	27752770	PMC5274649	CHO cell metabolism	metabolism	CHO cell metabolism	biological process	metabolism	COID291079	RESULTS	arg1
862a6000ef4e98f96bb44d4797917c92	27752770	PMC5274649	CHO cell metabolism	metabolism	CHO cell metabolism	chinese hamster ovary (CHO)	CHO	COID806780	RESULTS	arg1
294ca1daf20c7b60215a394f820261cb	27752770	PMC5274649	glucose	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
08c381e94475e5ecde18cd13d07f7ae9	27752770	PMC5274649	determination of viable and total cell densities (VCD and TCD)	determination	determination	cell culture parameters	cell densities	COID283414	RESULTS	arg0
a76606225b168ddc10e704173bd6fded	27752770	PMC5274649	growth	growth	specific cell growth and cell viabilities	cell culture parameters	growth	COID203666	RESULTS	arg1
970cfc4a43946603c7c3445cae7ad441	27752770	PMC5274649	determination of viable and total cell densities (VCD and TCD)	determination	determination	cell culture parameters	VCD	COID384695	RESULTS	arg0
78d45b3d22400850e2ac89df59ac3090	27752770	PMC5274649	viabilities	viabilities	specific cell growth and cell viabilities	process parameters or process control	viabilities	COID222142	RESULTS	arg1
592e8f6322c883fd8564abc9cfc0bcf4	27752770	PMC5274649	culture pH (Table 4)	pH	culture pH	bioreactor conditions	culture pH	COID689332	RESULTS	arg0
208fff6d7dfc0f5d0926223f27031beb	27752770	PMC5274649	(i) The content of acidic charge variant 1 (deamidation of asparagine to aspartate on one light chain)	content	The content	product quality attributes	acidic charge variant	COID086024	RESULTS	arg1
d8a011d7542dfb567dd334922298aa4d	27752770	PMC5274649	(i) The content of acidic charge variant 1 (deamidation of asparagine to aspartate on one light chain)	content	The content	PTM	deamidation	COID565107	RESULTS	arg1
ef8000c63c0e7089fef47e2d05bc113d	27752770	PMC5274649	19 other amino acids	acids	19 other amino acids	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg1
9b0633a2c442b03a54f8f3551cd4d20c	27752770	PMC5274649	cell specific productivity	productivity	cell specific productivity	process condition	cell specific productivity	COID637897	RESULTS	arg1
6ed0b92a100d57936441eae4806b7629	27752770	PMC5274649	sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
a4251fa2b0a5c6de1c7c53d1ec94cdd6	27752770	PMC5274649	afucosylation	afucosylation	afucosylation	glycosylation	afucosylation	COID653555	RESULTS	arg1
dc6d8e4bc2744b5d3ece801fdd8037e4	27752770	PMC5274649	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
ab3fc90030428cf048f3fb9d8c977f84	27752770	PMC5274649	the deamidation reaction	reaction	the deamidation reaction	PTM	deamidation	COID565107	RESULTS	arg0
388f5497aa0d6acb57d935ba455504ad	27752770	PMC5274649	acidic charge variant 1	variant	acidic charge variant 1	product quality attributes	acidic charge variant	COID086024	RESULTS	arg1
6f05580a87a95046bb8f6ad18691a3a3	27752770	PMC5274649	monoclonal antibody production	production	monoclonal antibody production	monoclonal antibody	monoclonal antibody	COID242255	RESULTS	arg0
ac6f3d2bf77c6818727dfe76dc21a476	27752770	PMC5274649	C-terminal lysine residues	residues	C-terminal lysine residues	amino acid (subset of substrates)	C-terminal lysine	COID549534	RESULTS	arg1
e2ef4274ac2aaa09dda44d04bf00ca82	27752770	PMC5274649	specific growth	growth	specific growth	cell culture parameters	growth	COID203666	RESULTS	arg1
abaaaef82c375ebf0bd4ce3e6c7d31d3	27752770	PMC5274649	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
fb39951bd7a36db4c634811cba604522	27752770	PMC5274649	specific cell growth	growth	specific cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
2a08df297e38741a76063ac26d05428b	27752770	PMC5274649	specific productivity	productivity	specific productivity	process condition	specific productivity	COID731421	RESULTS	arg1
1423e66402b04b57c4f2251d90af76cb	27752770	PMC5274649	pO2	pO2	pO2	process condition	pO2	COID790678	RESULTS	arg0
c280524da460587a7abcd5d2f66c4e99	27752770	PMC5274649	q p	p	q p	flux rate	q p	COID599783	RESULTS	arg1
2f0969a30b080d92cdd3c0282ce16c12	27752770	PMC5274649	various amino acid consumption rates	rates	various amino acid consumption rates	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg1
81abf3617e46e9449ffe0c4c82f669c6	27752770	PMC5274649	Increased pCO2	pCO2	Increased pCO2	process condition	pCO2	COID255565	RESULTS	arg0
4c6fba98aa9358f9ff88f307d924d75a	27752770	PMC5274649	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
9eb5082b9b29fb07562583ef0ffbb539	27752770	PMC5274649	high sialylation	sialylation	high sialylation	glycosylation	sialylation	COID543327	RESULTS	arg0
04ce1018d0513ed5f0936f94c0a0e8dc	27752770	PMC5274649	Mannose 6 variants	variants	Mannose 6 variants	sugar (subset of carbon source)	Mannose	COID906305	RESULTS	arg1
8aa5c071580c9384e829a139f3947b06	27752770	PMC5274649	increased pO2	pO2	increased pO2	process condition	pO2	COID790678	RESULTS	arg0
2d0226af2e307c023bd73ba3def5a259	27752770	PMC5274649	glycosylation variant bG1SA_2	variant	glycosylation variant bG1SA_2	glycosylation	glycosylation	COID119643	RESULTS	arg1
384eb8f3949c685ff4f1aabe2c607bcb	27752770	PMC5274649	viabilities	viabilities	The overall batch process time and mean cell viabilities	process parameters or process control	viabilities	COID222142	RESULTS	arg0
687f39832de791a5c439659b1cab2c6f	27752770	PMC5274649	process pH	pH	process pH	bioreactor conditions	pH	COID893209	RESULTS	arg1
58c092b6ca1c8a559c41a55f9c9d3366	27752770	PMC5274649	pO2	pO2	pO2	process condition	pO2	COID790678	RESULTS	arg1
8d0633b488727a6678b98dc7910a9109	27752770	PMC5274649	pCO2	pCO2	pCO2	process condition	pCO2	COID255565	RESULTS	arg1
b98cfc60803c371a1d8214cd24015d1a	27752770	PMC5274649	time	time	The overall batch process time and mean cell viabilities	process parameters or process control	time	COID742277	RESULTS	arg0
91b3b6e2ab270962c31f49d733619de3	27752770	PMC5274649	acidic variant 2	variant	acidic variant 2	acid (subset of secondary raw materials)	acidic variant	COID106814	RESULTS	arg1
fe9ccb10a999943c3833e9ef039f5179	27752770	PMC5274649	culture pH (Fig. 4; Table 4)	pH	culture pH	bioreactor conditions	culture pH	COID689332	RESULTS	arg0
f6665a9bb5deac5e960ccef6045c9af1	27752770	PMC5274649	basic charge variant 2	variant	basic charge variant 2	product quality profile	charge variant	COID817650	RESULTS	arg1
1b1ecd99bf680bf4ee4b82949df8d698	27752770	PMC5274649	process pH whereby lowest rates were reduced to around 60 % when compared to the maximum consumption rates obtained in this DoE	pH	process pH	bioreactor conditions	pH	COID893209	RESULTS	arg0
1068eda0eea92057c43711c0493e536c	27752770	PMC5274649	q gluc	gluc	q gluc	sugar (subset of carbon source)	q gluc	COID367406	RESULTS	arg1
69255c0ad12727eeb54e7b002004a975	27752770	PMC5274649	GI values	values	GI values	product attributes	GI	COID293764	RESULTS	arg0
f8b61d5d5a59639c085ea714c5f01710	27752770	PMC5274649	aFI and SI values (Fig. 5a linear determination coefficient R 2 = 0.66; Fig. 5b linear determination coefficient R 2 = 0.36)	values	aFI and SI values	product attributes	SI	COID283454	RESULTS	arg1
727c05b39f4db5d888f88a8909fa7a52	27752770	PMC5274649	culture pH	pH	culture pH	bioreactor conditions	culture pH	COID689332	RESULTS	arg0
39b2fc918d758abdd5f256eaa39fb3a7	27752770	PMC5274649	basic charge variant 3	variant	basic charge variant 3	product quality profile	charge variant	COID817650	RESULTS	arg1
ef595e67aa17e79d358f7c7d7139e056	27752770	PMC5274649	specific ammonia production	production	specific ammonia production	by-product or waste	ammonia	COID714278	RESULTS	arg1
6ca7b35d8c0abd47fd8bca566b93b8fe	27752770	PMC5274649	lactate production	production	lactate production	by-product or waste	lactate	COID250920	RESULTS	arg0
c7cf939b14542db47837b5dc2fd0f3a9	27752770	PMC5274649	pH	pH	pH	bioreactor conditions	pH	COID893209	RESULTS	arg1
6f5c51a78d20351d3a9f8b6d99421c5a	28597152	PMC5777974	the core heptasaccharide that generate structural heterogeneity (glycoforms)	core	the core heptasaccharide	saccharides (subset of secondary raw materials)	heptasaccharide	COID475381	ABSTRACT	arg0
3e7060ddcfc2a88510bf20cac6cb7697	28597152	PMC5777974	structural heterogeneity (glycoforms)	glycoforms	structural heterogeneity (glycoforms)	clinical outcomes	heterogeneity	COID021590	ABSTRACT	arg1
d90bafa4c86ff00eeea0bc57e8db0fea	28597152	PMC5777974	structural heterogeneity (glycoforms)	glycoforms	structural heterogeneity (glycoforms)	recombinant protein	glycoforms	COID288767	ABSTRACT	arg1
c0795d3953317152de0db0e4df953887	28597152	PMC5777974	outer-arm sugars attached to the core heptasaccharide that generate structural heterogeneity (glycoforms)	sugars	outer-arm sugars	saccharides (subset of secondary raw materials)	heptasaccharide	COID475381	ABSTRACT	arg0
3340a2eaa61b0bff93093b132d47817e	28597152	PMC5777974	unique biological activities	activities	unique biological activities	clinical outcomes	biological activities	COID518861	ABSTRACT	arg1
52dd369a5ed4763c187730f6844414d5	28597152	PMC5777974	outer-arm sugars attached to the core heptasaccharide that generate structural heterogeneity (glycoforms)	sugars	outer-arm sugars	clinical outcomes	heterogeneity	COID021590	ABSTRACT	arg0
6fe2a9013c5d0e30a320831f1217448b	28597152	PMC5777974	outer-arm sugars attached to the core heptasaccharide that generate structural heterogeneity (glycoforms)	sugars	outer-arm sugars	recombinant protein	glycoforms	COID288767	ABSTRACT	arg0
0d94408a4e1885848418684755192fde	28597152	PMC5777974	outer-arm sugars attached to the core heptasaccharide that generate structural heterogeneity (glycoforms)	sugars	outer-arm sugars	clinical outcomes	heterogeneity	COID021590	ABSTRACT	arg1
59bf9aebfbe517956f82db92117e2db9	28597152	PMC5777974	outer-arm sugars attached to the core heptasaccharide that generate structural heterogeneity (glycoforms)	sugars	outer-arm sugars	recombinant protein	glycoforms	COID288767	ABSTRACT	arg1
9b1686ef575635c79dba70418dcb967a	28597152	PMC5777974	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg0
f1ddba495f4fac79cd5b49cbea5fcfa2	28597152	PMC5777974	structure/function	structure/function	structure/function	process condition	function	COID532355	ABSTRACT	arg1
21581eaa521efbe6b1647656184121e2	28597152	PMC5777974	fucose	fucose	fucose	sugar (subset of carbon source)	fucose	COID275575	ABSTRACT	arg0
169f9db26ad23663bfc06bd4874ed746	28597152	PMC5777974	efficient and quantitative glycan analysis techniques	techniques	efficient and quantitative glycan analysis techniques	sugar (subset of carbon source)	glycan	COID626759	ABSTRACT	arg0
35d90dc458c601f271c1865b7e916b49	28597152	PMC5777974	quality control	control	quality control	product quality attributes	quality	COID109463	ABSTRACT	arg1
fc401d2f9af4ee771daeafe70844ebf8	28921534	PMC5765507	this cell line	line	this cell line	cell line	cell line	COID702829	ABSTRACT	arg0
911ff44125ca3b1cecd63de423543b2e	28921534	PMC5765507	the production of bi-antennary glycan structures for further processing	production	the production	sugar (subset of carbon source)	glycan structures	COID684992	ABSTRACT	arg1
1d1eddd8d85ba20b81dee775965495ab	28921534	PMC5765507	Mild hypothermia	hypothermia	Mild hypothermia	process parameters or process control	hypothermia	COID361582	ABSTRACT	arg0
1d4bfeb80376e8586582f249396d0204	28921534	PMC5765507	specific protein productivity	productivity	specific protein productivity	process condition	productivity	COID731421	ABSTRACT	arg1
7b6ec9190229a0472ea242568bb3ee6d	28921534	PMC5765507	mild hypothermic temperatures	temperatures	mild hypothermic temperatures	bioreactor conditions	hypothermic temperatures	COID331219	ABSTRACT	arg0
e33875788da02ec00d7d861fcc7a58d9	28921534	PMC5765507	quality	quality	quality	product quality attributes	quality	COID109463	ABSTRACT	arg1
dbb4a84715ea61f5f9d419ccbec405e0	28921534	PMC5765507	yield	yield	yield	overall titer or batch yield	yield	COID809703	ABSTRACT	arg1
a30d04c8aaf919864441845d194b431b	28921534	PMC5765507	the fast provision of recombinant protein material	provision	the fast provision	recombinant protein	recombinant protein	COID593158	ABSTRACT	arg0
b15aa33f9128c0378a1d192d0f4077db	28921534	PMC5765507	Transient gene expression (TGE)	expression	Transient gene expression	genotype	gene	COID185502	ABSTRACT	arg1
a27b074b5896a1a09c968c6990f0c8eb	29511312	PMC5840386	a CHO-K1 cell line that produces an anti-Her2 monoclonal antibody	line	a CHO-K1 cell line	chinese hamster ovary (CHO)	CHO-K1 cell line	COID324081	RESULTS	arg0
1406baa2685b0197f072e8664045d65f	29511312	PMC5840386	an anti-Her2 monoclonal antibody	antibody	an anti-Her2 monoclonal antibody	monoclonal antibody	monoclonal antibody	COID242255	RESULTS	arg1
9114675844038e46875f50bfd85cc174	29511312	PMC5840386	0.5, 1, 2, 3, 10 or 20 g/l maltose	maltose	0.5, 1, 2, 3, 10 or 20 g/l maltose	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
15929c0753913217353cdeafa75c6714	29511312	PMC5840386	4 g/l glucose supplemented with 0.5, 1, 2, 3, 10 or 20 g/l maltose, which gave maximum viable cell densities greater than 8 x 106 cells/ml	glucose	4 g/l glucose	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
6fc348ea5d9a01642462f6ac9789dffa	29511312	PMC5840386	4 g/l glucose	glucose	4 g/l glucose	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
b3c8370c3c622e2fbe2c5e99d0250c07	29511312	PMC5840386	media supplemented with 4 g/l glucose and 10 g/l or 20 g/l maltose	media	media	media characteristics	media	COID913636	RESULTS	arg1
236866c16944a7691f18f3a09ac82ce2	29511312	PMC5840386	10 g/l or 20 g/l maltose	maltose	10 g/l or 20 g/l maltose	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
c8b7a108fcd04ac9308e051ef59b2d5d	29511312	PMC5840386	their corresponding glucose culture having the same total sugar concentration	culture	their corresponding glucose culture	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
60854fa690424b8cc40132a93088269a	29511312	PMC5840386	maltose supplemented cultures with their corresponding glucose culture having the same total sugar concentration	maltose	maltose	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg1
c2c3bcbfb3c59965e9acb57a5cef3e53	29511312	PMC5840386	the maltose-supplemented fed-batch cultures	cultures	the maltose-supplemented fed-batch cultures	process mode	fed-batch	COID529446	RESULTS	arg0
0a92d173e91b3fa8b793cf5fc57f2de4	29511312	PMC5840386	maximum IgG titers observed in the maltose-supplemented fed-batch cultures	titers	maximum IgG titers	overall titer or batch yield	IgG titers	COID814559	RESULTS	arg1
b53ae50f5b62e82a606769c20084a3fc	29511312	PMC5840386	the maltose-supplemented fed-batch cultures	cultures	the maltose-supplemented fed-batch cultures	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
88c995111f7bf64a15e2e3d52f644704	29511312	PMC5840386	glutamine (and potentially other amino acids)	glutamine	glutamine	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg0
0d840397028c6af0de3969d72a42ab9e	29511312	PMC5840386	ammonium production	production	ammonium production	culture condition	ammonium	COID714150	RESULTS	arg1
da364cd25922c2defe6ba570c911cfaf	29511312	PMC5840386	the batch cultures (Fig. 3)	cultures	the batch cultures	process mode	batch	COID285438	RESULTS	arg0
cb476877fc373e5b0e5b80e172bb2d03	29511312	PMC5840386	the lactate consumption observed in the batch cultures (Fig. 3)	consumption	the lactate consumption	by-product or waste	lactate	COID250920	RESULTS	arg1
d0cfe73693839914065b4eb9c10c6e46	29511312	PMC5840386	the higher lactate levels in the glucose cultures	levels	the higher lactate levels	by-product or waste	lactate	COID250920	RESULTS	arg0
4da17efc7fb8c9610bbf395f54c5e0ca	29511312	PMC5840386	the IgG productivities from Day 7	productivities	the IgG productivities	antibody	IgG	COID713543	RESULTS	arg1
39f6a345f30f3f4fbd6bcc0677f39618	29511312	PMC5840386	the maltose-supplemented cultures	cultures	the maltose-supplemented cultures	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
bed7498c324786bf4afb5fa72f0e9634	29511312	PMC5840386	the glucose-only fed-batch cultures	cultures	the glucose-only fed-batch cultures	process mode	fed-batch	COID529446	RESULTS	arg1
8318bfc426f5e30a81d4705befddbe52	29511312	PMC5840386	the glucose-only fed-batch cultures	cultures	the glucose-only fed-batch cultures	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
3efffbae5f1ef17787fe1f5d8b8843f5	29511312	PMC5840386	maltose supplementation	supplementation	maltose supplementation	secondary raw materials	supplementation	COID566710	RESULTS	arg0
66453571d8a8a6a2e32150fe56ad8668	29511312	PMC5840386	glycan profiles in a way that is mostly similar to a later harvest	profiles	glycan profiles	product quality attributes	glycan profiles	COID521331	RESULTS	arg1
bb30f61e58f96b269acf3b2f3da774f1	29511312	PMC5840386	maltose supplementation	supplementation	maltose supplementation	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
b83165e6ac83bf09b53bebb82c01d43d	29511312	PMC5840386	glutamine	glutamine	glutamine	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg0
22fed22879a50d00f06625191240430d	29511312	PMC5840386	IgG productivity	productivity	IgG productivity	process condition	productivity	COID731421	RESULTS	arg1
69db40a80f804f0006c2b7940cb55657	29511312	PMC5840386	IgG productivity	productivity	IgG productivity	antibody	IgG	COID713543	RESULTS	arg1
fc8f3399989989be9fec57500d54ba0d	29511312	PMC5840386	20 g/l maltose	maltose	20 g/l maltose	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
597547e8ee54cd6d90f364bb41fa7dd0	29511312	PMC5840386	media supplemented with 4 g/l glucose and 20 g/l maltose	media	media	media characteristics	media	COID913636	RESULTS	arg1
8152d73fb1538220077545e521522b2a	29511312	PMC5840386	specific glutamine consumption rates	rates	specific glutamine consumption rates	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg0
e97e36deb7ae6b8cdba290531c36aa96	29511312	PMC5840386	the maltose-supplemented and glucose-only cultures (Table 2)	cultures	the maltose-supplemented and glucose-only cultures	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
98f2a9110177d76c0a7c3a7fe560e327	29511312	PMC5840386	the maltose-supplemented and glucose-only cultures (Table 2)	cultures	the maltose-supplemented and glucose-only cultures	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg1
57aaebfacbb7cd123898317e2e4c9640	29511312	PMC5840386	similar culture glucose concentrations	concentrations	similar culture glucose concentrations	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
b934872647d45a652bf7a99654aaa95e	29511312	PMC5840386	similar levels of high-mannose glycans	levels	similar levels	sugar (subset of carbon source)	high-mannose	COID981337	RESULTS	arg0
2c93756515735736cfbb68e76b781851	29511312	PMC5840386	maltose supplementation	supplementation	maltose supplementation	secondary raw materials	supplementation	COID566710	RESULTS	arg1
1850e3f627eb5a4cc9e4aafe33d44c73	29511312	PMC5840386	maltose supplementation	supplementation	maltose supplementation	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg1
81c03af463ed84fb607c19db801a22f3	29511312	PMC5840386	similar levels of high-mannose glycans	levels	similar levels	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg0
0e4fa6975cf377dc19a0704f447f30e4	29511312	PMC5840386	glucose-only cultures	cultures	glucose-only cultures	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
3470b9e71f3f3afee588f090d3c5b245	29511312	PMC5840386	glucose	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
ead9c1c1793a86ce0b94de1fd4ecc059	29511312	PMC5840386	osmolality	osmolality	osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg1
2c7a7fa4ed2e5bc4de957e754d51a3e0	29511312	PMC5840386	the 20 g/l maltose supplemented culture	culture	the 20 g/l maltose supplemented culture	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
628912cc5838518f85aee80041944f66	29511312	PMC5840386	a maximum IgG titer of 298 mg/l	titer	a maximum IgG titer	overall titer or batch yield	IgG titer	COID814559	RESULTS	arg1
48197f9ef078ca53954ca9986de1c7f8	29511312	PMC5840386	the same mass concentrations of maltose	concentrations	the same mass concentrations	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
f8412d581b7f16bf80905db5f8d2d049	29511312	PMC5840386	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
c0d5eb89a304b9d4567dfe42aaa8981b	29511312	PMC5840386	pH correction	correction	pH correction	bioreactor conditions	pH	COID893209	RESULTS	arg0
67f2256605136996835126f3bbc9e396	29511312	PMC5840386	the sialylation level	level	the sialylation level	glycosylation	sialylation	COID543327	RESULTS	arg0
f59293059860fefee27c82ee225a7c91	29511312	PMC5840386	ADCC	ADCC	ADCC	clinical outcomes	ADCC	COID386333	RESULTS	arg1
5d58b9620992b628c5a80a338f053f1f	29511312	PMC5840386	the glucose-only duplicate cultures	cultures	the glucose-only duplicate cultures	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
3699ed403867da4e3e839eb68e68912c	29511312	PMC5840386	lactate	lactate	lactate	by-product or waste	lactate	COID250920	RESULTS	arg1
fc475a008f427296b507c424dcd31147	29511312	PMC5840386	VCD	VCD	VCD	cell culture parameters	VCD	COID384695	RESULTS	arg1
2959cdda9f8908bc7e63d3bb2d9308b5	29511312	PMC5840386	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg0
aa9c15c2573e2466a6f61f30d50cef38	29511312	PMC5840386	glutamine consumption	consumption	glutamine consumption	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg1
40890faa798a387fe4f2ff86d635fcbc	29511312	PMC5840386	Glucose accumulation	accumulation	Glucose accumulation	sugar (subset of carbon source)	Glucose	COID367406	RESULTS	arg1
18eb5dd0510a619ae69a388b7e2ebabc	29511312	PMC5840386	other nutrients	nutrients	other nutrients	secondary raw materials	nutrients	COID423902	RESULTS	arg0
16ce9c4628912a49932b3a7d20f68dd9	29511312	PMC5840386	the growth of these cells	growth	the growth	cell culture parameters	growth	COID203666	RESULTS	arg1
f30fd082dde3c875c423a5b4a7194186	29511312	PMC5840386	residual glucose	glucose	residual glucose	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
fc7a188e8cac9758dd1e16c4ff30989c	29511312	PMC5840386	the observed cell growth	growth	the observed cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
e81bd184d95ee3de214d68efb1974743	29511312	PMC5840386	other amino acids	acids	other amino acids	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg0
88757114629f7b73feb753c19099eabc	29511312	PMC5840386	a main energy source in these cultures	source	a main energy source	cell nutrient	energy source	COID713213	RESULTS	arg0
b30400402a8c0a4627c04691413d2f1d	29511312	PMC5840386	similar culture glucose concentrations	concentrations	similar culture glucose concentrations	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
d112b89935c73b5adfcd317bf67dd4e5	29511312	PMC5840386	lower maltose concentration of 10 g/l	concentration	lower maltose concentration	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
74463d2b163914383be75129b468d081	29511312	PMC5840386	glucose accumulation	accumulation	glucose accumulation	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
c3cd3376bb969aea2e5524877dd5608f	29511312	PMC5840386	cultures with faster growth	cultures	cultures	cell culture parameters	growth	COID203666	RESULTS	arg0
e296aa0eb4ba0f0e03442448d75313a9	29511312	PMC5840386	faster glutamine consumption	consumption	faster glutamine consumption	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg1
8aa5be1d7b7751a623bdbe0be192b3aa	29511312	PMC5840386	the observed lactate consumption	consumption	the observed lactate consumption	by-product or waste	lactate	COID250920	RESULTS	arg1
92ee7abcb4031797b5572ae420d4d366	29511312	PMC5840386	this lactate toxicity	toxicity	this lactate toxicity	by-product or waste	lactate	COID250920	RESULTS	arg0
7626c1df8e0715422e8ccfeec2379aed	29511312	PMC5840386	the faster death phase observed for the 24 g/l glucose culture	phase	the faster death phase	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
e9a3d902366eb55ad1c5e152d7665aef	29511312	PMC5840386	the culture media of the other 3 cultures	media	the culture media	media characteristics	media	COID913636	RESULTS	arg0
85422ad455ee98491e85848d36672834	29511312	PMC5840386	similar osmolality	osmolality	similar osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg1
6d0700347f2c8b58ff97508a912be3a6	29511312	PMC5840386	the maltose-supplemented cultures	cultures	the maltose-supplemented cultures	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg1
118c016d8c359388dae5d15b65357a6c	29511312	PMC5840386	the highest maximum IgG titer	titer	the highest maximum IgG titer	overall titer or batch yield	IgG titer	COID814559	RESULTS	arg0
8e82eec59fde7494f56e0cdbf9a32b25	29511312	PMC5840386	the 20 g/l maltose supplemented culture	maltose	the 20 g/l maltose	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg1
3fce51bdf00facc40149dffd6c590ec5	29511312	PMC5840386	Application of maltose as energy source in protein-free CHO-K1 culture	Application	Application	cell nutrient	energy source	COID713213	TITLE	arg0
a4a1c27ff3550dd3594230a58c639950	29511312	PMC5840386	the production of recombinant monoclonal antibody	production	the production	monoclonal antibody	monoclonal antibody	COID242255	TITLE	arg1
d110221b17004efeee18921cdcaaf945	29511312	PMC5840386	Application of maltose as energy source in protein-free CHO-K1 culture	Application	Application	disaccharides (subset of carbon source)	maltose	COID396206	TITLE	arg0
d2b0f382d29c6567b984d4d14256be89	30552760	PMC6590254	Chinese hamster ovary cells	cells	Chinese hamster ovary cells	chinese hamster ovary (CHO)	Chinese hamster ovary cells	COID806780	ABSTRACT	arg0
8c1ad69ddf33ae02a5da21f9afb22fd9	30552760	PMC6590254	recombinant monoclonal antibodies produced in Chinese hamster ovary cells	antibodies	recombinant monoclonal antibodies	monoclonal antibody	monoclonal antibodies	COID242255	ABSTRACT	arg1
1b50f9878752e9727cf81dcad090e57d	30552760	PMC6590254	a CHO DG44 cell line expressing a recombinant immunoglobulin G1 (IgG1)	line	a CHO DG44 cell line	chinese hamster ovary (CHO)	CHO DG44 cell line	COID939621	ABSTRACT	arg0
a1bc935cf8ca384f73d7efa741c4573a	30552760	PMC6590254	fed-batch experiments performed with a CHO K1 and a CHO DG44 cell line expressing a recombinant immunoglobulin G1 (IgG1)	experiments	fed-batch experiments	process mode	fed-batch	COID529446	ABSTRACT	arg1
7f4d5e841490e028db2f07c76b1720ae	30552760	PMC6590254	a CHO K1	K1	a CHO K1	chinese hamster ovary (CHO)	CHO K1	COID324081	ABSTRACT	arg0
ab32d448733cc6cb7bbbdc30442b8a89	30552760	PMC6590254	the mAb1 in the CHO K1 cell line	mAb1	the mAb1	monoclonal antibody	mAb1	COID268135	RESULTS	arg0
fba8c1059d2a1272bb39037cde6c13a9	30552760	PMC6590254	the glycan species	species	the glycan species	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
041b77d2f3cea7ba3b0cd35ae0cbcc18	30552760	PMC6590254	the combination of ManNAc and DANA	combination	the combination	sugar (subset of carbon source)	ManNAc	COID135789	RESULTS	arg0
938a3a25385e8f7f183337d46f94cf3a	30552760	PMC6590254	a synergistic effect on sialylation	effect	a synergistic effect	glycosylation	sialylation	COID543327	RESULTS	arg1
be7b37174f0e80b165d2cf43c8bb30d5	30552760	PMC6590254	the combination of ManNAc and DANA	combination	the combination	sugar (subset of carbon source)	DANA	COID084256	RESULTS	arg0
9ec2893eac0687db65b93341b8c6b764	30552760	PMC6590254	glycoforms	glycoforms	glycoforms	recombinant protein	glycoforms	COID288767	RESULTS	arg0
204ce388797e37fcaab8644de388dad4	30552760	PMC6590254	cell culture parameters	parameters	cell culture parameters	process parameters or process control	culture parameters	COID160285	RESULTS	arg1
3e4a54f5aa81b597dac83da67df1f256	30552760	PMC6590254	cell culture parameters	parameters	cell culture parameters	cell culture parameters	cell culture	COID293414	RESULTS	arg1
72487fc85ea76d11c1b38a47efdbd910	30552760	PMC6590254	Compounds intended to increase high-mannose species	Compounds	Compounds	sugar (subset of carbon source)	high-mannose	COID981337	RESULTS	arg0
bdd25a4ce18d3807d5bd943072cc55ab	30552760	PMC6590254	their impact on glycan species, IVC and titer of mAb1	impact	their impact	monoclonal antibody	mAb1	COID268135	RESULTS	arg1
428616f1d2189407b053bade495a0e2c	30552760	PMC6590254	sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
8ceaed3e83614c1bda30a80e80a24683	30552760	PMC6590254	a CHO DG44 cell line	line	a CHO DG44 cell line	chinese hamster ovary (CHO)	CHO DG44 cell line	COID939621	RESULTS	arg0
938d6713e2576248872ec86b702fab1a	30552760	PMC6590254	mAb2	mAb2	mAb2	monoclonal antibody	mAb2	COID770105	RESULTS	arg1
794406fe1272d1871e2af8d3d9e2cad8	30552760	PMC6590254	the cultivation process	process	the cultivation process	media characteristics	cultivation process	COID699462	RESULTS	arg0
83edb5ef3b8997f2dffa297e1c33ba3d	30552760	PMC6590254	glycosylation profiles	profiles	glycosylation profiles	product attributes	glycosylation profiles	COID103232	RESULTS	arg1
0479cc8919a58eefa6c6664b6451d931	30552760	PMC6590254	total sialylation	sialylation	total sialylation	glycosylation	sialylation	COID543327	RESULTS	arg0
4819253a1c9362afb742da4b4fd74369	30552760	PMC6590254	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
5ee769165ccdccd2df4edf0fd32d3712	30552760	PMC6590254	the additives applied to reduce fucosylation	additives	the additives	glycosylation	fucosylation	COID810570	RESULTS	arg0
ac34f573f53aa05ced4fa0d6476024b4	30552760	PMC6590254	other glycan species (Supporting Information Figure 2)	species	other glycan species	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
1b938b047ebd397a96b8626a6de324a9	30552760	PMC6590254	supplementation	supplementation	supplementation	secondary raw materials	supplementation	COID566710	RESULTS	arg0
2d66266619da249f4ec46d1b1fdc71f0	30552760	PMC6590254	the Mn level already present in the medium	level	the Mn level	media characteristics	medium	COID921897	RESULTS	arg0
93336c06ea166ee325e09c76df9b125d	30552760	PMC6590254	the "on/off response" described as necessary to enable maximum galactosylation (Grainger & James, 2013)	"	the "on/off response"	glycosylation	galactosylation	COID475750	RESULTS	arg1
54d2737b982bb0eeffd992cc73406b43	30552760	PMC6590254	an appropriate choice of additive or combination of additives	choice	an appropriate choice	secondary raw materials	combination of additives	COID382945	RESULTS	arg0
d6938010dbf0f7528033336ae4134f33	30552760	PMC6590254	mAb1	mAb1	mAb1	monoclonal antibody	mAb1	COID268135	RESULTS	arg0
fe40b10b83854d50cad6a036091b81c1	30552760	PMC6590254	titer	titer	titer	overall titer or batch yield	titer	COID732378	RESULTS	arg1
4dc73bade117a76f9b73fc6d9c179b7a	30552760	PMC6590254	IVC	IVC	IVC	NYK	IVC	COID204694	RESULTS	arg1
0702b4afb7602d5ccc04fd12d6de6672	30552760	PMC6590254	glycan species	species	glycan species	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
74c118700cc5fc143e5130fb7ea2aa4c	30552760	PMC6590254	Kifunensine	Kifunensine	Kifunensine	secondary raw materials	Kifunensine	COID287309	RESULTS	arg0
fb833bf087a0fcb4f892c049f71f5941	30552760	PMC6590254	Man9 (+58.4%)	Man9	Man9	sugar (subset of carbon source)	Man9	COID436880	RESULTS	arg1
b118c49edd4078ca6356f2d3d7c75f2f	30552760	PMC6590254	a small impact (<5%) on other glycan species (Supporting Information Figure 2)	impact	a small impact	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
140382d854f8ce6e7fe873f15413a6c2	30552760	PMC6590254	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg0
a1f462c13edef22ea609ec9dc4af6931	30552760	PMC6590254	binding of sialic acid	binding	binding	sugar (subset of carbon source)	sialic acid	COID148212	RESULTS	arg1
5783d982771bd3ababf1e4d6560fcd7b	30552760	PMC6590254	mannosylation	mannosylation	mannosylation	glycosylation	mannosylation	COID543580	RESULTS	arg0
4227cd4b2dbd121e89ece878ac673a25	30552760	PMC6590254	IVC	IVC	IVC	NYK	IVC	COID204694	RESULTS	arg0
eea845947536551829199fc730fb3174	30552760	PMC6590254	dexamethasone	dexamethasone	dexamethasone	secondary raw materials	dexamethasone	COID895485	RESULTS	arg1
b5d4da8a67c5cecc9b8578ff7d8dabf3	30552760	PMC6590254	CHO cells	cells	CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	TITLE	arg0
0fdc85e54380813cda7da2165846432d	30552760	PMC6590254	IgG glycosylation produced in CHO cells	glycosylation	IgG glycosylation	product quality profile	IgG glycosylation	COID286158	TITLE	arg1
b863bcc5fadf50b76747d1d905257581	30682623	PMC6352710	factors that influence the dynamics, including sugar nucleotide donors, glycosyltransferases, and glycosidases	factors	factors	enzyme	glycosidases	COID984933	ABSTRACT	arg0
c980906d3a59eef37f16a98606448c1b	30682623	PMC6352710	glycosyltransferases	glycosyltransferases	glycosyltransferases	enzyme	glycosyltransferases	COID225633	ABSTRACT	arg1
ced8e670d7393461615c4a08809e5539	30682623	PMC6352710	factors that influence the dynamics, including sugar nucleotide donors, glycosyltransferases, and glycosidases	factors	factors	enzyme	glycosyltransferases	COID225633	ABSTRACT	arg0
09c35d15f63a2953365e4611627b91d3	30682623	PMC6352710	glycosidases	glycosidases	glycosidases	enzyme	glycosidases	COID984933	ABSTRACT	arg1
1484a0ac1ecbcdb2b9ed38ba1973c55a	30682623	PMC6352710	autoregulation of cytidine monophosphate-sialic acid biosynthesis	autoregulation	autoregulation	biochemical compound	biosynthesis	COID479844	ABSTRACT	arg0
22b54af71e9436bb8322afd0abc9397f	30682623	PMC6352710	sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
6ecbab84953b0347e9ee99bc27bf9dea	30682623	PMC6352710	autoregulation of cytidine monophosphate-sialic acid biosynthesis	autoregulation	autoregulation	sugar (subset of carbon source)	sialic acid	COID148212	ABSTRACT	arg0
21f5e8fc38c6a938ee21ca1ec2f4174e	30682623	PMC6352710	autoregulation of cytidine monophosphate-sialic acid biosynthesis	autoregulation	autoregulation	nucleotide or nucleoside	cytidine	COID172930	ABSTRACT	arg0
07856845ab483333d4aab9d2d9765020	30682623	PMC6352710	N-linked glycosylation	glycosylation	N-linked glycosylation	glycosylation	N-linked glycosylation	COID005169	ABSTRACT	arg0
158cd1496010416262266d109fad02f5	30682623	PMC6352710	immunogenicity	immunogenicity	immunogenicity	clinical outcomes	immunogenicity	COID444425	ABSTRACT	arg1
7c7e4b8e5fd46bf47b6dc48d40c8e5be	30682623	PMC6352710	pharmacokinetic clearance	clearance	pharmacokinetic clearance	clinical outcomes	pharmacokinetic	COID373370	ABSTRACT	arg1
734e5234041d3a078c10f6185c420cdc	30682623	PMC6352710	potency	potency	potency	clinical outcomes	potency	COID969445	ABSTRACT	arg1
d6f2f31b62f467493bb97d582e1e7625	30682623	PMC6352710	safety	safety	safety	clinical outcomes	safety	COID635261	ABSTRACT	arg1
b7eb75b2acf23b9676d71b485ad8daf4	30682623	PMC6352710	the galactosylated precursors	precursors	the galactosylated precursors	biochemical compound	precursors	COID871085	ABSTRACT	arg0
282504989dcc9b4aa775ce7bd0086d92	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	PTM	oxidative phosphorylation	COID850093	RESULTS	arg0
71dff765c10131cece76572745f85c50	30682623	PMC6352710	significant time dynamics in their corresponding gene sets, transcripts, and metabolites (Table 1)	dynamics	significant time dynamics	process parameters or process control	time	COID742277	RESULTS	arg1
7a7639980cdd4bdcef899aa7c6dd2e4d	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	metabolic pathways	pentose phosphate pathway	COID233901	RESULTS	arg0
d5ed297cd42d37c058e8579653f77c3c	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	biological process	metabolism	COID291079	RESULTS	arg0
d22777e8b321423d4561cb2fe6fc4e17	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	metabolic pathways	glycolysis	COID345655	RESULTS	arg0
6c32f165d3ee70666233bc40fac56d1c	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	amino acid (subset of substrates)	glutamate	COID485387	RESULTS	arg0
66ddc58cb0f3d4f7371dff6482a2c831	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg0
a87622cf8fbd1ed4104429bf23c5027a	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	biochemical compound	precursor	COID871085	RESULTS	arg0
aeca45dc9498d0a932ebda372fcdc4e5	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	acid (subset of secondary raw materials)	TCA	COID780120	RESULTS	arg0
f49deb6ab01f22af217007f409d2b881	30682623	PMC6352710	Other pathways linked to glycolysis and TCA cycle such as glutamine/glutamate metabolism (which serves as a precursor to N-acetylated NSD intermediates), pentose phosphate pathway (PPP), and oxidative phosphorylation	pathways	Other pathways	metabolic pathways	PPP	COID233901	RESULTS	arg0
30d7a0132d207dc7f31083ae295e9b6a	30682623	PMC6352710	multiple time points from the bioreactors for both fed-batch processes	points	multiple time points	process parameters or process control	time	COID742277	RESULTS	arg0
5eae26176f22ad41659e8a1224993753	30682623	PMC6352710	the cell pellet samples taken at multiple time points from the bioreactors for both fed-batch processes	samples	the cell pellet samples	vessel or process parameter or production scale	bioreactors	COID345693	RESULTS	arg1
09eef044945c3eda076ea00606edbd70	30682623	PMC6352710	the cell pellet samples taken at multiple time points from the bioreactors for both fed-batch processes	samples	the cell pellet samples	process mode	fed-batch	COID529446	RESULTS	arg1
fb61ea4d6dc9e4ff3ab15b1f05e7904e	30682623	PMC6352710	ManNAc-supplemented media	media	ManNAc-supplemented media	sugar (subset of carbon source)	ManNAc	COID135789	RESULTS	arg0
e6e1fd6d18e85ab785e7050b23317adb	30682623	PMC6352710	sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
daed196f4b4e177a6324c3c6bbfae626	30682623	PMC6352710	ManNAc-supplemented media	media	ManNAc-supplemented media	media characteristics	media	COID913636	RESULTS	arg0
1a9d3535ed5026b038a362d188eb2ddf	30682623	PMC6352710	1-L working volume bioreactors	bioreactors	1-L working volume bioreactors	vessel or process parameter or production scale	bioreactors	COID345693	RESULTS	arg0
785267105cd47636ac600f7b0ac2c2df	30682623	PMC6352710	two distinct 12-day fed-batch cell culture processes	processes	two distinct 12-day fed-batch cell culture processes	cell culture parameters	cell culture	COID293414	RESULTS	arg1
c94855a857516db164be79358203ea03	30682623	PMC6352710	two distinct 12-day fed-batch cell culture processes	processes	two distinct 12-day fed-batch cell culture processes	process mode	fed-batch	COID529446	RESULTS	arg1
26942d09fba208fa6828da1f1dd8115c	30682623	PMC6352710	key genes	genes	key genes	genotype	genes	COID185502	RESULTS	arg0
28fb03b3647d22fe85a66d9de494ef2c	30682623	PMC6352710	significant temporal dynamics (i.e., the genes and metabolites that were significantly perturbed over time) using a regression-based analysis (see Transparent Methods)	dynamics	significant temporal dynamics	process parameters or process control	time	COID742277	RESULTS	arg1
e2dac644d03587393271508a3abf9a96	30682623	PMC6352710	gene sets such as those related to NSD biosynthetic pathways, pentose phosphate pathway, and oxidative phosphorylation	sets	gene sets	genotype	gene	COID185502	RESULTS	arg0
e203f56282973bdf1706c45deb171590	30682623	PMC6352710	time dynamics	dynamics	time dynamics	process parameters or process control	time	COID742277	RESULTS	arg1
2cc88b160d49911b94d367e35f76dab5	30682623	PMC6352710	The tricarboxylic citric acid (TCA) cycle	cycle	The tricarboxylic citric acid (TCA) cycle	acid (subset of secondary raw materials)	tricarboxylic citric acid	COID780120	RESULTS	arg0
fa1ad852506c5c8ae53fc0c7e47ffa82	30682623	PMC6352710	glycolysis	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	RESULTS	arg1
5d2d13e322e801a60a035fc6e62e5cf9	30682623	PMC6352710	The tricarboxylic citric acid (TCA) cycle	cycle	The tricarboxylic citric acid (TCA) cycle	acid (subset of secondary raw materials)	TCA	COID780120	RESULTS	arg0
baccbceb0d12be081bf04e7f694adf88	30682623	PMC6352710	purine and pyrimidine metabolic pathways (Figure S4B)	pathways	purine and pyrimidine metabolic pathways	metabolic pathways	metabolic pathways	COID588672	RESULTS	arg1
9d761823c9d3758ed763d48bb836d6e2	30682623	PMC6352710	glutamine	glutamine	glutamine	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg1
e0dbfd884a952fba29ee532b08d9dc45	30682623	PMC6352710	gene/metabolites that had significant time dynamics	gene/metabolites	gene/metabolites	genotype	gene	COID185502	RESULTS	arg0
7867494df60146e123ff325a552fef44	30682623	PMC6352710	significant time dynamics	dynamics	significant time dynamics	process parameters or process control	time	COID742277	RESULTS	arg1
051c5e3438ba7fdbde7bdad7ec006a61	30682623	PMC6352710	mAbs	mAbs	mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg0
0cac0f82d4ee58f6c4529d62aeb24e67	30682623	PMC6352710	all the glycans attached to mAbs	glycans	all the glycans	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg1
96660d5610545d472c32f95fab17f779	30682623	PMC6352710	A CHO-K1 host-cell-derived clone	clone	A CHO-K1 host-cell-derived clone	chinese hamster ovary (CHO)	CHO-K1	COID324081	RESULTS	arg0
78971cddacd0fdf7964a34ae3cc9254f	30682623	PMC6352710	a model mAb	mAb	a model mAb	monoclonal antibody	mAb	COID242255	RESULTS	arg1
93c07670634cae5a530dbbb82e672d1c	30682623	PMC6352710	gene sets	sets	gene sets	genotype	gene	COID185502	RESULTS	arg0
b44ae5777bff1b143540124a1c1cadb9	30682623	PMC6352710	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
b8af7b89e36787b78bfd335c8b90aa06	30682623	PMC6352710	Metabolic Pathways	Pathways	Metabolic Pathways	metabolic pathways	Metabolic Pathways	COID588672	RESULTS	arg0
91a3e7002f0809899f6b70fc53a8354b	30682623	PMC6352710	N-Glycosylation Dynamics	Dynamics	N-Glycosylation Dynamics	glycosylation	N-Glycosylation	COID293911	RESULTS	arg1
1e4c849b4dcd539411e9f9629b8f1fa0	30682623	PMC6352710	The expression levels of the genes that encode the corresponding enzymes involved in the synthesis of GlcNAc1P	levels	The expression levels	genotype	genes	COID185502	RESULTS	arg0
d2dfe9c4a635b347c757cce0d79dca04	30682623	PMC6352710	any significant time dynamics (Data S12)	dynamics	any significant time dynamics	process parameters or process control	time	COID742277	RESULTS	arg1
5b575816e3020302d59963460da0170e	30682623	PMC6352710	genes	genes	genes	genotype	genes	COID185502	RESULTS	arg0
db3cae233b023a3cb106fd2a29c8d0f2	30682623	PMC6352710	NSD biosynthesis	biosynthesis	NSD biosynthesis	biochemical compound	biosynthesis	COID479844	RESULTS	arg1
23d76ed56e6ac62b31c22d348a19fc45	30682623	PMC6352710	TCA cycle	cycle	TCA cycle	acid (subset of secondary raw materials)	TCA	COID780120	RESULTS	arg1
6284ae3426b56491bad5996efe9ae071	30682623	PMC6352710	purine and pyrimidine biosynthesis	biosynthesis	purine and pyrimidine biosynthesis	biochemical compound	biosynthesis	COID479844	RESULTS	arg1
b56ebb8902182f2169de4b2e894d7cfb	30682623	PMC6352710	NSD biosynthesis	biosynthesis	NSD biosynthesis	biochemical compound	biosynthesis	COID479844	RESULTS	arg0
2817933beca4f6ad3b9c91ebaed569aa	30682623	PMC6352710	genes	genes	genes	genotype	genes	COID185502	RESULTS	arg1
9fbeb0b3b231b8e418ac605570328319	30682623	PMC6352710	TCA cycle	cycle	TCA cycle	acid (subset of secondary raw materials)	TCA	COID780120	RESULTS	arg0
e50b788c94353e250a90ddfb5f1b6e64	30682623	PMC6352710	glycolysis	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	RESULTS	arg0
67d6ed5b7d7f041f47b35136d31f67b4	30682623	PMC6352710	purine and pyrimidine biosynthesis	biosynthesis	purine and pyrimidine biosynthesis	biochemical compound	biosynthesis	COID479844	RESULTS	arg0
4dfcdb0cd3defb97c26732476c51c7b5	30682623	PMC6352710	These gene sets	sets	These gene sets	genotype	gene	COID185502	RESULTS	arg0
6de86d2994fcd7cbec4d4f2843b2994c	30682623	PMC6352710	significant time dynamics (TCGSA, Data S9)	dynamics	significant time dynamics	process parameters or process control	time	COID742277	RESULTS	arg1
bb2a9760d1359d5b2bf1e1527f7226c3	30682623	PMC6352710	The concentration of glycosyltransferases	concentration	The concentration	enzyme	glycosyltransferases	COID225633	RESULTS	arg0
530fcde92a6e2089ff88e9a953f8aca5	30682623	PMC6352710	the reaction rates for each of the glycosylation steps	reaction	the reaction rates	glycosylation	glycosylation	COID119643	RESULTS	arg1
d8ce98effa18e0c61dd748eb4827aa5b	30682623	PMC6352710	Key genes	genes	Key genes	genotype	genes	COID185502	RESULTS	arg0
174abf13bceb4660cb6f04eeda0814aa	30682623	PMC6352710	potential limiting factors for N-glycosylation	factors	potential limiting factors	glycosylation	N-glycosylation	COID293911	RESULTS	arg1
3e97b1be12b239fc7ad2ce467427e387	30682623	PMC6352710	these pathways that could be potential limiting factors for N-glycosylation	pathways	these pathways	glycosylation	N-glycosylation	COID293911	RESULTS	arg1
ded07ce50bcb9d914a0d0e427e5fc61e	30682623	PMC6352710	potential limiting factors for N-glycosylation	factors	potential limiting factors	glycosylation	N-glycosylation	COID293911	RESULTS	arg0
377ffa5702f803d55c2ff0d9259436a4	30682623	PMC6352710	Key genes	genes	Key genes	genotype	genes	COID185502	RESULTS	arg1
25b4a16425023a5d5f78ba3384b36dd6	30682623	PMC6352710	these pathways that could be potential limiting factors for N-glycosylation	pathways	these pathways	glycosylation	N-glycosylation	COID293911	RESULTS	arg0
bdd50a2940d2845df3430efe9380ba22	30682623	PMC6352710	UDP-GalNAc	UDP-GalNAc	UDP-GalNAc	substrates	UDP-GalNAc	COID756664	RESULTS	arg0
0442c416d172a9ea103ce273f7e7277e	30682623	PMC6352710	UDP-GlcNAc	UDP-GlcNAc	UDP-GlcNAc	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
02401950ca7b33a0855b0b83da27e3de	30682623	PMC6352710	the levels of major species (specifically galactosylation/agalactosylation)	levels	the levels	glycosylation	galactosylation	COID475750	RESULTS	arg0
fa50c39dca0d472b94e296c9c63093d8	30682623	PMC6352710	the two fed-batch processes	processes	the two fed-batch processes	process mode	fed-batch	COID529446	RESULTS	arg1
f96f2f76549ed287ead078422b63e8bc	30682623	PMC6352710	a small drop in the sialylation	drop	a small drop	glycosylation	sialylation	COID543327	RESULTS	arg0
e0d3ab3a08be7977506f6c561d64fab2	30682623	PMC6352710	the GlcNAc-supplemented condition	condition	the GlcNAc-supplemented condition	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
127b4b7ad4a011b84bfe290f3eafdde5	31425633	PMC7003473	amino acids	acids	amino acids	amino acid (subset of substrates)	amino acids	COID693703	ABSTRACT	arg0
a8d8db3585d3eb524d07cceef9112356	31425633	PMC7003473	glycan outcomes	outcomes	glycan outcomes	product attributes	glycan outcomes	COID339685	ABSTRACT	arg1
946caf0f00f8c67c9f68ae62781ea7f8	31425633	PMC7003473	the timing of the amino acid supplementation strategy	timing	the timing	secondary raw materials	supplementation	COID566710	RESULTS	arg0
611ef63c02af32f55f56a7e4de3a91b4	31425633	PMC7003473	amino acid correlations with glycan profiles	correlations	amino acid correlations	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg1
0c7c3c3cbeeb2ac86c499ccb70cf84ac	31425633	PMC7003473	the amino acid supplementation in feed strategies 5 and 7 (Figure 2d,f)	supplementation	the amino acid supplementation	secondary raw materials	supplementation	COID566710	RESULTS	arg0
66534cfb19459a8c831b253467d45812	31425633	PMC7003473	no effects on VCD growth	effects	no effects	cell culture parameters	growth	COID203666	RESULTS	arg1
df2b25eb594c3efbc7d9f402425beea2	31425633	PMC7003473	no effects on VCD growth	effects	no effects	cell culture parameters	VCD	COID384695	RESULTS	arg1
c0ac87a8f561cad9745f414eb1f8515a	31425633	PMC7003473	the amino acid supplementation in feed strategies 5 and 7 (Figure 2d,f)	supplementation	the amino acid supplementation	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg0
987c1bcf7fa070975573a8a2680f242e	31425633	PMC7003473	bioreactor nutrients	nutrients	bioreactor nutrients	vessel or process parameter or production scale	bioreactor	COID345693	RESULTS	arg0
227a20151984e9bc554e466cd2c88f95	31425633	PMC7003473	product quality	quality	product quality	product quality attributes	product quality	COID111751	RESULTS	arg1
787a6396119e4f5f192af3dc2a16ec1d	31425633	PMC7003473	bioreactor nutrients	nutrients	bioreactor nutrients	secondary raw materials	nutrients	COID423902	RESULTS	arg0
d32481c5f64ab5b88f8311e2aa2243f0	31425633	PMC7003473	different amino acid blends during upstream processing (Table 5)	blends	different amino acid blends	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg0
049984d992766ba36c00432c042f298f	31425633	PMC7003473	a better understanding of how the light and heavy chains constituting the mAb might have been affected by different amino acid blends during upstream processing (Table 5)	understanding	a better understanding	monoclonal antibody	mAb	COID242255	RESULTS	arg1
eb28647c6fd3cd521352565a8eb10bf2	31425633	PMC7003473	nine timepoints (1, 17, 24, 48, 66, 72, 96, 120, 144 hr) from the nine total bioreactor runs (five baseline runs, four experimental amino acid supplementation runs)	timepoints	nine timepoints	secondary raw materials	supplementation	COID566710	RESULTS	arg0
ea85aff17d22f4d90d42e3a4ad039524	31425633	PMC7003473	19 amino acids sampled at nine timepoints (1, 17, 24, 48, 66, 72, 96, 120, 144 hr) from the nine total bioreactor runs (five baseline runs, four experimental amino acid supplementation runs)	acids	19 amino acids	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg1
8fbba1cfc49f3e574afebd2a328884b6	31425633	PMC7003473	nine timepoints (1, 17, 24, 48, 66, 72, 96, 120, 144 hr) from the nine total bioreactor runs (five baseline runs, four experimental amino acid supplementation runs)	timepoints	nine timepoints	vessel or process parameter or production scale	bioreactor	COID345693	RESULTS	arg0
e1d9104383d94d8d7a93acb054492677	31425633	PMC7003473	nine timepoints (1, 17, 24, 48, 66, 72, 96, 120, 144 hr) from the nine total bioreactor runs (five baseline runs, four experimental amino acid supplementation runs)	timepoints	nine timepoints	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg0
6cb76c9fce6ac8b0fa3dce95cd99c67a	31425633	PMC7003473	the batch mode vessel	vessel	the batch mode vessel	vessel or process parameter or production scale	vessel	COID322748	RESULTS	arg0
5243e77db40700bc36b073c204921c19	31425633	PMC7003473	glucose	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
182e1d6a59a5b579add11132828bb8fa	31425633	PMC7003473	the batch mode vessel	vessel	the batch mode vessel	process mode	batch	COID285438	RESULTS	arg0
2192a3a0db79b99466add9161d5591d9	31425633	PMC7003473	The fed-batch conditions	conditions	The fed-batch conditions	process mode	fed-batch	COID529446	RESULTS	arg0
3ab24160979b7ead8040062581015e02	31425633	PMC7003473	viable cell density (VCD)	density	viable cell density	cell culture parameters	viable cell density	COID384695	RESULTS	arg1
e36696aff7f83cf77e0cd3478caa584a	31425633	PMC7003473	longer batch age performance (Feed strategies 4 and 6)	performance	longer batch age performance	process mode	batch	COID285438	RESULTS	arg0
0111faddb7d8a31f6fec11f4825b8bd8	31425633	PMC7003473	terminal galactosylation (G1F and G2F)	galactosylation	terminal galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
4302804afa71c17cb8826c9b0cb8f919	31425633	PMC7003473	the supplementation blends	blends	the supplementation blends	secondary raw materials	supplementation	COID566710	RESULTS	arg0
51977fa49a0c8edd87cd35988fecf857	31425633	PMC7003473	The other amino acids used in the supplementation blends	acids	The other amino acids	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg1
7bfe1d4584693b9227b4df4e8997e5b4	31425633	PMC7003473	process parameters	parameters	process parameters	process parameters or process control	process parameters	COID163282	RESULTS	arg0
0e3eeb5e0dcb510b7e81ba08181c2b10	31425633	PMC7003473	the final antibody product from these cultures	product	the final antibody product	antibody	antibody	COID278523	RESULTS	arg0
84490f6319b9b885b06b09a2c841c12d	31425633	PMC7003473	glycan profile	profile	glycan profile	product quality attributes	glycan profile	COID521331	RESULTS	arg1
e30fe2612d39b2c75f409033d5a70f5a	31425633	PMC7003473	charge variant profile	profile	charge variant profile	product quality profile	charge variant profile	COID820771	RESULTS	arg1
d33adeb52c72c840a1c416bf74e614ad	31425633	PMC7003473	The second amino acid addition	addition	The second amino acid addition	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg0
9da4470f1c99a0c75b6c973518508c4c	31425633	PMC7003473	its effect on the growth profiles of the cultures	effect	its effect	cell culture parameters	growth	COID203666	RESULTS	arg1
2160cc89c87aa1a080dc038fdab4b8fd	31425633	PMC7003473	each amino acid	acid	each amino acid	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg0
43e8bd766d9a82c5c12cee31df632125	31425633	PMC7003473	the same number of time points	number	the same number	process parameters or process control	time	COID742277	RESULTS	arg1
4253434bbf120376076ac1016d12fa64	31425633	PMC7003473	the growth profiles of the cultures	profiles	the growth profiles	cell culture parameters	growth	COID203666	RESULTS	arg1
f5c1eec08becad186588c3c99c66e3fa	31425633	PMC7003473	VCD	VCD	VCD	cell culture parameters	VCD	COID384695	RESULTS	arg1
6ae12bd837760ed121229ca84487ad76	31425633	PMC7003473	viability	viability	viability	process parameters or process control	viability	COID222142	RESULTS	arg1
3bbfbb67b6e7e30051c8909bf50b16f2	31425633	PMC7003473	Real-time quantification	quantification	Real-time quantification	process parameters or process control	time	COID742277	TITLE	arg0
e4679d7b62ba9b5b1da2d6573747a70d	31425633	PMC7003473	antibody product quality	quality	antibody product quality	product quality attributes	product quality	COID111751	TITLE	arg1
1d11806b18b06d0d808a104ce85a5886	31425633	PMC7003473	antibody product quality	quality	antibody product quality	antibody	antibody	COID278523	TITLE	arg1
d3582f8d0ad6837da346db6a767b320e	31425633	PMC7003473	the amino acid blends	blends	the amino acid blends	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg0
11754270a4e39d5dc967dd5f8bb1033d	31425633	PMC7003473	the antibody products produced between by the amino acid blends	products	the antibody products	antibody	antibody	COID278523	RESULTS	arg1
1354627cc81368cc5f58906882ab7685	31487120	PMC7027499	automated micro bioreactors alongside PAT with four commercial growth media focusing on antibody quality through N-glycosylation profiles	bioreactors	automated micro bioreactors	vessel or process parameter or production scale	bioreactors	COID345693	ABSTRACT	arg0
e86890f6e5c01e7db5c7bcb033d4a5e7	31487120	PMC7027499	an in-house model CHO DG44 cell line cultured in automated micro bioreactors alongside PAT with four commercial growth media focusing on antibody quality through N-glycosylation profiles	line	an in-house model CHO DG44 cell line	chinese hamster ovary (CHO)	CHO DG44 cell line	COID939621	ABSTRACT	arg1
9bcf83c3735d7b41a900531642907cc5	31487120	PMC7027499	commercial growth media	media	commercial growth media	cell culture parameters	growth	COID203666	RESULTS	arg0
ca99c87a6d07abc27a0664205fd07ef4	31487120	PMC7027499	the chemicals contained within commercial growth media	chemicals	the chemicals	media characteristics	media	COID913636	RESULTS	arg1
bd73c136f7ffc7390ad9c0b7d1cc6326	31487120	PMC7027499	commercial growth media	media	commercial growth media	media characteristics	media	COID913636	RESULTS	arg0
0e3e397610700a081b2cc0324b1021d3	31487120	PMC7027499	the chemicals contained within commercial growth media	chemicals	the chemicals	cell culture parameters	growth	COID203666	RESULTS	arg1
095b19690c73e072a99378b19f86434c	31487120	PMC7027499	culture medium	medium	culture medium	media characteristics	culture medium	COID180560	RESULTS	arg0
d8f21ce7755b1ce7e934c8ba7fc36dd1	31487120	PMC7027499	specific productivity profiles categorized by culture medium	profiles	specific productivity profiles	process condition	specific productivity	COID731421	RESULTS	arg1
aaa2c7c0d2b38b38f922e6846c19fe65	31487120	PMC7027499	Nutrient related cellular stress	stress	Nutrient related cellular stress	secondary raw materials	Nutrient	COID423902	RESULTS	arg0
a32857455b8bdcf164d9d7949af9927b	31487120	PMC7027499	antibody aglycosylation	aglycosylation	antibody aglycosylation	product quality attributes	aglycosylation	COID076549	RESULTS	arg1
63e90fa0487d29e88f23747b26149ff8	31487120	PMC7027499	antibody aglycosylation	aglycosylation	antibody aglycosylation	antibody	antibody	COID278523	RESULTS	arg1
1fcd38eaf758d481956ec1fd2159cdbd	31487120	PMC7027499	the aspects of metabolism related to consuming glucose for energy	aspects	the aspects	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
eec09ab322f9243c20badb5a015da3b6	31487120	PMC7027499	a causal relationship with the aspects of metabolism related to protein production	relationship	a causal relationship	biological process	metabolism	COID291079	RESULTS	arg1
87c9bc40f0259594f40c1d0859f64d4f	31487120	PMC7027499	two latent variables which characterize the impact of media selection on titer and product quality	variables	two latent variables	product quality attributes	product quality	COID111751	RESULTS	arg0
0ddcdf921f7dcaf7d40034f31a9ce5ce	31487120	PMC7027499	titer	titer	titer	overall titer or batch yield	titer	COID732378	RESULTS	arg1
10bf9e0c742439f4d4cce72ce6072c44	31487120	PMC7027499	two latent variables which characterize the impact of media selection on titer and product quality	variables	two latent variables	media characteristics	media	COID913636	RESULTS	arg0
727d420fcab8924604b19fb2edf1ede9	31487120	PMC7027499	product quality	quality	product quality	product quality attributes	product quality	COID111751	RESULTS	arg1
0a5286b672bfd03b31ee22b9a0c85551	31487120	PMC7027499	two latent variables which characterize the impact of media selection on titer and product quality	variables	two latent variables	overall titer or batch yield	titer	COID732378	RESULTS	arg0
a45b103997caedd72783a54c21dfde5a	31487120	PMC7027499	media selection	selection	media selection	media characteristics	media	COID913636	RESULTS	arg0
9be36c322056370ebe2743d561aad19a	31487120	PMC7027499	antibody glycosylation	glycosylation	antibody glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
5ee87815779709b2e61cb6bba028d046	31487120	PMC7027499	antibody glycosylation	glycosylation	antibody glycosylation	antibody	antibody	COID278523	RESULTS	arg1
b660490659e6e59fdf3bab2681cf3629	31487120	PMC7027499	ProCHO5 medium	medium	ProCHO5 medium	media characteristics	ProCHO5 medium	COID781761	RESULTS	arg0
d3e8ee3cf73a431eea9fc56d14e05da9	31487120	PMC7027499	galactosyltransferase enzymatic activity responsible for galactosylation	activity	galactosyltransferase enzymatic activity	enzyme	galactosyltransferase	COID703629	RESULTS	arg1
d28351c0d8688808ce635195da843aa0	31487120	PMC7027499	OptiCHO	OptiCHO	OptiCHO	chinese hamster ovary (CHO)	OptiCHO	COID017929	RESULTS	arg0
bcea98a1a0a089a1caab236d80418089	31487120	PMC7027499	Cell cultures grown in OptiCHO	cultures	Cell cultures	cell culture parameters	Cell cultures	COID293414	RESULTS	arg1
679afc61159fcc2cce29b52f4da4ac31	31487120	PMC7027499	each media	media	each media	media characteristics	media	COID913636	RESULTS	arg0
9d36d53c6e71c339457a8c5e97c0c6eb	31487120	PMC7027499	the subtler terminal galactosylation variabilities seen within each media	variabilities	the subtler terminal galactosylation variabilities	glycosylation	galactosylation	COID475750	RESULTS	arg1
b549188edb1308391202787b50791bae	31487120	PMC7027499	the different cellular functions	functions	the different cellular functions	process condition	functions	COID532355	RESULTS	arg0
c68a2889c4a27b3b5510410f2ebef4eb	31487120	PMC7027499	glycan outcomes	outcomes	glycan outcomes	product attributes	glycan outcomes	COID339685	RESULTS	arg1
24e965130924e8cad8755dc105689ab3	31487120	PMC7027499	metabolism	metabolism	metabolism	biological process	metabolism	COID291079	RESULTS	arg1
031847d70b0eb7fb1f913cd23692612d	31487120	PMC7027499	growth	growth	growth	cell culture parameters	growth	COID203666	RESULTS	arg1
a33afcaec9d614fe4b4f4038473c8a42	31487120	PMC7027499	lactate production	production	lactate production	by-product or waste	lactate	COID250920	RESULTS	arg0
346223a48d06f303e52df0e45819676d	31487120	PMC7027499	terminal galactosylation efficiency	efficiency	terminal galactosylation efficiency	glycosylation	galactosylation	COID475750	RESULTS	arg1
5ec7d82407bbebec83b27209e4472eaa	31487120	PMC7027499	titer	titer	titer	overall titer or batch yield	titer	COID732378	RESULTS	arg0
5d15237e61708ce453ef6c6d771ebc92	31487120	PMC7027499	glucose depletion	depletion	glucose depletion	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
8e1bd929b4e92f01e4b00cd5971b13e6	31487120	PMC7027499	aglycosylation outcomes	outcomes	aglycosylation outcomes	product quality attributes	aglycosylation	COID076549	RESULTS	arg1
4690333685b27a27bc4988f430c27dbc	31487120	PMC7027499	its glycan profile	profile	its glycan profile	product quality attributes	glycan profile	COID521331	RESULTS	arg0
f45fa7676141e6fb6df4644e4523cf7d	31487120	PMC7027499	The purified antibody	antibody	The purified antibody	antibody	antibody	COID278523	RESULTS	arg1
1e056a0f016df73d2825db3f5d146f03	31487120	PMC7027499	growth	growth	growth	cell culture parameters	growth	COID203666	RESULTS	arg0
155c50d9b7e418dae03582cb4702107b	31487120	PMC7027499	terminal galactosylation	galactosylation	terminal galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
004890230a3e8d66566955368dd3d017	31487120	PMC7027499	an impact on both of these aspects of cellular metabolism	impact	an impact	biological process	cellular metabolism	COID903943	RESULTS	arg1
9127c898b88cd9c8ec473bda28b82986	31487120	PMC7027499	the total product glycan profile	profile	the total product glycan profile	product quality attributes	glycan profile	COID521331	RESULTS	arg1
134f4b399ab3e84fbd2ee5549a4f313a	31487120	PMC7027499	productivity	productivity	productivity	process condition	productivity	COID731421	RESULTS	arg1
06e60d92f88673185f49817f5fd89e0e	31487120	PMC7027499	PowerCHO2	PowerCHO2	PowerCHO2	chinese hamster ovary (CHO)	PowerCHO2	COID568973	RESULTS	arg0
aeb84f875635f73a82b636b5bf418d07	31487120	PMC7027499	the most aglycosylation	aglycosylation	the most aglycosylation	product quality attributes	aglycosylation	COID076549	RESULTS	arg1
b4c7def52efce8ea4a6a04ad45316f8e	31487120	PMC7027499	cells grown in PowerCHO2 and Ex-Cell Advanced	cells	cells	chinese hamster ovary (CHO)	PowerCHO2	COID568973	RESULTS	arg0
26f68d9c7ae2e8dcad426065606e1827	31487120	PMC7027499	the largest amount of HM glycoforms	amount	the largest amount	recombinant protein	HM glycoforms	COID288767	RESULTS	arg1
04a1fba9201750ae61c42eb851b74788	31487120	PMC7027499	terminal galactosylation efficiency	efficiency	terminal galactosylation efficiency	glycosylation	galactosylation	COID475750	RESULTS	arg0
511474e9886dc2f7f602e09c2c61616e	31487120	PMC7027499	a strong positive correlation with glucose consumption	correlation	a strong positive correlation	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
e3d3f594470736350224d6142979f038	31487120	PMC7027499	the lowest specific productivity	productivity	the lowest specific productivity	process condition	specific productivity	COID731421	RESULTS	arg0
37901c7d0f9e0369d0f00e248298f0db	31487120	PMC7027499	the other media	media	the other media	media characteristics	media	COID913636	RESULTS	arg1
88fdc388e41c3dde72c1fa023763ad8f	31487120	PMC7027499	Multivariate data analysis of growth medium trends	analysis	Multivariate data analysis	cell culture parameters	growth	COID203666	TITLE	arg0
5a6c01e620269cebfa5d9030bae392af	31487120	PMC7027499	antibody glycosylation	glycosylation	antibody glycosylation	glycosylation	glycosylation	COID119643	TITLE	arg1
f1d1869ed0478c8aa347a0a10161e13c	31487120	PMC7027499	antibody glycosylation	glycosylation	antibody glycosylation	antibody	antibody	COID278523	TITLE	arg1
d3bc1c5bbc15d693614b8e5201f36f20	31487120	PMC7027499	Multivariate data analysis of growth medium trends	analysis	Multivariate data analysis	media characteristics	medium	COID921897	TITLE	arg0
8b9234d094d2d02e51504e5b2f6a6d71	31487120	PMC7027499	ProCHO5 cultures	cultures	ProCHO5 cultures	media	ProCHO5	COID988111	RESULTS	arg0
136141cae8c334df2abc3f57283ec93e	31487120	PMC7027499	G2F	G2F	G2F	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg1
d54873ea6f00c48c1cf3ea0a5cc4a4ac	31487120	PMC7027499	G1F	G1F	G1F	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg1
2360ad0717e2d7149005daaa7acab5bc	31544815	PMC6640710	the most promising strategy to reduce core fucosylation without cell line engineering	strategy	the most promising strategy	cell line	cell line	COID702829	ABSTRACT	arg0
6926888df3715c695565ec862830fc69	31544815	PMC6640710	core fucosylation	fucosylation	core fucosylation	glycosylation	core fucosylation	COID663555	ABSTRACT	arg1
c5cb5a3bab5d8d02461812ddd7bb704b	31544815	PMC6640710	Development of fucose analogues	Development	Development	substitution material	fucose analogues	COID400862	ABSTRACT	arg0
a3a07a99b434b22f963cf1818de7d298	31544815	PMC6640710	The glycosylation profile	profile	The glycosylation profile	product attributes	glycosylation profile	COID103232	RESULTS	arg0
8385b46910035c40a1268dda33449b71	31544815	PMC6640710	an impact on efficacy and safety of therapeutic antibodies	impact	an impact	antibody	antibodies	COID278523	RESULTS	arg1
be7d48a72de928efd72091321da0790e	31544815	PMC6640710	untreated CHO cells (control)	cells	untreated CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	RESULTS	arg0
3de10a19568723cdf15a0602212854a8	31544815	PMC6640710	the IgG produced in untreated CHO cells (control)	IgG	the IgG	antibody	IgG	COID713543	RESULTS	arg1
ffddddc5abeb94dcda7b1621f0946b46	31544815	PMC6640710	Galactosylation of the second branch	Galactosylation	Galactosylation	glycosylation	Galactosylation	COID475750	RESULTS	arg0
1d8b560fe11aecac2b909e55c4200590	31544815	PMC6640710	the di-galactosylated glycan G2F	G2F	the di-galactosylated glycan G2F	sugar (subset of carbon source)	di-galactosylated glycan G2F	COID847130	RESULTS	arg1
cf97cbd08961b8ba349a250f5c4f9719	31544815	PMC6640710	fucose analogues	analogues	fucose analogues	substitution material	fucose analogues	COID400862	RESULTS	arg0
58972e3f3000fddea43129454d6db90d	31544815	PMC6640710	the glycosylation profile	profile	the glycosylation profile	product attributes	glycosylation profile	COID103232	RESULTS	arg1
063eed0b904613c2aeff749b89b2ca58	31544815	PMC6640710	a CHO clone	clone	a CHO clone	chinese hamster ovary (CHO)	CHO	COID806780	RESULTS	arg0
abd05497a15bfe37560fae1581bcbf0c	31544815	PMC6640710	an IgG1	IgG1	an IgG1	antibody	IgG1	COID713543	RESULTS	arg1
6650eb5f500c0871f5a7b5a6192faff2	31544815	PMC6640710	acetylation	acetylation	acetylation	PTM	acetylation	COID878689	RESULTS	arg0
17e2099af60dc0bbb70f93e93bdfda8b	31544815	PMC6640710	core fucosylation (3.4% at 200 microM, 5.8% at 400 microM and 6.6% at 800 microM)	fucosylation	core fucosylation	glycosylation	core fucosylation	COID663555	RESULTS	arg1
71b8191acfe94515f15b21d56de72bfa	31544815	PMC6640710	safety	safety	safety	clinical outcomes	safety	COID635261	RESULTS	arg1
11276e915c3c60faef89dddabaa10715	31544815	PMC6640710	efficacy	efficacy	efficacy	clinical outcomes	efficacy	COID912630	RESULTS	arg1
32eaa159da44115be82a52e08c146a70	31544815	PMC6640710	core fucosylation	fucosylation	core fucosylation	glycosylation	core fucosylation	COID663555	RESULTS	arg1
7ffb26a48968e2105ae3029945df5a9f	31544815	PMC6640710	peracetylation	peracetylation	peracetylation	PTM	peracetylation	COID113739	RESULTS	arg0
096baff801f89e22f9390f6ffec9d8e7	31544815	PMC6640710	the impact of the fucose analogues	impact	the impact	substitution material	fucose analogues	COID400862	RESULTS	arg1
3e3cc0d7a639100bb405b717ce4f4090	31544815	PMC6640710	the glycosylation profile of two biological replicates	profile	the glycosylation profile	product attributes	glycosylation profile	COID103232	RESULTS	arg1
5bca53ee72d08a623d513df34ddbcf6e	31544815	PMC6640710	a similar VCD	VCD	a similar VCD	cell culture parameters	VCD	COID384695	RESULTS	arg0
366c51a7dfa61b4edbacb4b393453d8d	31544815	PMC6640710	the DMSO-treated condition	condition	the DMSO-treated condition	NYK	DMSO	COID418525	RESULTS	arg1
9f1024d97fcbabb6e2b327d66bc366e1	31544815	PMC6640710	no detectable changes of the glycosylation pattern compared to the control (Table 1)	changes	no detectable changes	product attributes	glycosylation pattern	COID857544	RESULTS	arg0
60c234c235a5452911aff5e97548071c	31544815	PMC6640710	The applied DMSO concentration	concentration	The applied DMSO concentration	NYK	DMSO	COID418525	RESULTS	arg1
8adbb32329d05eb741d35f621b3d37b3	31544815	PMC6640710	Acetylated and Non-Acetylated Fucose Analogues	Analogues	Acetylated and Non-Acetylated Fucose Analogues	substitution material	Fucose Analogues	COID400862	TITLE	arg0
2dc6ec98f3596e48bc274d4bb260553a	31544815	PMC6640710	IgG Glycosylation	Glycosylation	IgG Glycosylation	product quality profile	IgG Glycosylation	COID286158	TITLE	arg1
bcb46f19fca3ca2c91098e463c069d96	32170810	PMC7880547	biotherapeutic manufacturing of monoclonal antibodies (mAbs) and other biopharmaceuticals	manufacturing	biotherapeutic manufacturing	monoclonal antibody	monoclonal antibodies	COID242255	ABSTRACT	arg0
553288e46d441f68171afe3bc5dfa7d7	32170810	PMC7880547	Chinese hamster ovary (CHO) cells	cells	Chinese hamster ovary (CHO) cells	chinese hamster ovary (CHO)	Chinese hamster ovary	COID806780	ABSTRACT	arg1
de5e2077db9ce1453f8d99ce90c05005	32170810	PMC7880547	Chinese hamster ovary (CHO) cells	cells	Chinese hamster ovary (CHO) cells	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg1
deba7a1190426263c207d7615cf09104	32170810	PMC7880547	biotherapeutic manufacturing of monoclonal antibodies (mAbs) and other biopharmaceuticals	manufacturing	biotherapeutic manufacturing	monoclonal antibody	mAbs	COID242255	ABSTRACT	arg0
902589f5abb4296201b187b9998abca3	32170810	PMC7880547	Cellular energy metabolism	metabolism	Cellular energy metabolism	biological process	metabolism	COID291079	ABSTRACT	arg0
d226763cb160545430636a778f4a781a	32170810	PMC7880547	viability	viability	viability	process parameters or process control	viability	COID222142	ABSTRACT	arg1
5002f36cd878d296a6d295dc99463709	32170810	PMC7880547	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
dfd6d33cedc38cfe65c8ed685dc6f991	32170810	PMC7880547	specific productivity of a biotherapeutic	productivity	specific productivity	process condition	specific productivity	COID731421	ABSTRACT	arg1
e62e6d1c7bde6b8ccd21db9b037e2d72	32170810	PMC7880547	Ammonia concentration	concentration	Ammonia concentration	by-product or waste	Ammonia	COID714278	RESULTS	arg0
56a41ebb9dbfbc8c901d9c245b0581cc	32170810	PMC7880547	mAb N-glycosylation	N-glycosylation	mAb N-glycosylation	glycosylation	N-glycosylation	COID293911	RESULTS	arg1
5f61e8562a0d28bb15502938a517711e	32170810	PMC7880547	mAb N-glycosylation	N-glycosylation	mAb N-glycosylation	monoclonal antibody	mAb	COID242255	RESULTS	arg1
785c70e2e944b077620742afe418f8cd	32170810	PMC7880547	glycolysis	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	RESULTS	arg0
2d8e23ddc9c7967a216556f867f579a5	32170810	PMC7880547	pyruvate	pyruvate	pyruvate	carbon source (subset of secondary raw materials)	pyruvate	COID727438	RESULTS	arg1
da586629dd05702f4c863a069b9515d6	32170810	PMC7880547	the entry point into the mitochondria and the TCA cycle	point	the entry point	acid (subset of secondary raw materials)	TCA	COID780120	RESULTS	arg1
f81a363c2ffa87d86f74c4430cadb266	32748555	PMC7988551	GDP mannose-4,6-dehydratase (Gmds)	mannose-4,6-dehydratase	GDP mannose-4,6-dehydratase	enzyme	dehydratase	COID251243	ABSTRACT	arg0
937e5cc42f8387e4a073bd7321e73ec2	32748555	PMC7988551	guanosine diphosphate (GDP)-fucose synthesis	synthesis	guanosine diphosphate (GDP)-fucose synthesis	sugar (subset of carbon source)	fucose	COID275575	ABSTRACT	arg1
41e66934da7b41602f597463c4520d08	32748555	PMC7988551	GDP mannose-4,6-dehydratase (Gmds)	mannose-4,6-dehydratase	GDP mannose-4,6-dehydratase	sugar (subset of carbon source)	mannose	COID906305	ABSTRACT	arg0
8ed22b45507d83459356f143208630a9	32748555	PMC7988551	the ability of therapeutic mAbs to recruit effector cells such as natural killer cells, which induce the apoptosis of targeted cells	ability	the ability	cellular metabolic state	apoptosis	COID850789	ABSTRACT	arg0
08b6a25621638d988cbf9706a7a1d80a	32748555	PMC7988551	The ADCC efficacy	efficacy	The ADCC efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
2da69aa4478f7e57e01f4b658191e089	32748555	PMC7988551	The ADCC efficacy	efficacy	The ADCC efficacy	clinical outcomes	ADCC	COID386333	ABSTRACT	arg1
a17ab159202766e3704e7762f9374ccf	32748555	PMC7988551	the ability of therapeutic mAbs to recruit effector cells such as natural killer cells, which induce the apoptosis of targeted cells	ability	the ability	monoclonal antibody	mAbs	COID242255	ABSTRACT	arg0
2703afccc7dddc3ee9c0f3c0b47da1cc	32748555	PMC7988551	guanosine diphosphate (GDP)-fucose synthesis	synthesis	guanosine diphosphate (GDP)-fucose synthesis	sugar (subset of carbon source)	fucose	COID275575	ABSTRACT	arg0
a8736f28dcb8a2bfcbbd56aadd6a2226	32748555	PMC7988551	GDP mannose-4,6-dehydratase (Gmds)	mannose-4,6-dehydratase	GDP mannose-4,6-dehydratase	enzyme	dehydratase	COID251243	ABSTRACT	arg1
e32d75a732a4050e1b4cab496d29510d	32748555	PMC7988551	GDP mannose-4,6-dehydratase (Gmds)	mannose-4,6-dehydratase	GDP mannose-4,6-dehydratase	sugar (subset of carbon source)	mannose	COID906305	ABSTRACT	arg1
29f3ae766a06b7575126f52feee05004	32748555	PMC7988551	either KO cell line	line	either KO cell line	cell line	cell line	COID702829	ABSTRACT	arg0
082271ff5d478111246713574882fd60	32748555	PMC7988551	The mAbs generated from either KO cell line	mAbs	The mAbs	monoclonal antibody	mAbs	COID242255	ABSTRACT	arg1
ef2c572822706a9096ab52db66402292	32748555	PMC7988551	FX-/- CHO cells	cells	FX-/- CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	RESULTS	arg0
a1aff817f6f791e67d7274416023799e	32748555	PMC7988551	mAbs expressed from FX-/- CHO cells	mAbs	mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg1
6b0eb5262b1285b1cce5a372da402e80	32748555	PMC7988551	FX -/- and Gmds-/- CHOZN host cell lines	lines	FX -/- and Gmds-/- CHOZN host cell lines	cell line	host cell lines	COID702829	RESULTS	arg0
82c7349d23b25644f8487ca75a05d719	32748555	PMC7988551	mAbs produced from FX -/- and Gmds-/- CHOZN host cell lines	mAbs	mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg1
d3c88106d424f44919f52c204f3a9585	32748555	PMC7988551	critical attributes that affect either biophysics or function of therapeutic mAb in vitro	attributes	critical attributes	monoclonal antibody	mAb	COID242255	RESULTS	arg0
33caa0ab56e36bb7fe21490eec961bfa	32748555	PMC7988551	function	function	function	process condition	function	COID532355	RESULTS	arg1
ca570c211cbf03968e0511edfb9cd714	32748555	PMC7988551	The 90% of afucosylated mAb2 from FX-/- and 98% afucosylated mAb2 from Gmds-/- have no significant difference in FcgammaRIIIa bindings and in ADCC effects, which indicated either KO cell line	mAb2	The 90% of afucosylated mAb2 from FX-/- and 98% afucosylated mAb2	monoclonal antibody	mAb2	COID770105	RESULTS	arg0
d4f38abd2330777c94b2222f643df98c	32748555	PMC7988551	afucosylated mAbs	mAbs	afucosylated mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg1
93c289be70e4739c5e5c4eaf321bbe36	32748555	PMC7988551	mAbs expressed from FX-/- CHO cells	mAbs	mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg0
685cc4ad915496c07c6fc34032da7acf	32748555	PMC7988551	G1F-GlcNAc	G1F-GlcNAc	G1F-GlcNAc	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
59d6e6854fbbf73908ca7b6c73d25aec	32748555	PMC7988551	G1F-GlcNAc	G1F-GlcNAc	G1F-GlcNAc	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg1
bc902ebe50e04ba23f5b670ca076b3e3	32748555	PMC7988551	the hybrid glycans	glycans	the hybrid glycans	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg1
20fb8b382c67596b8826ef56dd9ae7db	32748555	PMC7988551	the two engineered cell lines	lines	the two engineered cell lines	cell line	cell lines	COID702829	RESULTS	arg0
28bd697cad02b4daed8d1b80c0f6a82a	32748555	PMC7988551	a second proprietary monoclonal antibody	antibody	a second proprietary monoclonal antibody	monoclonal antibody	monoclonal antibody	COID242255	RESULTS	arg1
b0d082eeb3f68c8bcd51cbaabd182858	32748555	PMC7988551	mAb2	mAb2	mAb2	monoclonal antibody	mAb2	COID770105	RESULTS	arg1
73aa92bfff95ba5f1849a5bad236e728	32748555	PMC7988551	Both KO cell lines	lines	Both KO cell lines	cell line	cell lines	COID702829	RESULTS	arg0
e3f733364f5e5bb2a3bbe5d35e7bd149	32748555	PMC7988551	the potential to be utilized for the manufacturing of afucosylated mAbs for clinical use	potential	the potential to be utilized for the manufacturing of afucosylated mAbs for clinical use	monoclonal antibody	mAbs	COID242255	RESULTS	arg1
b1b14f49d6e13975ee17bd5317de99a1	32748555	PMC7988551	the Glycan of 10.31GU	Glycan	the Glycan	sugar (subset of carbon source)	Glycan	COID626759	RESULTS	arg0
629b29c32119cf49b2c124e613e7d514	32748555	PMC7988551	a retention time of 22.34 min (Figure 4b)	time	a retention time	process parameters or process control	time	COID742277	RESULTS	arg1
b1163dcfd8b5442b10557c36665a6188	32748555	PMC7988551	the Glycan of 9.07GU	Glycan	the Glycan	sugar (subset of carbon source)	Glycan	COID626759	RESULTS	arg0
5e68ff89ce2fe9a9d09c6e74e4fb0985	32748555	PMC7988551	a retention time of 18.03 min	time	a retention time	process parameters or process control	time	COID742277	RESULTS	arg1
5ad043f5ac2e3b40ea07770f563745dc	32748555	PMC7988551	FX-/- and Gmds-/- CHO clones	clones	FX-/- and Gmds-/- CHO clones	chinese hamster ovary (CHO)	CHO	COID806780	RESULTS	arg0
8dc96ed9c096e10abe520194ba9f9ad6	32748555	PMC7988551	robust cell growth	growth	robust cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
009ebe0e3b3f6cca7909cc18d93d20c3	32748555	PMC7988551	the afucosylated mAb with the increased FcgammaRIIIa bindings	mAb	the afucosylated mAb	monoclonal antibody	mAb	COID242255	RESULTS	arg0
9481518a165de8beb425af8893b032af	32748555	PMC7988551	ADCC effects	effects	ADCC effects	clinical outcomes	ADCC	COID386333	RESULTS	arg1
eb1b4bfe5289feb3f375a98b1004412c	32748555	PMC7988551	similar levels of mAb1 titers ranging from 0.8 to 1.0 g/L	levels	similar levels	overall titer or batch yield	mAb1 titers	COID732378	RESULTS	arg0
1145a8c419325d2f488989d70f1b8bc5	32748555	PMC7988551	parental CHOZN cells that led to 0.8 to 1.1 g/L of mAb1 at day14	cells	parental CHOZN cells	monoclonal antibody	mAb1	COID268135	RESULTS	arg1
3d970cd87599c4794068213f9df1b397	33476097	PMC8365702	several mAbs	mAbs	several mAbs	monoclonal antibody	mAbs	COID242255	ABSTRACT	arg0
e54a590878cb620ee50c4dde2b5ed74b	33476097	PMC8365702	A potential interaction between HEXB and mAb-1	interaction	A potential interaction	monoclonal antibody	mAb-1	COID268135	ABSTRACT	arg1
14e2793d3400551eeb81deb526549c90	33476097	PMC8365702	other mAbs	mAbs	other mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg0
a73457b75dbb0e9138e8aeaea6eb7889	33476097	PMC8365702	the HEXB/mAb-1 interface compared to other mAbs, which supports stronger interactions between HEXB and mAb-1	interface	the HEXB/mAb-1 interface	monoclonal antibody	mAb-1	COID268135	RESULTS	arg1
496b8e87682da6231f63947c4683a5f1	33476097	PMC8365702	B-cells that recognize the HCP and promote an antibody response	B-cells	B-cells	recombinant protein	HCP	COID169903	RESULTS	arg0
43c314aa7544f206cb55bb8d3b040e2d	33476097	PMC8365702	an antibody response	response	an antibody response	antibody	antibody	COID278523	RESULTS	arg1
9ceec094b316a93b276281917e54450a	33476097	PMC8365702	the root cause for N-glycan GlcNAc removal	cause	the root cause	sugar (subset of carbon source)	N-glycan	COID216687	RESULTS	arg0
0be946051ae46811e68d609aebaa3d64	33476097	PMC8365702	N-glycan GlcNAc removal	removal	N-glycan GlcNAc removal	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
a21595eb979bdeb14e7af673b274bcd0	33476097	PMC8365702	the root cause for N-glycan GlcNAc removal	cause	the root cause	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg0
569720b1dc82f03ad91f253e8a649212	33476097	PMC8365702	N-glycan GlcNAc removal	removal	N-glycan GlcNAc removal	sugar (subset of carbon source)	N-glycan	COID216687	RESULTS	arg1
7ba43e93a81b10a8e2ca8c03d92bf6b1	33476097	PMC8365702	the substrates	substrates	the substrates	substrates	substrates	COID265919	RESULTS	arg0
069ea273f766076ddacfb73a82e57b6a	33476097	PMC8365702	mAb-1 from Process-1 and Process-2	mAb-1	mAb-1	monoclonal antibody	mAb-1	COID268135	RESULTS	arg1
1c1463d4e963d1048e21696f42f934bb	33476097	PMC8365702	GlcNAc hydrolysis	hydrolysis	GlcNAc hydrolysis	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
e0882234d8789632081bbbfcd8effd94	33476097	PMC8365702	NP-GlcNAc	NP-GlcNAc	NP-GlcNAc	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg0
3957c44c460cbb80966100d194aa65eb	33476097	PMC8365702	the lowest binding free energy to HEXB compared to other antibodies	energy	the lowest binding free energy	antibody	antibodies	COID278523	RESULTS	arg0
8488273b1b03f251ef761c79c0f6d2bf	33476097	PMC8365702	mAb-1	mAb-1	mAb-1	monoclonal antibody	mAb-1	COID268135	RESULTS	arg1
0c7cb5594fb119878ec733ad63fd5e2c	33656168	PMC8451748	two CHO cell lines	lines	two CHO cell lines	cell line	cell lines	COID702829	ABSTRACT	arg0
286addb0ca6f18eefe650950d9126e53	33656168	PMC8451748	the antibodies adalimumab and trastuzumab	antibodies	the antibodies adalimumab and trastuzumab	antibody	antibodies	COID278523	ABSTRACT	arg1
9e8d266352e02c387284648e0b658f92	33656168	PMC8451748	two CHO cell lines	lines	two CHO cell lines	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg0
c304ce548479f74283624b8911f2512b	33656168	PMC8451748	In-depth analysis of the produced antibodies	analysis	In-depth analysis	antibody	antibodies	COID278523	ABSTRACT	arg0
b5f4cea9e0ba45d62e5cc69427d6e5ec	33656168	PMC8451748	other posttranslational profiles such as methionine oxidation and deamidation	profiles	other posttranslational profiles	PTM	deamidation	COID565107	ABSTRACT	arg1
52f9e61f527ccd11edf5a90155a88675	33656168	PMC8451748	other posttranslational profiles such as methionine oxidation and deamidation	profiles	other posttranslational profiles	PTM	oxidation	COID907585	ABSTRACT	arg1
30185cee7486ae97afe2bb05702f71f4	33656168	PMC8451748	deamidation	deamidation	deamidation	PTM	deamidation	COID565107	ABSTRACT	arg1
86d944bae40d680fa25df1dd69248f65	33656168	PMC8451748	methionine oxidation	oxidation	methionine oxidation	PTM	oxidation	COID907585	ABSTRACT	arg1
d56c40490e9465325d1099db8b6c666a	33656168	PMC8451748	the same glycosylation pattern	pattern	the same glycosylation pattern	product attributes	glycosylation pattern	COID857544	ABSTRACT	arg1
ec153312d9c2a4477a027a11346abf7a	33656168	PMC8451748	the same glycosylation pattern	pattern	the same glycosylation pattern	product attributes	glycosylation pattern	COID857544	ABSTRACT	arg0
897cdfa4e86ab9338823c0988a4b4fb3	33656168	PMC8451748	In-depth analysis of the produced antibodies	analysis	In-depth analysis	antibody	antibodies	COID278523	ABSTRACT	arg1
3641b75856ceb4e736b9e084d4e13765	33656168	PMC8451748	continuous upstream production like perfusion systems	production	continuous upstream production	process mode	perfusion	COID329168	RESULTS	arg0
4ba62eacf301a175ff9b07a844864a80	33656168	PMC8451748	auxiliary buffer and media tanks needed for continuous upstream production like perfusion systems	tanks	auxiliary buffer and media tanks	media characteristics	media	COID913636	RESULTS	arg1
28ee83be5982ea027c79c76537d37903	33656168	PMC8451748	pH-adjustment	pH-adjustment	pH-adjustment	bioreactor conditions	pH	COID893209	RESULTS	arg0
ea89d85a5bee3a934e2028e12e9f8a44	33656168	PMC8451748	other media pH-adjustment	media	other media	media characteristics	media	COID913636	RESULTS	arg1
f3dafea7d2cab82312da154eb3063805	33656168	PMC8451748	The glycosylation pattern between continuous on-demand and batchwise reconstitution	pattern	The glycosylation pattern	product attributes	glycosylation pattern	COID857544	RESULTS	arg0
0c10850dabf84646174c4a21247ee84e	33656168	PMC8451748	only minor differences that are within the expected batch to batch variations for pharmaceutical mAb production (Planinc et al., ; Upton et al., )	differences	only minor differences	overall titer or batch yield	mAb production	COID022887	RESULTS	arg1
30f1cd3408e0f32701ea2934dec8e776	33656168	PMC8451748	only minor differences that are within the expected batch to batch variations for pharmaceutical mAb production (Planinc et al., ; Upton et al., )	differences	only minor differences	process mode	batch	COID285438	RESULTS	arg1
5f471bea3c313ac0145c32dc8be3b265	33656168	PMC8451748	auxiliary buffer and media tanks needed for continuous upstream production like perfusion systems	tanks	auxiliary buffer and media tanks	media characteristics	media	COID913636	RESULTS	arg0
605e9367f0fcb5bfac1fe724e2a71bcc	33656168	PMC8451748	continuous upstream production like perfusion systems	production	continuous upstream production	process mode	perfusion	COID329168	RESULTS	arg1
3156a4401e6008e68c957849d9bec0d4	33656168	PMC8451748	batch and on-demand reconstituted media	media	batch and on-demand reconstituted media	process mode	batch	COID285438	RESULTS	arg0
29ce1ee3429d45486342117351ddfa99	33656168	PMC8451748	antibodies obtained with batch and on-demand reconstituted media	antibodies	antibodies	antibody	antibodies	COID278523	RESULTS	arg1
90468e7e605d065f7caa967108258aa1	33656168	PMC8451748	batch and on-demand reconstituted media	media	batch and on-demand reconstituted media	media characteristics	media	COID913636	RESULTS	arg0
736d8e131aca0223d2acffec2f47dd51	33656168	PMC8451748	the aliquots showing constant osmolality and pH (Figure S2) neglecting aliquots corresponding to the noted process deviations	aliquots	the aliquots	bioreactor conditions	pH	COID893209	RESULTS	arg0
052c4c0580d1212c4b2be92b4315b6b7	33656168	PMC8451748	constant osmolality	osmolality	constant osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg1
c8e7ade2036984daf41ee394ec4518b3	33656168	PMC8451748	the relative abundance (A, B) of the individual amino acids	abundance	the relative abundance	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg0
98fba760dc5d3c9d2e25fce615e6f5b4	33656168	PMC8451748	a comparable profile to a conventional reconstituted media	profile	a comparable profile	media characteristics	media	COID913636	RESULTS	arg1
3072b4dd404c22d2fe71dcf2f587c6e0	33656168	PMC8451748	an insufficient supply of nutrients	supply	an insufficient supply	secondary raw materials	nutrients	COID423902	RESULTS	arg0
7fa8cb567b751edcb4f12257bbb4a51d	33656168	PMC8451748	the amino acid sequence of the POI	sequence	the amino acid sequence	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg1
6dcbdd97aa2e311d654ba7b88d4e42bd	33656168	PMC8451748	both cell lines	lines	both cell lines	cell line	cell lines	COID702829	RESULTS	arg0
c4e1958abbc9c456306d8c6c32f94e0f	33656168	PMC8451748	a comparable cell culture performance and metabolite profiles (Figure 4)	culture	a comparable cell culture performance and metabolite profiles	product quality attributes	cell culture performance	COID284912	RESULTS	arg1
bf1952ae1d73bc71cbee58b555dd55fd	33656168	PMC8451748	no additional pH adjustments	adjustments	no additional pH adjustments	bioreactor conditions	pH	COID893209	RESULTS	arg0
9bce5f52481d65a5dcf49925d8a1518f	33656168	PMC8451748	The reconstitution of the CDM Dynamis AGT	reconstitution	The reconstitution	media	Dynamis	COID624994	RESULTS	arg1
776878097a0e6d882084c0e50e3babd6	33656168	PMC8451748	analysis of the final titer at the day of the harvest	analysis	analysis	overall titer or batch yield	titer	COID732378	RESULTS	arg0
3209e14e9fcd9f81d94f10aad8465887	33656168	PMC8451748	comparable productivity of 0.193, 0.239, 0.235, 0.228 g L-1 for On-demand_1, On-demand_2, Batch_1, and Batch_2	productivity	comparable productivity	process condition	productivity	COID731421	RESULTS	arg1
03a791ab1b18a58f7f1f971fff622621	33656168	PMC8451748	metabolic response pathways which ultimately lead to a growth arrest (Altamirano et al., ; Carrillo-Cocom et al., ; Fomina-Yadlin et al., ; Gramer, ; Guo et al., ; Kilberg et al., , ; Popp et al., ; Xing et al., )	pathways	metabolic response pathways	cell culture parameters	growth	COID203666	RESULTS	arg1
2b06df4cf034aa0a5a92356209055710	33682619	PMC7946005	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	ABSTRACT	arg0
9899c3ebd868a015daa692e7f83fcf5f	33682619	PMC7946005	CDC	CDC	CDC	clinical outcomes	CDC	COID455860	ABSTRACT	arg1
1edd000e2dc8d8c033231f6e7641ce92	33682619	PMC7946005	the CDC potency	potency	the CDC potency	clinical outcomes	potency	COID969445	RESULTS	arg0
fb02a6c363346a019ff7244e3d4eb139	33682619	PMC7946005	Fc galactosylation	galactosylation	Fc galactosylation	product quality profile	Fc galactosylation	COID097777	RESULTS	arg1
1ba2618559d69dcf8d8e508838f66dfa	33682619	PMC7946005	the CDC potency	potency	the CDC potency	clinical outcomes	CDC	COID455860	RESULTS	arg0
42ba396b283fa09fb08dec4681c95096	33682619	PMC7946005	The RGY mutant of mAb B, an IgG1 with the same Fc as mAb A	mutant	The RGY mutant	monoclonal antibody	mAb	COID242255	RESULTS	arg0
76f2b39f9a83882111f2bda159d2ab47	33682619	PMC7946005	the IgG1 hexamer	hexamer	the IgG1 hexamer	antibody	IgG1	COID713543	RESULTS	arg1
131ef78152219fd7cf22d0829ada88aa	33682619	PMC7946005	terminal galactose	galactose	terminal galactose	sugar (subset of carbon source)	galactose	COID770311	RESULTS	arg0
60b4b3be91bf64de29ca42e1eb64b427	33682619	PMC7946005	CDC potency	potency	CDC potency	clinical outcomes	potency	COID969445	RESULTS	arg1
62d56e591a35dfe6b1572c83dd357feb	33682619	PMC7946005	CDC potency	potency	CDC potency	clinical outcomes	CDC	COID455860	RESULTS	arg1
b68b4b16520fa427c60464207170e60a	33682619	PMC7946005	12,000 L scale	scale	12,000 L scale	vessel or process parameter or production scale	scale	COID586187	RESULTS	arg0
f4547b3aff26a5ef2c12e7e156637cc9	33682619	PMC7946005	the process validation data of 426 historical small-scale cell culture research and development (R&D) samples at 2 L scale	data	the process validation data	cell culture parameters	cell culture	COID293414	RESULTS	arg1
13790a1aa1283f1535f29bb98adbe372	33682619	PMC7946005	CDC potency	potency	CDC potency	clinical outcomes	potency	COID969445	RESULTS	arg0
0139f7539121708ac7f5fdd9dccb26ec	33682619	PMC7946005	total galactose	galactose	total galactose	sugar (subset of carbon source)	galactose	COID770311	RESULTS	arg1
cc1bb5fecb621f657a46737157b909cc	33682619	PMC7946005	CDC potency	potency	CDC potency	clinical outcomes	CDC	COID455860	RESULTS	arg0
c2f759e22b1e5e31c93565c8d6237f3c	33682619	PMC7946005	the released glycan data following binominal distribution	distribution	the released glycan data following binominal distribution	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg0
1f59b19a7052e33ed06aa8be5080c792	33682619	PMC7946005	the intact protein level Fc galactosylation distribution reconstructed by the released glycan data following binominal distribution	distribution	the intact protein level Fc galactosylation distribution	product quality profile	Fc galactosylation	COID097777	RESULTS	arg1
c212caba08e4e6fb337350ed81eaf4de	33682619	PMC7946005	the reaction time (Figure 2a)	time	the reaction time	process parameters or process control	time	COID742277	RESULTS	arg0
78f7b5323fe5426c8566bb504828cbe1	33682619	PMC7946005	The level of Fc galactosylation	level	The level	product quality profile	Fc galactosylation	COID097777	RESULTS	arg1
78237f934c4f16f1d202501b3b128310	33738790	PMC8453549	CHO cells	cells	CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	ABSTRACT	arg0
213dc7e75d89a0f4f26a32b167a2f585	33738790	PMC8453549	the mechanism of cleavage	mechanism	the mechanism	PTM	cleavage	COID846179	ABSTRACT	arg1
45eb432dc7526bec04473008938e53dc	33738790	PMC8453549	high concentrations of lactate in spent media during fed-batch bioprocesses	concentrations	high concentrations	by-product or waste	lactate	COID250920	RESULTS	arg0
399fb8fff401111f766d68be781bad26	33738790	PMC8453549	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
7309c96371fb4b61db724f3d66e61954	33738790	PMC8453549	IgG titer	titer	IgG titer	overall titer or batch yield	IgG titer	COID814559	RESULTS	arg1
5b0b6ab1fbd6914f2e62cba4f7abd534	33738790	PMC8453549	lactate levels	levels	lactate levels	by-product or waste	lactate	COID250920	RESULTS	arg0
f8c7e838d28ed0cb2c7271e5e6e3a74b	33738790	PMC8453549	cell growth and productivity	cell	cell growth and productivity	process condition	productivity	COID731421	RESULTS	arg1
fc5295803ab9553e99e82d3fcfddc661	33738790	PMC8453549	cell growth and productivity	cell	cell growth and productivity	cell culture parameters	cell growth	COID093598	RESULTS	arg1
1baefc12157f48dfeb1318c496fbdea9	33738790	PMC8453549	6.2 g/L lactate (or higher)	lactate	6.2 g/L lactate	by-product or waste	lactate	COID250920	RESULTS	arg0
22c7c5a6a540dfe5782ba6b86c474a97	33738790	PMC8453549	an effect of overall productivity	effect	an effect	process condition	productivity	COID731421	RESULTS	arg1
caee192f7ed267eddf3040d208580b91	33742789	PMC8459231	iron in CCM	iron	iron	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	ABSTRACT	arg0
f4771ce263fe6abab01c5d9aeb4dca5a	33742789	PMC8459231	Chinese hamster ovary (CHO) cell line	line	Chinese hamster ovary (CHO) cell line	chinese hamster ovary (CHO)	Chinese hamster ovary	COID806780	ABSTRACT	arg1
d0b74d09fb5596f8b68d5849843205dd	33742789	PMC8459231	Chinese hamster ovary (CHO) cell line	line	Chinese hamster ovary (CHO) cell line	cell line	cell line	COID702829	ABSTRACT	arg1
594cb6d5e86783afd53910761dd3658a	33742789	PMC8459231	Chinese hamster ovary (CHO) cell line	line	Chinese hamster ovary (CHO) cell line	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg1
fb0811a8035b596c9f6b2395aa67597b	33742789	PMC8459231	Cell culture medium (CCM) composition	composition	Cell culture medium (CCM) composition	media characteristics	culture medium	COID180560	ABSTRACT	arg0
778d963a1a17df024dfc1fc01d03e0d3	33742789	PMC8459231	CQAs	CQAs	CQAs	product quality attributes	CQAs	COID162607	ABSTRACT	arg1
788b162c04d0c85ad6b220c0020c5768	33742789	PMC8459231	Cell culture medium (CCM) composition	composition	Cell culture medium (CCM) composition	cell culture parameters	Cell culture	COID293414	ABSTRACT	arg0
71407f5c7ea52dddcc8f7c009d5c7ce5	33742789	PMC8459231	critical quality attributes (CQAs)	attributes	critical quality attributes	product quality attributes	critical quality attributes	COID162607	ABSTRACT	arg1
2aaf4c85d67b1eb8a338ae928281fb25	33742789	PMC8459231	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
4204cb61f533e0ed481789ad7777c27c	33742789	PMC8459231	manganese impurity rather than iron	iron	iron	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	ABSTRACT	arg0
8945828c70b22f68f059a4aa13435040	33742789	PMC8459231	altered glycosylation levels	levels	altered glycosylation levels	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
0564ef7a058c6dcc31f52d12d33f9457	33742789	PMC8459231	prolonged viability	viability	prolonged viability	process parameters or process control	prolonged viability	COID937191	ABSTRACT	arg1
9affbfac4982583637588e8ea84e358e	33742789	PMC8459231	titer	titer	titer	overall titer or batch yield	titer	COID732378	ABSTRACT	arg1
4b7a1c65f8a0d2b06cf09b96aea03b6b	33742789	PMC8459231	manganese impurity rather than iron	impurity	manganese impurity	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	ABSTRACT	arg0
f52099245f46cfb4b395822e6a62bf74	33742789	PMC8459231	manganese impurity rather than iron	impurity	manganese impurity	process condition	impurity	COID901557	ABSTRACT	arg0
255bbbaec3b98435349888cdc8313e54	33742789	PMC8459231	the root cause for increased cell growth, titer, and prolonged viability, as well as altered glycosylation levels	cause	the root cause	process parameters or process control	prolonged viability	COID937191	ABSTRACT	arg0
4639b3a8683715e146e9d85f7823c4cd	33742789	PMC8459231	the root cause for increased cell growth, titer, and prolonged viability, as well as altered glycosylation levels	cause	the root cause	cell culture parameters	cell growth	COID093598	ABSTRACT	arg0
fa1d1dde56cd05f46f3ac6f52fa459cf	33742789	PMC8459231	the root cause for increased cell growth, titer, and prolonged viability, as well as altered glycosylation levels	cause	the root cause	overall titer or batch yield	titer	COID732378	ABSTRACT	arg0
c7d0d308574bc94a4607146d6ffc80bf	33742789	PMC8459231	the root cause for increased cell growth, titer, and prolonged viability, as well as altered glycosylation levels	cause	the root cause	glycosylation	glycosylation	COID119643	ABSTRACT	arg0
2616a5d985c52e93815bbde88c2a4d8d	33742789	PMC8459231	the medium	medium	the medium	media characteristics	medium	COID921897	ABSTRACT	arg0
7a115b5666f08579fe3b7f5641d0283a	33742789	PMC8459231	iron	iron	iron	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	ABSTRACT	arg1
e5d1c4f5f136830485106b3b4e385339	33742789	PMC8459231	high and low manganese-contaminated iron sources	sources	high and low manganese-contaminated iron sources	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
3029689b592e66c9c683aa94b48ca3c3	33742789	PMC8459231	IgG quality	quality	IgG quality	product quality attributes	quality	COID109463	RESULTS	arg1
bb9b899c130028d946505027b5ae80d3	33742789	PMC8459231	IgG quality	quality	IgG quality	antibody	IgG	COID713543	RESULTS	arg1
1f584a7906498a08fbc0bbe179da7746	33742789	PMC8459231	high and low manganese-contaminated iron sources	sources	high and low manganese-contaminated iron sources	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
4450fc06b2511f324eadfefb48fc1545	33742789	PMC8459231	ammonium	ammonium	ammonium	culture condition	ammonium	COID714150	RESULTS	arg0
39a1c0d29fb7a508fe32c69f7101d531	33742789	PMC8459231	cell line 3 (Figure 8b)	line	cell line 3	cell line	cell line	COID702829	RESULTS	arg0
674b8740162e1538197345ad1ff3f466	33742789	PMC8459231	fusion protein produced by cell line 3 (Figure 8b)	protein	fusion protein	recombinant protein	fusion protein	COID506208	RESULTS	arg1
6e992f2d6396c335b89265189f216112	33742789	PMC8459231	high and low manganese-contaminated FC iron sources	sources	high and low manganese-contaminated FC iron sources	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
6117e4b397c4e1dc7614d07ec2b4215c	33742789	PMC8459231	further cell lines	lines	further cell lines	cell line	cell lines	COID702829	RESULTS	arg1
5089c0a0c79dd59553a5b9adfe1776f6	33742789	PMC8459231	high and low manganese-contaminated FC iron sources	sources	high and low manganese-contaminated FC iron sources	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
0eac9fc7ddc267a9cf8cb2d80a3a3880	33742789	PMC8459231	cell line 3	line	cell line 3	cell line	cell line	COID702829	RESULTS	arg0
e44fdc0a09e607bd8f40dd90b03f0c03	33742789	PMC8459231	the fusion protein produced by cell line 3	protein	the fusion protein	recombinant protein	fusion protein	COID506208	RESULTS	arg1
ce5b0a2fb88cf7cde2ca90710cf00f55	33742789	PMC8459231	increasing iron amounts in CCM	amounts	increasing iron amounts	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
f2251b37e194c6afcd9a62d20bfa30f1	33742789	PMC8459231	Iron deficient medium	medium	Iron deficient medium	media characteristics	medium	COID921897	RESULTS	arg0
3f17f5b48068c30b50f3e4524ee6723d	33742789	PMC8459231	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
9e686aa48285710c4470e027a5ff1e7c	33742789	PMC8459231	Iron deficient medium	medium	Iron deficient medium	trace metals or minerals (subset of secondary raw materials)	Iron	COID094956	RESULTS	arg0
c34575ab8f37ac3e8916189eac0c215f	33742789	PMC8459231	no titer production	production	no titer production	overall titer or batch yield	titer	COID732378	RESULTS	arg1
598637a931411902241dab10f63dbd77	33742789	PMC8459231	FCSynt indicating the positive impact of manganese on productivity (Figure 5c)	FCSynt	FCSynt	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
6498fbd4bd4471068e3e9798b8052e30	33742789	PMC8459231	productivity (Figure 5c)	productivity	productivity	process condition	productivity	COID731421	RESULTS	arg1
8d3fe571632c703743269fbbaaafb1d6	33742789	PMC8459231	attributes other than iron and ammonium levels	attributes	attributes	culture condition	ammonium	COID714150	RESULTS	arg0
bbd200910114a65c698d6b95d514b339	33742789	PMC8459231	viability	viability	viability	process parameters or process control	viability	COID222142	RESULTS	arg1
737f4a07b0558672a2fdf856d4b2630f	33742789	PMC8459231	attributes other than iron and ammonium levels	attributes	attributes	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
9380f1421dd6c3a4f8c45c708c540020	33742789	PMC8459231	growth	growth	growth	cell culture parameters	growth	COID203666	RESULTS	arg1
05469318d880cacac0cff9965c03720e	33742789	PMC8459231	IgG glycosylation	glycosylation	IgG glycosylation	product quality profile	IgG glycosylation	COID286158	RESULTS	arg1
933ccb05e996d6f3ca2478c4ab49f456	33742789	PMC8459231	different iron sources	sources	different iron sources	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
911039381b3109f445b166f254f2baf3	33742789	PMC8459231	cell line 2	line	cell line 2	cell line	cell line	COID702829	RESULTS	arg0
801c7dcf591f50e8bd1a2d27aef8a147	33742789	PMC8459231	mAb2 produced by cell line 2	mAb2	mAb2	monoclonal antibody	mAb2	COID770105	RESULTS	arg1
9e1cae55bff5e10d929a67af230e0482	33742789	PMC8459231	increasing amounts of manganese in CCM	amounts	increasing amounts	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
49a8acc9478dec484197c7732d574701	33742789	PMC8459231	prolonged viabilities (Figure 6b)	viabilities	prolonged viabilities	process parameters or process control	prolonged viabilities	COID937191	RESULTS	arg1
30432b93ae79a0b316350c884b883c5a	33742789	PMC8459231	usage of either FCPurch or FCSynt supplemented with manganese	usage	usage	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
fd64a6f8940c9c09f01a9b9a2d9c2e76	33742789	PMC8459231	a prolonged viability	viability	a prolonged viability	process parameters or process control	prolonged viability	COID937191	RESULTS	arg1
ee0954b35fb7733804c0f7f6e6a7f96e	33742789	PMC8459231	Titer profiles	profiles	Titer profiles	overall titer or batch yield	Titer	COID732378	RESULTS	arg0
95c3b3e2376105293d786e1e8ee58114	33742789	PMC8459231	only slight variations between the different tested iron sources (Figure 4c)	variations	only slight variations	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg1
ec8fd6d5c562513dfad4582568fbcbb6	33742789	PMC8459231	iron	iron	iron	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
f29b3b5eb187720628e4d95e973198eb	33742789	PMC8459231	protein glycosylation	glycosylation	protein glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
d9bbcf1cd7e361226cb8ca76089e227f	33742789	PMC8459231	manganese	manganese	manganese	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
91315f35daa7d7eb441e03692ae82baf	33742789	PMC8459231	aggregation levels	levels	aggregation levels	process condition	aggregation	COID720685	RESULTS	arg1
cd92660aac48c3d184027a7a0d256914	33742789	PMC8459231	antibody galactosylation	galactosylation	antibody galactosylation	glycosylation	antibody galactosylation	COID740922	RESULTS	arg1
85d4ac52fb9680b0e151a9ee1aadcdb1	33742789	PMC8459231	cell metabolism	metabolism	cell metabolism	biological process	metabolism	COID291079	RESULTS	arg1
945524e926d0e7af64844f3b94b7de6a	33742789	PMC8459231	the increase in cell growth	increase	the increase	cell culture parameters	cell growth	COID093598	RESULTS	arg0
17a34162f77dbb88ce80557ffb79e32d	33742789	PMC8459231	viability (Figure 1b)	viability	viability	process parameters or process control	viability	COID222142	RESULTS	arg1
b1ca3ee3106792fe9e9ac129ea4c02e5	33742789	PMC8459231	the observed changes in cell performance and CQAs	changes	the observed changes	product quality attributes	CQAs	COID162607	RESULTS	arg1
7604751081599cc41df019ca42fc0942	33742789	PMC8459231	a lower cell growth	growth	a lower cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg0
521b7792a1db791b636dbfa8f059fcce	33742789	PMC8459231	usage of FC as iron source in CCM	usage	usage	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg1
2b2e5f1467db2f97e7d7f59ca04f96b3	33804825	PMC8037477	The addition of nutrients and accumulation of metabolites in a fed-batch culture of Chinese hamster ovary (CHO) cells	addition	The addition	secondary raw materials	nutrients	COID423902	ABSTRACT	arg0
30d6aa1bf5df920db98e1ed969d6a393	33804825	PMC8037477	extracellular osmolality	osmolality	extracellular osmolality	process parameters or process control	osmolality	COID710653	ABSTRACT	arg1
520eae18fd8924123cc64ce852e5c54a	33804825	PMC8037477	Osmolality modulation using NaCl up to 470 mOsm kg-1	modulation	Osmolality modulation	process parameters or process control	Osmolality	COID710653	ABSTRACT	arg0
80c029c3961088dce614c1c029293bdc	33804825	PMC8037477	a consistently positive effect on specific antibody productivity and titre	effect	a consistently positive effect	process condition	productivity	COID731421	ABSTRACT	arg1
49ba342db40951f030639ffe479d9ac5	33804825	PMC8037477	a consistently positive effect on specific antibody productivity and titre	effect	a consistently positive effect	antibody	antibody	COID278523	ABSTRACT	arg1
2ba6c2caf0e8e3bb73b42d4e7ae03ba6	33804825	PMC8037477	specific antibody productivity	productivity	specific antibody productivity	process condition	productivity	COID731421	ABSTRACT	arg1
3c7c3a172a5d52b1acac82d4fdddee04	33804825	PMC8037477	specific antibody productivity	productivity	specific antibody productivity	antibody	antibody	COID278523	ABSTRACT	arg1
cae347c5e529f5e56676ce6e04e93ace	33804825	PMC8037477	osmolality	osmolality	osmolality	process parameters or process control	osmolality	COID710653	ABSTRACT	arg0
1f52c9ba77e46fc5c4988f97a635508f	33804825	PMC8037477	specific monoclonal antibody (mAb) productivity	productivity	specific monoclonal antibody (mAb) productivity	monoclonal antibody	monoclonal antibody	COID242255	ABSTRACT	arg1
e1e5eabf67fe6c19c21a0d8d47a1be83	33804825	PMC8037477	specific monoclonal antibody (mAb) productivity	productivity	specific monoclonal antibody (mAb) productivity	process condition	productivity	COID731421	ABSTRACT	arg1
4a8a850eb23aca1d1b7778f06e2e8dfe	33804825	PMC8037477	specific monoclonal antibody (mAb) productivity	productivity	specific monoclonal antibody (mAb) productivity	monoclonal antibody	mAb	COID242255	ABSTRACT	arg1
f53cf72381d84fdcc8ebc171a2d01cc0	33804825	PMC8037477	CHO cell growth	growth	CHO cell growth	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
f011f9295345a9a71f80b7e630bd4002	33804825	PMC8037477	CHO cell growth	growth	CHO cell growth	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg1
784d1cd839f687dec88a97c90bf4b602	33804825	PMC8037477	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
918d412f5ec0781fa66b7d094c0fe205	33804825	PMC8037477	a spiked medium	medium	a spiked medium	media characteristics	medium	COID921897	RESULTS	arg0
d9d93a4a2c734d237f2e42aba222548a	33804825	PMC8037477	a batch CHO cell culture's performance	performance	a batch CHO cell culture's performance	cell culture parameters	cell culture	COID293414	RESULTS	arg1
679332e1bb23a4a018b722eb068b5dbc	33804825	PMC8037477	a batch CHO cell culture's performance	performance	a batch CHO cell culture's performance	process mode	batch	COID285438	RESULTS	arg1
1940616f891bb32e6aeb675b9772ec97	33804825	PMC8037477	a batch CHO cell culture's performance	performance	a batch CHO cell culture's performance	chinese hamster ovary (CHO)	CHO	COID806780	RESULTS	arg1
e8a6a4a9fc6870339541800d0e7c9bb5	33804825	PMC8037477	b4GalT	b4GalT	b4GalT	enzyme	b4GalT	COID856080	RESULTS	arg0
f0a68b5163b8de11b57f15b14b9eab54	33804825	PMC8037477	mAb galactosylation	galactosylation	mAb galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
d5f73b75227c65c3aa1f9ec67a506134	33804825	PMC8037477	mAb galactosylation	galactosylation	mAb galactosylation	monoclonal antibody	mAb	COID242255	RESULTS	arg1
8a8a0a56d7b2ffce2800bc3d35ef3d95	33804825	PMC8037477	b-1,4-galactosyltransferase (b4GalT)	b-1,4-galactosyltransferase	b-1,4-galactosyltransferase	enzyme	galactosyltransferase	COID703629	RESULTS	arg0
831cef10ee75f9afd6f72a0a1034d9fb	33804825	PMC8037477	hyperosmolality	hyperosmolality	hyperosmolality	process parameters or process control	hyperosmolality	COID710478	RESULTS	arg0
dbedf9f410b3271e08e92ef990812254	33804825	PMC8037477	specific cell growth rate	rate	specific cell growth rate	cell culture parameters	cell growth	COID093598	RESULTS	arg1
93371f91bac69fa70192932c745fd83e	33804825	PMC8037477	specific cell growth rate	rate	specific cell growth rate	cell culture parameters	growth rate	COID957002	RESULTS	arg1
8e8762fba3517a90d830cc59ced32131	33804825	PMC8037477	Hyperosmolality	Hyperosmolality	Hyperosmolality	process parameters or process control	Hyperosmolality	COID710478	RESULTS	arg0
ea6d0ddc35b875ef150e31e793a6024c	33804825	PMC8037477	Specific Antibody Productivity and Glycosylation	Antibody	Specific Antibody Productivity and Glycosylation	glycosylation	Glycosylation	COID119643	RESULTS	arg1
46d539ad7f50bb7a763f97f2b7439ba6	33804825	PMC8037477	Specific Antibody Productivity and Glycosylation	Antibody	Specific Antibody Productivity and Glycosylation	process condition	Productivity	COID731421	RESULTS	arg1
13f1fbca495322903cd95ec5830bc0a9	33804825	PMC8037477	Specific Antibody Productivity and Glycosylation	Antibody	Specific Antibody Productivity and Glycosylation	antibody	Antibody	COID278523	RESULTS	arg1
69f8daedff094a08814b3f94ef0d49d1	33804825	PMC8037477	The high rate of antibody synthesis and secretion	rate	The high rate	antibody	antibody	COID278523	RESULTS	arg0
90d383cec607e5ac98b5e6559c2f4e99	33804825	PMC8037477	limited antibody residence time	time	limited antibody residence time	process parameters or process control	time	COID742277	RESULTS	arg1
57d72a1347d64ebaaba67baef0750fe4	33804825	PMC8037477	Cell Growth and Metabolism	Cell	Cell Growth and Metabolism	cell culture parameters	Cell Growth	COID093598	RESULTS	arg1
c3ed4c8d221dc5b21e58161622611757	33804825	PMC8037477	Cell Growth and Metabolism	Cell	Cell Growth and Metabolism	biological process	Metabolism	COID291079	RESULTS	arg1
7f8a3324074114d61e1527544b481832	33804825	PMC8037477	osmolarity	osmolarity	osmolarity	process parameters or process control	osmolarity	COID052118	RESULTS	arg0
2b0a957ba82c267b0aa67f7179146c34	33804825	PMC8037477	CHO cell growth rate	rate	CHO cell growth rate	cell culture parameters	cell growth	COID093598	RESULTS	arg1
714e6753240f40337abf3980984bf99c	33804825	PMC8037477	CHO cell growth rate	rate	CHO cell growth rate	cell culture parameters	growth rate	COID957002	RESULTS	arg1
a7f69b408dfacc6c634601b2550c5273	33804825	PMC8037477	CHO cell growth rate	rate	CHO cell growth rate	chinese hamster ovary (CHO)	CHO	COID806780	RESULTS	arg1
75d0dac3a78bd0861d99c783455d7890	33804825	PMC8037477	Several process parameters	parameters	Several process parameters	process parameters or process control	process parameters	COID163282	RESULTS	arg0
0daf7dd9de92f860a42963fcd8a2994a	33804825	PMC8037477	recombinant protein glycosylation	glycosylation	recombinant protein glycosylation	recombinant protein	recombinant protein	COID593158	RESULTS	arg1
dddd5464ed75a91245aad164c6efb3b6	33804825	PMC8037477	recombinant protein glycosylation	glycosylation	recombinant protein glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
9a311fb2abaabe3092eed7b841d606ad	33804825	PMC8037477	culture pH	pH	culture pH	bioreactor conditions	culture pH	COID689332	RESULTS	arg0
2347f9396d2384eface1f41c54465715	33804825	PMC8037477	temperature	temperature	temperature	bioreactor conditions	temperature	COID692615	RESULTS	arg0
bc57bb5f369b358c9bdd81916d9706b9	33804825	PMC8037477	ammonia levels	levels	ammonia levels	by-product or waste	ammonia	COID714278	RESULTS	arg0
dbfd6d2a1e0f117d6b8791c97aed2244	33804825	PMC8037477	the cultures with osmolality levels of 320 mOsm kg-1, 420 mOsm kg-1 and 470 mOsm kg-1 that presented the highest ammonia concentrations at harvest (Figure 2)	cultures	the cultures	by-product or waste	ammonia	COID714278	RESULTS	arg0
bc229296a328abf7515344521c8961db	33804825	PMC8037477	IgG galactosylation (Figure 6)	galactosylation	IgG galactosylation	product quality profile	IgG galactosylation	COID983193	RESULTS	arg1
695563f74324211f7698b76019ebacd4	33804825	PMC8037477	the accumulation of metabolic by-products in fed-batch cultures	accumulation	the accumulation	by-product or waste	metabolic by-products	COID531384	RESULTS	arg0
8d099a2de10b0bdfd946b9dc2849e2d6	33804825	PMC8037477	Hyperosmolality	Hyperosmolality	Hyperosmolality	process parameters or process control	Hyperosmolality	COID710478	RESULTS	arg1
df7ac08ddd55bf368e92c33a788eb12b	33804825	PMC8037477	The shift from lactate production to consumption	shift	The shift	by-product or waste	lactate	COID250920	RESULTS	arg1
70746e95441b045ded75ef454d383bcd	33804825	PMC8037477	specific mAb productivity	productivity	specific mAb productivity	process condition	mAb productivity	COID842515	RESULTS	arg0
3107ee989af06574937c3acee04d4e4b	33804825	PMC8037477	the value of osmolality	value	the value	process parameters or process control	osmolality	COID710653	RESULTS	arg1
58f4ad193f1f7bc6a566d6b06151b16f	33804825	PMC8037477	lactate production	production	lactate production	by-product or waste	lactate	COID250920	RESULTS	arg1
1acb66f9419b5f5ab99ed3a4264fc482	33804825	PMC8037477	glucose consumption	consumption	glucose consumption	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
c33e85b3992d208ce43e1cbfb2001f86	33804825	PMC8037477	tepa productivity	productivity	tepa productivity	process condition	productivity	COID731421	RESULTS	arg1
2fb0622b193ab4ac80c742d1fd73f70c	34542245	PMC9286570	N-1 perfusion cell culture	culture	N-1 perfusion cell culture	cell culture parameters	cell culture	COID293414	ABSTRACT	arg0
d1046244916bcb70585452f4be91f1cc	34542245	PMC9286570	a robust intensified FB (iFB)	FB	a robust intensified FB	process mode	iFB	COID504685	ABSTRACT	arg1
c1f3ae45673bef6b20570fb3ad5563c6	34542245	PMC9286570	N-1 perfusion cell culture	culture	N-1 perfusion cell culture	process mode	perfusion	COID329168	ABSTRACT	arg0
eda8a70e40f16768b3d682d7f4124bac	34542245	PMC9286570	iFB	iFB	iFB	process mode	iFB	COID504685	ABSTRACT	arg1
ac1d62f7eaf57f3a71bdee4d1bd8be1e	34542245	PMC9286570	the fluxes of the main pathways glycolysis, TCA and PPP	fluxes	the fluxes	metabolic pathways	glycolysis	COID345655	RESULTS	arg0
eb0b6d73318b5fba4e2a8a2891838b72	34542245	PMC9286570	iFB_5	iFB_5	iFB_5	process mode	iFB_5	COID504685	RESULTS	arg1
15555c1abddbc73cd0cfed9999adfd3a	34542245	PMC9286570	the fluxes of the main pathways glycolysis, TCA and PPP	fluxes	the fluxes	acid (subset of secondary raw materials)	TCA	COID780120	RESULTS	arg0
221ccc0aa72d204520f19f22a01d03cd	34542245	PMC9286570	the fluxes of the main pathways glycolysis, TCA and PPP	fluxes	the fluxes	metabolic pathways	PPP	COID233901	RESULTS	arg0
b4cf82a42449d0df91149610ef3d7333	34542245	PMC9286570	only a small correction of the specific growth rate	correction	only a small correction	cell culture parameters	growth rate	COID957002	RESULTS	arg0
d6fcfe5ebb87f839e91c6b9e0884a8c5	34542245	PMC9286570	in vitro trimmed mannosylated mAb1 isoforms	isoforms	in vitro trimmed mannosylated mAb1 isoforms	monoclonal antibody	mAb1	COID268135	RESULTS	arg0
6a0f2e0c741b283fe1f149b109278ba9	34542245	PMC9286570	its effector functions	functions	its effector functions	process condition	functions	COID532355	RESULTS	arg1
df0c88e79218530a3cef735a96855fc6	34542245	PMC9286570	reduced cell growth	growth	reduced cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg0
8e9cbed2f1704c2f71d5da59fa32bf59	34542245	PMC9286570	the cell-specific productivity	productivity	the cell-specific productivity	process condition	cell-specific productivity	COID637897	RESULTS	arg1
1745a442669f72f5b5709b50418c2508	34542245	PMC9286570	viability	viability	viability	process parameters or process control	viability	COID222142	RESULTS	arg0
22754de5d3df613137d995e36f662683	34542245	PMC9286570	the iFB	iFB	the iFB	process mode	iFB	COID504685	RESULTS	arg0
5c61fb2b9d8974195a26ed3621668149	34542245	PMC9286570	a similar growth pattern (Figure 3(a,b))	pattern	a similar growth pattern	cell culture parameters	growth	COID203666	RESULTS	arg1
21e9e20670ea2b78db40149d246ed919	34542245	PMC9286570	BA supplementation	supplementation	BA supplementation	secondary raw materials	BA supplementation	COID689497	RESULTS	arg0
e8c7984e72b31a05ab1b79e9b64df77c	34542245	PMC9286570	cell specific productivity	productivity	cell specific productivity	process condition	cell specific productivity	COID637897	RESULTS	arg1
6e1002423f8675ee73d197237ed14fee	34542245	PMC9286570	the final viability of up to 25%	viability	the final viability	process parameters or process control	viability	COID222142	RESULTS	arg0
a60c4f42dd3021870d8a9751e2b542d9	34542245	PMC9286570	iFB	iFB	iFB	process mode	iFB	COID504685	RESULTS	arg1
1ded0aae05c34724a254112642eff8f0	34575094	PMC8469772	monoclonal antibody (mAb) expression	expression	monoclonal antibody (mAb) expression	monoclonal antibody	monoclonal antibody	COID242255	ABSTRACT	arg0
4b27ee0c4afce02fb40f0fe3d8e44abb	34575094	PMC8469772	Chinese hamster ovary (CHO) cells	cells	Chinese hamster ovary (CHO) cells	chinese hamster ovary (CHO)	Chinese hamster ovary	COID806780	ABSTRACT	arg1
459da5fb60be4fa71bf1fe2888a2239e	34575094	PMC8469772	Chinese hamster ovary (CHO) cells	cells	Chinese hamster ovary (CHO) cells	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg1
221a0d22cd5ecc64564a9dbc91900aba	34575094	PMC8469772	monoclonal antibody (mAb) expression	expression	monoclonal antibody (mAb) expression	monoclonal antibody	mAb	COID242255	ABSTRACT	arg0
81bfac08bffdc17a0c54d6853d9d3844	34575094	PMC8469772	the most important host system used for monoclonal antibody (mAb) expression	system	the most important host system	monoclonal antibody	mAb	COID242255	ABSTRACT	arg1
bbe412cb7198261ca5951bae3b3ce3a1	34575094	PMC8469772	the most important host system used for monoclonal antibody (mAb) expression	system	the most important host system	monoclonal antibody	monoclonal antibody	COID242255	ABSTRACT	arg1
f603f707aaacd21effd001d038f76858	34575094	PMC8469772	Antibodies charge variants	variants	Antibodies charge variants	product quality profile	charge variants	COID817650	RESULTS	arg0
49676c6736d8a9f3770dbd724151544d	34575094	PMC8469772	pharmacokinetics	pharmacokinetics	pharmacokinetics	clinical outcomes	pharmacokinetics	COID373370	RESULTS	arg1
dcc3ad0a96abde707dba10d40acdb648	34575094	PMC8469772	Antibodies charge variants	variants	Antibodies charge variants	antibody	Antibodies	COID278523	RESULTS	arg0
411e06259cc06cddb1706ca4018b7db4	34575094	PMC8469772	a high concentration of lactate, NH4+, or osmolality	concentration	a high concentration	process parameters or process control	osmolality	COID710653	RESULTS	arg0
3332186d5e500fe607bbd2dca38d64e1	34575094	PMC8469772	the maintenance of cell viability	maintenance	the maintenance	cell culture parameters	cell viability	COID547964	RESULTS	arg1
f5da27a3a91ee15d298f1966af1fa48b	34575094	PMC8469772	a high concentration of lactate, NH4+, or osmolality	concentration	a high concentration	by-product or waste	lactate	COID250920	RESULTS	arg0
1cb699072b6e6a9875f733c9b73254da	34575094	PMC8469772	the expression of antibodies	expression	the expression	antibody	antibodies	COID278523	RESULTS	arg1
aa352a0802a0cc294e216c23a9426948	34575094	PMC8469772	CHO cells	cells	CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	RESULTS	arg0
81d10f6d88e4f8b9b43f985afd9f9833	34575094	PMC8469772	IgG antibodies produced in CHO cells	antibodies	IgG antibodies	antibody	antibodies	COID278523	RESULTS	arg1
91d68c177c662cf948b0a4d8032001cf	34575094	PMC8469772	IgG antibodies produced in CHO cells	antibodies	IgG antibodies	antibody	IgG	COID713543	RESULTS	arg1
9ea9c4019178881797261eee227a0559	34575094	PMC8469772	nutrient levels	levels	nutrient levels	secondary raw materials	nutrient	COID423902	RESULTS	arg0
379ab6d2234178cf145a9031f74a5af6	34575094	PMC8469772	the cell growth cycle	cycle	the cell growth cycle	cell culture parameters	cell growth	COID093598	RESULTS	arg1
4e3c98e0b13aa7727f0c302aae4a0380	34575094	PMC8469772	osmolality	osmolality	osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg0
1c15535224958b192a3e7f311cb90042	34575094	PMC8469772	The cell line B	B	The cell line B	cell line	cell line	COID702829	RESULTS	arg0
13a2bc6f52a25831be755f3afbddf794	34575094	PMC8469772	no obvious difference in VCD between different feeding processes	difference	no obvious difference	cell culture parameters	VCD	COID384695	RESULTS	arg1
1ef68ea8b4bb6cb86545f4d9e1c35383	34575094	PMC8469772	other quality attributes	attributes	other quality attributes	product quality attributes	quality	COID109463	RESULTS	arg0
24c591101c4632748735e0e5e6e61490	34575094	PMC8469772	the three kinds of fed-batch processes	kinds	the three kinds	process mode	fed-batch	COID529446	RESULTS	arg1
15540944dfab4daae2aeddac22189e19	34935124	PMC9306616	the transcription of its host gene SDK1	transcription	the transcription	genotype	gene	COID185502	ABSTRACT	arg0
5516590bf0f55e5b430f4dc4304868b5	34935124	PMC9306616	Comprehensive multi-OMICs based experimental analyses unraveled the root cause of this atypical sialylation: (1) expression of the cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene was spontaneously switched on, (2) CMAH mRNA showed an anti-correlated expression to the newly discovered Cricetulus griseus (cgr) specific microRNA cgr-miR-111 and exhibits two putative miR-111 binding sites, (3) miR-111 expression	expression	Comprehensive multi-OMICs based experimental analyses unraveled the root cause of this atypical sialylation: (1) expression of the cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene was spontaneously switched on, (2) CMAH mRNA showed an anti-correlated expression to the newly discovered Cricetulus griseus (cgr) specific microRNA cgr-miR-111 and exhibits two putative miR-111 binding sites, (3) miR-111 expression	glycosylation	sialylation	COID543327	ABSTRACT	arg1
4fdaf59c4cd53fd0968fc913f4d905d5	34935124	PMC9306616	Four genes	genes	Four genes	genotype	genes	COID185502	RESULTS	arg0
a031c4fd457bd011343851590c01cf8f	34935124	PMC9306616	the N-glycan biosynthesis pathway	pathway	the N-glycan biosynthesis pathway	biochemical compound	biosynthesis	COID479844	RESULTS	arg1
b06bfdae794cd4b7b57a2f042232932f	34935124	PMC9306616	the N-glycan biosynthesis pathway	pathway	the N-glycan biosynthesis pathway	sugar (subset of carbon source)	N-glycan	COID216687	RESULTS	arg1
cb32b6696ee74381dafb65efa4612be4	34935124	PMC9306616	the NGNA sialylation	sialylation	the NGNA sialylation	glycosylation	sialylation	COID543327	RESULTS	arg0
033f1814d3cbd44fcac065a446f11192	34935124	PMC9306616	the CMAH knockout clones	clones	the CMAH knockout clones	genotype	knockout	COID494346	RESULTS	arg1
c203db85d7e0e7c7c1a97faf4aba4775	34935124	PMC9306616	the NGNA sialylation	sialylation	the NGNA sialylation	amino acid (subset of substrates)	NGNA	COID390231	RESULTS	arg0
7c848f90655213205720e60b17ddfc31	34935124	PMC9306616	Twenty-seven miR-111 anti-correlated genes	genes	Twenty-seven miR-111 anti-correlated genes	genotype	genes	COID185502	RESULTS	arg0
6a14390c4e020a5111d3da8d1a34a1eb	34935124	PMC9306616	functional annotation indicating a role in protein glycosylation (Table 1)	annotation	functional annotation	glycosylation	glycosylation	COID119643	RESULTS	arg1
718812c6738fa53e23463723b5a97581	34935124	PMC9306616	the factors "Clone" and "Time	factors	the factors	process parameters or process control	Time	COID742277	RESULTS	arg0
e3f041df6ade537041956ee4a51a56b6	34935124	PMC9306616	Gene expression profiles	profiles	Gene expression profiles	genotype	Gene	COID185502	RESULTS	arg1
1cc61716aba1c6e8d4318785f43215b5	35087805	PMC8786911	a bioreactor	bioreactor	a bioreactor	vessel or process parameter or production scale	bioreactor	COID345693	ABSTRACT	arg0
276b6743f763288aae5273967de129c7	35087805	PMC8786911	a model mAb grown in a bioreactor	mAb	a model mAb	monoclonal antibody	mAb	COID242255	ABSTRACT	arg1
7b47d0cfdb1b6ab44061b21d094cafed	35087805	PMC8786911	CHO for 1) cell line selection	CHO	CHO	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg0
0fb876c2a700134a320bf3fdcd492526	35087805	PMC8786911	Chinese Hamster Ovary (CHO) cells	cells	Chinese Hamster Ovary (CHO) cells	chinese hamster ovary (CHO)	Chinese Hamster Ovary	COID806780	ABSTRACT	arg0
dacd5596985818e65235d0f9d8ae2dfc	35087805	PMC8786911	a mAb expressed in Chinese Hamster Ovary (CHO) cells	mAb	a mAb	monoclonal antibody	mAb	COID242255	ABSTRACT	arg1
fe0b179e5bdf2591a48afe9a3931f91c	35087805	PMC8786911	Chinese Hamster Ovary (CHO) cells	cells	Chinese Hamster Ovary (CHO) cells	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg0
e90c00072c9aab23c01bf75f99ff33cd	35087805	PMC8786911	a 25 ml shake flask	flask	a 25 ml shake flask	vessel or process parameter or production scale	shake flask	COID796805	RESULTS	arg0
374b0223a426cb770c4ee52e913b9ef0	35087805	PMC8786911	a 14 days fed-batch cell culture process	process	a 14 days fed-batch cell culture process	cell culture parameters	cell culture	COID293414	RESULTS	arg1
141bba4f956adabb2cb284dfb122b6a3	35087805	PMC8786911	a 14 days fed-batch cell culture process	process	a 14 days fed-batch cell culture process	process mode	fed-batch	COID529446	RESULTS	arg1
8afda02e1474fee9b64b05bfeccdbd8f	35087805	PMC8786911	the levels of sialylation, galactosylation, and fucosylation	levels	the levels	glycosylation	fucosylation	COID810570	RESULTS	arg0
970967b4c6b5a7d22b7187bd903357cc	35087805	PMC8786911	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
2ed27bec9ae8cb3ac99dd6554b60976c	35087805	PMC8786911	the levels of sialylation, galactosylation, and fucosylation	levels	the levels	glycosylation	sialylation	COID543327	RESULTS	arg0
ef50c8f80d971ae585d1ed233f901b3c	35087805	PMC8786911	the levels of sialylation, galactosylation, and fucosylation	levels	the levels	glycosylation	galactosylation	COID475750	RESULTS	arg0
d67305a87277cfe77f9bb260b62a35f6	35087805	PMC8786911	fucosylation	fucosylation	fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
b9666223b30ba41a05d04bbd6074ad42	35087805	PMC8786911	sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
a970f5c256339a110642828381f79b4b	35087805	PMC8786911	the VRC01 mAb	mAb	the VRC01 mAb	monoclonal antibody	mAb	COID242255	RESULTS	arg0
1662826994f308b9db7abe7945e10446	35087805	PMC8786911	The individual glycan species identified for the VRC01 mAb	species	The individual glycan species	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
7ff46b8a2d77a1eaa0ecb2ecb3276cd7	35087805	PMC8786911	Media	Media	Media 2 and 3	media characteristics	Media	COID913636	RESULTS	arg0
2020db09e05471898daca834222cc204	35087805	PMC8786911	afucosylated glycans seen in Media 2 and 3	glycans	afucosylated glycans	sugar (subset of carbon source)	afucosylated glycans	COID239021	RESULTS	arg1
6b90b5234bcb172c70435fc11b7d10f2	35087805	PMC8786911	the different cell culture media	media	the different cell culture media	cell culture parameters	cell culture	COID293414	RESULTS	arg0
00d6d49316d122ef5c4fe2a947ff5444	35087805	PMC8786911	the VRC01 glycosylation characteristics	characteristics	the VRC01 glycosylation characteristics	glycosylation	glycosylation	COID119643	RESULTS	arg1
61be74d1e7b903b3fec83e791387436a	35087805	PMC8786911	the different cell culture media	media	the different cell culture media	media characteristics	media	COID913636	RESULTS	arg0
084553d5a119273c5d08872ff2617df7	35087805	PMC8786911	greater glucose/nutrient consumption	consumption	greater glucose/nutrient consumption	secondary raw materials	nutrient	COID423902	RESULTS	arg0
7b339876a7acd78ae4d7910cf5832687	35087805	PMC8786911	apoptosis	apoptosis	apoptosis	cellular metabolic state	apoptosis	COID850789	RESULTS	arg1
58801b286dc02d8cf672237ece1a20ad	35087805	PMC8786911	greater glucose/nutrient consumption	consumption	greater glucose/nutrient consumption	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
429917547d0c2eace53323e540080900	35087805	PMC8786911	the cell culture phase	phase	the cell culture phase	cell culture parameters	cell culture	COID293414	RESULTS	arg0
73a127fdd7adbdd8997e702aed2d514c	35087805	PMC8786911	The relatively constant levels of glycoforms such as A2G(4)2S(3)1, F(6) A2G(4)2S(3)1, F(6)A2G(4)2S(3,3)2, and A2G(4)2S(3,6)2 (all of them representing terminally sialylated forms)	levels	The relatively constant levels	recombinant protein	glycoforms	COID288767	RESULTS	arg1
d70b0025bf4b995a0c839ca4a43c591a	35087805	PMC8786911	The glycan analysis of the VRC01 using the standard library search method	analysis	The glycan analysis	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg0
aef5848853b9ff28479d7e686f9346db	35087805	PMC8786911	the identification of 53 confirmed N-glycans	identification	the identification	sugar (subset of carbon source)	N-glycans	COID216687	RESULTS	arg1
fba53e2ab64f6851414f56573917789d	35087805	PMC8786911	greater than ~10-fold higher mannose forms	forms	greater than ~10-fold higher mannose forms	sugar (subset of carbon source)	mannose	COID906305	RESULTS	arg0
20f85d939716cdacb449643014ae57a0	35087805	PMC8786911	The 6-level DO process	process	The 6-level DO process	bioreactor conditions	DO	COID661988	RESULTS	arg1
8ce03182d70c9a686c2224ed9b835554	35087805	PMC8786911	lactate production	production	lactate production	by-product or waste	lactate	COID250920	RESULTS	arg0
34f62d68b8ed564c06e49401d72d3818	35087805	PMC8786911	the levels of afucosylated glycans	levels	the levels	sugar (subset of carbon source)	afucosylated glycans	COID239021	RESULTS	arg0
a62ac4370d26db701e4b6945dac464dc	35087805	PMC8786911	the antibody-mediated cell cytotoxicity	cytotoxicity	the antibody-mediated cell cytotoxicity	antibody	antibody	COID278523	RESULTS	arg1
390d945e3eb05850fbbf8b1e02053784	35087805	PMC8786911	a modest increase in the levels of mono-sialylation	increase	a modest increase	glycosylation	sialylation	COID543327	RESULTS	arg0
c9cce07ca773473adf92a01e1914e9a1	35087805	PMC8786911	Medium 1	Medium	Medium 1	media characteristics	Medium	COID921897	RESULTS	arg1
dd9834140ed251be8bc5e1a08040bec0	35182428	PMC9310845	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg0
b9c7bb9e30c260ecf505950b96df9f83	35182428	PMC9310845	the metabolic pathways involved in glycosylation	pathways	the metabolic pathways	metabolic pathways	metabolic pathways	COID588672	ABSTRACT	arg1
95fec36b93bdc1cbfd307d6b2d44a63e	35182428	PMC9310845	the metabolic pathways involved in glycosylation	pathways	the metabolic pathways	metabolic pathways	metabolic pathways	COID588672	ABSTRACT	arg0
eb2b76026d3f0c76877f07744a972a04	35182428	PMC9310845	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
c4e69e082780c316b38b5c1eebe59e14	35441833	PMC9542549	scale-up	scale-up	scale-up	vessel or process parameter or production scale	scale	COID586187	ABSTRACT	arg0
4e8e4808e6717e470a1fa73c460e1cfd	35441833	PMC9542549	pH	pH	pH	bioreactor conditions	pH	COID893209	ABSTRACT	arg1
ffa3a8b796a0d09b3c9783cfcc38b614	35441833	PMC9542549	all cell lines	lines	all cell lines	cell line	cell lines	COID702829	ABSTRACT	arg0
445ab8bf67ee8eaaa8a3d1aef7caf391	35441833	PMC9542549	lactate accumulation	accumulation	lactate accumulation	by-product or waste	lactate	COID250920	ABSTRACT	arg1
e2e9c96b8030b7681aa3985c2cc70341	35441833	PMC9542549	Fluctuations in pH	Fluctuations	Fluctuations	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
d87ec87dda3510ddc5477bb81bd876f5	35441833	PMC9542549	product quality	quality	product quality	product quality attributes	product quality	COID111751	ABSTRACT	arg1
d27a4f1cd08ecbcf087691f99ac95f1a	35441833	PMC9542549	productivity	productivity	productivity	process condition	productivity	COID731421	ABSTRACT	arg1
e8bf2fac95e67dd5b42b0d22971f74d7	35441833	PMC9542549	growth	growth	growth	cell culture parameters	growth	COID203666	ABSTRACT	arg1
2b9401d82b6031f36ce412038bf24013	35441833	PMC9542549	DOT fluctuations	fluctuations	DOT fluctuations	NYK	DOT fluctuations	COID332196	RESULTS	arg0
9606befb5cad9784d7feb660cda71527	35441833	PMC9542549	a "low" peak VCD industrial cell line	line	a "low" peak VCD industrial cell line	cell line	cell line	COID702829	RESULTS	arg1
68a96780ce96e9329de66a56c707d29b	35441833	PMC9542549	a "low" peak VCD industrial cell line	line	a "low" peak VCD industrial cell line	cell culture parameters	VCD	COID384695	RESULTS	arg1
d2a5f8006ff046bd9f488c1771cb07be	35441833	PMC9542549	pH	pH	pH	bioreactor conditions	pH	COID893209	RESULTS	arg0
51752ee3364662ac848e8e3001698f64	35441833	PMC9542549	antibody glycosylation	glycosylation	antibody glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
bbc59dff8d2810c6884a5e81d665ba64	35441833	PMC9542549	antibody glycosylation	glycosylation	antibody glycosylation	antibody	antibody	COID278523	RESULTS	arg1
dfb6a420fbe21a5ace268b0be342168c	35441833	PMC9542549	pure nitrogen	nitrogen	pure nitrogen	gases (subset of secondary raw materials)	nitrogen	COID546348	RESULTS	arg0
b5ab04028ccf12d3f11978c28f11d879	35441833	PMC9542549	quicker CO2	CO2	quicker CO2	gases (subset of secondary raw materials)	CO2	COID132568	RESULTS	arg1
62656124fa1d63ff0b85daf2ba3fb42f	35441833	PMC9542549	O2 stripping	stripping	O2 stripping	gases (subset of secondary raw materials)	O2	COID472476	RESULTS	arg1
d05c0eb30c32e0f8c1b2c98c8b322b24	35441833	PMC9542549	media additions to the bioreactors	additions	media additions	media characteristics	media	COID913636	RESULTS	arg0
71eb0b67f54ce29709974c6fbd965ba3	35441833	PMC9542549	culture conditions	conditions	culture conditions	culture condition	culture conditions	COID626277	RESULTS	arg1
b8ac8b21f0692daf2a117d83e4ade300	35441833	PMC9542549	many factors including media additions to the bioreactors and differing lactate production by the cells	factors	many factors	vessel or process parameter or production scale	bioreactors	COID345693	RESULTS	arg0
bc234b05d2323f1292c20958f7910634	35441833	PMC9542549	many factors including media additions to the bioreactors and differing lactate production by the cells	factors	many factors	by-product or waste	lactate	COID250920	RESULTS	arg0
5c39eb3d80136de425ae250ca7658163	35441833	PMC9542549	many factors including media additions to the bioreactors and differing lactate production by the cells	factors	many factors	media characteristics	media	COID913636	RESULTS	arg0
4e7c89d2381ab6ba4ac9bb2720876772	35441833	PMC9542549	pH-fluctuated vessels which had lactate production rates twice as high as controls between day 0 and 6	vessels	pH-fluctuated vessels	vessel or process parameter or production scale	pH-fluctuated vessels	COID322748	RESULTS	arg0
6d34c1ab8a65f69c77bb431f4e2bdb36	35441833	PMC9542549	lactate production rates	rates	lactate production rates	process parameters or process control	production rates	COID014362	RESULTS	arg1
7e98f5247e3ebb37272fa44cabc9dce0	35441833	PMC9542549	lactate production rates	rates	lactate production rates	by-product or waste	lactate	COID250920	RESULTS	arg1
a8c188adace65cd0b8dcf4cc3dab65bc	35441833	PMC9542549	literature observations concerning the effects of higher pH on CHO cell culture kinetics	observations	literature observations	cell culture parameters	cell culture	COID293414	RESULTS	arg0
9e7fc88b76101cf5ad2d30b91f7adcf8	35441833	PMC9542549	CHO cell culture kinetics	kinetics	CHO cell culture kinetics	chinese hamster ovary (CHO)	CHO	COID806780	RESULTS	arg1
a2f88b01655321c2f90145af3191faf4	35441833	PMC9542549	literature observations concerning the effects of higher pH on CHO cell culture kinetics	observations	literature observations	chinese hamster ovary (CHO)	CHO	COID806780	RESULTS	arg0
c1430064e5625f1fac62697b19cf7451	35441833	PMC9542549	CHO cell culture kinetics	kinetics	CHO cell culture kinetics	cell culture parameters	cell culture	COID293414	RESULTS	arg1
80e8ee785d6dadd2a8dfabf152d904d2	35441833	PMC9542549	literature observations concerning the effects of higher pH on CHO cell culture kinetics	observations	literature observations	bioreactor conditions	pH	COID893209	RESULTS	arg0
1871d3fa3ee71d511ee90633a21dc6ba	35441833	PMC9542549	higher pH	pH	higher pH	bioreactor conditions	pH	COID893209	RESULTS	arg0
0d69d84102092f06772b9d27cf3716bb	35441833	PMC9542549	decreased levels of G0F and elevated G1F + G2F glycans	levels	decreased levels	sugar (subset of carbon source)	G2F glycans	COID847130	RESULTS	arg0
17c9c28378978572811b1e8df4104d15	35441833	PMC9542549	the 30% DOT control	control	the 30% DOT control	NYK	DOT	COID003597	RESULTS	arg1
d063b0d2b0c3c5f8896acb77d0bb0b06	35441833	PMC9542549	decreased levels of G0F and elevated G1F + G2F glycans	levels	decreased levels	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg0
9ae5e7dd68a89df0302c931e273e45f2	35441833	PMC9542549	decreased levels of G0F and elevated G1F + G2F glycans	levels	decreased levels	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg0
4ebcbad9ff3584c29bf49a67073eb7c0	35441833	PMC9542549	DOT-fluctuated vessels	vessels	DOT-fluctuated vessels	vessel or process parameter or production scale	DOT-fluctuated vessels	COID853468	RESULTS	arg1
42e1166777c2a5ccc563ed701173cd9e	35441833	PMC9542549	the performance of control vessels and those exposed to pH and DOT fluctuations	performance	the performance	NYK	DOT fluctuations	COID332196	RESULTS	arg0
c9064f3de77e64d230e9ce8f3630b85f	35441833	PMC9542549	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
dabe39bc6f526206538dcfdba593ee8b	35441833	PMC9542549	the performance of control vessels and those exposed to pH and DOT fluctuations	performance	the performance	vessel or process parameter or production scale	vessels	COID322748	RESULTS	arg0
3346e97f958ed355e40cae6c42ea2fd7	35441833	PMC9542549	the performance of control vessels and those exposed to pH and DOT fluctuations	performance	the performance	bioreactor conditions	pH	COID893209	RESULTS	arg0
c3133bc3b3814fd888ed221d7a7ebe07	35441833	PMC9542549	antibody productivity	productivity	antibody productivity	process condition	productivity	COID731421	RESULTS	arg1
4876b7d8f9b5e584565c7e6cf32fc25e	35441833	PMC9542549	antibody productivity	productivity	antibody productivity	antibody	antibody	COID278523	RESULTS	arg1
f66eb805220b882bee4933b22688b9b4	35441833	PMC9542549	lactate concentration	concentration	lactate concentration	by-product or waste	lactate	COID250920	RESULTS	arg1
5d7f265a361a5f1e6cf71b7322b82c7a	35441833	PMC9542549	the DOT fluctuations	fluctuations	the DOT fluctuations	NYK	DOT fluctuations	COID332196	RESULTS	arg0
616ead315176a1b151da814ce99a7a1f	35441833	PMC9542549	the glycan profiles in a similar manner	profiles	the glycan profiles	product quality attributes	glycan profiles	COID521331	RESULTS	arg1
b36348bc2bcbec9334445eb791fc1b3a	35441833	PMC9542549	qgluc	qgluc	qgluc	sugar (subset of carbon source)	qgluc	COID367406	RESULTS	arg1
794583f7aa7bd57c127636602f091f7e	35441833	PMC9542549	Specific glucose consumption	consumption	Specific glucose consumption	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
4ef6ce668f26e7084155e96c5f41645b	35441833	PMC9542549	The DOT-fluctuated vessels	vessels	The DOT-fluctuated vessels	vessel or process parameter or production scale	DOT-fluctuated vessels	COID853468	RESULTS	arg0
093b0b41d5efaaf4bd47db661ef8df71	35441833	PMC9542549	minimal lactate consumption	consumption	minimal lactate consumption	by-product or waste	lactate	COID250920	RESULTS	arg1
871bc89db986bd684b88280b1a6745dd	35441833	PMC9542549	the overall lower DOT that cells are exposed to in these cultures, rather than the fluctuation itself	DOT	the overall lower DOT	NYK	DOT	COID003597	RESULTS	arg0
25f879d25d74f3b346454e53bec5a55b	35441833	PMC9542549	the effects seen in the DO-fluctuated vessels	effects	the effects	vessel or process parameter or production scale	DO-fluctuated vessels	COID322748	RESULTS	arg1
26db4ad99ce38c79be93c0a38f8021b6	35441833	PMC9542549	cell growth (Figure 4)	growth	cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
265177226de9feffb88053c4858f0733	35441833	PMC9542549	pH fluctuations	fluctuations	pH fluctuations	bioreactor conditions	pH	COID893209	RESULTS	arg0
e12e05e319101c572ffd3b2b6a5b4f95	35441833	PMC9542549	productivity	productivity	productivity	process condition	productivity	COID731421	RESULTS	arg1
c0232141e3e9818a8addce491409a9a1	35441833	PMC9542549	lactate levels	levels	lactate levels	by-product or waste	lactate	COID250920	RESULTS	arg1
db75c125b481dae4e47f6aaaae44f60b	35441833	PMC9542549	growth	growth	growth	cell culture parameters	growth	COID203666	RESULTS	arg1
45a5f1a0a00a8dca3a62561471806aa3	35441833	PMC9542549	glycosylation (although largely under non-fluctuating conditions)	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
372c5f3f966b00377efc55ba5c2ff561	35441833	PMC9542549	changing process parameters	parameters	changing process parameters	process parameters or process control	process parameters	COID163282	RESULTS	arg0
917db533e9a39cca602e6aa3a99a9c15	35441833	PMC9542549	DOT	DOT	DOT	NYK	DOT	COID003597	RESULTS	arg0
92e2010b8c25a206eceea4b6f8a7756d	35441833	PMC9542549	fluctuating culture conditions	conditions	fluctuating culture conditions	cell culture parameters	fluctuating culture conditions	COID754846	RESULTS	arg0
c703bb3e43e29eb8a966250731923c2c	35441833	PMC9542549	key product quality attributes	attributes	key product quality attributes	product quality attributes	product quality	COID111751	RESULTS	arg1
75430b2757305e1e220b9931c2398d41	35441833	PMC9542549	DOT	DOT	DOT	NYK	DOT	COID003597	RESULTS	arg1
61067097c9d9a16300b53ab04c5945e6	35441833	PMC9542549	The control and pH-fluctuated vessels	vessels	The control and pH-fluctuated vessels	vessel or process parameter or production scale	pH-fluctuated vessels	COID322748	RESULTS	arg0
64d08606b694a62255120f561cecec15	35441833	PMC9542549	very similar growth profiles peaking around 62 x 106 cells ml-1	profiles	very similar growth profiles	cell culture parameters	growth	COID203666	RESULTS	arg1
682933b557fb3c294ec5dd220b227847	35441833	PMC9542549	other cell lines	lines	other cell lines	cell line	cell lines	COID702829	RESULTS	arg1
643fbc61507f94ebb93ccb6fa68f87be	35441833	PMC9542549	The 60 min pH fluctuations	fluctuations	The 60 min pH fluctuations	bioreactor conditions	pH	COID893209	RESULTS	arg0
cb649935ed06ba1e3b7cee4c0bd6425f	35441833	PMC9542549	growth	growth	slightly lower growth and product titre	cell culture parameters	growth	COID203666	RESULTS	arg1
da758b9b428059537b2a0c01453d8950	35441833	PMC9542549	product quality	quality	product quality	product quality attributes	product quality	COID111751	RESULTS	arg1
57b6755619be2323ea83ff8b2090c605	35441833	PMC9542549	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
1a73fdfd7e676f45262f325766874c32	35441833	PMC9542549	the rates of enzymatic reactions in the Golgi apparatus which can in turn affect glycosylation	rates	the rates	glycosylation	glycosylation	COID119643	RESULTS	arg1
8d55d35e1102f52e3af4038967ef2fc0	35441833	PMC9542549	differing lactate production by the cells	production	differing lactate production	by-product or waste	lactate	COID250920	RESULTS	arg0
ce5af77e2b21272f432960684633af98	35441833	PMC9542549	pH control	control	pH control	bioreactor conditions	pH control	COID492476	RESULTS	arg0
e4364ef04033a972e5e3f909f829cc48	35441833	PMC9542549	The transient deviations seen in these control bioreactors every 2 days	deviations	The transient deviations	vessel or process parameter or production scale	bioreactors	COID345693	RESULTS	arg1
4ba84dcef8958d0ae42c6ceb5900f040	35441833	PMC9542549	The pH-fluctuated vessels	vessels	The pH-fluctuated vessels	vessel or process parameter or production scale	pH-fluctuated vessels	COID322748	RESULTS	arg0
f68761b11964f9daf1c5b752682dc387	35441833	PMC9542549	similar levels of Man5	levels	similar levels	sugar (subset of carbon source)	Man5	COID568402	RESULTS	arg1
70cabcffd4ddc59cbc4acec79707e032	35441833	PMC9542549	DOT oscillations	oscillations	DOT oscillations	NYK	DOT	COID003597	RESULTS	arg0
d0f485d4dc0292d27d058b2dd2242726	35441833	PMC9542549	N-linked glycosylation	glycosylation	N-linked glycosylation	glycosylation	N-linked glycosylation	COID005169	RESULTS	arg1
3824eaa508a803c2ed3c42d049aebe1d	35441833	PMC9542549	viable cell density	density	viable cell density	cell culture parameters	viable cell density	COID384695	RESULTS	arg0
4d358b1e5e5d48e552bb61b09c9685b3	35441833	PMC9542549	the 15, 30, and 60 min pH fluctuated cultures	cultures	the 15, 30, and 60 min pH fluctuated cultures	bioreactor conditions	pH	COID893209	RESULTS	arg1
644038ed4abaf18eda8f47592269222c	35441833	PMC9542549	similar levels of Man5	levels	similar levels	sugar (subset of carbon source)	Man5	COID568402	RESULTS	arg0
659e74464e3ce7dd9adad5ccd22b4e33	35441833	PMC9542549	The pH-fluctuated vessels	vessels	The pH-fluctuated vessels	vessel or process parameter or production scale	pH-fluctuated vessels	COID322748	RESULTS	arg1
485c245a952cf13365aa2cdedf0b0230	35441833	PMC9542549	fluctuated vessels	vessels	fluctuated vessels	vessel or process parameter or production scale	fluctuated vessels	COID322748	RESULTS	arg1
e16dc6496d9b40d6092c300ea9ce0b5d	35441833	PMC9542549	lactate levels	levels	lactate levels	by-product or waste	lactate	COID250920	RESULTS	arg0
6bf29a339ce8a43b6f35cab8f1c33d09	35441833	PMC9542549	the bioreactor set-points	set-points	the bioreactor set-points	vessel or process parameter or production scale	bioreactor	COID345693	RESULTS	arg0
998622b1ba2d055bb1f4f3bc0b508229	35441833	PMC9542549	pH 7.0-7.5	pH	pH 7.0-7.5	bioreactor conditions	pH	COID893209	RESULTS	arg1
6641b2060eadbcd22bacf248f7dcd856	35441833	PMC9542549	a 35% decrease in growth	decrease	a 35% decrease	cell culture parameters	growth	COID203666	RESULTS	arg0
8fa3dd6cda145bffdf3db5f7cf4a5419	35441833	PMC9542549	DOT-fluctuated cultures	cultures	DOT-fluctuated cultures	NYK	DOT	COID003597	RESULTS	arg1
b608d8aa702bba85b0e5c8bba0bbd1e2	35441833	PMC9542549	DOT fluctuations	fluctuations	DOT fluctuations	NYK	DOT fluctuations	COID332196	TITLE	arg0
528e07506870fb7d4fcb09711a2d8ea5	35441833	PMC9542549	CHO cell culture performance	performance	CHO cell culture performance	product quality attributes	cell culture performance	COID284912	TITLE	arg1
45145f64c21e0b3225a19a53e2330839	35441833	PMC9542549	CHO cell culture performance	performance	CHO cell culture performance	chinese hamster ovary (CHO)	CHO	COID806780	TITLE	arg1
6296d2b507617a56a914891ad8e6a5c5	35441833	PMC9542549	pH	pH	pH	bioreactor conditions	pH	COID893209	TITLE	arg0
a73976c686a8b32be9ccbe6c043d1136	35441833	PMC9542549	Development of a miniature bioreactor model	Development	Development	vessel or process parameter or production scale	bioreactor	COID345693	TITLE	arg0
e542086a074162bff12d9b609ec554d8	35470430	PMC9541590	The present strategy for the selection of the media/feeds and glucose concentrations, including a TAFE approach,	strategy	The present strategy	media characteristics	media	COID913636	RESULTS	arg0
02691b4c6bbcee0a3fc4d9c3df8c2a3c	35470430	PMC9541590	a stable cell-specific glucose consumption	consumption	a stable cell-specific glucose consumption	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
1fb717518cc4af66b041b1143564b5be	35470430	PMC9541590	The present strategy for the selection of the media/feeds and glucose concentrations, including a TAFE approach,	strategy	The present strategy	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
a501a06ef13a8e90b3609569308c0910	35470430	PMC9541590	stable operation of the perfusion process with minimized cell-specific productivity of lactate (Supporting Information: Figure S4)	operation	stable operation	process condition	cell-specific productivity	COID637897	RESULTS	arg1
252ab6943c46f296199c8fca9b3151eb	35470430	PMC9541590	stable operation of the perfusion process with minimized cell-specific productivity of lactate (Supporting Information: Figure S4)	operation	stable operation	process mode	perfusion	COID329168	RESULTS	arg1
a964865d8e8d53902da3b8293acc8088	35470430	PMC9541590	A small-scale perfusion process with 0.2 L working volume integrated with a downstream process	process	A small-scale perfusion process	process mode	perfusion	COID329168	RESULTS	arg0
27a321bd729ae37b5229a441f615f895	35470430	PMC9541590	the technical feasibility for long-term operation of the novel ICB before pilot-scale testing	feasibility	the technical feasibility	vessel or process parameter or production scale	scale	COID586187	RESULTS	arg1
ac66571bab325038b4ce1004bb1a660d	35737825	PMC9235890	the integrated viable cell density (IVCD)	density	the integrated viable cell density	cell culture parameters	viable cell density	COID384695	RESULTS	arg0
dfdc4b1db324615c3bd2c4cd07210fdb	35737825	PMC9235890	the product titer plotted against the integrated viable cell density (IVCD)	titer	the product titer	overall titer or batch yield	product titer	COID382077	RESULTS	arg1
f8cfe81e674313819c3a8cf35d0f12f4	35737825	PMC9235890	the DR cell lines	lines	the DR cell lines	cell line	cell lines	COID702829	RESULTS	arg0
719d2ba35231c401adb784043fc7c245	35737825	PMC9235890	any further growth	growth	any further growth	cell culture parameters	growth	COID203666	RESULTS	arg1
d1f12f26c1adefd488fe99f3a06ccbe5	35737825	PMC9235890	changing glycosylation patterns	patterns	changing glycosylation patterns	product attributes	glycosylation patterns	COID857544	RESULTS	arg0
7b42122559d1387049de6a991ac4a05f	35737825	PMC9235890	antibody binding	binding	antibody binding	antibody	antibody	COID278523	RESULTS	arg1
80653605efa16181a79717212143cf02	35737825	PMC9235890	approximately 1 mM higher ammonium concentrations	concentrations	approximately 1 mM higher ammonium concentrations	culture condition	ammonium	COID714150	RESULTS	arg0
3273977feafecdf4f1d0165c6b5f8621	35737825	PMC9235890	DR cell lines	lines	DR cell lines	cell line	cell lines	COID702829	RESULTS	arg1
4ff1fe3d984da4ca3ef2e56d681b775c	35737825	PMC9235890	higher maximum cell densities of 15 and 18 x 106 cells/mL	densities	higher maximum cell densities	cell culture parameters	cell densities	COID283414	RESULTS	arg0
452b4e2654024611ac0ba9a7d96350fe	35737825	PMC9235890	The DR1 cell line	line	The DR1 cell line	cell line	cell line	COID702829	RESULTS	arg1
8cb5e5a5edebf96c4b879a721e95022c	37456731	PMC10349264	The cultivation conducted with enriched media as wash buffer (cFB PerfM; black line)	cultivation	The cultivation	media characteristics	media	COID913636	RESULTS	arg0
b8644b32c61a599a9640721fd5c1403b	37456731	PMC10349264	overall consistent growth between the FB cycles	growth	overall consistent growth	cell culture parameters	growth	COID203666	RESULTS	arg1
d9daa3366c9cf379c3bcfd201054d1da	37456731	PMC10349264	metabolic byproducts	byproducts	metabolic byproducts	by-product or waste	metabolic byproducts	COID531384	RESULTS	arg0
494301a9f0df9faad5033ea2749ba471	37456731	PMC10349264	the glycan distribution	distribution	the glycan distribution	product quality profile	glycan distribution	COID651165	RESULTS	arg1
a118eb851eef32aa6d962513ff6c9173	37456731	PMC10349264	the third investigated scenario (Figure 1C) with an elongated FB duration of 3 days and reinoculation cell densities of 20 x 106 cells/mL, VCC 20 3d,	scenario	the third investigated scenario	cell culture parameters	cell densities	COID283414	RESULTS	arg0
5f1406c5730613a4543cf9d5417ba314	37456731	PMC10349264	a stable cell growth	growth	a stable cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
316091c5690938070745c324249e431c	37731040	PMC10511539	a CHO cell engineering platform	platform	a CHO cell engineering platform	chinese hamster ovary (CHO)	CHO	COID806780	ABSTRACT	arg0
24a134c55bd5f374f2eb7ef3dd82a732	37731040	PMC10511539	modulation of multiple gene expression	modulation	modulation	genotype	gene	COID185502	ABSTRACT	arg1
319e8eb3d6c7fc11d6fa11b523e788b1	37731040	PMC10511539	these engineered mAbs	mAbs	these engineered mAbs	monoclonal antibody	mAbs	COID242255	ABSTRACT	arg0
b7e9a1c8ea3c335be2353573d98f96e4	37731040	PMC10511539	different degrees of effector cell activation and CDC	degrees	different degrees	clinical outcomes	CDC	COID455860	ABSTRACT	arg1
7071d978a4fd5dcd2b0644fb992ca76b	37731040	PMC10511539	gene deletion	deletion	gene deletion	genotype	gene	COID185502	ABSTRACT	arg0
7188e663e13223978761c839d7d919f2	37731040	PMC10511539	the expression of multiple genes at defined ratios and levels	expression	the expression	genotype	genes	COID185502	ABSTRACT	arg1
d9b42dac07a41200175124f0f66b675e	37731040	PMC10511539	the ADCC Reporter Bioassay kit	kit	the ADCC Reporter Bioassay kit	clinical outcomes	ADCC	COID386333	RESULTS	arg0
e02c70a14ae2390691823c93d2322fd0	37731040	PMC10511539	a reliable indicator of ADCC potency in different antibody samples	indicator	a reliable indicator	clinical outcomes	potency	COID969445	RESULTS	arg1
a9806e85197f52bdbb12bd8c103b8c45	37731040	PMC10511539	its co-expression with cGNTIII	co-expression	its co-expression	genotype	cGNTIII	COID316428	RESULTS	arg0
25f87eb5d46b56d3af056da1a8e2c09b	37731040	PMC10511539	the effect of cGNTIII on bisecting glycan, non-fucosylation, and galactosylation	effect	the effect	glycosylation	galactosylation	COID475750	RESULTS	arg1
b05d3772b380f4dcd0b8378d2aa8f41e	37731040	PMC10511539	the effect of cGNTIII on bisecting glycan, non-fucosylation, and galactosylation	effect	the effect	glycosylation	fucosylation	COID810570	RESULTS	arg1
4a32a4e7f9ef58356bda2816e602bd8c	37731040	PMC10511539	the effect of cGNTIII on bisecting glycan, non-fucosylation, and galactosylation	effect	the effect	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
9bea0fdd5b89374c240b2a05d48b6287	37731040	PMC10511539	medium-expressing cGNTIII pools	pools	medium-expressing cGNTIII pools	genotype	cGNTIII	COID316428	RESULTS	arg0
f552c147c8e3b5fdf8749cdc8040767d	37731040	PMC10511539	10-20% IgGs carrying M5A1B glycans (Fig. 4D)	IgGs	10-20% IgGs	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg1
9417491f78b11c0dae0214b61fdd0c51	37731040	PMC10511539	medium-expressing cGNTIII pools	pools	medium-expressing cGNTIII pools	media characteristics	medium	COID921897	RESULTS	arg0
f1f87e8a3b8fe36c0442dcb56b44e94c	37731040	PMC10511539	medium	medium	medium	media characteristics	medium	COID921897	RESULTS	arg0
f906f5ba231f16960186710a5e15af25	37731040	PMC10511539	little changes to the CDC function of Rituximab IgG1	changes	little changes	antibody	IgG1	COID713543	RESULTS	arg1
feac3b3cff769a84d43d82112e5722ec	37731040	PMC10511539	the wild-type CHO cells	cells	the wild-type CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	RESULTS	arg0
28bbd28468c47b921ae73321a8e29e2a	37731040	PMC10511539	mAbs produced in the wild-type CHO cells	mAbs	mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg1
fea040a15fdcb9d7b17452acbe3db2c2	37731040	PMC10511539	overexpression of cGNTIII gene	overexpression	overexpression	genotype	cGNTIII gene	COID316428	RESULTS	arg0
d083b9b888b3e84e0038b81c09ddcc96	37731040	PMC10511539	the production of many bisecting glycans such as FA2B, FA1BG1, M5A1B, and M5A1BG1	production	the production	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg1
dd126fdb3a5c50fc1cea29f9c1c8879c	37731040	PMC10511539	cGNTIII	cGNTIII	cGNTIII	genotype	cGNTIII	COID316428	RESULTS	arg0
09ea03c91aa0c5afe09adef65ee741b6	37731040	PMC10511539	non-fucosylation	non-fucosylation	non-fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
d83a91ea43ab27d15613b0ee6df21015	37731040	PMC10511539	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
3d7bbf8b8a7e8c3bea9cde61aadf3af2	37731040	PMC10511539	bisecting glycan	glycan	bisecting glycan	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
b0d4e879f9fe6c717efc939e6128d195	37731040	PMC10511539	Fc non-fucosylation	non-fucosylation	Fc non-fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg0
655b82bb3eaadb0c2c20cc4c3ff37530	37731040	PMC10511539	ECA efficacy	efficacy	ECA efficacy	clinical outcomes	efficacy	COID912630	RESULTS	arg1
42fe76620676bf43191eb4edfd36b3fd	37731040	PMC10511539	CDC against CD20-positive cancer cells	CDC	CDC	clinical outcomes	CDC	COID455860	RESULTS	arg0
2edbbcc7862c6ba982c626fa219d81af	37731040	PMC10511539	The purified antibodies	antibodies	The purified antibodies	antibody	antibodies	COID278523	RESULTS	arg1
f88d96a574d98aec1e5a7e374cf4aae6	37731040	PMC10511539	the presence of human serum	presence	the presence	serum or serum replacements	human serum	COID211221	RESULTS	arg0
c9d5f0a4929559b91bfb845e7db440b8	37731040	PMC10511539	The different combinations of MANII and cGNTIII gene expressions	combinations	The different combinations	genotype	cGNTIII gene	COID316428	RESULTS	arg0
77e483f44b778a5758ca1a529be5e5f7	37731040	PMC10511539	the unchanged integrated viable cell density (IVCD)	density	the unchanged integrated viable cell density	cell culture parameters	viable cell density	COID384695	RESULTS	arg1
55f7cb02dd44704e1f6c505924f25896	37731040	PMC10511539	Co-expression of MANII and cGNTIII genes at high levels	Co-expression	Co-expression	genotype	cGNTIII genes	COID316428	RESULTS	arg0
6b5c47bc196a8b43459abc5832b8b848	37731040	PMC10511539	rituximab IgG1	IgG1	rituximab IgG1	antibody	IgG1	COID713543	RESULTS	arg1
5fb77c2a116e61a1dca9e2c43af9cd10	37731040	PMC10511539	different N-glycosylation profiles	profiles	different N-glycosylation profiles	product attributes	N-glycosylation profiles	COID683283	RESULTS	arg0
c68b906875b53cb6bf68e0d792e65e4e	37731040	PMC10511539	rituximab effector functions	functions	rituximab effector functions	process condition	functions	COID532355	RESULTS	arg1
f6af07c375f066cd5b47324ecf24c57a	37731040	PMC10511539	the mAbs produced in these pools	mAbs	the mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg0
bc61fd6af34d2f3a6bddc943f8345d87	37731040	PMC10511539	similar glycan profiles	profiles	similar glycan profiles	product quality attributes	glycan profiles	COID521331	RESULTS	arg1
41659f4bbe71cde0bb749d7bfdee22fc	chapter_1	978-1-4987-6285-4	the metabolic load of cell culture	load	the metabolic load	cell culture parameters	cell culture	COID293414	CHAPTER 1	arg0
e925ec7c5884ac835bae1bf860ec3338	chapter_1	978-1-4987-6285-4	terms of nutrient and oxygen consumption rate per unit reactor volume	terms	terms	secondary raw materials	nutrient	COID423902	CHAPTER 1	arg1
ca9cada72af3031d6cd3f4e31dd684f5	chapter_1	978-1-4987-6285-4	terms of nutrient and oxygen consumption rate per unit reactor volume	terms	terms	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 1	arg1
1703b94453e594a579d4c44e82420b34	chapter_10	978-1-4987-6285-4	a perfusion process	process	a perfusion process	process mode	perfusion	COID329168	CHAPTER 10	arg0
1e515fb935cb6993db7f6ee24d6c70bc	chapter_10	978-1-4987-6285-4	the equipment turnover time	time	the equipment turnover time	process parameters or process control	time	COID742277	CHAPTER 10	arg1
78c294ff0f210d2506905db17c5ed3fa	chapter_10	978-1-4987-6285-4	the development of less complex media	development	the development	media characteristics	media	COID913636	CHAPTER 10	arg0
8dd189b7b5eb8e99b7d7da8642235b7e	chapter_10	978-1-4987-6285-4	The increased adoption of perfusion	adoption	The increased adoption	process mode	perfusion	COID329168	CHAPTER 10	arg1
6082daace60c84cb4151e28e7180599c	chapter_11	978-1-4987-6285-4	time	time	time	process parameters or process control	time	COID742277	CHAPTER 11	arg0
bc1d0fddc9231f9e4710152b81d03946	chapter_11	978-1-4987-6285-4	the dissolved oxygen concentration	concentration	the dissolved oxygen concentration	bioreactor conditions	dissolved oxygen	COID661988	CHAPTER 11	arg1
715b4363fd0bf2cd336f56b50f9970fe	chapter_11	978-1-4987-6285-4	the dissolved oxygen level	level	the dissolved oxygen level	bioreactor conditions	dissolved oxygen	COID661988	CHAPTER 11	arg1
a7cb73ed59166d5de985bf7e7228a451	chapter_11	978-1-4987-6285-4	The time profile of	profile	The time profile	process parameters or process control	time	COID742277	CHAPTER 11	arg0
68215f7db8f5a09069f658b0ccc13842	chapter_11	978-1-4987-6285-4	dissolved oxygen level	level	dissolved oxygen level	bioreactor conditions	dissolved oxygen	COID661988	CHAPTER 11	arg1
c3a286b4c390b10d774fa79848d02acf	chapter_11	978-1-4987-6285-4	â¢ The accumulation of carbon dioxide to a high level	accumulation	â¢ The accumulation	gases (subset of secondary raw materials)	carbon dioxide	COID132568	CHAPTER 11	arg0
5c851f19a2b01aa76ab01dba3aa5d1da	chapter_11	978-1-4987-6285-4	growth inhibition	inhibition	growth inhibition	cell culture parameters	growth	COID203666	CHAPTER 11	arg1
9c91a82b7040bbc00078bbf6f94c9bb2	chapter_3_1	978-1-4987-6285-4	the accumulation of aliphatic amino acid degradation products	accumulation	the accumulation	degradation	degradation	COID049441	CHAPTER 3	arg0
722622a9ba309c88587ecc79529a057b	chapter_3_1	978-1-4987-6285-4	growth inhibition	inhibition	growth inhibition	cell culture parameters	growth	COID203666	CHAPTER 3	arg1
a1cb434f38291b965c81ac19862228fe	chapter_3_1	978-1-4987-6285-4	the accumulation of aliphatic amino acid degradation products	accumulation	the accumulation	amino acid (subset of substrates)	amino acid	COID693703	CHAPTER 3	arg0
107495639be55895fbbfbd8bd82a2516	chapter_3_2	978-1-4987-6285-4	the corresponding accumulation of lactate and ammonium in culture	accumulation	the corresponding accumulation	culture condition	ammonium	COID714150	CHAPTER 3	arg0
4a7243a2d33cbe1a4ed2e0fa5d93f5f7	chapter_3_2	978-1-4987-6285-4	growth inhibition	inhibition	growth inhibition	cell culture parameters	growth	COID203666	CHAPTER 3	arg1
6e1d5b0f1cd9ffbdcb52bdd77742feb5	chapter_3_2	978-1-4987-6285-4	the corresponding accumulation of lactate and ammonium in culture	accumulation	the corresponding accumulation	by-product or waste	lactate	COID250920	CHAPTER 3	arg0
b887b753e8348a36aa910eac818f57d9	chapter_3_2	978-1-4987-6285-4	low productivity	productivity	low productivity	process condition	productivity	COID731421	CHAPTER 3	arg1
b56a413fc6f4917ce4c3a38e21d324ba	chapter_3_2	978-1-4987-6285-4	The excessive consumption of glucose and glutamine	consumption	The excessive consumption	amino acid (subset of substrates)	glutamine	COID962935	CHAPTER 3	arg0
8962e6112365be2c62cb58169ad7f2bb	chapter_3_2	978-1-4987-6285-4	The excessive consumption of glucose and glutamine	consumption	The excessive consumption	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg0
60382fca54f54ac7f48260779aea74e2	chapter_3_1	978-1-4987-6285-4	the accumulation of metabolic byproducts	accumulation	the accumulation	by-product or waste	metabolic byproducts	COID531384	CHAPTER 3	arg0
f41292737f37d0bfaef8587369fbafbe	chapter_3_1	978-1-4987-6285-4	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 3	arg1
ff3a4092a49a11d2279c2789a215d9b2	chapter_3_1	978-1-4987-6285-4	Lactate accumulation in culture	accumulation	Lactate accumulation	by-product or waste	Lactate	COID250920	CHAPTER 3	arg0
02aae9a4cc99cf48c3a1791a4ff96eb0	chapter_3_1	978-1-4987-6285-4	growth-inhibitory	growth-inhibitory	growth-inhibitory	cell culture parameters	growth	COID203666	CHAPTER 3	arg1
9c6938341f75850f655a34303e891be3	chapter_3_1	978-1-4987-6285-4	glycerol 3-phosphate	3-phosphate	glycerol 3-phosphate	carbon source (subset of secondary raw materials)	glycerol	COID217249	CHAPTER 3	arg0
3a96564fa6095ff4fb470eb0dee014be	chapter_3_1	978-1-4987-6285-4	reductive biosynthesis	biosynthesis	reductive biosynthesis	biochemical compound	biosynthesis	COID479844	CHAPTER 3	arg1
97199f62a658ce65ba41088920d4e962	chapter_3_2	978-1-4987-6285-4	An antibody elicited by and against the protein therapeutic	antibody	An antibody	antibody	antibody	COID278523	CHAPTER 3	arg0
7e59b450d8d53285dca4d631d6a52ed3	chapter_3_2	978-1-4987-6285-4	an unintended drop in efficacy	drop	an unintended drop	clinical outcomes	efficacy	COID912630	CHAPTER 3	arg1
4efd1ed509498e7f7762a2ce75daa38b	chapter_5	978-1-4987-6285-4	time	time	time	process parameters or process control	time	COID742277	CHAPTER 5	arg0
b931a9fb729f5f464b0664e19954f863	chapter_5	978-1-4987-6285-4	the nutrient concentration	concentration	the nutrient concentration	media parameter or raw material	nutrient concentration	COID287635	CHAPTER 5	arg1
9be0f17629c290fc63a545a621490bab	chapter_6	978-1-4987-6285-4	A change in this metabolic shift behavior of the cell line	change	A change	cell line	cell line	COID702829	CHAPTER 6	arg0
0f2e5ff75df3ca2df75920ca1f46cdca	chapter_6	978-1-4987-6285-4	the productivity to decrease	productivity	the productivity	process condition	productivity	COID731421	CHAPTER 6	arg1
a833d9a056dfd67a4d4325ce3d1c9e61	chapter_7	978-1-4987-6285-4	the DHFR gene amplification system	system	the DHFR gene amplification system	enzyme	DHFR	COID400950	CHAPTER 7	arg0
218200be8df077b9ce6d4168521ca850	chapter_7	978-1-4987-6285-4	Dihydrofolate reductase	reductase	Dihydrofolate reductase	enzyme	Dihydrofolate reductase	COID400950	CHAPTER 7	arg1
57bc3c8795d9d9af7c38161d7d6416fe	chapter_7	978-1-4987-6285-4	the DHFR gene amplification system	system	the DHFR gene amplification system	genotype	gene	COID185502	CHAPTER 7	arg0
84c38a1f47806ff4ce54877069d2f5eb	chapter_7	978-1-4987-6285-4	the pH	pH	the pH	bioreactor conditions	pH	COID893209	CHAPTER 7	arg0
1dc15118b2dbcf4fdf7bd54b15dc9722	chapter_7	978-1-4987-6285-4	lactate production	production	lactate production	by-product or waste	lactate	COID250920	CHAPTER 7	arg1
db95df0cda7208c5c6265d2251edc9c8	chapter_7	978-1-4987-6285-4	Many media	media	Many media	media characteristics	media	COID913636	CHAPTER 7	arg0
cbf0a0acb46bfdb8897d2096bd8a2eba	chapter_7	978-1-4987-6285-4	low concentrations of sodium bicarbonate and HEPES	concentrations	low concentrations	buffer (subset of secondary raw materials)	sodium bicarbonate	COID760948	CHAPTER 7	arg1
c9d03e24e9fe2ce6c51ef877d4dc5278	chapter_8	978-1-4987-6285-4	Excessively large aggregates	aggregates	Excessively large aggregates	product quality attributes	aggregates	COID879651	CHAPTER 8	arg0
bf043f425e2a3e1994f7f0b3dba91707	chapter_8	978-1-4987-6285-4	a lower viability that may influence product quality if the product is degraded or otherwise modified by enzymes released by lysed cells	viability	a lower viability	process parameters or process control	viability	COID222142	CHAPTER 8	arg1
5f79d9deb7399d97dd81915685552ee3	chapter_8	978-1-4987-6285-4	the typical oxygen demand in a mammalian cell culture	demand	the typical oxygen demand	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 8	arg0
c3aa53bdf854ba03dae0644225bf098d	chapter_8	978-1-4987-6285-4	a mammalian cell culture	culture	a mammalian cell culture	cell culture parameters	cell culture	COID293414	CHAPTER 8	arg1
d94bce0ea98ad42aa79e72ee74cedf96	chapter_8	978-1-4987-6285-4	The oxygen transfer capacity in a cell culture bioreactor	capacity	The oxygen transfer capacity	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 8	arg0
34183a7b0657d4a8840dd776f2f35fd6	chapter_8	978-1-4987-6285-4	a cell culture bioreactor	bioreactor	a cell culture bioreactor	cell culture parameters	cell culture	COID293414	CHAPTER 8	arg1
7d902cbda75d6b9e0ee092d477723298	chapter_8	978-1-4987-6285-4	a cell culture bioreactor	bioreactor	a cell culture bioreactor	vessel or process parameter or production scale	bioreactor	COID345693	CHAPTER 8	arg1
5a709145dc232af59024ebeac9ab2794	chapter_9	978-1-4987-6285-4	The accumulation of lactate, ammonium, and other metabolites of amino acid degradation in a bioreactor	accumulation	The accumulation	culture condition	ammonium	COID714150	CHAPTER 9	arg0
2156e6a0f9a54283bf02f0f3fc4d5ccf	chapter_9	978-1-4987-6285-4	growth	growth	growth	cell culture parameters	growth	COID203666	CHAPTER 9	arg1
0d1f42fee1eb134ec9ad298a14206d28	chapter_9	978-1-4987-6285-4	The accumulation of lactate, ammonium, and other metabolites of amino acid degradation in a bioreactor	accumulation	The accumulation	by-product or waste	lactate	COID250920	CHAPTER 9	arg0
4b44925bc348b9bb7cbbf2685d6b88fe	chapter_9	978-1-4987-6285-4	Excessively high nutrient levels	levels	Excessively high nutrient levels	secondary raw materials	nutrient	COID423902	CHAPTER 9	arg0
41e03a29c714d30086bb8cba79caae47	chapter_9	978-1-4987-6285-4	growth inhibition	inhibition	growth inhibition	cell culture parameters	growth	COID203666	CHAPTER 9	arg1
5a6a47df79172100a952082bc1d8f021	chapter_9	978-1-4987-6285-4	the accompanying high osmolality	osmolality	the accompanying high osmolality	process parameters or process control	osmolality	COID710653	CHAPTER 9	arg0
c662c977ef7644c837c101880479cec6	chapter_9	978-1-4987-6285-4	overly high osmolality	osmolality	overly high osmolality	process parameters or process control	osmolality	COID710653	CHAPTER 9	arg0
e60ff0746a3ca38b33510c8c272caa98	chapter_9	978-1-4987-6285-4	cell viability	viability	cell viability	cell culture parameters	cell viability	COID547964	CHAPTER 9	arg1
d90ee30e01bf5e688f013c1cab47910d	chapter_9	978-1-4987-6285-4	Some fed-batch culture processes	processes	Some fed-batch culture processes	process mode	fed-batch	COID529446	CHAPTER 9	arg0
9cd5c35195b729f84474003df8c83804	chapter_9	978-1-4987-6285-4	the cultivation temperature	temperature	the cultivation temperature	bioreactor conditions	temperature	COID692615	CHAPTER 9	arg1
7189a3ad51f1bab4f44554acee18e9ea	chapter_9	978-1-4987-6285-4	The temperature shift	shift	The temperature shift	bioreactor conditions	temperature	COID692615	CHAPTER 9	arg0
279ce07713c7488c895f8c172ebb6780	chapter_9	978-1-4987-6285-4	a greater effect on cell growth	effect	a greater effect	cell culture parameters	cell growth	COID093598	CHAPTER 9	arg0
9e5d140a5ce45c9959554d3d715c2402	chapter_9	978-1-4987-6285-4	the reduction of substrate	reduction	the reduction	substrates	substrate	COID265919	CHAPTER 9	arg1
336f86de7800d250e62938923cc55ee0	16609957		FUT8 knockout	FUT8	FUT8 knockout	genotype	knockout	COID494346	ABSTRACT	arg0
1a8b0c109d73aada9155fc21c02ad91a	16609957		robust manufacture of fucose-negative therapeutic antibodies with enhanced ADCC	manufacture	robust manufacture	clinical outcomes	ADCC	COID386333	ABSTRACT	arg1
6fc409f356e879af397f19ebabdcf85d	16609957		robust manufacture of fucose-negative therapeutic antibodies with enhanced ADCC	manufacture	robust manufacture	non-fucosylated antibody	fucose-negative therapeutic antibodies	COID842930	ABSTRACT	arg1
a5b28082f9b5d919274b258de91137b0	16609957		YB2/0	YB2/0	YB2/0	cell line	YB2/0	COID969855	ABSTRACT	arg0
f1d73dbf0cf2fc27f72aa0a98d8e7ed3	16609957		The amount of fucose-negative antibody produced by Lec13 and YB2/0	amount	The amount	non-fucosylated antibody	fucose-negative antibody	COID842930	ABSTRACT	arg1
7b6130cc75ee12351e200d8232c66356	16609957		Lec13	Lec13	Lec13	cell line	Lec13	COID415606	ABSTRACT	arg0
923fb10db1649d51a9741fcddd6784d5	20159578		antibody heterogeneity	heterogeneity	antibody heterogeneity	clinical outcomes	heterogeneity	COID021590	ABSTRACT	arg0
3116d4016dbff7810e07ab32bd46ce6f	20159578		a decrease in cell viability	decrease	a decrease	cell culture parameters	cell viability	COID547964	ABSTRACT	arg1
1feae46313157fbb0337819cbb0e9777	20639190		Antibodies lacking core fucosylation	Antibodies	Antibodies	glycosylation	core fucosylation	COID663555	ABSTRACT	arg0
eb64b5bcc3b0b39b159a75548575d63f	20639190		ADCC	ADCC	ADCC	clinical outcomes	ADCC	COID386333	ABSTRACT	arg1
d5f7644d0e96f07797829260ff0b669a	20639190		a significantly enhanced antibody-dependent cell-mediated cytotoxicity (ADCC)	cytotoxicity	antibody-dependent cell-mediated cytotoxicity	clinical outcomes	antibody-dependent cell-mediated cytotoxicity	COID386333	ABSTRACT	arg1
5b72a76537ef4a897e2fb7706d5336ea	20639190		heterologous expression of the prokaryotic enzyme GDP-6-deoxy-d-lyxo-4-hexulose reductase within the cytosol	expression	heterologous expression	enzyme	GDP-6-deoxy-d-lyxo-4-hexulose reductase	COID569267	ABSTRACT	arg0
7f29d79941d19aeb64baca8e0b90fae0	20639190		the fucose de novo pathway	pathway	the fucose de novo pathway	biological process	fucose de novo pathway	COID327903	ABSTRACT	arg1
f5a2cdce5dd82badb5a0c5b8fb007cc7	24326352		the lack of N-glycosylation	lack	the lack	glycosylation	N-glycosylation	COID293911	ABSTRACT	arg0
935fbeec46fe828ad82f4d61d7a8abd6	24326352		the formation of dimers	formation	the formation	product quality attributes	dimers	COID438141	ABSTRACT	arg1
36b264e8fa933efc94956d7ef0926125	24728980		A2	A2	A2	product quality attributes	A2	COID087025	ABSTRACT	arg1
f6fd658d744a078aed535436535046a2	24728980		FA2	FA2	FA2	product quality attributes	FA2	COID087024	ABSTRACT	arg1
65ceb89dc4554c1a6bf18ee09b2eebc4	24728980		significant main effects (as well as interaction effects) of media supplementation with manganese, galactose, ammonia	significant main effects	significant main effects (as well as interaction effects) of media supplementation	by-product or waste	ammonia	COID714278	ABSTRACT	arg0
ea6e8e0bc43dd70fc740e7a445767f57	24728980		MnCl2	MnCl2	MnCl2	secondary raw materials	MnCl2	COID426404	ABSTRACT	arg0
247fde8d3a14818fa38ecedef870c505	25014402		GI and SI levels	levels	GI and SI levels	product attributes	GI	COID293764	ABSTRACT	arg0
6fab673166dff79f41f29efb2c77ea8e	25014402		Lower initial concentrations of glutamine	concentrations	Lower initial concentrations	amino acid (subset of substrates)	glutamine	COID962935	ABSTRACT	arg1
ac698bace573f933986c6bb0eac4df03	25014402		GI and SI levels	levels	GI and SI levels	product attributes	SI	COID283454	ABSTRACT	arg0
1cb37d87243ad5b446bbe80d6ad3d9e5	25565276		HM increase	increase	HM increase	sugar (subset of carbon source)	HM	COID981337	ABSTRACT	arg0
bac85244524f298354f9218f09fb2288	25565276		the decrease in G0F glycan	decrease	the decrease	sugar (subset of carbon source)	G0F glycan	COID847830	ABSTRACT	arg1
6cc8d37cc4679b6cbd6260415b279fd0	26222761		addition of 20 mM N-acetyl-D-glucosamine (GlcNAc)	addition	addition	sugar (subset of carbon source)	N-acetyl-D-glucosamine	COID510815	ABSTRACT	arg0
405712ea40b08210bb1110c31ef516c3	26222761		relative abundance of galactosylated IgG	abundance	relative abundance	product quality profile	galactosylated IgG	COID983193	ABSTRACT	arg1
aef28b954be85614344059f3db8add26	26222761		supplementation with 10 mM mannose	supplementation	supplementation	sugar (subset of carbon source)	mannose	COID906305	ABSTRACT	arg0
5ef70df716f8c3d27c39c1d73adaeaa0	26222761		GlcNAc occupancy of IgG	occupancy	GlcNAc occupancy	sugar (subset of carbon source)	GlcNAc	COID510815	ABSTRACT	arg1
38b429c51f1d2dc301223baba1bc9779	27832969		time	time	time	process parameters or process control	time	COID742277	ABSTRACT	arg0
fe38358fec5081e40f38d527a06a1781	27832969		sialylation	sialylation	sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
56514ea96f158f8ee60f5d0abbf29413	27832969		high mannose type N-glycans from the cell glycoproteins	N-glycans	high mannose type N-glycans	sugar (subset of carbon source)	high mannose type N-glycans	COID932230	ABSTRACT	arg1
60a4bf6a719b5072d50b807ce4f50aa2	27977914		Peak viable cell densities	densities	Peak viable cell densities	cell culture parameters	viable cell densities	COID384695	ABSTRACT	arg0
285dfa5c277c258b1bdd773bf6225244	27977914		BR as a potential consequence of lower pH, different medium exchange strategy	strategy	BR as a potential consequence of lower pH, different medium exchange strategy	media characteristics	medium	COID921897	ABSTRACT	arg1
129a4ed38c25c008492e8dd74cd1fd76	27977914		BR as a potential consequence of lower pH, different medium exchange strategy	strategy	BR as a potential consequence of lower pH, different medium exchange strategy	bioreactor conditions	pH	COID893209	ABSTRACT	arg1
8016a37de0a6b9bee724e0fd13289602	27977914		dissolved oxygen limitations	limitations	dissolved oxygen limitations	bioreactor conditions	dissolved oxygen	COID661988	ABSTRACT	arg1
3edbd901bce6c288c095b87922aeff1f	28409838		high ammonia levels reached at high viable cell densities (VCD) values	levels	high ammonia levels	by-product or waste	ammonia	COID714278	ABSTRACT	arg0
e27b26dd7b27143c3b33fe0643279c6f	28409838		the processing to complex glycan structures	processing	the processing	sugar (subset of carbon source)	glycan structures	COID684992	ABSTRACT	arg1
1984e0b219bdfe1b0d13ae9f27d2ea99	28465212		high raffinose concentrations	concentrations	high raffinose concentrations	sugar (subset of carbon source)	raffinose	COID985703	ABSTRACT	arg0
082a6bbbd987e2713700ba817410679a	28465212		cell growth and productivity	cell	cell growth and productivity	process condition	productivity	COID731421	ABSTRACT	arg1
c38cd60eb9da513c21b028ee4685d415	28465212		cell growth and productivity	cell	cell growth and productivity	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
660f6377defb43814175ce7002fad8d7	29673624		N-linked complex glycoform and core fucose levels	levels	N-linked complex glycoform and core fucose levels	recombinant protein	N-linked complex glycoform	COID210842	ABSTRACT	arg1
20a4723a13daa25d68e72022873cf67d	29673624		N-linked complex glycoform and core fucose levels	levels	N-linked complex glycoform and core fucose levels	sugar (subset of carbon source)	core fucose	COID067033	ABSTRACT	arg1
5db00b325af68f201dc3c397839905bc	29673624		high mannose level	level	high mannose level	sugar (subset of carbon source)	high mannose	COID981337	ABSTRACT	arg1
07ff740363278f96203c856250ccc692	29851298		intra-lot heterogeneity	heterogeneity	intra-lot heterogeneity	clinical outcomes	heterogeneity	COID021590	ABSTRACT	arg0
3a7003bc1cbd49a08f03b8a59b9e9843	29851298		perfusion cultures	cultures	perfusion cultures	process mode	perfusion cultures	COID368508	ABSTRACT	arg1
e6dc0d48ea199cebbcc58d9ce39a567c	29923054		Ultra-low carbon dioxide partial pressure	pressure	Ultra-low carbon dioxide partial pressure	process condition	carbon dioxide partial pressure	COID255565	ABSTRACT	arg0
5fd3da29199c0a37d34c4dbab04b11bd	29923054		the galactosylation of a monoclonal antibody produced in Chinese hamster ovary cells in a bioreactor	galactosylation	the galactosylation	glycosylation	galactosylation	COID475750	ABSTRACT	arg1
19c88449fd1b0944f8c528b41d76c105	30327978		Nickel concentrations below 500 ÂµM	concentrations	Nickel concentrations	trace metals or minerals (subset of secondary raw materials)	Nickel	COID232036	ABSTRACT	arg0
b483f1767b559048937a8ac7461fe30c	30327978		glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
d1a6169f796777da649d8ac168634b6e	30552760	PMC6590254	addition of 800 ÂµM 2-F-peracetyl fucose	addition	addition	sugar (subset of carbon source)	2-F-peracetyl fucose	COID847827	ABSTRACT	arg0
54317a9e59513a8b8923131db51671ce	30552760	PMC6590254	Fucosylation	Fucosylation	Fucosylation	glycosylation	Fucosylation	COID810570	ABSTRACT	arg1
17af2ce402d65c091c1a01d5c8f0e447	30959136		the highest production yields (1.2 g/L)	yields	the highest production yields	overall titer or batch yield	production yields	COID711358	ABSTRACT	arg0
b383148f1cc56afb5648f64bdb046d79	30959136		the temperature	temperature	the temperature	bioreactor conditions	temperature	COID692615	ABSTRACT	arg1
fae04e7555403f859b3132c641289d1e	31544815	PMC6640710	5-alkynylfucose	5-alkynylfucose	5-alkynylfucose	sugar (subset of carbon source)	5-alkynylfucose	COID256307	ABSTRACT	arg0
63e217494ff812a5fbce8e764fe55e28	31544815	PMC6640710	a significant higher incorporation of the alkynylated fucose analogue	incorporation	a significant higher incorporation	substitution material	fucose analogue	COID400862	ABSTRACT	arg1
00c4169f86e4d52ae829f6877457b589	34289087		cell cycle	cycle	cell cycle	biological process	cell cycle	COID780295	ABSTRACT	arg1
84e83a76e0604b6099138f0edf5a91dd	34575094	PMC8469772	a lower content of high-mannose glycoforms	content	a lower content	recombinant protein	high-mannose glycoforms	COID965734	ABSTRACT	arg0
690c9db2c5087aad61eb7cb3f2729cc4	34575094	PMC8469772	the antibody C12 produced by the continuous feeding method	C12	the antibody C12	antibody	antibody	COID278523	ABSTRACT	arg1
fca5e5f99f46f036da5690a523d5de47	23172735	PMC4226405	approximately 25-fold less antibody produced from siRNA treated cultures	antibody	approximately 25-fold less antibody	antibody	antibody	COID278523	RESULTS	arg1
378e1f1ad26019611419c702ad297ea8	23172735	PMC4226405	a decrease in gene expression with	decrease	a decrease	genotype	gene	COID185502	RESULTS	arg0
d0b53c9a0318b2d8d260a5bc172c673f	23172735	PMC4226405	siRNA concentration	concentration	siRNA concentration	NYK	siRNA	COID416464	RESULTS	arg1
3c917b4cc1a444c688436228e43b9c8b	23172735	PMC4226405	time	time	time	process parameters or process control	time	COID742277	RESULTS	arg0
27583c9a9e3ee471e494eb030fc9d281	23172735	PMC4226405	fut8 expression	expression	fut8 expression	genotype	fut8 expression	COID939656	RESULTS	arg1
bc1508aa58f899511fe25f58c1a9ef5c	23172735	PMC4226405	fut8 and gmds mRNA expression	expression	fut8 and gmds mRNA expression	enzyme	fut8	COID212341	RESULTS	arg0
6a19e2876cabf356d13820a7cc303028	23172735	PMC4226405	bioreactors	bioreactors	bioreactors	vessel or process parameter or production scale	bioreactors	COID345693	RESULTS	arg1
1f73c2789de732cf4aa98636188574a6	25042542	PMC4282109	all high mannose glycans	glycans	all high mannose glycans	sugar (subset of carbon source)	high mannose	COID981337	RESULTS	arg0
aa6be40a56f413b8d34e5c835065ad06	25042542	PMC4282109	all tested mAbs	mAbs	all tested mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg1
911d50dbd7887e4e5bc43bdd462a3751	25042542	PMC4282109	all high mannose glycans	glycans	all high mannose glycans	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg0
ff41e8d1afd6614aaf572a2735cdebf7	25042542	PMC4282109	VCDs	VCDs	VCDs	cell culture parameters	VCDs	COID384695	RESULTS	arg0
a619e09876bc70dac15d2e26a52b2c6e	25042542	PMC4282109	the mRNA levels of many enzymes and transporters involved in the N-linked glycosylation pathway	levels	the mRNA levels	glycosylation	N-linked glycosylation	COID005169	RESULTS	arg0
239cd42ef621696a1966583e9c6efc44	25042542	PMC4282109	the temperature shift condition	condition	the temperature shift condition	bioreactor conditions	temperature	COID692615	RESULTS	arg1
40ab6ec0245a4fc82260e9e02afaa53d	25641927	PMC4492121	The IgG produced in ST6GAL1_OE_32 host cell line	IgG	The IgG	antibody	IgG	COID713543	RESULTS	arg0
39da6deabd4c56683b99ead808a09c09	25641927	PMC4492121	a lower relative abundance of the G0F and G2F glycoforms	abundance	a lower relative abundance	recombinant protein	glycoforms	COID288767	RESULTS	arg1
60a6ae2829955973fdf31645b1ff9b07	25641927	PMC4492121	a lower relative abundance of the G0F and G2F glycoforms	abundance	a lower relative abundance	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg1
b226a88d37e7bca2350d17891ec2ab6b	25641927	PMC4492121	a lower relative abundance of the G0F and G2F glycoforms	abundance	a lower relative abundance	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg1
0276f11c42974bc3cc3f2f90f8a851db	26910040	PMC4947490	the supplemented cultivation of cell line B	cultivation	the supplemented cultivation	cell line	cell line	COID702829	RESULTS	arg0
0e7d896b609626f14b648f009bbe1d0a	26910040	PMC4947490	a decrease in OUR	decrease	a decrease	biological process	OUR	COID844361	RESULTS	arg1
59fefd9c43eaf968982804ab0c3dcd95	26910040	PMC4947490	the cultivations with cell line B (day 7)	cultivations	the cultivations	cell line	cell line	COID702829	RESULTS	arg0
c9ce7214b261787bf3ef1af6389fe0d7	26910040	PMC4947490	the first decrease in OUR	decrease	the first decrease	biological process	OUR	COID844361	RESULTS	arg1
70142d4190a3cdf6557d791771d79f6f	27559765	PMC5098448	High mannose type glycan structures	structures	High mannose type glycan structures	sugar (subset of carbon source)	glycan structures	COID684992	RESULTS	arg0
83239f5b4951aff8dc8ff03e8961b2f1	27559765	PMC5098448	decreased CDC	CDC	decreased CDC	clinical outcomes	CDC	COID455860	RESULTS	arg1
0db27984a3fe274439bb2c13f28ad653	27559765	PMC5098448	High mannose type glycan structures	structures	High mannose type glycan structures	sugar (subset of carbon source)	High mannose	COID981337	RESULTS	arg0
8d98925db46477e8650c2f3725ba1f9d	27752770	PMC5274649	lower pH values	values	lower pH values	bioreactor conditions	pH	COID893209	RESULTS	arg0
abe85dfe0779797d6cdfeea57b3d0538	27752770	PMC5274649	higher deamidation rates	deamidation	higher deamidation rates	PTM	deamidation	COID565107	RESULTS	arg1
20fb08d188a2b7c051c27b27d2157733	28951949	PMC5656727	The specific glucose consumption based on cell number	consumption	The specific glucose consumption	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
6e29c809ee497651da65de26d561c49b	28951949	PMC5656727	only a slight decrease (4.5 to 4.1 mumol x 10-6 cells x day-1) from the NI to the SI phase	decrease	only a slight decrease	product attributes	SI	COID283454	RESULTS	arg1
e89a426d5b5dddc12e9dea52ea2830dc	29511312	PMC5840386	a means to fine-tune monoclonal antibody glycosylation profile	means	a means	product attributes	glycosylation profile	COID103232	RESULTS	arg0
f03d7723af3e5454b2f7e7d18cfa8978	29511312	PMC5840386	the sialylation level	level	the sialylation level	glycosylation	sialylation	COID543327	RESULTS	arg1
ef2159ba928ebfafd0de443ae2ca4062	29511312	PMC5840386	a means to fine-tune monoclonal antibody glycosylation profile	means	a means	monoclonal antibody	monoclonal antibody	COID242255	RESULTS	arg0
9c65c1a98832d319e65396aab06225e7	30552760	PMC6590254	addition of 800 microM 2-F-peracetyl fucose	addition	addition	sugar (subset of carbon source)	2-F-peracetyl fucose	COID847827	ABSTRACT	arg0
0ea39bcbb29d8b7ba9e23d8b9bcce67d	30552760	PMC6590254	Supplementation with the fucosyltransferase inhibitor Reactive Red 120	Supplementation	Supplementation	secondary raw materials	Supplementation	COID566710	RESULTS	arg0
a84740552053a10b6babd8bb8d4a4224	30552760	PMC6590254	fucosylation	fucosylation	fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
9ea06c2ccb61b26c8d368559488875b7	30552760	PMC6590254	The fucose derivative 2F-PerAcFuc	2F-PerAcFuc	The fucose derivative 2F-PerAcFuc	sugar (subset of carbon source)	fucose	COID275575	RESULTS	arg0
5c31642adc8fab529cff1a9619211f2f	30552760	PMC6590254	fucosylation than Reactive Red 120 or MPA	fucosylation	fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
d3d0e37201d8ec7e4cc6121c43834fea	30552760	PMC6590254	a well-known fucosyltransferase inhibitor	inhibitor	a well-known fucosyltransferase inhibitor	enzyme	fucosyltransferase	COID212341	RESULTS	arg0
49055e8efc327e51383b3389673b78a4	30552760	PMC6590254	a well-known fucosyltransferase inhibitor	inhibitor	a well-known fucosyltransferase inhibitor	secondary raw materials	inhibitor	COID760391	RESULTS	arg0
fe6a8868e456a1f8019168e4dded5661	30552760	PMC6590254	MPA	MPA	MPA	NYK	MPA	COID265438	RESULTS	arg0
84b21201f9e486d8bf753e086fd6e7a0	30552760	PMC6590254	fucosylation (3.4%)	fucosylation	fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
1fc907eb27196caf2f5c0cb6d3b27b70	30552760	PMC6590254	time-dependent	time-dependent	time-dependent	process parameters or process control	time	COID742277	RESULTS	arg0
3562aaca608623b1ec850d1bd2b7eb3f	30552760	PMC6590254	total sialylation	sialylation	total sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
a6ddadaf01609c517662fd95a5a4c6d5	30552760	PMC6590254	the sialidase activity	activity	the sialidase activity	enzyme	sialidase	COID070440	RESULTS	arg0
7c48f79895354869c3c05310a362e6a0	30552760	PMC6590254	the lower sialylation level observed after D10	level	the lower sialylation level	glycosylation	sialylation	COID543327	RESULTS	arg1
c2effa0653aa193d19616778931e1033	30552760	PMC6590254	the addition of compounds that specifically reduce fucosylation	addition	the addition	glycosylation	fucosylation	COID810570	RESULTS	arg0
ae8a28f29fcb69e960bcfc5fa2f3dbca	30552760	PMC6590254	Fucosylation	Fucosylation	Fucosylation	glycosylation	Fucosylation	COID810570	RESULTS	arg1
20a7ca42d8afc57dcbcaf159cce1bd37	30552760	PMC6590254	DMSO (solvent used for solubilization of 2F-PerAcFuc)	DMSO	DMSO	NYK	DMSO	COID418525	RESULTS	arg0
17fd4399f9a5b0328f329fd732f6a391	30552760	PMC6590254	a decreased IVC	IVC	a decreased IVC	NYK	IVC	COID204694	RESULTS	arg1
66ea54b903e663139d1143cda92493ad	30552760	PMC6590254	100 mM ammonium chloride	chloride	100 mM ammonium chloride	nitrogen sources (subset of secondary raw materials)	ammonium chloride	COID969984	RESULTS	arg0
efd3eb26387d26dc6890d77eb91194d7	30552760	PMC6590254	total galactosylation	galactosylation	total galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
c97167eb9d1acf24e052295bfa436b58	30552760	PMC6590254	total galactosylation	galactosylation	total galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg0
f77ffc65eee45d1577b921f356fa6389	30552760	PMC6590254	100 mM ammonium chloride	chloride	100 mM ammonium chloride	nitrogen sources (subset of secondary raw materials)	ammonium chloride	COID969984	RESULTS	arg1
3a391b49c602ba782792d0d1a9cb5a49	30682623	PMC6352710	Inhibition of the epimerase function of GNE by slightly higher concentrations of CMP-Sia	Inhibition	Inhibition	process condition	function	COID532355	RESULTS	arg0
1418f73f66516c55b8774ad4591bb453	30682623	PMC6352710	inhibition of UDP-GlcNAc conversion to downstream intermediates including Neu5Ac	inhibition	inhibition	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
1bcc1ad5dfaa5be06148e5bc3d41b001	30682623	PMC6352710	the epimerase function of GNE	function	the epimerase function	process condition	function	COID532355	RESULTS	arg0
5cf5763c1062eaf8676df07feff422c9	30682623	PMC6352710	the relatively lower peak lactate levels when compared with the CC process	levels	the relatively lower peak lactate levels	by-product or waste	lactate	COID250920	RESULTS	arg0
95efabe6a0c41bf637d262038e43271c	30682623	PMC6352710	The higher viable cell density observed in the HD process	density	The higher viable cell density	cell culture parameters	viable cell density	COID384695	RESULTS	arg1
04ad126d3c28adf210e215bdc02d882c	30682623	PMC6352710	time (Figure 2B)	time	time	process parameters or process control	time	COID742277	RESULTS	arg0
9d8deccbe4f46e1a5564637f06fef8a0	30682623	PMC6352710	Galactosylation	Galactosylation	Galactosylation	glycosylation	Galactosylation	COID475750	RESULTS	arg1
ddba811f02297056765dd7befe65276b	30682623	PMC6352710	time	time	time	process parameters or process control	time	COID742277	RESULTS	arg0
1fcfaffc9b385ad5541a928d8e549197	30682623	PMC6352710	terminally galactosylated species (term-gal) that have either one (G1) or two (G2) galactoses terminating the glycan chain	species	terminally galactosylated species	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
1d88a36da2492398b2d2f39e3c5ceafd	30682623	PMC6352710	transketolase (TKT) and ribose-5-phosphate isomerase (RPIA) enzymes in the PPP	enzymes	transketolase (TKT) and ribose-5-phosphate isomerase (RPIA) enzymes	metabolic pathways	PPP	COID233901	RESULTS	arg1
5e652058c60ed11d0494f445ad8dcca9	30682623	PMC6352710	the GlcNAc-supplemented condition	condition	the GlcNAc-supplemented condition	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg0
e299df5aa73392b1225d7fc01f39c25a	30682623	PMC6352710	a small drop in the sialylation	drop	a small drop	glycosylation	sialylation	COID543327	RESULTS	arg1
324f0ebe0347d507ac5de3adf4c40ce1	31425633	PMC7003473	lower amounts of terminal galactosylation (G1F and G2F)	amounts	lower amounts	glycosylation	galactosylation	COID475750	RESULTS	arg1
1a78c9ebab1d97163b5456453fa84033	31425633	PMC7003473	lower amounts of terminal galactosylation (G1F and G2F)	amounts	lower amounts	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg1
ae54dd3e742b53ca5f63b365bacfcfff	31425633	PMC7003473	lower amounts of terminal galactosylation (G1F and G2F)	amounts	lower amounts	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg1
30570549856b9dcf0b760df7c7b9918c	31425633	PMC7003473	the full course of the fed-batch mode run	course	the full course	process mode	fed-batch	COID529446	RESULTS	arg0
d46db7b9daf1806a77d3abe758cb122e	31425633	PMC7003473	the culture concentrations of tyrosine (Tyr)	concentrations	the culture concentrations	media parameter or raw material	tyrosine	COID500516	RESULTS	arg1
8ea21148e29f71cba61d87d19c018615	31487120	PMC7027499	cultures consuming lowered levels of glucose and producing lowered levels of lactate during the stationary phase (Days 5 and 6)	cultures	cultures	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
5c9a3d11a8b2023f61b366db41d139be	31487120	PMC7027499	more protein which contained a higher proportion of immature glycoforms	protein	more protein	recombinant protein	glycoforms	COID288767	RESULTS	arg1
3715c862ef35ac14687d3828ea30234f	31487120	PMC7027499	the cells that consume elevated levels of glutamine during the lag phase	cells	the cells	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg0
066651549e2b5f8991c6195f43a2296a	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	recombinant protein	glycoforms	COID288767	RESULTS	arg1
b9b25764fdde656b0430eafeef650355	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg1
af62aa20edecf72a4e5ba8d62dd3e7a9	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg1
52c09278464e9ef5fe47e882848d81d0	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg1
0dc90c9f1c0e27cdc4cc04cfcae0a2f6	31487120	PMC7027499	cells that utilize more glucose for energy during the stationary phase of the culture	cells	cells	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
997a80087f43970b431f91f0d0338047	31487120	PMC7027499	cells with lower productivity	cells	cells	process condition	productivity	COID731421	RESULTS	arg1
98ee3f715c6e74aa1ad3140e3e432845	31487120	PMC7027499	the lowest amount of terminal galactosylation	amount	the lowest amount	glycosylation	galactosylation	COID475750	RESULTS	arg1
22d5e5bfd122fa5cac826afb77107011	31487120	PMC7027499	lowered glutamine consumption during the stationary phase (Days 5 and 6)	consumption	lowered glutamine consumption	amino acid (subset of substrates)	glutamine	COID962935	RESULTS	arg0
1b873084ed158d390b4855a662741de7	31487120	PMC7027499	protein that contained a higher proportion of immature HM glycoforms	protein	protein	recombinant protein	HM glycoforms	COID288767	RESULTS	arg1
3f39d5df32cc7dec83ca906d13a075e1	31544815	PMC6640710	all inhibitors tested	inhibitors	all inhibitors	secondary raw materials	inhibitors	COID760391	RESULTS	arg0
7f30d2823fd6ddca9d64f8f3475a6084	31544815	PMC6640710	IgG core fucosylation	fucosylation	IgG core fucosylation	glycosylation	core fucosylation	COID663555	RESULTS	arg1
37cfa1e077370cde58d9692e1dd344b4	31544815	PMC6640710	IgG core fucosylation	fucosylation	IgG core fucosylation	antibody	IgG	COID713543	RESULTS	arg1
86252e993daf458d2f46cb9f34a4e5ed	31544815	PMC6640710	5-AlkFuc compared to 2F-Fuc	5-AlkFuc	5-AlkFuc	sugar (subset of carbon source)	5-AlkFuc	COID256307	RESULTS	arg0
a4db4534f59b5563b9025b5cde2b8bd4	31544815	PMC6640710	the IgG fucosylation	fucosylation	the IgG fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
f474fca938f5eadba741e9cdb8de8665	31544815	PMC6640710	the IgG fucosylation	fucosylation	the IgG fucosylation	antibody	IgG	COID713543	RESULTS	arg1
d04b447346d08640abf9014551895ee3	31544815	PMC6640710	The reduction of core fucosylation in the Fc-part of antibodies	reduction	The reduction	glycosylation	core fucosylation	COID663555	RESULTS	arg0
a5f3bb47c3da4db97baa4fe27fbf0e28	31544815	PMC6640710	enhanced ADCC	ADCC	enhanced ADCC	clinical outcomes	ADCC	COID386333	RESULTS	arg1
932bf4036a49565585d78e1f8f2f329a	31544815	PMC6640710	increasing inhibitor concentrations	concentrations	increasing inhibitor concentrations	secondary raw materials	inhibitor	COID760391	RESULTS	arg0
6e6ecb1d8ea2c63e3424fe85f984e276	31544815	PMC6640710	the impact of peracetylation	impact	the impact	PTM	peracetylation	COID113739	RESULTS	arg1
e441d155c42cd1d0a6cdc7542f6defd6	31544815	PMC6640710	all fucose analogues	analogues	all fucose analogues	substitution material	fucose analogues	COID400862	RESULTS	arg0
8e43a09c7060c9fb39790f4facd72131	31544815	PMC6640710	total fucosylation	fucosylation	total fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
26f94bad871b60a39f86ad2fba2c43f3	33476097	PMC8365702	mAb-1	mAb-1	mAb-1	monoclonal antibody	mAb-1	COID268135	RESULTS	arg0
981b2109d83523b1627f70541602ec2e	33476097	PMC8365702	the lowest binding free energy to HEXB compared to other antibodies	energy	the lowest binding free energy	antibody	antibodies	COID278523	RESULTS	arg1
e3cee3c6fd4bdf90d25c41b2c2ad6110	33656168	PMC8451748	the maximum possible yield	yield	the maximum possible yield	overall titer or batch yield	yield	COID809703	RESULTS	arg1
440a2fb9bb15fba97a9d2d58f159c09b	33656168	PMC8451748	cellular growth	growth	cellular growth	cell culture parameters	growth	COID203666	RESULTS	arg1
e370aeb0f517468942b9ffae86e15594	33738790	PMC8453549	the IgG titer on Day 14	titer	the IgG titer	overall titer or batch yield	IgG titer	COID814559	RESULTS	arg0
0a15bcc601022e189215a62f1ac34efc	33738790	PMC8453549	the condition where 8.5 g/L lactate was spiked on Day 7	condition	the condition	by-product or waste	lactate	COID250920	RESULTS	arg1
57cb3d8cdc909ab3c93e2bcfc171714e	33742789	PMC8459231	usage of FC as iron source in CCM	usage	usage	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
b4f2e18d5e121720452b7f155af62099	33742789	PMC8459231	a lower cell growth	growth	a lower cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
8601d8b728c1c31bee5084ef877d4b06	33742789	PMC8459231	time	time	time	process parameters or process control	time	COID742277	RESULTS	arg0
ab560dfa55ad9d73b565e5cc2dbf90ed	33742789	PMC8459231	iron concentration	concentration	iron concentration	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg1
09f939afc36151ad3edd1f727d596e4e	33742789	PMC8459231	iron concentration	concentration	iron concentration	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
e1810f047e3d72117178c74d531fb050	33742789	PMC8459231	terminal sialylation level	level	terminal sialylation level	glycosylation	sialylation	COID543327	RESULTS	arg1
260cd3c2199da1d60d761d33e469e36c	33742789	PMC8459231	an increase in iron concentration	increase	an increase	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg0
f919998fce32a5ef7990d470f9ae5d9a	33742789	PMC8459231	a faster decrease in viability (Figure 1b)	decrease	a faster decrease	process parameters or process control	viability	COID222142	RESULTS	arg1
afd0d9beef57bce69bc754fac433194d	33804825	PMC8037477	Feed C supplementation	supplementation	Feed C supplementation	secondary raw materials	supplementation	COID566710	ABSTRACT	arg0
3568b1c5edc04def4a7a746058b803d1	33804825	PMC8037477	a significant reduction in galactosylated antibody structures	reduction	a significant reduction	antibody	antibody	COID278523	ABSTRACT	arg1
e224b8af4907149f87d6d72a5a6386bf	33804825	PMC8037477	increased intracellular pH conditions that inhibit b4GalT activity and expression, and consequently lead to reduced protein galactosylation	conditions	increased intracellular pH conditions	bioreactor conditions	pH	COID893209	RESULTS	arg0
382640fcb90191eaa4f01af6c2c4b306	33804825	PMC8037477	b4GalT activity	activity	b4GalT activity	enzyme	b4GalT	COID856080	RESULTS	arg1
b7f36afda19b051476003868d7e2e342	33804825	PMC8037477	reduced protein galactosylation	galactosylation	reduced protein galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
3933d6d5f56feaf84770aa53c716208c	33804825	PMC8037477	the highest osmolality condition (500 mOsm kg-1 Feed C)	condition	the highest osmolality condition	process parameters or process control	osmolality	COID710653	RESULTS	arg0
da2810a10db1965e7e3b6f8f957ada9e	33804825	PMC8037477	significantly lower levels of core fucosylation	levels	significantly lower levels	glycosylation	core fucosylation	COID663555	RESULTS	arg1
7fb8ad6cc0ceba040bcac0f114b6e15c	34542245	PMC9286570	butyric acid (BA)	acid	butyric acid	acid (subset of secondary raw materials)	butyric acid	COID365093	ABSTRACT	arg0
6d4f186e278543152f997dba27d73859	34542245	PMC9286570	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
c3d7a0c01a35b6f173c9b47e28c79f80	34542245	PMC9286570	BA	BA	BA	acid (subset of secondary raw materials)	BA	COID365093	ABSTRACT	arg0
3244e5f899e91bd7f0101d58db0f23c1	34542245	PMC9286570	these reduced viabilities	viabilities	these reduced viabilities	process parameters or process control	viabilities	COID222142	RESULTS	arg0
ec5238175e8aaf6fc8ce62e509227616	34542245	PMC9286570	higher process impurities	impurities	higher process impurities	process condition	impurities	COID901557	RESULTS	arg1
e0958cbe67fed0a283bd40b560bd35f1	34575094	PMC8469772	substrate concentration	concentration	substrate concentration	substrates	substrate	COID265919	RESULTS	arg0
01c5de5a04e519ec1fb4b4709a1a75e6	34575094	PMC8469772	the production of metabolic byproducts (lactate and NH4+)	production	the production	by-product or waste	metabolic byproducts	COID531384	RESULTS	arg1
5f8f4f0db930794f3519e763ef2d9648	34575094	PMC8469772	the production of metabolic byproducts (lactate and NH4+)	production	the production	by-product or waste	lactate	COID250920	RESULTS	arg1
fe114c6f3fb57ff47a1f30eeed4a0ed4	34575094	PMC8469772	the fed-batch process	process	the fed-batch process	process mode	fed-batch	COID529446	RESULTS	arg0
00b7a09e0a966954d6d39ad5834dfc91	34575094	PMC8469772	the disadvantages of low production efficiency and easy accumulation of metabolic byproducts	disadvantages	the disadvantages	by-product or waste	metabolic byproducts	COID531384	RESULTS	arg1
4c1a823e8f3b2879774f73b9ba341cf3	34575094	PMC8469772	cell line A	A	cell line A	cell line	cell line	COID702829	RESULTS	arg0
512efbb626b1a90d88bcb37820e8cce1	34575094	PMC8469772	lower lactate and NH4+ levels	levels	lower lactate and NH4+ levels	by-product or waste	lactate	COID250920	RESULTS	arg1
1754218dd0e3d8f98aa9409e2adb7d14	34575094	PMC8469772	a lower osmolality	osmolality	a lower osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg0
cd7fa3c7f82d6315ed414e6bf873fcb4	34575094	PMC8469772	a lower high-mannose glycoform content	content	a lower high-mannose glycoform content	recombinant protein	high-mannose glycoform	COID965734	RESULTS	arg1
a7bda55a26ba72c9c94f996cb0b78ff9	35441833	PMC9542549	the fastest growing cell line tested	line	the fastest growing cell line	cell line	cell line	COID702829	ABSTRACT	arg0
a5bb5aac6bff1ca1e1a963615060ba3a	35441833	PMC9542549	a 35% decrease in cell growth and product titre	decrease	a 35% decrease	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
9da902d4a1eca0024df434215a704af9	35441833	PMC9542549	DOT-fluctuated vessels	vessels	DOT-fluctuated vessels	vessel or process parameter or production scale	DOT-fluctuated vessels	COID853468	RESULTS	arg0
009358e7522e0be9ed4ac2fe8df15499	35441833	PMC9542549	decreased levels of G0F and elevated G1F + G2F glycans	levels	decreased levels	sugar (subset of carbon source)	G2F glycans	COID847130	RESULTS	arg1
c6a308f419c0a15f53814cda2c187ea7	35441833	PMC9542549	decreased levels of G0F and elevated G1F + G2F glycans	levels	decreased levels	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg1
40b68ad12bbebaa6e03c3509fcac4a49	35441833	PMC9542549	decreased levels of G0F and elevated G1F + G2F glycans	levels	decreased levels	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg1
a79a8969f2b15ac5165aee22a341f65b	35441833	PMC9542549	the lower DOT cultures The agreement between the findings of our small-scale studies (15 ml) and these larger scale studies (>3 L) supports the use of the miniature bioreactor platform for studying the response of different cell lines to culture heterogeneities	cultures	the lower DOT cultures The agreement between the findings of our small-scale studies (15 ml) and these larger scale studies (>3 L) supports the use of the miniature bioreactor platform for studying the response of different cell lines to culture heterogeneities	vessel or process parameter or production scale	bioreactor	COID345693	RESULTS	arg0
14acdbe40b68d7f15b8b238472a7ecdf	35441833	PMC9542549	increased glycolysis	glycolysis	increased glycolysis	metabolic pathways	glycolysis	COID345655	RESULTS	arg1
26121e7fc953e174a0c3711f0334ffd4	35441833	PMC9542549	the lower DOT cultures The agreement between the findings of our small-scale studies (15 ml) and these larger scale studies (>3 L) supports the use of the miniature bioreactor platform for studying the response of different cell lines to culture heterogeneities	cultures	the lower DOT cultures The agreement between the findings of our small-scale studies (15 ml) and these larger scale studies (>3 L) supports the use of the miniature bioreactor platform for studying the response of different cell lines to culture heterogeneities	vessel or process parameter or production scale	scale	COID586187	RESULTS	arg0
00288799d746d7be1c4f9722cdb8c8ef	35441833	PMC9542549	12% lower levels of G1F + G2F	levels	12% lower levels	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg1
6811038bc196c8c90f679839db3b0d86	35441833	PMC9542549	12% lower levels of G1F + G2F	levels	12% lower levels	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg1
0ec488ba82de1ec58838e4574952cfd2	35441833	PMC9542549	drop pH	pH	drop pH	bioreactor conditions	pH	COID893209	RESULTS	arg1
124d9f81220f4946ba2dc78300f1bc43	35441833	PMC9542549	DO-fluctuated cultures	cultures	DO-fluctuated cultures	bioreactor conditions	DO	COID661988	RESULTS	arg0
3793b2f908caa7d1aa9ff82b264be9ab	35441833	PMC9542549	lower peak VCD values	values	lower peak VCD values	cell culture parameters	VCD	COID384695	RESULTS	arg1
91aa3d8b9357bc65ed35b1132640cabf	35441833	PMC9542549	the overall lower (30%) DOT	DOT	the overall lower (30%) DOT	NYK	DOT	COID003597	RESULTS	arg0
66153ce339fae5b6273c00db77950f7e	35441833	PMC9542549	the increased lactate accumulation	accumulation	the increased lactate accumulation	by-product or waste	lactate	COID250920	RESULTS	arg1
e9ce5361cd3028e7f5f2ac1316c8226b	35441833	PMC9542549	DOT-fluctuated cultures	cultures	DOT-fluctuated cultures	NYK	DOT	COID003597	RESULTS	arg0
0adc7e8ef76c7e307847df83ce12fe55	35441833	PMC9542549	peak antibody titres between 2.5 and 3.1 gl-1; significantly lower than controls (p value <0.05)	titres	peak antibody titres	antibody	antibody	COID278523	RESULTS	arg1
96409750b0ad6616ee66c261c0a61ccf	35441833	PMC9542549	a 35% decrease in growth	decrease	a 35% decrease	cell culture parameters	growth	COID203666	RESULTS	arg1
eda621f05d7fc7f3803b000115fb1e68	35441833	PMC9542549	the oxygen consumption rate of the cells	rate	the oxygen consumption rate	gases (subset of secondary raw materials)	oxygen	COID472476	RESULTS	arg0
f9426d8e263a56074e469f720b3f2620	35441833	PMC9542549	the DOT to drop even quicker	DOT	the DOT	NYK	DOT	COID003597	RESULTS	arg1
f382524b0f6655a2dd6aaf8201844bd3	35441833	PMC9542549	Man5 levels	levels	Man5 levels	sugar (subset of carbon source)	Man5	COID568402	RESULTS	arg0
0e4dbdcae6d8c8f48d6519fea92e38f0	35441833	PMC9542549	pH-fluctuated vessels	vessels	pH-fluctuated vessels	vessel or process parameter or production scale	pH-fluctuated vessels	COID322748	RESULTS	arg1
41cdc15b90a1426612d02fcdd4dc15e2	35441833	PMC9542549	pH-fluctuated vessels	vessels	pH-fluctuated vessels	vessel or process parameter or production scale	pH-fluctuated vessels	COID322748	RESULTS	arg0
e8a90a74e9ac49d9da610adbc7fa5da4	35441833	PMC9542549	Man5 levels	levels	Man5 levels	sugar (subset of carbon source)	Man5	COID568402	RESULTS	arg1
a5879ddb3dc313d26c98fe1db75fa233	35441833	PMC9542549	growth	growth	slightly lower growth and product titre	cell culture parameters	growth	COID203666	RESULTS	arg0
201155b883efcc35a491486675c58174	35441833	PMC9542549	The 60 min pH fluctuations	fluctuations	The 60 min pH fluctuations	bioreactor conditions	pH	COID893209	RESULTS	arg1
800e4c76aab4080f55a44cf780b45d39	35737825	PMC9235890	Cell death in bioreactors	death	Cell death	vessel or process parameter or production scale	bioreactors	COID345693	ABSTRACT	arg0
5e6f7d9cb8f31550c2ba2505277247d0	35737825	PMC9235890	productivity	productivity	productivity	process condition	productivity	COID731421	ABSTRACT	arg1
334c315a0cc4f284dccb8add7a3e94f2	35737825	PMC9235890	the death-resistant cell lines	lines	the death-resistant cell lines	cell line	death-resistant cell lines	COID434844	ABSTRACT	arg0
e213929a92990e90c01cd93974585fb1	35737825	PMC9235890	slower drops in viability	drops	slower drops	process parameters or process control	viability	COID222142	ABSTRACT	arg1
d8080e8b12d2fa69e01a3695b90c688c	35737825	PMC9235890	The perfusion process	process	The perfusion process	process mode	perfusion	COID329168	RESULTS	arg0
882b11ca886f3f101ff10326d3b92b05	35737825	PMC9235890	ammonium concentrations	concentrations	ammonium concentrations	culture condition	ammonium	COID714150	RESULTS	arg1
c9fd8031224ee01d5e0a77d66b318818	37456731	PMC10349264	low media usage	usage	low media usage	media characteristics	media	COID913636	RESULTS	arg0
5689a77065f26c0b2aa0d7ae5c06a6be	37456731	PMC10349264	increased peak cell densities known from perfusion cultures and low media usage as in a fed batch operation	densities	increased peak cell densities	cell culture parameters	cell densities	COID283414	RESULTS	arg1
94888dee2eb530c1ba0504af4011d743	37456731	PMC10349264	the time course	course	the time course	process parameters or process control	time	COID742277	RESULTS	arg0
a614a7635a8ac0cc96bad6832f9acf4a	37456731	PMC10349264	specific growth rate	rate	specific growth rate	cell culture parameters	growth rate	COID957002	RESULTS	arg1
f7de96b52de96da955455daa65a22d6a	37456731	PMC10349264	viability	viability	viability	process parameters or process control	viability	COID222142	RESULTS	arg1
304398a750b7518ab19ebea70fc522fa	37456731	PMC10349264	cell densities	densities	cell densities	cell culture parameters	cell densities	COID283414	RESULTS	arg0
1b9557b4c82e512b80adedabca61a552	37456731	PMC10349264	the perfusion process	process	the perfusion process	process mode	perfusion	COID329168	RESULTS	arg1
def6dacc3a335df13b9ccfa0f1155da3	37731040	PMC10511539	Overexpressing cGNTIII in mammalian cells	cGNTIII	Overexpressing cGNTIII	genotype	cGNTIII	COID316428	RESULTS	arg0
e7e23621cb45df1a931a213cfadae279	37731040	PMC10511539	antibodies with bisecting glycan structures and reduced fucose content	antibodies	antibodies	antibody	antibodies	COID278523	RESULTS	arg1
2df1c5dfc52ee8f277deb9878372b0cb	37731040	PMC10511539	The qP	qP	The qP	flux rate	qP	COID599783	RESULTS	arg0
31b6b4ff3149bc2304fe2ec719ed8053	37731040	PMC10511539	cGNTIII gene	gene	cGNTIII gene	genotype	cGNTIII gene	COID316428	RESULTS	arg1
cf94018dc2f7309c670a70fa28dc019f	37731040	PMC10511539	high-level overexpression of cGNTIII	overexpression	high-level overexpression	genotype	cGNTIII	COID316428	RESULTS	arg0
195e98a980865e0ff4c12f3efba81a3a	37731040	PMC10511539	a reduction in the galactosylation level of IgG1s (Fig. 4F)	reduction	a reduction	glycosylation	galactosylation	COID475750	RESULTS	arg1
bc4b9c4309412f330a26bb0af44a76c7	chapter_11	978-1-4987-6285-4	the dissolution of nitrogen into water	dissolution	the dissolution	gases (subset of secondary raw materials)	nitrogen	COID546348	CHAPTER 11	arg0
fce0d8df331af343cb5fe4d3fa65979b	chapter_11	978-1-4987-6285-4	the transfer of oxygen	transfer	the transfer	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 11	arg1
509783219c0b29409a1a675e160a2399	chapter_12	978-1-4987-6285-4	the aeration rate that is used to control the dissolved oxygen level	aeration	the aeration rate	bioreactor conditions	aeration	COID371755	CHAPTER 12	arg0
f90ff95d5d6a1c99d66dfcb1295a9e7e	chapter_12	978-1-4987-6285-4	the dissolved oxygen level	level	the dissolved oxygen level	bioreactor conditions	dissolved oxygen	COID661988	CHAPTER 12	arg1
c840487ed8880cdbfef2d5c8e21c0a07	chapter_2	978-1-4987-6285-4	the completely folded protein with an N-glycan that does not have any terminal glucose	protein	the completely folded protein	sugar (subset of carbon source)	N-glycan	COID216687	CHAPTER 2	arg0
40298820b7111e1101c3db2faca80341	chapter_2	978-1-4987-6285-4	any terminal glucose	glucose	any terminal glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 2	arg1
f52f49ad51b211304234e4c1769c9f21	chapter_3_2	978-1-4987-6285-4	IgG molecules that do not have a fucose on their mannose core	molecules	IgG molecules	antibody	IgG	COID713543	CHAPTER 3	arg0
7a5849dc7f02a90409279f4cefc6996c	chapter_3_2	978-1-4987-6285-4	a fucose on their mannose core	fucose	a fucose	sugar (subset of carbon source)	fucose	COID275575	CHAPTER 3	arg1
1a8d88f3310d090976957f72a1baf495	chapter_3_2	978-1-4987-6285-4	a greater than 10-fold higher ADCC activity	activity	a greater than 10-fold higher ADCC activity	clinical outcomes	ADCC	COID386333	CHAPTER 3	arg1
73fd8d456857a3452bde36446c66fe95	chapter_4	978-1-4987-6285-4	A process parameter that does not impact a CQA but may affect process consistency	parameter	A process parameter	process parameters or process control	process parameter	COID163282	CHAPTER 4	arg0
3e8bbfe1f841d9313d19d92587855368	chapter_4	978-1-4987-6285-4	a CQA	CQA	a CQA	product quality attributes	CQA	COID162607	CHAPTER 4	arg1
e10ae44f1c485bdb039841bf0b6fc16a	11150551		sodium butyrate	butyrate	sodium butyrate	secondary raw materials	butyrate	COID702790	ABSTRACT	arg0
86d12d1ce4d4a52a40fdc0d51640eef2	11150551		glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
06e8ad42399c577ee98e975ccddbd5c8	11150551		the presence of butyrate	presence	the presence	secondary raw materials	butyrate	COID702790	ABSTRACT	arg0
2e79b20dc548fe9e6710955b57784a92	11150551		The glycoform profile of each antibody produced	antibody	each antibody	product attributes	glycoform profile	COID912805	ABSTRACT	arg1
8b8b800f07527d9a7e5751f86e56bdec	24326352		the glycosylation patterns of monomeric, dimeric, and large aggregated forms of the antibody	patterns	the glycosylation patterns	product attributes	glycosylation patterns	COID857544	ABSTRACT	arg0
555852c7b07c74468f28f16817c3aa9b	24326352		monomeric, dimeric, and large aggregated forms of the antibody	forms	monomeric, dimeric, and large aggregated forms	product quality attributes	large aggregated	COID879651	ABSTRACT	arg1
0425cff798d3b7d53e5a46a1f3e6835d	25931375		addition of up to 40 mM galactose	addition	addition	sugar (subset of carbon source)	galactose	COID770311	ABSTRACT	arg0
510fef5462addd077310737c647ef835	25931375		Cell culture performance	performance	Cell culture performance	product quality attributes	Cell culture performance	COID284912	ABSTRACT	arg1
c83ba7e1051d6d13eaa8ee7a588afc53	26587969		Glycation	Glycation	Glycation	glycosylation	Glycation	COID274291	ABSTRACT	arg0
5d9439e0096bd16f65105a300ee5547d	26587969		the historical bolus glucose feeding regimen	regimen	the historical bolus glucose feeding regimen	sugar (subset of carbon source)	glucose	COID367406	ABSTRACT	arg1
35ceb1e48538b195779dd938504d3ac5	26587969		the historical bolus glucose feeding regimen	regimen	the historical bolus glucose feeding regimen	process parameters or process control	bolus	COID693522	ABSTRACT	arg1
bef26a3bc1d92d39e67b4f03f5836d46	26587969		the historical bolus glucose feeding regimen	regimen	the historical bolus glucose feeding regimen	sugar (subset of carbon source)	glucose	COID367406	ABSTRACT	arg0
3991d25866d357b091dacc3ca83966dc	26587969		Glycation	Glycation	Glycation	glycosylation	Glycation	COID274291	ABSTRACT	arg1
9fd810a1625bf7e2aae3fed04860ef94	26587969		the historical bolus glucose feeding regimen	regimen	the historical bolus glucose feeding regimen	process parameters or process control	bolus	COID693522	ABSTRACT	arg0
29d9de4eb0214d2e3afd14ac990aeced	27453130		the process conditions	conditions	the process conditions	process condition	process conditions	COID106153	ABSTRACT	arg0
9c51b160d32379408e756d1318ef757e	27453130		Volumetric recombinant antibody yields	yields	Volumetric recombinant antibody yields	overall titer or batch yield	Volumetric recombinant antibody yields	COID088953	ABSTRACT	arg1
54748a6c0bf1f5b719f1b76e78583554	29673624		cell productivity (less than 10%)	productivity	cell productivity	process condition	productivity	COID731421	ABSTRACT	arg1
5efc91c1558db911a041e8c9b5e2b651	29885096		The use of disposable vessels to minimize stainless steel surface exposure to the cell culture	use	The use	vessel or process parameter or production scale	disposable vessels	COID795419	ABSTRACT	arg0
c7a5414edea008217053334c032abfe1	29885096		comparable terminal galactosylation levels to those measured in pilot and commercial bioreactors	levels	comparable terminal galactosylation levels	glycosylation	galactosylation	COID475750	ABSTRACT	arg1
cc9d388cc9aa7681a14a8ed65c4361e1	29923054		pCO2	pCO2	pCO2	process condition	pCO2	COID255565	ABSTRACT	arg0
81e93a3446b566bb871c51abf8a843b1	29923054		the monoclonal antibody (mAb) N-glycosylation profile in Chinese hamster ovary (CHO) cell culture	profile	the monoclonal antibody (mAb) N-glycosylation profile	product attributes	N-glycosylation profile	COID683283	ABSTRACT	arg1
3d78aacf2ee3545ed462886e29995609	23172735	PMC4226405	siRNA transfection into cells grown in shake flasks	transfection	siRNA transfection	NYK	siRNA	COID416464	RESULTS	arg0
ebf707f1af7ecfc49bb2b903c7160574	23172735	PMC4226405	cell growth characteristics	characteristics	cell growth characteristics	cell culture parameters	cell growth	COID093598	RESULTS	arg1
829ac5b92924dbefe0bfd44f8dae7133	23172735	PMC4226405	protein productivity	productivity	protein productivity	process condition	productivity	COID731421	RESULTS	arg1
a8ff90b2ae20d4419039301322e63363	23172735	PMC4226405	siRNA addition	addition	siRNA addition	NYK	siRNA	COID416464	RESULTS	arg0
c7431ec9bd7d30bd879c547e9b192088	23172735	PMC4226405	growth	growth	growth	cell culture parameters	growth	COID203666	RESULTS	arg1
aa37433be9033d8e80a54a8f8833212c	25042542	PMC4282109	A selective Cdk4/6 inhibitor	inhibitor	A selective Cdk4/6 inhibitor	secondary raw materials	inhibitor	COID760391	RESULTS	arg0
5c3b8ccdbba6b5b18fd44e1321a7550a	25042542	PMC4282109	other phases of the cell cycle in which cells should continue to progress and eventually decline in number	phases	other phases	biological process	cell cycle	COID780295	RESULTS	arg1
cf29b83e649c5cac8d1f004857078473	25875452	PMC4622614	Fc glycan	glycan	Fc glycan	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg0
eede499c1be609d56002ad39a864beb9	25875452	PMC4622614	the basic and acidic variants	variants	the basic and acidic variants	acid (subset of secondary raw materials)	acidic variants	COID106814	RESULTS	arg1
908ec50c5fb1c44b2af33380a26bb5c8	25875452	PMC4622614	this increased galactosylation	galactosylation	this increased galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg0
4a45829a670a5cf4dd849b28f10e3043	25875452	PMC4622614	a higher sialylation	sialylation	a higher sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
d6f70b4a434b2491ec7b7d4bcd706bbe	27559765	PMC5098448	High-mannose type glycans	glycans	High-mannose type glycans	sugar (subset of carbon source)	High-mannose	COID981337	RESULTS	arg0
c2017185a7e92f2b3d2119ae02b3fb8e	27559765	PMC5098448	a satisfactory explanation for the observed behavior of our charge variants in the CDC assay	explanation	a satisfactory explanation	product quality profile	charge variants	COID817650	RESULTS	arg1
037da5b6ca8e6f63754eb773513ad55c	27559765	PMC5098448	High-mannose type glycans	glycans	High-mannose type glycans	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg0
b16d2c7d1483afec446370a7b8ff0a1e	27752770	PMC5274649	All fermentation runs at pH 6.8	runs	All fermentation runs	bioreactor conditions	pH	COID893209	RESULTS	arg0
0b586eb92a20c0a419dd685ac854dcac	27752770	PMC5274649	no significant ammonia consumption	consumption	no significant ammonia consumption	by-product or waste	ammonia	COID714278	RESULTS	arg1
c9bd91d1f744a82e301ecaa29d94cd3d	29511312	PMC5840386	maltose metabolism	metabolism	maltose metabolism	biological process	metabolism	COID291079	RESULTS	arg0
2f7d6bb8e08659efda3600571fb2dac3	29511312	PMC5840386	maltose metabolism	metabolism	maltose metabolism	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
dd1a0eb34b0cccf90d4117458d3c6a95	30552760	PMC6590254	a similar amount of the glucosidase inhibitor deoxynojirimycin (1.3 mM)	amount	a similar amount	enzyme inhibitor	glucosidase inhibitor deoxynojirimycin	COID003598	RESULTS	arg0
94d51d4af85044ac4a11268fce254cfe	30552760	PMC6590254	mAb1 glycosylation	glycosylation	mAb1 glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
b9db521e29738ac5badfa468dadd15ad	30552760	PMC6590254	mAb1 glycosylation	glycosylation	mAb1 glycosylation	monoclonal antibody	mAb1	COID268135	RESULTS	arg1
f8b54284bb792251a498c0bf16174486	30552760	PMC6590254	the cultivation mode	mode	the cultivation mode	media characteristics	cultivation mode	COID699462	RESULTS	arg0
6393dfb3c66a9978ce6b9e8257e8f9d8	30552760	PMC6590254	the increase seen for CuCl2	increase	the increase	trace metals or minerals (subset of secondary raw materials)	CuCl2	COID901856	RESULTS	arg0
47d553eff93265d65b7594ca75b45d01	30552760	PMC6590254	Qp	Qp	Qp	flux rate	Qp	COID599783	RESULTS	arg1
1c1802adc2738b672d8fd1528ca6f9c2	30552760	PMC6590254	the cultivation conditions	conditions	the cultivation conditions	media characteristics	cultivation conditions	COID699462	RESULTS	arg0
fbfa686411bebce2dc65ec1a5c353d24	30552760	PMC6590254	total fucosylation	fucosylation	total fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg1
18f52ea916a9cc7ba52c12821076d654	30552760	PMC6590254	Mannostatin A (0.1 mM in feed)	A	Mannostatin A	NYK	Mannostatin A	COID631700	RESULTS	arg0
35f0657f673dcfa7fae609f7adbc0039	30552760	PMC6590254	glycosylation	glycosylation	glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
4f06e0c32e2d7dcd0f7596c2c732ef8b	31425633	PMC7003473	a second supplementation event (amino acid blend A + B) that occurred 50+ hours after the first amino acid supplementation	event	a second supplementation event	secondary raw materials	supplementation	COID566710	RESULTS	arg0
3bfd45807f5d9498b26ce8354307c46c	31425633	PMC7003473	This combination of amino acids	combination	This combination	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg1
32ca7397f802d2f836039130058b0721	31425633	PMC7003473	VCD growth	growth	VCD growth	cell culture parameters	growth	COID203666	RESULTS	arg1
7f49159e4ff87b3ddda940f93a7a5b77	31425633	PMC7003473	VCD growth	growth	VCD growth	cell culture parameters	VCD	COID384695	RESULTS	arg1
28f6af02f732474a4524d5d8a3025a5f	31544815	PMC6640710	The applied DMSO concentration	concentration	The applied DMSO concentration	NYK	DMSO	COID418525	RESULTS	arg0
aa7a25202c6e8419f2f05474ffcf0689	31544815	PMC6640710	no detectable changes of the glycosylation pattern compared to the control (Table 1)	changes	no detectable changes	product attributes	glycosylation pattern	COID857544	RESULTS	arg1
4c5e2c7ba2b9529392bf856bc6ca7df2	33738790	PMC8453549	concentrations up to 4.6 g/L lactate on Day 7	concentrations	concentrations	by-product or waste	lactate	COID250920	RESULTS	arg0
85913920787471bb672ede8bfd455622	33738790	PMC8453549	VCD	VCD	VCD	cell culture parameters	VCD	COID384695	RESULTS	arg1
0217fb514d5576930558e3a350855f98	33738790	PMC8453549	viability	viability	viability	process parameters or process control	viability	COID222142	RESULTS	arg1
f5ef14f9720cfa850d357c786d81c185	33742789	PMC8459231	Detected terminal sialylation	sialylation	Detected terminal sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
3893750a61042100338300d59d4fa9aa	34575094	PMC8469772	the CHO cells	cells	the CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	RESULTS	arg0
c33f9249d3b43fd7fb0dba9a9f0e7fda	34575094	PMC8469772	many metabolic byproducts	byproducts	many metabolic byproducts	by-product or waste	metabolic byproducts	COID531384	RESULTS	arg1
2eeff8197cdd91a2d83e199c46bd6346	35087805	PMC8786911	mAbs	mAbs	mAbs	monoclonal antibody	mAbs	COID242255	RESULTS	arg0
46723f6f6698ac61d1c2612f7eb00840	35087805	PMC8786911	The higher levels of sialylation observed in VRC01	levels	The higher levels	glycosylation	sialylation	COID543327	RESULTS	arg1
ab06d997ae40ef5dc48c7db3c4247555	35441833	PMC9542549	the buffering capacity of the media, which inherently makes it more difficult to maintain a stable pH set point	capacity	the buffering capacity	media characteristics	media	COID913636	RESULTS	arg0
c4aa01980147ed817739aa419ac031c9	35441833	PMC9542549	the DOT control system	system	the DOT control system	NYK	DOT	COID003597	RESULTS	arg1
85e34629a8a3c82b25ed68e7b760d630	35441833	PMC9542549	the buffering capacity of the media, which inherently makes it more difficult to maintain a stable pH set point	capacity	the buffering capacity	bioreactor conditions	pH	COID893209	RESULTS	arg0
889e22c4272e8930a192f4f50ca37410	37731040	PMC10511539	the cell growth	growth	the cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
fef2a204b25a86ce3350b339d38e37e2	chapter_1	978-1-4987-6285-4	the bioreactor to increase the cell concentration	bioreactor	the bioreactor	vessel or process parameter or production scale	bioreactor	COID345693	CHAPTER 1	arg0
124bc7a8e165101673ff3e6c63f56d6e	chapter_1	978-1-4987-6285-4	the cell concentration	concentration	the cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 1	arg1
88520db9f96af711e6a69b9db4b39d02	chapter_1	978-1-4987-6285-4	The addition of medium	addition	The addition	media characteristics	medium	COID921897	CHAPTER 1	arg0
063c8c93226e00ec9faebdcba7a2d19b	chapter_1	978-1-4987-6285-4	the osmolality of the culture broth	osmolality	the osmolality	process parameters or process control	osmolality	COID710653	CHAPTER 1	arg1
b62336a487bb0666dd0b848d3d4edf4a	chapter_1	978-1-4987-6285-4	A higher content of sialic acid on erythropoietin and many other proteins	content	A higher content	sugar (subset of carbon source)	sialic acid	COID148212	CHAPTER 1	arg0
f0dc0fdc5082b3974f641ba901adaffc	chapter_1	978-1-4987-6285-4	the circulation half-life of those proteins	half-life	the circulation half-life	process parameters or process control	half-life	COID125212	CHAPTER 1	arg1
ce82bb58e9c5500225d32c82604beb05	chapter_1	978-1-4987-6285-4	high mannose content	content	high mannose content	sugar (subset of carbon source)	high mannose	COID981337	CHAPTER 1	arg1
6b031790c787907959daf3e5fdf9e6b8	chapter_11	978-1-4987-6285-4	small reactors with a low oxygen demand â¢ Sparging -Gas holdup in the reactor	reactors	small reactors	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 11	arg0
6d47251eac5d1cf7c3893d88250968ad	chapter_11	978-1-4987-6285-4	bubble-free aeration -Only used in small reactors with a low oxygen demand â¢ Sparging -Gas holdup in the reactor	aeration	bubble-free aeration	bioreactor conditions	aeration	COID371755	CHAPTER 11	arg1
af6ea9b642cf2a6753f65bc4d96d2533	chapter_12	978-1-4987-6285-4	oxygen transfer capacity needed for a high process productivity	capacity	oxygen transfer capacity	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 12	arg0
f2ab22606ffcfe156958b24fae3414fa	chapter_12	978-1-4987-6285-4	a high process productivity	productivity	a high process productivity	process condition	productivity	COID731421	CHAPTER 12	arg1
bad470c1aa00bec8b7ad3ebc85f414db	chapter_12	978-1-4987-6285-4	a high process productivity	productivity	a high process productivity	process condition	productivity	COID731421	CHAPTER 12	arg0
009a32791f7c88a6c080e7277a70d417	chapter_12	978-1-4987-6285-4	oxygen transfer capacity needed for a high process productivity	capacity	oxygen transfer capacity	gases (subset of secondary raw materials)	oxygen	COID472476	CHAPTER 12	arg1
85cdf62ecd30a1f388f3e3d4f015db68	chapter_12	978-1-4987-6285-4	scale (Eq	scale	scale	vessel or process parameter or production scale	scale	COID586187	CHAPTER 12	arg0
f6353d251dc25ee5dba51ebdc182eb1d	chapter_12	978-1-4987-6285-4	mixing time	time	mixing time	process parameters or process control	time	COID742277	CHAPTER 12	arg1
15aea1d761111c96a1bd16683db5ca81	chapter_12	978-1-4987-6285-4	The greater height of the large-scale reactor	height	The greater height	vessel or process parameter or production scale	scale	COID586187	CHAPTER 12	arg0
891211bf019d38dd20d89919db508859	chapter_12	978-1-4987-6285-4	the travel time for air bubbles reaching the top of the reactor	time	the travel time	process parameters or process control	time	COID742277	CHAPTER 12	arg1
891ca6ff5afaafc013ef52e2a3c327ff	chapter_2	978-1-4987-6285-4	The addition of glycan to the protein	addition	The addition	sugar (subset of carbon source)	glycan	COID626759	CHAPTER 2	arg0
e203772aa4b5d3ec5d50fb2ac82c3896	chapter_2	978-1-4987-6285-4	its stability in a soluble form	stability	its stability	process condition	stability	COID548988	CHAPTER 2	arg1
bc307d620815db242e53a3dfc22a24d1	chapter_3_1	978-1-4987-6285-4	isomerization to fructose 6-phosphate (F6P)	isomerization	isomerization	carbon source (subset of secondary raw materials)	fructose	COID532749	CHAPTER 3	arg0
c7cb879a50f4b4d33305039241b3d991	chapter_3_1	978-1-4987-6285-4	the second The three runs with high product titers (dark gray) and low product titers (light gray)	runs	The three runs	overall titer or batch yield	product titers	COID382077	CHAPTER 3	arg1
b1a38fbb6e482bbe3669c1f5334ccdfa	chapter_3_1	978-1-4987-6285-4	glucose at low levels to reduce glycolysis flux and thereby reduce lactate flux	glucose	glucose	sugar (subset of carbon source)	glucose	COID367406	CHAPTER 3	arg0
76d2544010d18f741f1b5bfa1ccfe65f	chapter_3_1	978-1-4987-6285-4	glycolysis flux	flux	glycolysis flux	metabolic pathways	glycolysis	COID345655	CHAPTER 3	arg1
0c42ebc593dff5d57d64d9d33e1f275d	chapter_3_1	978-1-4987-6285-4	some bioprocess fed-batch cultures	cultures	some bioprocess fed-batch cultures	process mode	fed-batch	COID529446	CHAPTER 3	arg0
c270118f56a67af30f61a57ab22fcda0	chapter_3_1	978-1-4987-6285-4	the lactate consumption seen in the late culture stage (when lactate accumulates to high levels) in some bioprocess fed-batch cultures	consumption	the lactate consumption	by-product or waste	lactate	COID250920	CHAPTER 3	arg1
279e2292149dbff52d46ae526dbfb525	chapter_3_1	978-1-4987-6285-4	the reduction of glycolysis flux at high lactate levels	reduction	the reduction	metabolic pathways	glycolysis	COID345655	CHAPTER 3	arg1
7d1e5c5644b551805054bb609188f981	chapter_3_1	978-1-4987-6285-4	a characteristic which may facilitate the reduction of glycolysis flux at high lactate levels	characteristic	a characteristic	metabolic pathways	glycolysis	COID345655	CHAPTER 3	arg0
570a86cc99feb9ed2c757745c6cdc130	chapter_3_1	978-1-4987-6285-4	the reduction of glycolysis flux at high lactate levels	reduction	the reduction	by-product or waste	lactate	COID250920	CHAPTER 3	arg1
c55153cc20742ddbb631e15da630c48a	chapter_3_1	978-1-4987-6285-4	a characteristic which may facilitate the reduction of glycolysis flux at high lactate levels	characteristic	a characteristic	by-product or waste	lactate	COID250920	CHAPTER 3	arg0
5061db5ac963aace4a1b4006d2c7d5a3	chapter_3_2	978-1-4987-6285-4	Glycans that are not trimmed and still have 5 or more mannose residues	Glycans	Glycans	sugar (subset of carbon source)	Glycans	COID626759	CHAPTER 3	arg0
28b2ca72840d6e70547caeec6d2867d0	chapter_3_2	978-1-4987-6285-4	5 or more mannose residues	residues	5 or more mannose residues	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg1
67ebca3088e51a8091ab339b8c36b804	chapter_3_2	978-1-4987-6285-4	a greater than 10-fold higher ADCC activity	activity	a greater than 10-fold higher ADCC activity	clinical outcomes	ADCC	COID386333	CHAPTER 3	arg0
278bc633385304c1e41961ea18f7bba1	chapter_3_2	978-1-4987-6285-4	IgG molecules that do not have a fucose on their mannose core	molecules	IgG molecules	antibody	IgG	COID713543	CHAPTER 3	arg1
a2a5c2062ded778125d696ca81099cef	chapter_3_2	978-1-4987-6285-4	Higher sialic acid content on erythropoietin (EPO)	content	Higher sialic acid content	sugar (subset of carbon source)	sialic acid	COID148212	CHAPTER 3	arg0
566cba0001dbc8de358e8d51e0c53d98	chapter_3_2	978-1-4987-6285-4	its circulation half-life	half-life	its circulation half-life	process parameters or process control	half-life	COID125212	CHAPTER 3	arg1
d12e1bf97cc5ee4a5ccbc9df8f846d45	chapter_3_2	978-1-4987-6285-4	The terminal receiving mannose	mannose	The terminal receiving mannose	sugar (subset of carbon source)	mannose	COID906305	CHAPTER 3	arg0
42acaffc61d821fc3c39a31f1162dcb1	chapter_3_2	978-1-4987-6285-4	a pair of which (carbon 2 and carbon 4, or carbon 2 and carbon 6) can be extended by the addition of a GlcNAc	pair	a pair	sugar (subset of carbon source)	GlcNAc	COID510815	CHAPTER 3	arg1
00b772c6ee1d5ed530511704628bb2c2	chapter_3_2	978-1-4987-6285-4	Lactate consumption in the late stage of culture	consumption	Lactate consumption	by-product or waste	Lactate	COID250920	CHAPTER 3	arg0
09b094a9921e8bd35ce39b5c616fe840	chapter_3_2	978-1-4987-6285-4	a high productivity	productivity	a high productivity	process condition	productivity	COID731421	CHAPTER 3	arg1
e541175729742c893f11abc9edb3db79	chapter_4	978-1-4987-6285-4	ADCC	ADCC	ADCC	clinical outcomes	ADCC	COID386333	CHAPTER 4	arg1
62b467166a0b6cf61ad9235607b4c0fd	chapter_4	978-1-4987-6285-4	complement-dependent cytotoxicity (CDC)	cytotoxicity	complement-dependent cytotoxicity	clinical outcomes	complement-dependent cytotoxicity	COID455860	CHAPTER 4	arg1
fdc92eb2d0dc3be58bee4f25f61c3bf6	chapter_4	978-1-4987-6285-4	CDC	CDC	CDC	clinical outcomes	CDC	COID455860	CHAPTER 4	arg1
812cfa3dd50f53a8f11afcc639d432c2	chapter_4	978-1-4987-6285-4	antibody-dependent cellular cytotoxicity (ADCC)	cytotoxicity	antibody-dependent cellular cytotoxicity	clinical outcomes	antibody-dependent cellular cytotoxicity	COID386333	CHAPTER 4	arg1
48ce61c2bc94345fa74f0258a7dd4210	chapter_5	978-1-4987-6285-4	culture time	time	culture time	process parameters or process control	culture time	COID763032	CHAPTER 5	arg0
d3b861cac181ff1c134e3085a00713f5	chapter_5	978-1-4987-6285-4	the osmolality	osmolality	the osmolality	process parameters or process control	osmolality	COID710653	CHAPTER 5	arg1
f59e419839f6418c7522d7bd565dd0d7	chapter_6	978-1-4987-6285-4	9 The afucosylated form of IgG	form	9 The afucosylated form	antibody	IgG	COID713543	CHAPTER 6	arg0
da8ebbd5e850371f24e8421cf82adac7	chapter_6	978-1-4987-6285-4	antibody-dependent cellular cytotoxicity	cytotoxicity	antibody-dependent cellular cytotoxicity	clinical outcomes	antibody-dependent cellular cytotoxicity	COID386333	CHAPTER 6	arg1
55f2cf92f16fdbcf5dceed82d145daf2	chapter_6	978-1-4987-6285-4	A n ideal production cell line	line	A n ideal production cell line	cell line	cell line	COID702829	CHAPTER 6	arg0
abd78b75f24d0b8d3af8ffe73e5f2818	chapter_6	978-1-4987-6285-4	a high productivity	productivity	a high productivity	process condition	productivity	COID731421	CHAPTER 6	arg1
9d417ba24b873ade8c098e827d932f43	chapter_7	978-1-4987-6285-4	the medium to reduce cell aggregation and adhesion to surfaces and facilitate the adaptation to suspension growth	medium	the medium to reduce cell aggregation and adhesion to surfaces and facilitate the adaptation to suspension growth	cell culture parameters	growth	COID203666	CHAPTER 7	arg0
d91cb844621e500dd0935eb7e37a6c2e	chapter_7	978-1-4987-6285-4	cell aggregation	aggregation	cell aggregation	process condition	aggregation	COID720685	CHAPTER 7	arg1
ab41051f560c88eab87315d76538905c	chapter_7	978-1-4987-6285-4	the medium to reduce cell aggregation and adhesion to surfaces and facilitate the adaptation to suspension growth	medium	the medium to reduce cell aggregation and adhesion to surfaces and facilitate the adaptation to suspension growth	media characteristics	medium	COID921897	CHAPTER 7	arg0
cc7e14be63d759a208fef28d19a287f1	chapter_7	978-1-4987-6285-4	a substantially lower growth rate	rate	a substantially lower growth rate	cell culture parameters	growth rate	COID957002	CHAPTER 7	arg0
da718d2c8f3f92976297236961abe283	chapter_7	978-1-4987-6285-4	only a basal medium supplemented with a few non-protein compounds (thus a protein-free medium), but at a substantially lower growth rate	medium	only a basal medium	media characteristics	medium	COID921897	CHAPTER 7	arg1
0cc9060484b44e8b23342b378beff798	chapter_7	978-1-4987-6285-4	DMEM (which has higher nutrient levels and supports higher cell concentration)	DMEM	DMEM	media	DMEM	COID880081	CHAPTER 7	arg0
eaa8c60864d6466a1600356e4322ec6f	chapter_7	978-1-4987-6285-4	higher nutrient levels	levels	higher nutrient levels	secondary raw materials	nutrient	COID423902	CHAPTER 7	arg1
3337d014c0febc3a730a1719e44162bd	chapter_7	978-1-4987-6285-4	the employment of these industrial media	employment	the employment	media characteristics	media	COID913636	CHAPTER 7	arg0
efefdffd313e1de592c2d8e75b13d473	chapter_7	978-1-4987-6285-4	the high cell density	density	the high cell density	cell culture parameters	high cell density	COID283414	CHAPTER 7	arg1
f658b3f61564d5d33e28d027bcefeef8	chapter_7	978-1-4987-6285-4	media	media	Nowadays, most industrial media	media characteristics	media	COID913636	CHAPTER 7	arg0
d9b1d90e231366ff235d618b6738f1fa	chapter_7	978-1-4987-6285-4	higher levels of nutritional components, including amino acids, other organics, and a small number of salts (such as phosphate and magnesium, which will be discussed later), in order to meet the stoichiometric needs of generating more biomass	levels	higher levels	amino acid (subset of substrates)	amino acids	COID693703	CHAPTER 7	arg1
45af318fbfcc92aa30d97a07aab389bd	chapter_8	978-1-4987-6285-4	large amounts of lactate, ammonium, and other metabolites that inhibited cell growth	amounts	large amounts	culture condition	ammonium	COID714150	CHAPTER 8	arg0
d80de144d6b3406aa2da198f8805a275	chapter_8	978-1-4987-6285-4	cell growth	growth	cell growth	cell culture parameters	cell growth	COID093598	CHAPTER 8	arg1
0883c8a00cee7828b30633e6fb67908a	chapter_8	978-1-4987-6285-4	large amounts of lactate, ammonium, and other metabolites that inhibited cell growth	amounts	large amounts	by-product or waste	lactate	COID250920	CHAPTER 8	arg0
c0c3bbb686222a50c7bfffc80dc8d168	chapter_9	978-1-4987-6285-4	common practice to decrease the operating temperature after a period of rapid growth in fed-batch culture	practice	common practice	cell culture parameters	growth	COID203666	CHAPTER 9	arg0
d9b8e92c1461f0b7b407c6ed518d36fc	chapter_9	978-1-4987-6285-4	the operating temperature	temperature	the operating temperature	bioreactor conditions	temperature	COID692615	CHAPTER 9	arg1
30f9db95f4d9b00d8fff8e177f11e3e7	chapter_9	978-1-4987-6285-4	The initial level of nutrients in cell culture processes	level	The initial level	secondary raw materials	nutrients	COID423902	CHAPTER 9	arg0
d074ec1e089dc401986f6f25802c2329	chapter_9	978-1-4987-6285-4	cell culture processes	processes	cell culture processes	cell culture parameters	cell culture	COID293414	CHAPTER 9	arg1
a827b3edb75e98f05e0a864d3f61a396	chapter_9	978-1-4987-6285-4	a highly concentrated feed medium	medium	a highly concentrated feed medium	media characteristics	medium	COID921897	CHAPTER 9	arg0
ba23ea51ed95146e2148b9b46ccaf65b	chapter_9	978-1-4987-6285-4	the amount of nutrients that can be delivered using a fixed volume of feed	amount	the amount	secondary raw materials	nutrients	COID423902	CHAPTER 9	arg1
0ee0e8c540b6b49bad39eb712833cc3e	chapter_9	978-1-4987-6285-4	Higher osmolality in the production stage	osmolality	Higher osmolality	process parameters or process control	osmolality	COID710653	CHAPTER 9	arg0
57607a35e7df4d43d4a9040ad56ea426	chapter_9	978-1-4987-6285-4	The additional nutrient supply	supply	The additional nutrient supply	secondary raw materials	nutrient	COID423902	CHAPTER 9	arg0
6e03fc4040e3667de1476b7405f30a22	chapter_9	978-1-4987-6285-4	the cell concentration	concentration	the cell concentration	process parameters or process control	cell concentration	COID623648	CHAPTER 9	arg1
d055b1041efeae04075a468c6d614335	11150551		butyrate	butyrate	butyrate	secondary raw materials	butyrate	COID702790	ABSTRACT	arg0
dcd35193f514e3539006cfdcdb117bb9	11150551		biological activity	activity	biological activity	clinical outcomes	biological activity	COID518861	ABSTRACT	arg1
e125ba0cf054e74a4d93ea99ef280a7f	15593097		very low glutamine (<0.1 mM) or glucose (<0.70 mM) concentrations	concentrations	very low glutamine (<0.1 mM) or glucose (<0.70 mM) concentrations	amino acid (subset of substrates)	glutamine	COID962935	ABSTRACT	arg0
1153c36057acfe881ce827f3cb8fd34b	15593097		decreased sialylation	sialylation	decreased sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
a7c879597d6807b904135a3d90da1a62	15593097		very low glutamine (<0.1 mM) or glucose (<0.70 mM) concentrations	concentrations	very low glutamine (<0.1 mM) or glucose (<0.70 mM) concentrations	sugar (subset of carbon source)	glucose	COID367406	ABSTRACT	arg0
15bc380f46a7d238a038c5413ee4a41e	15593097		increased presence of minor glycan species consisting of hybrid and high-mannose types	presence	increased presence	sugar (subset of carbon source)	glycan	COID626759	ABSTRACT	arg1
0d236fb61b71f3734fbf6f58c8abae2c	15593097		increased presence of minor glycan species consisting of hybrid and high-mannose types	presence	increased presence	sugar (subset of carbon source)	high-mannose	COID981337	ABSTRACT	arg1
a8644bed582dfce84e0b1c2093c6e944	15593097		IFN-gamma purified at low culture viability	IFN-gamma	IFN-gamma	process parameters or process control	culture viability	COID640988	ABSTRACT	arg0
fcd1dfdd4e40f4459d8d3d9c9be645de	15593097		both lower sialylation as well as glycans of lower molecular masses, which can be attributed to extensive degradation by intracellular glycosidases released by cytolysis	glycans	glycans	sugar (subset of carbon source)	glycans of lower molecular masses	COID129671	ABSTRACT	arg1
5ec66b4586a983f655ec76f989f2a5d3	15593097		both lower sialylation as well as glycans of lower molecular masses, which can be attributed to extensive degradation by intracellular glycosidases released by cytolysis	sialylation	both lower sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
80b65cba069ead20f970d04b15cb07aa	15903239		samples isolated from repeated fed-batch cultures	samples	samples	process mode	fed-batch	COID529446	ABSTRACT	arg0
57c2b458b4abbda610608738b83c590e	15903239		extent of sialylation	extent	extent	glycosylation	sialylation	COID543327	ABSTRACT	arg1
d1e2bbada607f21834af93211468da43	15903239		relative glycan content	content	relative glycan content	product attributes	relative glycan content	COID604263	ABSTRACT	arg1
f079a88ed19438cd9186abb54301a80a	16609957		remaining synthesis of GDP-fucose via de novo pathway for the CHO line and the elevation of FUT8 expression by the YB2/0 cells	synthesis	remaining synthesis	genotype	FUT8 expression	COID939656	ABSTRACT	arg0
4028b3505d8b9c37cac9307b3dfc5c93	20639190		an increased efficacy of anti-tumor activity	efficacy	an increased efficacy	clinical outcomes	anti-tumor activity	COID117042	ABSTRACT	arg1
0f63fbba0d57eaa4474e8bc76cdfb89e	22699308		Antibodies bearing high levels of N-linked mannose-5 glycan (Man5)	Antibodies	Antibodies	sugar (subset of carbon source)	N-linked mannose-5 glycan	COID568402	ABSTRACT	arg0
7f2ee08b8b59618d182a977746c01126	22699308		enhanced antibody-dependent cell-mediated cytotoxicity (ADCC)	cytotoxicity	antibody-dependent cell-mediated cytotoxicity	clinical outcomes	antibody-dependent cell-mediated cytotoxicity	COID386333	ABSTRACT	arg1
86d4f20b0ce69b72958b79edc120e3bf	22699308		Antibodies bearing high levels of N-linked mannose-5 glycan (Man5)	Antibodies	Antibodies	sugar (subset of carbon source)	Man5	COID568402	ABSTRACT	arg0
d69c28acd420b2c9bfd0f04db31eb5a4	22699308		ADCC	ADCC	ADCC	clinical outcomes	ADCC	COID386333	ABSTRACT	arg1
4eff0f24f34a7d5c26530ed56c1f7ddb	22699308		the antibodies bearing the high mannose glycoform	antibodies	the antibodies	antibody	antibodies	COID278523	ABSTRACT	arg1
a56aa41dd551304e4f601f9b8fb6e2f0	24315529		the aggregates	aggregates	the aggregates	product quality attributes	aggregates	COID879651	ABSTRACT	arg0
80590689beaf3f36664006693ad52d20	24315529		the potential risks posed by the aggregates, such as an unexpected immune response	risks	the potential risks	clinical outcomes	unexpected immune response	COID806124	ABSTRACT	arg1
249d77e09d17a75becfa52613411e863	24315529		the addition of trehalose to recombinant CHO cell cultures	addition	the addition	disaccharides (subset of carbon source)	trehalose	COID264187	ABSTRACT	arg0
b71616bfdabdcc77ce8fc2ee9bbfe1e7	24315529		quality improvement in the production of therapeutic antibodies	improvement	quality improvement	product quality attributes	quality	COID109463	ABSTRACT	arg1
43d76368408926193f9fd9aea4514039	24692242		new CD platform	CD platform	CD platform	process condition	CD platform	COID720695	ABSTRACT	arg0
3d0cda175c48632c0a57e6272e16d39f	24692242		G0F percentages	G0F	G0F	sugar (subset of carbon source)	G0F	COID847830	ABSTRACT	arg1
d64f4e24f8d26f2fb8f61bb3ca070839	24692242		G1F and G2F were observed	G1F	G1F	sugar (subset of carbon source)	G1F	COID847930	ABSTRACT	arg1
b891dfd1e61a0e09253b58d6db757f13	24692242		G1F and G2F were observed	G2F	G2F	sugar (subset of carbon source)	G2F	COID847130	ABSTRACT	arg1
5547aa569253ca887c602aa904df1e0d	24728980		the relative abundance of M51	abundance	the relative abundance	product quality attributes	M51	COID088024	ABSTRACT	arg1
450394886d2650686d25e06c3399013a	24911584		restoration of GnT I	restoration	restoration	enzyme	GnT I	COID947151	ABSTRACT	arg0
1212f57998439aee6fc22f3411a52be2	24911584		the sialylation of a model glycoprotein, erythropoietin, produced in CHO-gmt4 cells	sialylation	the sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
240914775de266938b54093ee2f0f9ef	24911584		CHO-gmt4 cells	cells	CHO-gmt4 cells	chinese hamster ovary (CHO)	CHO-gmt4 cells	COID585656	ABSTRACT	arg0
60e9a6d0bca38435513a27afbd2024f1	24911584		glycoproteins with mannose-terminated N-glycans	glycoproteins	glycoproteins	sugar (subset of carbon source)	mannose-terminated N-glycans	COID789192	ABSTRACT	arg1
e14aa04d4ab2b172ec75a28d0a45ecb7	25014402		cultures started with higher initial glutamine levels	cultures	cultures	amino acid (subset of substrates)	glutamine	COID962935	ABSTRACT	arg1
4a8dc5d2aab190fd842f68a305dc535f	25014402		cultures started with higher initial glutamine levels	cultures	cultures	amino acid (subset of substrates)	glutamine	COID962935	ABSTRACT	arg0
ae6347cbf06c320ebb968f05d0785cf9	25014402		GI and SI levels	levels	GI and SI levels	product attributes	GI	COID293764	ABSTRACT	arg1
df471c0683361b6fdf02be9e7793435e	25014402		GI and SI levels	levels	GI and SI levels	product attributes	SI	COID283454	ABSTRACT	arg1
119f4e6ba35988401be743654e419789	25931375		Addition of 20 mM galactose to the bioreactor	Addition	Addition	sugar (subset of carbon source)	galactose	COID770311	ABSTRACT	arg0
2c3544e8a24dad1b16289a12345639fe	25931375		the increase of 44 % for total sialic acid content and 20.3 % for sialylated glycans	increase	the increase	sugar (subset of carbon source)	sialic acid	COID148212	ABSTRACT	arg1
a5a6e86645fc025aee03b46600469e81	25931375		the increase of 44 % for total sialic acid content and 20.3 % for sialylated glycans	increase	the increase	sugar (subset of carbon source)	sialylated glycans	COID113402	ABSTRACT	arg1
c2896a76ba503f522232b61598a80ad7	25931375		the lack of protein galactosylation	lack	the lack	glycosylation	galactosylation	COID475750	ABSTRACT	arg0
0e0e3841506a4c4f47b2739323f05410	25931375		the reduction of sialic acid content	reduction	the reduction	sugar (subset of carbon source)	sialic acid	COID148212	ABSTRACT	arg1
101da4f6fce060c797511215db570430	26222761		the addition of 20 mM galactose	addition	the addition	sugar (subset of carbon source)	galactose	COID770311	ABSTRACT	arg0
e20ddeb78504a2c184898369a0e77656	26222761		a reproducible increase of galactosylated IgG from 14% to 25%	increase	a reproducible increase	product quality profile	galactosylated IgG	COID983193	ABSTRACT	arg1
b3bb2d12adb2d24d8f0dc22c43f9481e	26654938		the S-sulfocysteine process	process	the S-sulfocysteine process	secondary raw materials	S-sulfocysteine	COID617511	ABSTRACT	arg0
8f2e2f18666d52a71ddfa29e5694150a	26654938		specific productivity	productivity	specific productivity	process condition	specific productivity	COID731421	ABSTRACT	arg1
f35a937bd6c5a46444bc1dafb296c17c	26654938		titer	titer	titer	overall titer or batch yield	titer	COID732378	ABSTRACT	arg1
02a5bf847c4ad13df69498fed7958dd7	26654938		titer	titer	titer	overall titer or batch yield	titer	COID732378	ABSTRACT	arg0
21b7dff758de663debd74b697638e688	26654938		the S-sulfocysteine process	process	the S-sulfocysteine process	secondary raw materials	S-sulfocysteine	COID617511	ABSTRACT	arg1
835a2505c11b8134cd8ee9c57b05d45e	26910040	PMC4947490	the decrease in cell respiration and in specific productivity	decrease	the decrease	process condition	specific productivity	COID731421	ABSTRACT	arg0
50f01407d711f744cf7713cff2e4740f	26910040	PMC4947490	high specific productivity	productivity	high specific productivity	process condition	specific productivity	COID731421	ABSTRACT	arg0
7c20d0e2bbc0475ab566e631430305ac	26910040	PMC4947490	An increase in high mannose content	increase	An increase	sugar (subset of carbon source)	high mannose	COID981337	ABSTRACT	arg1
6a67fcdf8d3e736949407b9c13244f43	27453130		the glucose consumption and lactate production rates	rates	the glucose consumption and lactate production rates	process parameters or process control	production rates	COID014362	ABSTRACT	arg0
5c959a2332fd99df29371f0902f6c702	27453130		pH-controlled bioreactors	bioreactors	pH-controlled bioreactors	vessel or process parameter or production scale	bioreactors	COID345693	ABSTRACT	arg1
82a8412376c9663f18323a42fcb4218d	27453130		pH-controlled bioreactors	bioreactors	pH-controlled bioreactors	bioreactor conditions	pH	COID893209	ABSTRACT	arg1
4b3a12f5977e4015346b723794bd014d	27453130		the glucose consumption and lactate production rates	rates	the glucose consumption and lactate production rates	sugar (subset of carbon source)	glucose	COID367406	ABSTRACT	arg0
c7e6635eba665bd4039b64dbdb3169ff	27453130		the glucose consumption and lactate production rates	rates	the glucose consumption and lactate production rates	by-product or waste	lactate	COID250920	ABSTRACT	arg0
496f13802e957c7c88956245122117b4	27453130		The cell density	density	The cell density	cell culture parameters	cell density	COID283414	ABSTRACT	arg0
8dfa77bbc2a06e8d90919409ab31e5ce	27453130		the OSRs	OSRs	the OSRs	vessel or process parameter or production scale	OSRs	COID030179	ABSTRACT	arg1
8f7b2aa30e5a7e83c3dfb07b50063ee7	27453130		the STRs	STRs	the STRs	vessel or process parameter or production scale	STRs	COID383436	ABSTRACT	arg1
01e8eee8df8a2e0322aaf4807d7f36e2	27453130		viability	viability	viability	process parameters or process control	viability	COID222142	ABSTRACT	arg0
de29bf0ab966baaaacf272b3b04ad4c7	27943633		glycoprofiling of IgG with four amino acid substitutions expressed from an Î±-2,3 sialyltransferase knockout-Î±-2,6 sialyltransferase stable clone	glycoprofiling	glycoprofiling	genotype	amino acid substitutions	COID828360	ABSTRACT	arg0
4931db863d00028a07c4e35fbe34f46a	27943633		more than 62% biantennary disialylated glycans	glycans	more than 62% biantennary disialylated glycans	sugar (subset of carbon source)	biantennary disialylated glycans	COID144537	ABSTRACT	arg1
2e7af4cd270c06be02197451757cda55	27943633		more than 77% sialylated glycans	glycans	more than 77% sialylated glycans	sugar (subset of carbon source)	sialylated glycans	COID113402	ABSTRACT	arg1
3d77c9c67c1999cd2b73792e4a2425f5	28409838		the production of a confined mAb N-linked glycosylation pattern	production	the production	product attributes	N-linked glycosylation pattern, mAb	COID545748	ABSTRACT	arg0
183f618ba192c77862b6c15e32e8575b	28409838		bioactivity	bioactivity	bioactivity	product quality attributes	bioactivity	COID046028	ABSTRACT	arg1
740364b53ee170a4b14f77a7e5973b01	28409838		the production of a confined mAb N-linked glycosylation pattern	production	the production	product attributes	N-linked glycosylation pattern	COID545748	ABSTRACT	arg0
42678730d8834f4104ddf0649a01076a	28409838		therapeutic efficacy	efficacy	therapeutic efficacy	clinical outcomes	therapeutic efficacy	COID151356	ABSTRACT	arg1
5188c3781da6cc5b8de441e0a6eac222	28409838		the supplementation of either galactose, or manganese as well as their synergy	supplementation	the supplementation	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	ABSTRACT	arg0
4eb79064cdde8cb074783a8a503a5c46	28409838		the proportion of complex forms	proportion	the proportion	process outcome	proportion of complex forms	COID157309	ABSTRACT	arg1
3e0deedffdf117a79b1562691a12b1ca	28409838		the supplementation of either galactose, or manganese as well as their synergy	supplementation	the supplementation	sugar (subset of carbon source)	galactose	COID770311	ABSTRACT	arg0
9f26ffdf3ac3c6b0f62dcf150aab8be6	28465212		raffinose	raffinose	raffinose	sugar (subset of carbon source)	raffinose	COID985703	ABSTRACT	arg0
e9c0c1b2f174cf4d9f64304f9a061800	28465212		mannose 5 glycans	glycans	mannose 5 glycans	sugar (subset of carbon source)	mannose 5 glycans	COID667485	ABSTRACT	arg1
5b47b4e554428d6557641178c51cd1fa	29704441		the addition of DCA to the cell culture	addition	the addition	secondary raw materials	DCA	COID715212	ABSTRACT	arg0
a57cc45cadec8ffa3c32e8a8ffd5a518	29704441		antibody titers	titers	antibody titers	overall titer or batch yield	antibody titers	COID307661	ABSTRACT	arg1
d99e9caed6d5ad336c0ff2f2c06c0e36	29885096		the 2-L glass bioreactor setup	setup	the 2-L glass bioreactor setup	vessel or process parameter or production scale	2-L glass bioreactor	COID536478	ABSTRACT	arg0
50815e1df0b9022f9e0e34d10dbdd6c0	29885096		higher overall levels of terminal galactosylation	levels	higher overall levels	glycosylation	galactosylation	COID475750	ABSTRACT	arg1
9d69344728667f024799009cac648681	29913209		These supplementations	supplementations	These supplementations	secondary raw materials	supplementations	COID566710	ABSTRACT	arg0
8ab1519cf80fe697afc8ca0b40f33e13	29913209		impact glycoform distributions	distributions	impact glycoform distributions	product quality profile	glycoform distributions	COID259199	ABSTRACT	arg1
1ab1f27475f7712f035a46c100d0ac5d	29913209		nucleotide-sugar intracellular pools	pools	nucleotide-sugar intracellular pools	nucleotide or nucleoside	nucleotide-sugar intracellular pools	COID982927	ABSTRACT	arg1
5e6ca7af12c4962081e258e1387f1c54	30088083		the increase in cultivating pH	increase	the increase	bioreactor conditions	cultivating pH	COID890185	ABSTRACT	arg0
5d4a137ca10428adf6ba03f0c300e282	30088083		cell-specific productivity	productivity	cell-specific productivity	process condition	cell-specific productivity	COID637897	ABSTRACT	arg1
14f2d16fa36c723a7e9771ceb8094c88	30088083		antibody galactosylation	galactosylation	antibody galactosylation	glycosylation	antibody galactosylation	COID740922	ABSTRACT	arg1
1416af89a04bcb1041578ce1a8d46edc	30088083		increased culture pH due to base addition	pH	increased culture pH	bioreactor conditions	culture pH	COID689332	ABSTRACT	arg0
638d4b5dfdc77b2c0adc6b6b24191839	30088083		Lactate production increase	production	Lactate production	by-product or waste	Lactate	COID250920	ABSTRACT	arg1
baf5e21f80afba392e6fb04a5b212239	30327978		Cobalt at 50 ÂµM concentration	Cobalt	Cobalt	trace metals or minerals (subset of secondary raw materials)	Cobalt	COID584412	ABSTRACT	arg0
32081fddeea217996c455986e8573cab	30327978		slight increase in G1F glycans (mono galactosylated)	increase	slight increase	sugar (subset of carbon source)	G1F glycans	COID847930	ABSTRACT	arg1
66f30a783020f9111cab319bdaa8aa6d	30327978		slight increase in G1F glycans (mono galactosylated)	increase	slight increase	sugar (subset of carbon source)	mono galactosylated	COID592818	ABSTRACT	arg1
3fff3b3995ed402d223219b5ac60bf57	30414355		time	time	time	process parameters or process control	time	COID742277	ABSTRACT	arg0
9c16843f103679e565a7e0f5a7cd80bf	30414355		The degree of galactosylation	degree	The degree	glycosylation	galactosylation	COID475750	ABSTRACT	arg1
676027d2691adc20b9b2f054cb8d0c01	30552760	PMC6590254	15 ÂµM kifunensine supplementation leading to an 85.8% increase in high-mannose containing species	supplementation	15 ÂµM kifunensine supplementation	secondary raw materials	kifunensine	COID287309	ABSTRACT	arg0
8e1208065e783cf32409c46c0e859832	30552760	PMC6590254	the highest impact on mannosylation	impact	the highest impact	glycosylation	mannosylation	COID543580	ABSTRACT	arg1
046dbd02aa6ec714f12612afe4d8c469	30552760	PMC6590254	15 ÂµM kifunensine supplementation	supplementation	15 ÂµM kifunensine supplementation	secondary raw materials	kifunensine	COID287309	ABSTRACT	arg0
41a2f863cea7a7fc31c55c0159bf0ea5	30552760	PMC6590254	an 85.8% increase in high-mannose containing species	increase	an 85.8% increase	sugar (subset of carbon source)	high-mannose	COID981337	ABSTRACT	arg1
3690409992693e58e0c57a9cd0cdb615	30554388		sodium chloride	chloride	sodium chloride	trace metals or minerals (subset of secondary raw materials)	sodium chloride	COID277511	ABSTRACT	arg0
f8090aef884bccf685afb28d7288b5c9	30554388		hyperosmolality induced by sodium chloride	hyperosmolality	hyperosmolality	process parameters or process control	hyperosmolality	COID710478	ABSTRACT	arg1
9673a4922301e897ac7d4e51badfdd84	30554388		the contents of non-glycosylation heavy chain (NGHC) and man5	contents	the contents	glycosylation	glycosylation	COID119643	ABSTRACT	arg0
8d75c9dbe5d7faaec92b580561a8e201	30554388		fed-batch cultures	cultures	fed-batch cultures	process mode	fed-batch	COID529446	ABSTRACT	arg1
59b41fb61c098cc5609d18ca7297677e	30554388		the contents of non-glycosylation heavy chain (NGHC) and man5	contents	the contents	sugar (subset of carbon source)	man5	COID568402	ABSTRACT	arg0
caaafd4b8b1b0903a3fc83aed0c3f943	30597531		manganese	manganese	manganese	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	ABSTRACT	arg0
4d576039e03fad52967c177326401ec4	30597531		The extent of afucosylation	extent	The extent	glycosylation	afucosylation	COID653555	ABSTRACT	arg0
55c017cad805439bf093181ff9f1ba50	30597531		the antibody-dependent cellular cytotoxicity (ADCC) activity of a monoclonal antibody (mAb)	activity	the antibody-dependent cellular cytotoxicity (ADCC) activity	clinical outcomes	ADCC	COID386333	ABSTRACT	arg1
da008ac429e29fd218124f212aa544c8	30597531		the antibody-dependent cellular cytotoxicity (ADCC) activity of a monoclonal antibody (mAb)	activity	the antibody-dependent cellular cytotoxicity (ADCC) activity	clinical outcomes	antibody-dependent cellular cytotoxicity	COID386333	ABSTRACT	arg1
e8fd7049fc2b88c7bfe752492599d438	30959136		a more galactosylated glycan profile than a bioreactor culture initiated at 34 Â°C during growth and downshifted to 30 Â°C during the production phase	profile	a more galactosylated glycan profile	product quality attributes	galactosylated glycan profile	COID142990	ABSTRACT	arg0
e76baf2acf2461bbc9f2b3aa8665a8ef	30959136		this production protocol	protocol	this production protocol	process parameters or process control	protocol	COID625051	ABSTRACT	arg1
b7e8e3acc66a1399eb0a465602ae98c2	30959136		a bioreactor culture initiated at 34 Â°C during growth and downshifted to 30 Â°C during the production phase	culture	a bioreactor culture	vessel or process parameter or production scale	bioreactor	COID345693	ABSTRACT	arg1
89dd6b81b0f955000246034290598fd8	30982137		The production of anti-HER2 antibody from the FUT8 gene knockout CHO-S cells in the bioreactor	production	The production	chinese hamster ovary (CHO)	FUT8 gene knockout CHO-S	COID438040	ABSTRACT	arg0
457ff9f1e102c124958095c048a488b4	30982137		the bioreactor	bioreactor	the bioreactor	vessel or process parameter or production scale	bioreactor	COID345693	ABSTRACT	arg1
31919d0cbd0acea598d7681de31fbb0d	30982137		The production of anti-HER2 antibody from the FUT8 gene knockout CHO-S cells in the bioreactor	production	The production	antibody	antibody	COID278523	ABSTRACT	arg0
45331e2392c6059b33a32a6df796c506	30982137		the shake flask system	system	the shake flask system	vessel or process parameter or production scale	shake flask	COID796805	ABSTRACT	arg1
3d7e9c514defb9e7392a5e7552df70bc	30982137		the wild-type antibody	antibody	the wild-type antibody	antibody	antibody	COID278523	ABSTRACT	arg0
37fcd04da319f2a6d8038cf4cf1a2cbe	30982137		The antibody-dependent cellular cytotoxicity activity of the defucosylated antibody	activity	The antibody-dependent cellular cytotoxicity activity	clinical outcomes	antibody-dependent cellular cytotoxicity	COID386333	ABSTRACT	arg1
ad0495e434c628bafa5a4fde2e26f0c3	31049620	PMC7027499	Loss of protein sialylation during glycoprotein-producing bioprocesses	Loss	Loss	glycosylation	sialylation	COID543327	ABSTRACT	arg0
0cc4097ffe0e792c1b94da1e788e4f92	31049620	PMC7027499	subsequent clinical efficacy	efficacy	subsequent clinical efficacy	clinical outcomes	efficacy	COID912630	ABSTRACT	arg1
0f8f5f0d652e4ba7a1e3d4def7b71dd5	35737825	PMC9235890	increased glycosylation in the light chain	glycosylation	increased glycosylation	glycosylation	glycosylation	COID119643	ABSTRACT	arg1
c97418000e81578f8a94cb1b95c2331d	23172735	PMC4226405	FUT8	FUT8	FUT8	enzyme	FUT8	COID212341	RESULTS	arg0
4a3939fabfdf308c8f7b6dc7f8237682	23172735	PMC4226405	levels of core afucosylation	levels	levels	glycosylation	afucosylation	COID653555	RESULTS	arg1
7a918bcbf637581454b026825b75ca2d	23172735	PMC4226405	Addition of FUT8 and GMDS siRNA	Addition	Addition	NYK	siRNA	COID416464	RESULTS	arg0
5d05ca0ac6aa81bcc4491ecfaf66119c	23172735	PMC4226405	total levels of core afucosylation of antibody	levels	total levels	glycosylation	afucosylation	COID653555	RESULTS	arg1
15e0eba6f8e5ec49ed096869d8d7f787	23172735	PMC4226405	Addition of FUT8 and GMDS siRNA	Addition	Addition	enzyme	FUT8	COID212341	RESULTS	arg0
f305b50fc3d8de68b1b2207d3d246251	23172735	PMC4226405	Addition of FUT8 and GMDS siRNA	Addition	Addition	enzyme	GMDS	COID390450	RESULTS	arg0
59de65c2c84edbf6bcfb21a751c5f60c	23172735	PMC4226405	A predominant effect of core afucosylation on an antibody	effect	A predominant effect	glycosylation	afucosylation	COID653555	RESULTS	arg0
f421f0bab89eb77f649432a16f9251cb	23172735	PMC4226405	binding with FcgammaRIIIa which then promotes increased ADCC	binding	binding	clinical outcomes	ADCC	COID386333	RESULTS	arg1
cc5e2cd6da5c27e7fe8d58d3616d31ce	23172735	PMC4226405	A predominant effect of core afucosylation on an antibody	effect	A predominant effect	antibody	antibody	COID278523	RESULTS	arg0
4a1e14f25c345edf37e6938324b5f04f	23172735	PMC4226405	Peak OD450 for antibody produced from siRNA treated runs	OD450	Peak OD450	NYK	siRNA	COID416464	RESULTS	arg0
babd6f664396d6250184d9837b849ab5	23172735	PMC4226405	total levels of core afucosylation of antibody	levels	total levels	glycosylation	afucosylation	COID653555	RESULTS	arg0
e414e5ec2d24c2c7b326d0e17576720c	23172735	PMC4226405	Addition of FUT8 and GMDS siRNA	Addition	Addition	NYK	siRNA	COID416464	RESULTS	arg1
79cb41f634b27b8c61c26a71c59c8420	23172735	PMC4226405	Addition of FUT8 and GMDS siRNA	Addition	Addition	enzyme	FUT8	COID212341	RESULTS	arg1
ecfe211404024c33fe4b221438a6d4f7	23172735	PMC4226405	Addition of FUT8 and GMDS siRNA	Addition	Addition	enzyme	GMDS	COID390450	RESULTS	arg1
74a0ce1315fa7b5728df867f08f6a468	25042542	PMC4282109	a complete and exclusive G0/G1 arrest	arrest	a complete and exclusive G0/G1 arrest	cell cycle pathway G0/G1/M/G2	G0/G1 arrest	COID007895	RESULTS	arg0
e4b270e3d80faac7d02001a67ae5b924	25042542	PMC4282109	qP more than two fold in all CHO cell lines	qP	qP	flux rate	qP	COID599783	RESULTS	arg1
e13e099603415a4f88b03cd191a32d86	25042542	PMC4282109	the specific and complete cell cycle G0/G1 arrest observed	arrest	the specific and complete cell cycle G0/G1 arrest	cell cycle pathway G0/G1/M/G2	G0/G1 arrest	COID007895	RESULTS	arg0
0fd59cfe5574d6a7a69a707857ec817b	25042542	PMC4282109	specific productivity (qP)	productivity	specific productivity	process condition	specific productivity	COID731421	RESULTS	arg1
643d701a950a035ebb431ab3e8b8caf0	25042542	PMC4282109	the specific and complete cell cycle G0/G1 arrest observed	arrest	the specific and complete cell cycle G0/G1 arrest	biological process	cell cycle	COID780295	RESULTS	arg0
ba268d3d93eb8cd6f83948ea1ae5ea70	25641927	PMC4492121	overexpression of St6gal1	overexpression	overexpression	enzyme	St6gal1	COID749247	ABSTRACT	arg0
a0a6b20d5af0f0bcfececcb3bc91539a	25641927	PMC4492121	recombinant proteins with increased sialylation and more human-like glycoprofiles	proteins	recombinant proteins	recombinant protein	recombinant proteins	COID593158	ABSTRACT	arg1
6e3dcdec0210eeb3108769a3800449f9	25641927	PMC4492121	increased total SA content	content	increased total SA content	sugar (subset of carbon source)	SA	COID148212	ABSTRACT	arg1
690d5b0e82292ca417c0c0c7d2fe49ea	25641927	PMC4492121	the total SA (mol/mol) in IgG produced by the enriched ST6GAL1 Clone 27	SA	the total SA	sugar (subset of carbon source)	SA	COID148212	ABSTRACT	arg0
6c95a4243120280f80314924c5ccd857	25641927	PMC4492121	IgG produced in ST6GAL1_OE_32 host cell line	IgG	IgG	antibody	IgG	COID713543	RESULTS	arg0
aeb3866c76e2b6b0dc5cc25cbc7c49a5	25641927	PMC4492121	more sialic acid	acid	more sialic acid	sugar (subset of carbon source)	sialic acid	COID148212	RESULTS	arg1
2867a1ce843aafeab725dad1ec96c1ec	25641927	PMC4492121	a lower relative abundance of the G0F and G2F glycoforms	abundance	a lower relative abundance	recombinant protein	glycoforms	COID288767	RESULTS	arg0
d37a226f14944739fb9e998eb90732fe	25641927	PMC4492121	a lower relative abundance of the G0F and G2F glycoforms	abundance	a lower relative abundance	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg0
1172eb9d22ddd344ab381de4d3ee0e8e	25641927	PMC4492121	a lower relative abundance of the G0F and G2F glycoforms	abundance	a lower relative abundance	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg0
1911d2d997f99afeda02345405ead527	25641927	PMC4492121	significantly more IgG	IgG	significantly more IgG	antibody	IgG	COID713543	RESULTS	arg0
69a5ca96be617323bea75b01842f0775	25641927	PMC4492121	the nonengineered host cell line using minus glutamine selection (Figure 9A)	line	the nonengineered host cell line	cell line	host cell line	COID702829	RESULTS	arg1
b9708627788c548a4dea1a9ff2b03c6e	25641927	PMC4492121	the two stable pools generated from ST6GAL1_OE_32 host cell line	pools	the two stable pools	cell line	host cell line	COID702829	RESULTS	arg0
dafaa6776929f1f7961e6a1daaddafcd	25641927	PMC4492121	significantly more IgG	IgG	significantly more IgG	antibody	IgG	COID713543	RESULTS	arg1
f783f7c06338310ccec983b4e2b9d75b	25641927	PMC4492121	Higher levels of St6gal1 expression in ST6GAL1_OE_32	levels	Higher levels	enzyme	St6gal1	COID749247	RESULTS	arg0
9cfb8546812c42a4646d7ee5731d1ccc	25641927	PMC4492121	higher relative content alpha2,6-linked sialylated glycans	glycans	higher relative content alpha2,6-linked sialylated glycans	sugar (subset of carbon source)	sialylated glycans	COID113402	RESULTS	arg1
739039ed67165271e567ccbbbd5e93f3	25641927	PMC4492121	CHOZN GS host cell line (Figure 9B)	line	CHOZN GS host cell line	cell line	host cell line	COID702829	RESULTS	arg0
814f02cdff16f2f72c2b4c49ef66b5a9	25641927	PMC4492121	the increased relative content of more complex glycoforms (G1FS1, G2FS1, and G2FS2)	content	the increased relative content	recombinant protein	glycoforms	COID288767	RESULTS	arg1
5a308270cf091806fbd6154d4f72ecad	25641927	PMC4492121	Higher levels of St6gal1 expression in ST6GAL1_OE_32	levels	Higher levels	enzyme	St6gal1	COID749247	RESULTS	arg1
b79efef4bc0ba398f52bc2d612d27fe8	25641927	PMC4492121	the two stable pools generated from ST6GAL1_OE_32 host cell line	pools	the two stable pools	cell line	host cell line	COID702829	RESULTS	arg1
66aea472b92406961ea37918384008ff	25875452	PMC4622614	beta-galactoside alpha-2,6-sialyltransferase 1 (ST6)	alpha-2,6-sialyltransferase	beta-galactoside alpha-2,6-sialyltransferase 1	enzyme	beta-galactoside alpha-2,6-sialyltransferase 1	COID749247	RESULTS	arg0
4afbb12c3529283a494adac7995685a8	25875452	PMC4622614	galactosylation	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
338bfa8ba033971b39a465a78999be66	25875452	PMC4622614	alpha2,6-sialylation	alpha2,6-sialylation	alpha2,6-sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
c235cf8defce16d9d86793e94e0d9241	25875452	PMC4622614	a high level of galactosylation	level	a high level	glycosylation	galactosylation	COID475750	RESULTS	arg0
4020e38af18f5bc21d86eee5092a96a2	25875452	PMC4622614	This increased sialylation	sialylation	This increased sialylation	glycosylation	sialylation	COID543327	RESULTS	arg1
d858649f59448bb142900bd164ca8422	25875452	PMC4622614	The human membrane-associated beta-1,4-galactosyltransferase 1 (GT)	beta-1,4-galactosyltransferase	The human membrane-associated beta-1,4-galactosyltransferase 1	enzyme	galactosyltransferase	COID703629	RESULTS	arg0
9826bc5ece839cd5e71c15b5ff709350	26910040	PMC4947490	the rate of product formation	rate	the rate	flux rate	product formation	COID187355	ABSTRACT	arg0
96c4918931241f410376dff79c0754e5	26910040	PMC4947490	Osmolality	Osmolality	Osmolality	process parameters or process control	Osmolality	COID710653	RESULTS	arg0
317535d9d03ac6f295eff7eb40531650	26910040	PMC4947490	high mannose content in cell culture processes	content	high mannose content	sugar (subset of carbon source)	high mannose	COID981337	RESULTS	arg1
d4ff67a6f3b0fc104b84649da1ea708f	26910040	PMC4947490	qP	qP	qP	flux rate	qP	COID599783	RESULTS	arg0
e29fb4c705abef216c3caec1d61c7f0d	26910040	PMC4947490	high mannose content	content	high mannose content	sugar (subset of carbon source)	high mannose	COID981337	RESULTS	arg1
4907f8fce4fd4c9d2b23b2ca69fdb738	26910040	PMC4947490	The two "qP high" cultivations	cultivations	The two "qP high" cultivations	flux rate	qP	COID599783	RESULTS	arg0
afbe44f67af7e84dea154c0fecb0fcad	26910040	PMC4947490	a high specific productivity	productivity	a high specific productivity	process condition	specific productivity	COID731421	RESULTS	arg1
2d0e58e15717435f9132ad60031923fc	26910040	PMC4947490	the supplemented cultures of both cell lines A and B	cultures	the supplemented cultures	cell line	cell lines	COID702829	RESULTS	arg0
13cd221185090281d27e154cf1aca08c	26910040	PMC4947490	a high and nearly constant qP	qP	a high and nearly constant qP	flux rate	qP	COID599783	RESULTS	arg1
3300f655dc7b71d972048a584de47c51	26910040	PMC4947490	both cell lines	lines	both cell lines	cell line	cell lines	COID702829	RESULTS	arg0
e78d380555c02c96815b65e39b8e6903	26910040	PMC4947490	high variations in qP	variations	high variations	flux rate	qP	COID599783	RESULTS	arg1
4ed365250e976e2360cecdbfdd2b4bd2	26910040	PMC4947490	the DoE cultivations in order to investigate the effect of the experimental factors on the accumulation of this pre-mature glycoform	cultivations	the DoE cultivations	recombinant protein	glycoform	COID288767	RESULTS	arg0
d4ff391af7fcef15407688859bc73d60	26910040	PMC4947490	High mannose content	content	High mannose content	sugar (subset of carbon source)	High mannose	COID981337	RESULTS	arg1
4d193ffb964a2cf4c8cbf8c0aceefd30	26910040	PMC4947490	high qP values	values	high qP values	flux rate	qP	COID599783	RESULTS	arg0
97ff43e53293cc9fd11a05b096770747	26910040	PMC4947490	the abundance of M5 glycoforms	abundance	the abundance	recombinant protein	glycoforms	COID288767	RESULTS	arg1
e19450632c5fc2df978164b024132cd8	27559765	PMC5098448	Basic charge variants	variants	Basic charge variants	product quality profile	charge variants	COID817650	ABSTRACT	arg0
460c0be3ba1eeb3052d1d09e3676d337	27559765	PMC5098448	increased binding to cell surface receptor FcgammaRIIIa, which plays a major role in regulating effector functions	binding	increased binding	process condition	functions	COID532355	ABSTRACT	arg1
69bdf42084387d2623235872272ee467	27559765	PMC5098448	Our glycan data	data	Our glycan data	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg0
f2136e6fc07e241eec42f7878340c152	27559765	PMC5098448	a much higher amount of sialylated glycan structures in the acidic charge variant fractions	amount	a much higher amount	sugar (subset of carbon source)	glycan structures	COID684992	RESULTS	arg1
0070cb024853da87ce410dd9fc1e56d7	27559765	PMC5098448	a much higher amount of sialylated glycan structures in the acidic charge variant fractions	amount	a much higher amount	sugar (subset of carbon source)	sialylated glycan	COID113402	RESULTS	arg1
674c2fc7b8f5b8ca0f9cc6b5b6a09d8d	27559765	PMC5098448	a much higher amount of sialylated glycan structures in the acidic charge variant fractions	amount	a much higher amount	sugar (subset of carbon source)	glycan structures	COID684992	RESULTS	arg0
455055b74ecc79977fa58fbd80703b52	27559765	PMC5098448	Our glycan data	data	Our glycan data	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
0c8216d85254632934c4495f17b7d368	27559765	PMC5098448	a much higher amount of sialylated glycan structures in the acidic charge variant fractions	amount	a much higher amount	sugar (subset of carbon source)	sialylated glycan	COID113402	RESULTS	arg0
f5665b7195d3f5e1884ff6e0442d6a58	27559765	PMC5098448	its microheterogeneity pattern	pattern	its microheterogeneity pattern	clinical outcomes	microheterogeneity	COID021590	RESULTS	arg0
d58d41b8b263ed828117ad3ed1a35775	27559765	PMC5098448	an additional preparative scale experiment	experiment	an additional preparative scale experiment	vessel or process parameter or production scale	scale	COID586187	RESULTS	arg1
4918806ae38b365b9619fb2bebdf9149	27559765	PMC5098448	slightly lower amounts of non-fucosylated glycans than B1	amounts	slightly lower amounts	sugar (subset of carbon source)	glycans	COID626759	RESULTS	arg0
22430d6c5ed929a312ff6177ee18bca4	27559765	PMC5098448	this batch B2	B2	this batch B2	process mode	batch	COID285438	RESULTS	arg1
3e31c0699a2d9954d5837a6f5b88826f	27752770	PMC5274649	higher pH values	values	higher pH values	bioreactor conditions	pH	COID893209	RESULTS	arg0
76f6a98796ebae5f94574543f3e4d0fe	27752770	PMC5274649	a higher consumption of several amino acids (Ser, Asp, Val, Ile, Arg and His)	consumption	a higher consumption	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg1
96a25bd6a968b3ba8edbeadf81f2f5ed	27752770	PMC5274649	a higher consumption of several amino acids (Ser, Asp, Val, Ile, Arg and His)	consumption	a higher consumption	amino acid (subset of substrates)	Ser	COID865161	RESULTS	arg1
35b99af5dbb1a5955b308f25b311e75e	27752770	PMC5274649	a way that high pH set points led to high q p values	way	a way	bioreactor conditions	pH	COID893209	RESULTS	arg0
7418df797e8b8833b9e9d8474a0e3754	27752770	PMC5274649	high q p values	values	high q p values	flux rate	q p	COID599783	RESULTS	arg1
b717444efbe51deae19fa34cafd9cdb2	27752770	PMC5274649	fermentation conditions that induce high specific growth rates	conditions	fermentation conditions	cell culture parameters	growth rates	COID957002	RESULTS	arg0
508eacf07d4e32c0433a3d207e04678f	27752770	PMC5274649	high specific production rates for this cell line	production	high specific production rates	process parameters or process control	production rates	COID014362	RESULTS	arg1
1c7593a511ca8c6121d2838152687e36	27752770	PMC5274649	2 lower pH values	values	2 lower pH values	bioreactor conditions	pH	COID893209	RESULTS	arg0
89b85c2d19df084c1d00ca4a89a13598	27752770	PMC5274649	lower acidic variants	variants	lower acidic variants	acid (subset of secondary raw materials)	acidic variants	COID106814	RESULTS	arg1
e18e217982f8027aea67675f78a437bc	27752770	PMC5274649	pH 6.8	pH	pH 6.8	bioreactor conditions	pH	COID893209	RESULTS	arg0
e88841d0af47070be96dddcf0dc658d0	27752770	PMC5274649	the highest protein deamidation	deamidation	the highest protein deamidation	PTM	deamidation	COID565107	RESULTS	arg1
31a2bd459da288fb92130f2d743d3b03	27752770	PMC5274649	higher cell growth	growth	higher cell growth	cell culture parameters	cell growth	COID093598	RESULTS	arg1
a98c6da1e417a2a4cebc36deaf6dc930	27752770	PMC5274649	high Mannose 8 (Fig. 5c linear determination coefficient R 2 = 0.82) variants	variants	high Mannose 8 (Fig. 5c linear determination coefficient R 2 = 0.82) variants	sugar (subset of carbon source)	high Mannose	COID981337	RESULTS	arg1
fb90ce1dd63fdb394eafb47394c5f000	27752770	PMC5274649	high pH set points	points	high pH set points	bioreactor conditions	pH	COID893209	RESULTS	arg0
e36f65a490178ff2e9ec23cdc7b60143	27752770	PMC5274649	general higher final ammonia concentrations	concentrations	general higher final ammonia concentrations	by-product or waste	ammonia	COID714278	RESULTS	arg1
ac6411ba65f22b0037e70622fbe44d27	27752770	PMC5274649	Runs at highest pH values	Runs	Runs	bioreactor conditions	pH	COID893209	RESULTS	arg0
bb5b15389b98a646ada63155003bb3d9	27752770	PMC5274649	significantly more lactate	lactate	significantly more lactate	by-product or waste	lactate	COID250920	RESULTS	arg1
36b561f245fd1b9664395c6bcec986f9	28921534	PMC5765507	TGE in mild hypothermic conditions	TGE	TGE	bioreactor conditions	hypothermic conditions	COID718157	ABSTRACT	arg0
a7875e100ceb31c3efd74efcfccbda0b	28921534	PMC5765507	a 76% increase in qP	increase	a 76% increase	flux rate	qP	COID599783	ABSTRACT	arg1
3f6dda0967a2d352c3532eb447ca4c33	28951949	PMC5656727	the cell volume-specific consumption rates of all the essential amino acids	rates	the cell volume-specific consumption rates	amino acid (subset of substrates)	amino acids	COID693703	RESULTS	arg0
9c2bfd03af6e7ef727768f29e5ba3d9d	28951949	PMC5656727	the cell volume increases in the SI phase	increases	the cell volume increases	product attributes	SI	COID283454	RESULTS	arg1
f65f118b80981e293d3befe09da88fd0	28951949	PMC5656727	Average specific productivity expressed per cell	productivity	Average specific productivity	process condition	specific productivity	COID731421	RESULTS	arg0
a34002d2469a9109091375c5c3380054	28951949	PMC5656727	the SI phase compared to the NI phase	phase	the SI phase	product attributes	SI	COID283454	RESULTS	arg1
5179e5ed77cb9c2010c022a72f359093	29511312	PMC5840386	the presence of maltose	presence	the presence	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
d5e0b32fe4f25d7f68b9355da6edc120	29511312	PMC5840386	the use of a lower glucose feed to result in the observed higher maximum IgG titers in Fig. 4G	use	the use	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg1
0818da5b4776e10dae80004d7d037b0d	29511312	PMC5840386	the cultures with higher maltose concentrations	cultures	the cultures	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
1f379825adae67af9bbd04d7bcb9247c	29511312	PMC5840386	more glycolysis intermediates that were processed to lactate when the cells die	intermediates	more glycolysis intermediates	metabolic pathways	glycolysis	COID345655	RESULTS	arg1
a8f98b1166a070a4ee970ad5a63665a8	29511312	PMC5840386	maltose concentrations lower than 3 g/l after glucose depletion	concentrations	maltose concentrations	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
2c6ed5e7d252ce5a731faff867a496a2	29511312	PMC5840386	slower growth observed at maltose concentrations lower than 3 g/l after glucose depletion	growth	slower growth	cell culture parameters	growth	COID203666	RESULTS	arg1
53b0e9be2a15dbe5f9b4ffb3f914b3f4	29511312	PMC5840386	the glucose-only cultures (Table 2)	cultures	the glucose-only cultures	sugar (subset of carbon source)	glucose	COID367406	RESULTS	arg0
4fe858af70559746edd62c23ba1c53dd	29511312	PMC5840386	the maltose-supplemented cultures compared to the glucose-only cultures (Table 2), to possibly allow slower and more productive maltose-supplemented cultures	cultures	the maltose-supplemented cultures	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg1
7d09e4e5ddf8cbae12ffe6cf457b3d99	29511312	PMC5840386	lower levels of sialylated glycans	levels	lower levels	sugar (subset of carbon source)	sialylated glycans	COID113402	RESULTS	arg0
f07b1601c0e8ee5c28b3a6608c4c15f9	29511312	PMC5840386	Glucose-only #1 culture	culture	Glucose-only #1 culture	sugar (subset of carbon source)	Glucose	COID367406	RESULTS	arg0
756a4e32a0c7c417ab73a1c813bea9e7	29511312	PMC5840386	a higher maximum VCD	VCD	a higher maximum VCD	cell culture parameters	VCD	COID384695	RESULTS	arg1
50b260b12b6b2a3e9f0227f5b522ebd9	29511312	PMC5840386	less increase in osmolality	increase	less increase	process parameters or process control	osmolality	COID710653	RESULTS	arg1
1d81f1597e2c2034770d78275f652977	29511312	PMC5840386	the 20 g/l maltose supplemented culture	maltose	the 20 g/l maltose	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
c03e9273309e80785e6667addc3b80eb	29511312	PMC5840386	the highest maximum IgG titer	titer	the highest maximum IgG titer	overall titer or batch yield	IgG titer	COID814559	RESULTS	arg1
0f8bc65e64e27eb6e412e61e58da45ed	29511312	PMC5840386	the maltose supplemented cultures	maltose	the maltose	disaccharides (subset of carbon source)	maltose	COID396206	RESULTS	arg0
ecb8ab43ae490dd85797d7025f72f1d7	29511312	PMC5840386	13% to 17% lower specific IgG productivities up to Day 6	productivities	13% to 17% lower specific IgG productivities	antibody	IgG	COID713543	RESULTS	arg1
8f3176920e0d490fc3e7c16d8a79218a	30552760	PMC6590254	15 microM kifunensine supplementation leading to an 85.8% increase in high-mannose containing species	supplementation	15 microM kifunensine supplementation	secondary raw materials	supplementation	COID566710	ABSTRACT	arg0
fcb2b9b831121c2bf5e15d34e05891a8	30552760	PMC6590254	15 microM kifunensine supplementation leading to an 85.8% increase in high-mannose containing species	supplementation	15 microM kifunensine supplementation	secondary raw materials	kifunensine	COID287309	ABSTRACT	arg0
a3c52be65a3c0f1ad5335c91e9ceac45	30552760	PMC6590254	the addition of 30 microM dexamethasone	addition	the addition	secondary raw materials	dexamethasone	COID895485	ABSTRACT	arg0
751090df493c68277cab32e71c8ca6cf	30552760	PMC6590254	6.9% increased sialylation	sialylation	6.9% increased sialylation	glycosylation	sialylation	COID543327	ABSTRACT	arg1
459bdcdb54cc20e618b41da70ddd03f5	30552760	PMC6590254	the addition of compounds to increase sialylation (750 microM DANA, 50 mM ManNAc, 5 mg/ml fetuin, 0.5 mM CuCl2 on Day 8, and 30 microM dexamethasone)	addition	the addition	secondary raw materials	dexamethasone	COID895485	RESULTS	arg0
f37193dd63e07a5802960be0a5d3e7f7	30552760	PMC6590254	the addition of compounds to increase sialylation (750 microM DANA, 50 mM ManNAc, 5 mg/ml fetuin, 0.5 mM CuCl2 on Day 8, and 30 microM dexamethasone)	addition	the addition	sugar (subset of carbon source)	ManNAc	COID135789	RESULTS	arg0
e6cc1c2fef3a4ff40f1ac74b8f73aff7	30552760	PMC6590254	the addition of compounds to increase sialylation (750 microM DANA, 50 mM ManNAc, 5 mg/ml fetuin, 0.5 mM CuCl2 on Day 8, and 30 microM dexamethasone)	addition	the addition	trace metals or minerals (subset of secondary raw materials)	CuCl2	COID901856	RESULTS	arg0
e208d60c26b2fd07bba5c31341757151	30552760	PMC6590254	the addition of compounds to increase sialylation (750 microM DANA, 50 mM ManNAc, 5 mg/ml fetuin, 0.5 mM CuCl2 on Day 8, and 30 microM dexamethasone)	addition	the addition	sugar (subset of carbon source)	DANA	COID084256	RESULTS	arg0
3b5c10c11fc23716e0a1de2f95c8b406	30552760	PMC6590254	the additive dexamethasone	dexamethasone	the additive dexamethasone	secondary raw materials	dexamethasone	COID895485	RESULTS	arg0
76bb044f4695f5d06f5f3300c6d90734	30552760	PMC6590254	the total amount of sialylated glycans (30 microM dexamethasone) as well as disialylated species (10 microM dexamethasone) concurrent with a positive effect on titer	amount	the total amount	sugar (subset of carbon source)	sialylated glycans	COID113402	RESULTS	arg1
279f1728ca58f9ac531a701a517b1d9a	30552760	PMC6590254	the total amount of sialylated glycans (30 microM dexamethasone) as well as disialylated species (10 microM dexamethasone) concurrent with a positive effect on titer	amount	the total amount	overall titer or batch yield	titer	COID732378	RESULTS	arg1
439c77f82a31339e5e3637cd4726c6cc	30552760	PMC6590254	the medium	medium	the medium	media characteristics	medium	COID921897	RESULTS	arg0
17ccdeccf6563e0d64387b412402793d	30552760	PMC6590254	uridine added to the medium in this study	uridine	uridine	nucleotide or nucleoside	uridine	COID485269	RESULTS	arg1
a2ce45dea6440abd63c2c04a33da2b8f	30552760	PMC6590254	Combinations of cytidine (Cyt), fucose (Fuc), and uridine	Combinations	Combinations	nucleotide or nucleoside	cytidine	COID172930	RESULTS	arg0
2592695840afaaca76fd8eccb8f31fd8	30552760	PMC6590254	galactosylation (Figure 5a)	galactosylation	galactosylation	glycosylation	galactosylation	COID475750	RESULTS	arg1
7bd27eb3d9fdf6bd675c595a4b3c68dd	30552760	PMC6590254	Combinations of cytidine (Cyt), fucose (Fuc), and uridine	Combinations	Combinations	nucleotide or nucleoside	uridine	COID485269	RESULTS	arg0
7c7bbfd1f5b55b264573e3660175f5eb	30552760	PMC6590254	Combinations of cytidine (Cyt), fucose (Fuc), and uridine	Combinations	Combinations	sugar (subset of carbon source)	fucose	COID275575	RESULTS	arg0
e426477954f2098a4ce992794bf9c8a4	30552760	PMC6590254	sole addition of manganese chloride (Mn) or a mixture of Mn and galactose (Gal) with or without uridine	addition	sole addition	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
6900bb7160d6e481ff9ee837c56912dc	30552760	PMC6590254	833 mM sucrose	sucrose	833 mM sucrose	disaccharides (subset of carbon source)	sucrose	COID945298	RESULTS	arg0
b7f80d5a7299d5020c1a72dce21eebd6	30552760	PMC6590254	Man5 (+4.6%, +4.1% +4.1%, and +1.7%, respectively) but no other high-mannose forms	Man5	Man5	sugar (subset of carbon source)	Man5	COID568402	RESULTS	arg1
d867033f3337e80a3efd122473d5e7cb	30552760	PMC6590254	Man5 (+4.6%, +4.1% +4.1%, and +1.7%, respectively) but no other high-mannose forms	forms	other high-mannose forms	sugar (subset of carbon source)	high-mannose	COID981337	RESULTS	arg1
fe08fe3f5e88462cfff0abccfb4f137e	30552760	PMC6590254	150 nM monensin	monensin	150 nM monensin	NYK	monensin	COID766386	RESULTS	arg0
e05a3b861d89459e4adb763ee8fb51cb	30552760	PMC6590254	raffinose	raffinose	raffinose	sugar (subset of carbon source)	raffinose	COID985703	RESULTS	arg0
d01ffd2e4b4edba3a706433749f54951	30552760	PMC6590254	the mass fraction of sialylated glycan	fraction	the mass fraction	sugar (subset of carbon source)	sialylated glycan	COID113402	RESULTS	arg0
f9cce063b6d9512083595042eb0f3cb2	30552760	PMC6590254	supplementation with DANA alone	supplementation	supplementation	secondary raw materials	supplementation	COID566710	RESULTS	arg1
2799397a06300e3b01666ed0d679f40b	30552760	PMC6590254	the combination DANA/ManNAc	DANA/ManNAc	the combination DANA/ManNAc	sugar (subset of carbon source)	ManNAc	COID135789	RESULTS	arg1
3bcb88c127134bbd942d62912e4b55bd	30552760	PMC6590254	the combination DANA/ManNAc	DANA/ManNAc	the combination DANA/ManNAc	sugar (subset of carbon source)	DANA	COID084256	RESULTS	arg1
4718f2b905636e087444164e4a32ddf7	30552760	PMC6590254	an increase in galactosylation	increase	an increase	glycosylation	galactosylation	COID475750	RESULTS	arg1
41e826a1ef56004abfc2c813feab035f	30552760	PMC6590254	mAb2	mAb2	mAb2	monoclonal antibody	mAb2	COID770105	RESULTS	arg0
87f97c79aaca27f5751c7ef9489ac475	30552760	PMC6590254	additional Fab glycosylation	glycosylation	additional Fab glycosylation	glycosylation	glycosylation	COID119643	RESULTS	arg1
955a89e91644d9c61e47842e77405c9e	30552760	PMC6590254	increased Qp	Qp	increased Qp	flux rate	Qp	COID599783	RESULTS	arg1
07fcfcad24e8c9b120373106660fad87	30552760	PMC6590254	the increase in mannosylation in the conditions with additives	increase	the increase	glycosylation	mannosylation	COID543580	RESULTS	arg0
c757933067e9a9b2387bb778bbc54601	30552760	PMC6590254	the growth phase	phase	the growth phase	cell culture parameters	growth	COID203666	RESULTS	arg1
25b173d681d5b07dccad883aac63119a	30682623	PMC6352710	the levels of high mannose species, which is primarily the glycan core with five or more mannose moieties, and the agalactosylated species (G0)	levels	the levels	sugar (subset of carbon source)	high mannose	COID981337	RESULTS	arg1
851ec9dab7bd162cb34c80b9a9a28dd3	30682623	PMC6352710	the levels of high mannose species, which is primarily the glycan core with five or more mannose moieties, and the agalactosylated species (G0)	levels	the levels	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
ded00f7fa2fbd9591613fef76059530c	30682623	PMC6352710	an attempt to increase and maintain a sustained level of galactosylation and sialylation in fed-batch cultures	attempt	an attempt to increase and maintain a sustained level of galactosylation and sialylation in fed-batch cultures	glycosylation	galactosylation	COID475750	RESULTS	arg0
40e11ae3b3b1dc23243d36d0e4686e6b	30682623	PMC6352710	a sustained level of galactosylation and sialylation in fed-batch cultures	level	a sustained level	glycosylation	sialylation	COID543327	RESULTS	arg1
0b80257a65904744d3691a9a9039ce0a	30682623	PMC6352710	an attempt to increase and maintain a sustained level of galactosylation and sialylation in fed-batch cultures	attempt	an attempt to increase and maintain a sustained level of galactosylation and sialylation in fed-batch cultures	glycosylation	sialylation	COID543327	RESULTS	arg0
a29bad52580ba0deea997170973cd76a	30682623	PMC6352710	a sustained level of galactosylation and sialylation in fed-batch cultures	level	a sustained level	glycosylation	galactosylation	COID475750	RESULTS	arg1
b92a99b107e9994de54afed1b7d46dc9	30682623	PMC6352710	The expression levels of most of the genes in this gene set	levels	The expression levels	genotype	genes	COID185502	RESULTS	arg1
a27a80d1b6dc3fa6bf08dec7fc508c81	30682623	PMC6352710	NADH dehydrogenase 1 alpha subcomplex 7 (NDUFA7) from oxidative phosphorylation	subcomplex	NADH dehydrogenase 1 alpha subcomplex 7	PTM	oxidative phosphorylation	COID850093	RESULTS	arg1
1ffee6ee0cb014183a3374b448d79274	30682623	PMC6352710	time (Figure S5)	time	time	process parameters or process control	time	COID742277	RESULTS	arg0
8fe2ed00df22502309a4e38b515f841a	30682623	PMC6352710	beta-1,4-galactosyltransferase 1 (B4GALT1)	beta-1,4-galactosyltransferase	beta-1,4-galactosyltransferase 1	enzyme	galactosyltransferase	COID703629	RESULTS	arg1
6b39664bf9436f8ea36093cdf4d17db5	30682623	PMC6352710	time (Figure 5B)	time	time	process parameters or process control	time	COID742277	RESULTS	arg0
726b6648fce82ca60388df877b8f485f	30682623	PMC6352710	the levels of UDP-GlcNAc	levels	the levels	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
049a2aa6384a32cbb78067ea15502dad	30682623	PMC6352710	Specific productivity	productivity	Specific productivity	process condition	Specific productivity	COID731421	RESULTS	arg1
db0e6ef61bfd99d492dfa8ab5da40471	31425633	PMC7003473	the increase of amino acid correlations with glycan profiles	increase	the increase	product quality attributes	glycan profiles	COID521331	RESULTS	arg1
067e87181aedca2aa544a2d792fe34c9	31425633	PMC7003473	the increase of amino acid correlations with glycan profiles	increase	the increase	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg1
c5e7b76efa2b5aab9af50bfb31a5b46d	31425633	PMC7003473	the timing of the amino acid supplementation strategy	timing	the timing	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg0
c3bfdf18fcf767a95b5bbfd6aedc7a67	31425633	PMC7003473	the beneficial effect of prolonging bioreactor production time and	effect	the beneficial effect	vessel or process parameter or production scale	bioreactor	COID345693	RESULTS	arg0
0c4f4613ff0540ab03204ff5b2907c83	31425633	PMC7003473	the VCD	VCD	the VCD	cell culture parameters	VCD	COID384695	RESULTS	arg1
90f5b6695f66707f787347ec81216833	31425633	PMC7003473	the beneficial effect of prolonging bioreactor production time and	effect	the beneficial effect	process parameters or process control	time	COID742277	RESULTS	arg0
9dbd0783ecbf31d8512e96d34cf9610f	31425633	PMC7003473	higher amounts of high mannose species production	amounts	higher amounts	sugar (subset of carbon source)	high mannose	COID981337	RESULTS	arg1
6096c4f5d7b99ef83ad27f07cb706e9f	31425633	PMC7003473	high mannose species production	production	high mannose species production	sugar (subset of carbon source)	high mannose	COID981337	RESULTS	arg1
ad33d4dc5a6282504c060a9ce442ffec	31487120	PMC7027499	diverse amounts of terminal galactosylation, high mannose glycoforms, and aglycosylation	amounts	diverse amounts	glycosylation	galactosylation	COID475750	ABSTRACT	arg1
eea96f0e10078f9ce8c3a74e9e1b4df7	31487120	PMC7027499	diverse amounts of terminal galactosylation, high mannose glycoforms, and aglycosylation	amounts	diverse amounts	product quality attributes	aglycosylation	COID076549	ABSTRACT	arg1
ed125218390594e374bc10989cd4025c	31487120	PMC7027499	an increase of immature glycoforms such as HM	increase	an increase	recombinant protein	glycoforms	COID288767	RESULTS	arg1
9372e830da20804600a7e559ce516eda	31487120	PMC7027499	an increase of immature glycoforms such as HM	increase	an increase	sugar (subset of carbon source)	HM	COID981337	RESULTS	arg1
5445ac428f7c4d0e16aef52592398fca	31487120	PMC7027499	Culture medium	medium	Culture medium	media characteristics	Culture medium	COID180560	RESULTS	arg0
697558fa5ce2d898d5213e62c1f3f5cf	31487120	PMC7027499	the abundance of HM glycoforms which can be characteristic of cellular stress and causes incomplete processing during N-glycan biosynthesis.6, 23, 24 This cellular stress can manifest differently, either as a reduction in galactosylation, or increases in either HM glycoforms or aglycosylation	abundance	the abundance	recombinant protein	HM glycoforms	COID288767	RESULTS	arg1
ef82674f28a2111311b37b3189abd2bc	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	recombinant protein	glycoforms	COID288767	RESULTS	arg0
c5e5f19f53377a3a036a7eec9749a50e	31487120	PMC7027499	a lower degree of G0F, G1F, and G2F glycoforms	degree	a lower degree	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg1
0a7ab5e971a8aa31a0306423e56c4cf2	31487120	PMC7027499	a lower degree of G0F, G1F, and G2F glycoforms	degree	a lower degree	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg1
7c75204b118994a6d06d40996abfe97a	31487120	PMC7027499	a lower degree of G0F, G1F, and G2F glycoforms	degree	a lower degree	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg1
ff2afd4f7b87ea8bcc99fb069a597b64	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg0
5d689a16bbf871b8f8bcd1bab539747e	31487120	PMC7027499	a lower degree of G0F, G1F, and G2F glycoforms	degree	a lower degree	recombinant protein	glycoforms	COID288767	RESULTS	arg1
632c19582686628a85fa277feedd1063	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg0
c0e11ad82862d4762a499b2650ff2d43	31487120	PMC7027499	protein that has a lower degree of G0F, G1F, and G2F glycoforms	protein	protein	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg0
cc239a9b6aac4cb4c8bb1f954e40f5d7	31487120	PMC7027499	the end of the cell culture	end	the end	cell culture parameters	cell culture	COID293414	RESULTS	arg0
932a861ec72498b6442f905d8fef1b77	31487120	PMC7027499	protein produced at the end of the cell culture due to more protein being produced at the higher cell densities that are reached in the latter stages of the process, and due to the cells' increased productivity as they enter the stationary phase during this time	protein	protein	cell culture parameters	cell densities	COID283414	RESULTS	arg1
d37bfb5b0df6de5a3cdbb38ec71a19bb	31487120	PMC7027499	the most G0F (more than G1F and G2F combined, 53.189% vs. 32.423%)	G0F	the most G0F	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg1
bc672975fdf33f92cd29c078e4fcd71a	31544815	PMC6640710	the IgG fucosylation	fucosylation	the IgG fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg0
572d848728341f67a5a7622951102305	31544815	PMC6640710	a significant higher incorporation of the alkynylated fucose analogue	incorporation	a significant higher incorporation	substitution material	fucose analogue	COID400862	RESULTS	arg1
bbc7448058d76c56cbd1ef5dbce13754	31544815	PMC6640710	the IgG fucosylation	fucosylation	the IgG fucosylation	antibody	IgG	COID713543	RESULTS	arg0
2c9406c1b8ecae2e860a3d8adb8a5c63	31544815	PMC6640710	a more effective reduction of the IgG fucosylation by 5-AlkFuc compared to 2F-Fuc	reduction	a more effective reduction	glycosylation	fucosylation	COID810570	RESULTS	arg0
02bb7af74e6c3c89c61546f8ac994dbf	31544815	PMC6640710	a more effective reduction of the IgG fucosylation by 5-AlkFuc compared to 2F-Fuc	reduction	a more effective reduction	antibody	IgG	COID713543	RESULTS	arg0
6d182e011ba7b4ce2a2eec881348367d	31544815	PMC6640710	5-AlkFuc	5-AlkFuc	5-AlkFuc	sugar (subset of carbon source)	5-AlkFuc	COID256307	RESULTS	arg0
0c77b9457e0d714f48cda20bfca98491	31544815	PMC6640710	higher incorporation of the fucose analogue	incorporation	higher incorporation	substitution material	fucose analogue	COID400862	RESULTS	arg1
de1e2edcf6ab35c6772fa15f16f0bc88	31544815	PMC6640710	more pronounced reduction in core fucosylation (3.4% at 200 microM, 5.8% at 400 microM and 6.6% at 800 microM)	reduction	more pronounced reduction	glycosylation	core fucosylation	COID663555	RESULTS	arg1
4279835520be4255f21cab42c27d7da7	31544815	PMC6640710	the effect of the acetylation	effect	the effect	PTM	acetylation	COID878689	RESULTS	arg0
51540d34efef7e081a82ac052fe087d2	31544815	PMC6640710	increasing concentrations of the inhibitors	concentrations	increasing concentrations	secondary raw materials	inhibitors	COID760391	RESULTS	arg1
53f8981489fdbce024109ba0d2e26163	31544815	PMC6640710	core fucosylation	fucosylation	core fucosylation	glycosylation	core fucosylation	COID663555	RESULTS	arg0
46f3463a77c1d6ef569473dc2b847fb1	32170810	PMC7880547	The time course plot	plot	The time course plot	process parameters or process control	time	COID742277	RESULTS	arg0
862e591d0c8e2507327e256897fa0b41	32170810	PMC7880547	significant increases of fructose	increases	significant increases	carbon source (subset of secondary raw materials)	fructose	COID532749	RESULTS	arg1
ad52218e587370f62a9525c4591fd288	32170810	PMC7880547	CHO cells	cells	CHO cells	chinese hamster ovary (CHO)	CHO cells	COID806780	RESULTS	arg0
af8ff443fb7a105071815967970e0b1d	32170810	PMC7880547	increased apoptosis	apoptosis	increased apoptosis	cellular metabolic state	apoptosis	COID850789	RESULTS	arg1
4b67f3184446df3c78f573219d97c813	33476097	PMC8365702	an Instant PC glycan assay (Figure 1)	assay	an Instant PC glycan assay	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg0
5f5465cec84ec112e4f35a314740191c	33476097	PMC8365702	Significant removal of GlcNAc in G0F and G1F and increase of G0F-GlcNAc and Core F	removal	Significant removal	sugar (subset of carbon source)	GlcNAc	COID510815	RESULTS	arg1
e523ccb9921c82cb8a03689fe0d3631e	33656168	PMC8451748	the marginally higher VCD which was caused by the more concentrated on-demand medium	VCD	the marginally higher VCD	cell culture parameters	VCD	COID384695	RESULTS	arg0
6abde079be889c3982723507c460374d	33656168	PMC8451748	This slightly higher by-product formation for the on-demand cultures	formation	This slightly higher by-product formation	flux rate	product formation	COID187355	RESULTS	arg1
ce59e2de25a7b97057131a4140953b61	33656168	PMC8451748	the more concentrated on-demand medium	medium	the more concentrated on-demand medium	media characteristics	medium	COID921897	RESULTS	arg0
fa833f2176522026ad4781e3a77fc46b	33656168	PMC8451748	the marginally higher VCD which was caused by the more concentrated on-demand medium	VCD	the marginally higher VCD	cell culture parameters	VCD	COID384695	RESULTS	arg1
b012e64d863314135cef00192cb0a0b4	33656168	PMC8451748	bolus addition	addition	bolus addition	process parameters or process control	bolus	COID693522	RESULTS	arg0
7c1bb7ebe93bca13f4ea4f99b6aba777	33656168	PMC8451748	a similar rate which required bolus addition from Day 4 onwards for both cell lines	rate	a similar rate	cell line	cell lines	COID702829	RESULTS	arg1
94d1d35ad1b9b20c89156ebd0195ab90	33656168	PMC8451748	a comparable rate that required bolus addition from Day 5 onwards for all cell cultures	rate	a comparable rate	cell culture parameters	cell cultures	COID293414	RESULTS	arg1
b19549e4f13b5c6a79b36ea33fa62caa	33682619	PMC7946005	Fc glycan terminal galactosylation	galactosylation	Fc glycan terminal galactosylation	glycosylation	galactosylation	COID475750	ABSTRACT	arg0
1e5c7c8cc111741c0bee152730f268cd	33682619	PMC7946005	the three-dimensional conformation of the Fc, which facilitates the IgG1 hexamerization, thus enhancing C1q avidity and subsequent complement activation	conformation	the three-dimensional conformation	antibody	IgG1	COID713543	ABSTRACT	arg1
19284979df80cefbf6d649e8f9d8d21f	33682619	PMC7946005	Fc glycan terminal galactosylation	galactosylation	Fc glycan terminal galactosylation	sugar (subset of carbon source)	glycan	COID626759	ABSTRACT	arg0
c9da9a25a27c2dde1f8f9bf437e21442	33682619	PMC7946005	the presence of a terminal galactose	presence	the presence	sugar (subset of carbon source)	galactose	COID770311	RESULTS	arg0
4b5d345f43c17be3d90ff99689aa3dff	33682619	PMC7946005	the IgG hexamer formation for complement activation	formation	the IgG hexamer formation	antibody	IgG	COID713543	RESULTS	arg1
e3a31154c70af6ef27424aa374b3ac0c	33682619	PMC7946005	Fc galactosylation	galactosylation	Fc galactosylation	product quality profile	Fc galactosylation	COID097777	TITLE	arg0
4a4836f52f52785fd351bbba89ccce35	33682619	PMC7946005	immunoglobulin G hexamerization for complement activation	hexamerization	immunoglobulin G hexamerization	antibody	immunoglobulin G	COID713543	TITLE	arg1
4a468ff7ea472012b7e4f3926036b3bd	33742789	PMC8459231	increased cell growth	growth	increased cell growth	cell culture parameters	cell growth	COID093598	ABSTRACT	arg1
d927be75dea2a1bea79b7f5659de7a97	33742789	PMC8459231	elevated levels of manganese in CCM	levels	elevated levels	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
b308605094cf5fc0ac6bb7ea5b1a4e52	33742789	PMC8459231	an increased cell performance for both, cell line 2 and cell line 3	performance	an increased cell performance	cell line	cell line	COID702829	RESULTS	arg1
b33f29ebdc559273862e726e311bb5d1	33742789	PMC8459231	the impact of manganese to significantly increase terminal galactosylation level and thus the necessity to keep manganese levels constant for the production of recombinant proteins	impact	the impact	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
c4e45ef8b9d380ec005140b57e659c9c	33742789	PMC8459231	terminal galactosylation level	level	terminal galactosylation level	glycosylation	galactosylation	COID475750	RESULTS	arg1
7c7a222d2d7e5dd703f23d9325ead946	33742789	PMC8459231	the positive effect that manganese can have on cell performance, but also shows the impact of manganese to significantly increase terminal galactosylation level and thus the necessity to keep manganese levels constant for the production of recombinant proteins	effect	the positive effect	glycosylation	galactosylation	COID475750	RESULTS	arg1
8829deaa7e51a329cf3b1fc7d055cd17	33742789	PMC8459231	Aggregation profile upon FC usage	profile	Aggregation profile	process condition	Aggregation	COID720685	RESULTS	arg0
a53b583b17038b21cb4c490452bbf07a	33742789	PMC8459231	the same small dose-dependent increase in HMWs for increasing iron amounts like FAC (data not shown)	increase	the same small dose-dependent increase	trace metals or minerals (subset of secondary raw materials)	iron	COID094956	RESULTS	arg1
19e2c4c4710fd53d6ce6acb284cf671b	33742789	PMC8459231	terminal galactosylation levels	levels	terminal galactosylation levels	glycosylation	galactosylation	COID475750	RESULTS	arg1
c83c1ba1dd9a1b4279e7338eecfd407b	33742789	PMC8459231	usage of FCPurch and FCSynt supplemented with manganese	usage	usage	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
a5f47c527debc8f32797b33692fc7fd4	33742789	PMC8459231	a significant increase in terminal galactosylated species of mAb2 in comparison to FCSynt (absolute increase of more than 13%)	increase	a significant increase	monoclonal antibody	mAb2	COID770105	RESULTS	arg1
2ef7671a6de8531d5f9b566d50970d29	33742789	PMC8459231	increasing amounts of manganese	amounts	increasing amounts	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg0
57491e6c8e9ac6bf136cc796ae7eabb4	33742789	PMC8459231	a significant increase in terminal galactosylation species	increase	a significant increase	glycosylation	galactosylation	COID475750	RESULTS	arg1
9cc5e84e84e7342d178919869e7ad29e	33742789	PMC8459231	titer	titer	titer	overall titer or batch yield	titer	COID732378	RESULTS	arg0
4d02337043ba9288c90af2fe674975d8	33742789	PMC8459231	the high and low manganese containing conditions	conditions	the high and low manganese containing conditions	trace metals or minerals (subset of secondary raw materials)	manganese	COID333220	RESULTS	arg1
c93a71933306145b974d3992c5571b05	33804825	PMC8037477	elevated ammonia levels	levels	elevated ammonia levels	by-product or waste	ammonia	COID714278	RESULTS	arg0
da22c196adf610f8a348d734d073e20c	33804825	PMC8037477	increased intracellular pH conditions that inhibit b4GalT activity and expression, and consequently lead to reduced protein galactosylation	conditions	increased intracellular pH conditions	bioreactor conditions	pH	COID893209	RESULTS	arg1
175d0cb7bb281c2f5ee7e7a1dda236a7	33804825	PMC8037477	elevated osmolality	osmolality	elevated osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg0
710900e3f0ecd4f5bf32c928e37c5d5a	33804825	PMC8037477	an increased apoptosis rate	rate	an increased apoptosis rate	cellular metabolic state	apoptosis	COID850789	RESULTS	arg1
eeedd4b7afe1c14cfdf78082f22e9d3d	33804825	PMC8037477	Cell cycle distribution	distribution	Cell cycle distribution	biological process	Cell cycle	COID780295	RESULTS	arg0
f63ba0833790d9d22963f84106d1979c	33804825	PMC8037477	the overall cell volume increase during culture based on the increase in the cell subpopulation in the G2/M phase seen in late stage culture	increase	the overall cell volume increase	cell cycle pathway G0/G1/M/G2	G2/M phase	COID055784	RESULTS	arg1
cf9398dc7ae1c0df2afb84df53db0cbb	33804825	PMC8037477	parallel to an increase of the cells in the G1 phase (RNA content results are shown in Appendix A Figure A2)	parallel	parallel	product quality attributes	A2	COID087025	RESULTS	arg0
f012aebae0e6d484504678269c1f87c4	33804825	PMC8037477	the proportion of cells in the G2/M phase	proportion	the proportion	cell cycle pathway G0/G1/M/G2	G2/M phase	COID055784	RESULTS	arg1
5837bdfbcf15cf492d58c758370e4be6	33804825	PMC8037477	The two culture conditions	conditions	The two culture conditions	culture condition	culture conditions	COID626277	RESULTS	arg0
34bfef13113749898d24548610ee8270	33804825	PMC8037477	a relatively high specific productivity	productivity	a relatively high specific productivity	process condition	specific productivity	COID731421	RESULTS	arg1
a4382438afdc3e3a88b8ac3e55810747	33804825	PMC8037477	core-fucosylation	core-fucosylation	core-fucosylation	glycosylation	fucosylation	COID810570	RESULTS	arg0
2fffc0107df1748030b08d91e5757faf	33804825	PMC8037477	an unexpected behaviour among the cultures that include the addition of Feed C for osmolality regulation	behaviour	an unexpected behaviour	process parameters or process control	osmolality	COID710653	RESULTS	arg1
a6e2aef1765b79e9fd094535fdd14eca	34542245	PMC9286570	cell-specific productivity from ~25 to 37 pg/(cell d)	productivity	cell-specific productivity	process condition	cell-specific productivity	COID637897	ABSTRACT	arg1
81b9a9df64a60621204436191c263e69	34542245	PMC9286570	the doubled STY of iFB_5 + BA	STY	the doubled STY	process mode	iFB_5	COID504685	RESULTS	arg0
745716b19b4bb3a3e426d50315f2aef5	34542245	PMC9286570	a potential 70% annual increase of product generated with a single production bioreactor	increase	a potential 70% annual increase	vessel or process parameter or production scale	bioreactor	COID345693	RESULTS	arg1
0410e6d6c5cf42f1da047046e5ab3178	34542245	PMC9286570	the doubled STY of iFB_5 + BA	STY	the doubled STY	acid (subset of secondary raw materials)	BA	COID365093	RESULTS	arg0
5cf7b8331d59577be56597d182046aff	34542245	PMC9286570	IgG productivity	productivity	IgG productivity	process condition	productivity	COID731421	RESULTS	arg0
c66c2e5b2b4f878f0488c023d025f4e5	34542245	PMC9286570	the iFB_5 (0.35 pmol/c d)	iFB_5	the iFB_5	process mode	iFB_5	COID504685	RESULTS	arg1
70438b83cd993f05a264b0adb3dc5128	34542245	PMC9286570	IgG productivity	productivity	IgG productivity	antibody	IgG	COID713543	RESULTS	arg0
9c7540bda77e0eb053758d9c0cc592f4	34542245	PMC9286570	BA	BA	BA	acid (subset of secondary raw materials)	BA	COID365093	RESULTS	arg0
d083c3420b267cdd3cebc770bc9f3cb6	34542245	PMC9286570	productivity	productivity	productivity	process condition	productivity	COID731421	RESULTS	arg1
6596c5096bb29ccfd244877302a6ee89	34542245	PMC9286570	iFB	iFB	iFB	process mode	iFB	COID504685	RESULTS	arg0
fc7f3b4cd593763cd5a1bb48e58b24cf	34542245	PMC9286570	a difference in the final viability of up to 25%	difference	a difference	process parameters or process control	viability	COID222142	RESULTS	arg1
cd796013448ce270331510f1c0caaec9	34542245	PMC9286570	an increase in cell specific productivity	increase	an increase	process condition	cell specific productivity	COID637897	RESULTS	arg1
707bfc3f89b2d8ab1f2f0c5c68659b1e	34542245	PMC9286570	the cell-specific productivity	productivity	the cell-specific productivity	process condition	cell-specific productivity	COID637897	RESULTS	arg0
fc794db521dfb3c2f4c013eff4a59951	34542245	PMC9286570	iFB (Figure 3(e))	iFB	iFB	process mode	iFB	COID504685	RESULTS	arg1
147b81db9f0a695d231f1f2c7045e1c1	34542245	PMC9286570	BA supplementation (Figure 3(d)) resulting in an average value of 37 pg/c d	supplementation	BA supplementation	secondary raw materials	BA supplementation	COID689497	RESULTS	arg1
d4a00ea4d821bf86f57b50f46db3e1da	34575094	PMC8469772	the fed-batch culture mode	mode	the fed-batch culture mode	process mode	fed-batch	COID529446	ABSTRACT	arg0
3ecbed493d50c38857d6c9e229a27267	34575094	PMC8469772	mAb expression in CHO cells	expression	mAb expression	monoclonal antibody	mAb	COID242255	ABSTRACT	arg1
9ee6cfe45b6e22819d14261e15722889	34575094	PMC8469772	the antibody C12 produced by the continuous feeding method	C12	the antibody C12	antibody	antibody	COID278523	ABSTRACT	arg0
05167b65521b978620b6539eb6dcfa0d	34575094	PMC8469772	a lower content of high-mannose glycoforms	content	a lower content	recombinant protein	high-mannose glycoforms	COID965734	ABSTRACT	arg1
cc09de81a74da8bae6e43892c86923ce	34575094	PMC8469772	Low osmolality	osmolality	Low osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg0
f2f38aab28c393c6ea6a2df9bba868e4	34575094	PMC8469772	traditional bolus feeding	feeding	traditional bolus feeding	process parameters or process control	bolus	COID693522	RESULTS	arg0
d5cebae415d8c16f4b32c7fc123f700d	34575094	PMC8469772	higher metabolic by-products	by-products	higher metabolic by-products	by-product or waste	metabolic by-products	COID531384	RESULTS	arg1
41461088d9ab8760de3e66b160964e85	34575094	PMC8469772	The low substrate concentration	concentration	The low substrate concentration	substrates	substrate	COID265919	RESULTS	arg0
785feb685d39b01aa28bbdcde05e09de	34575094	PMC8469772	lactate and NH4+ generation	generation	lactate and NH4+ generation	by-product or waste	lactate	COID250920	RESULTS	arg1
b78663581e846064f985fd3d09bc2a6a	34575094	PMC8469772	more metabolic byproducts	byproducts	more metabolic byproducts	by-product or waste	metabolic byproducts	COID531384	RESULTS	arg0
f9d3dcfbc423a507bab4b59335b25f55	34575094	PMC8469772	the increase of antibody expression	increase	the increase	antibody	antibody	COID278523	RESULTS	arg1
e1ce2ead8d46cfa658c0f88b3015400e	34575094	PMC8469772	bolus feeding	feeding	bolus feeding	process parameters or process control	bolus	COID693522	RESULTS	arg0
58ce57f683a968510b5505a1566a454b	34575094	PMC8469772	osmolality	osmolality	osmolality	process parameters or process control	osmolality	COID710653	RESULTS	arg1
94df533e5edad65764a2dce85f88c2b2	34575094	PMC8469772	nutrient concentration	concentration	nutrient concentration	media parameter or raw material	nutrient concentration	COID287635	RESULTS	arg1
4d7694bc3995b92e399b849fdfda21a4	34575094	PMC8469772	higher metabolic by-products	by-products	higher metabolic by-products	by-product or waste	metabolic by-products	COID531384	RESULTS	arg0
397d83849c80fb5e86b89fb1c4b13567	34575094	PMC8469772	traditional bolus feeding	feeding	traditional bolus feeding	process parameters or process control	bolus	COID693522	RESULTS	arg1
81e0be0f052e4d0cc075e18d3e005029	34575094	PMC8469772	cell line A and B	line	cell line A and B	cell line	cell line	COID702829	RESULTS	arg0
9fad7ffe21c557f1c5286183d95e5e63	34575094	PMC8469772	the residual amino acid levels of different processes under three high feeding amounts	levels	the residual amino acid levels	amino acid (subset of substrates)	amino acid	COID693703	RESULTS	arg1
b938eee9384889f4ae90c057e0bfde04	35087805	PMC8786911	the increasing cell culture duration until day 8	duration	the increasing cell culture duration	cell culture parameters	cell culture	COID293414	RESULTS	arg0
e969db8bd2d99ae6ba9487b7e31801a9	35087805	PMC8786911	the relative abundance of certain glycan species such as F(6)A2, F(6)A2(6)G(4)1, F(6)A2(3)G(4)1,	abundance	the relative abundance	sugar (subset of carbon source)	glycan	COID626759	RESULTS	arg1
d582c14daa4bc33a4618f5784a3ca74c	35087805	PMC8786911	the relative abundance of certain glycan species such as F(6)A2, F(6)A2(6)G(4)1, F(6)A2(3)G(4)1,	abundance	the relative abundance	product quality attributes	A2	COID087025	RESULTS	arg1
baab7fc82822d8756f6df50c0dd6358b	35087805	PMC8786911	a distinctively lower lactate profile than the other cell clones	profile	a distinctively lower lactate profile	by-product or waste	lactate	COID250920	RESULTS	arg0
0da9724fe3a9b18ea080475ead345bca	35087805	PMC8786911	the other cell clones	clones	the other cell clones	cell line	cell clones	COID964819	RESULTS	arg1
045d1c4cf8bed6d63872d8f3a0385358	35087805	PMC8786911	the G2F species (peak 6)	species	the G2F species	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg0
413b8b74a540a4ecb34d280139990502	35087805	PMC8786911	abundance in the 6-level DO process	abundance	abundance	bioreactor conditions	DO	COID661988	RESULTS	arg1
2bdd9ea25c8def4a51a91a6131212ac7	35087805	PMC8786911	the 2-level DO process	process	the 2-level DO process	bioreactor conditions	DO	COID661988	RESULTS	arg1
c03182d64c6031b0daea6320b2b05419	35441833	PMC9542549	The miniature bioreactor system described in this work	system	The miniature bioreactor system	vessel or process parameter or production scale	bioreactor	COID345693	ABSTRACT	arg0
a91e1c5dcb0898937d3d7df44c3b6bb7	35441833	PMC9542549	a platform for use during early stage cell culture process development to identify cell lines that may be adversely impacted by the pH and DOT heterogeneities encountered on scale-up	platform	a platform	cell culture parameters	cell culture	COID293414	ABSTRACT	arg1
e7e0c02210e2fc341ca216ec8e5f36b6	35441833	PMC9542549	a platform for use during early stage cell culture process development to identify cell lines that may be adversely impacted by the pH and DOT heterogeneities encountered on scale-up	platform	a platform	cell line	cell lines	COID702829	ABSTRACT	arg1
383ee7fc0963ac3d9c381eed2e13d0b3	35441833	PMC9542549	DOT heterogeneities	heterogeneities	DOT heterogeneities	clinical outcomes	heterogeneities	COID021590	ABSTRACT	arg0
069b73d38bb10f33fb608b3a7aa88388	35441833	PMC9542549	cell lines that may be adversely impacted by the pH and DOT heterogeneities encountered on scale-up	lines	cell lines	cell line	cell lines	COID702829	ABSTRACT	arg1
f8a4ef733e60f1d3ffe411be4c0ac148	35441833	PMC9542549	DOT heterogeneities	heterogeneities	DOT heterogeneities	NYK	DOT	COID003597	ABSTRACT	arg0
60f002f80f1f53b4bed08cbe5559d079	35441833	PMC9542549	pH	pH	pH	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
2454eadad4c4e21e2245d50a3344960f	35441833	PMC9542549	a significant increase in lactate accumulation	increase	a significant increase	by-product or waste	lactate	COID250920	ABSTRACT	arg1
a555ee81b0e981a19792863ff3cdb4e3	35441833	PMC9542549	fluctuating DOT in a hybridoma cell line	DOT	fluctuating DOT	NYK	DOT	COID003597	RESULTS	arg0
483e48233663068de1cb7a1d43e555ea	35441833	PMC9542549	higher lactate yield	yield	higher lactate yield	by-product or waste	lactate	COID250920	RESULTS	arg1
a84f959d85f155b1f5857cfb7ac2ff06	35441833	PMC9542549	higher lactate yield	yield	higher lactate yield	overall titer or batch yield	yield	COID809703	RESULTS	arg1
99c0595985009ce471d96f8b6ecd48e9	35441833	PMC9542549	a "high" peak VCD industrial cell line	line	a "high" peak VCD industrial cell line	cell line	cell line	COID702829	RESULTS	arg1
e454fa7ff8455a821dfd52a0bdac9823	35441833	PMC9542549	a "high" peak VCD industrial cell line	line	a "high" peak VCD industrial cell line	cell culture parameters	VCD	COID384695	RESULTS	arg1
f4f294ea3053f52b99f3045de781e804	35441833	PMC9542549	large scale	scale	large scale	vessel or process parameter or production scale	scale	COID586187	RESULTS	arg0
18705842315bc14634cb21b8aad67c89	35441833	PMC9542549	high-cell density cultures performed at large scale	cultures	high-cell density cultures	cell culture parameters	cell density	COID283414	RESULTS	arg1
cbac5341f16b734e4116d4bbeb097fbe	35441833	PMC9542549	12% lower levels of G1F + G2F	levels	12% lower levels	sugar (subset of carbon source)	G1F	COID847930	RESULTS	arg0
4e1c2b0329421a82d9c55a7710221795	35441833	PMC9542549	12% lower levels of G1F + G2F	levels	12% lower levels	sugar (subset of carbon source)	G2F	COID847130	RESULTS	arg0
f5b692dd6f3d1b2cc6439ff5aa4fbc9b	35441833	PMC9542549	the high-cell densities achieved	densities	the high-cell densities	cell culture parameters	cell densities	COID283414	RESULTS	arg0
1a40730f84ccd130b51bf58d44ecab97	35441833	PMC9542549	increased lactate accumulation	accumulation	increased lactate accumulation	by-product or waste	lactate	COID250920	RESULTS	arg1
252ab690031d17b30105c73ef64a8b8b	35441833	PMC9542549	high-oxygen uptake rates	rates	high-oxygen uptake rates	biological process	oxygen uptake rates	COID844361	RESULTS	arg1
2ccad37ed285e9236e5b2fb86b16bbee	35441833	PMC9542549	glycolysis	glycolysis	glycolysis	metabolic pathways	glycolysis	COID345655	RESULTS	arg1
23448af0648adde3f210f61f6737db23	35441833	PMC9542549	higher lactate accumulation	accumulation	higher lactate accumulation	by-product or waste	lactate	COID250920	RESULTS	arg1
29101f33e46f7f902fe868b62cd03c2c	35441833	PMC9542549	up to 11% higher levels of G0F	levels	up to 11% higher levels	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg1
5a90dfd61a3d2efca0036688f2ede637	35441833	PMC9542549	cultures with fluctuating DOT conditions	cultures	cultures	NYK	DOT	COID003597	RESULTS	arg0
defcfb6a047386844ecbc733648882f9	35441833	PMC9542549	significant differences to control cultures in the case of the "high" growing AZCL_3 cell line	differences	significant differences	cell line	cell line	COID702829	RESULTS	arg1
e22d9ef43bd4b08fd5a8638d84825cef	35441833	PMC9542549	all DO-fluctuated vessels	vessels	all DO-fluctuated vessels	vessel or process parameter or production scale	DO-fluctuated vessels	COID322748	RESULTS	arg0
a19df47abf0341256ee01364bbc85be2	35441833	PMC9542549	higher qgluc	qgluc	higher qgluc	sugar (subset of carbon source)	qgluc	COID367406	RESULTS	arg1
7b4a963acc3c98c2a6437f435de4d4c3	35441833	PMC9542549	better bioreactor control	control	better bioreactor control	vessel or process parameter or production scale	bioreactor	COID345693	RESULTS	arg0
6ae7ded0fa8d65c3ef7c206fe3d81d59	35441833	PMC9542549	Higher growing cell lines	lines	Higher growing cell lines	cell line	Higher growing cell lines	COID379160	RESULTS	arg1
100550f7045d452c921d497115c8a137	35441833	PMC9542549	Fluctuated vessels	vessels	Fluctuated vessels	vessel or process parameter or production scale	Fluctuated vessels	COID322748	RESULTS	arg0
b7b2da7a509c3109b5860c56a6de2297	35441833	PMC9542549	higher initial lactate production (qlac)	production	higher initial lactate production	by-product or waste	lactate	COID250920	RESULTS	arg1
58a37d0bd9f417a0fc488b08c2746475	35441833	PMC9542549	lower peak VCD values	values	lower peak VCD values	cell culture parameters	VCD	COID384695	RESULTS	arg0
8e07fc8c8d9de72cfc8fef800e1eae10	35441833	PMC9542549	DO-fluctuated cultures	cultures	DO-fluctuated cultures	bioreactor conditions	DO	COID661988	RESULTS	arg1
de2823488db1bc46b6b80f364cd1fc16	35441833	PMC9542549	higher lactate accumulation	accumulation	higher lactate accumulation	by-product or waste	lactate	COID250920	RESULTS	arg0
736a7c2296c435771235996ac6a0e9dc	35441833	PMC9542549	up to 11% higher levels of G0F	levels	up to 11% higher levels	sugar (subset of carbon source)	G0F	COID847830	RESULTS	arg0
cd1e301bff5061d88fcc282bf06fd489	35441833	PMC9542549	higher qgluc	qgluc	higher qgluc	sugar (subset of carbon source)	qgluc	COID367406	RESULTS	arg0
b96ac3a29a1627cdda15567a3a5370bb	35441833	PMC9542549	all DO-fluctuated vessels	vessels	all DO-fluctuated vessels	vessel or process parameter or production scale	DO-fluctuated vessels	COID322748	RESULTS	arg1
208b7eaea06909f8d67272dd554c8d0d	35441833	PMC9542549	slightly lower peak lactate concentrations (particularly Control 3) below 2 gl-1	concentrations	slightly lower peak lactate concentrations	by-product or waste	lactate	COID250920	RESULTS	arg0
b3dd86f247ff3f83790eda70cb8e2298	35441833	PMC9542549	vessels	vessels	the pH and DOT fluctuated vessels	vessel or process parameter or production scale	vessels	COID322748	RESULTS	arg1
af647999ef5c38c10638f91a33d7c6c1	35441833	PMC9542549	pH	pH	the pH and DOT fluctuated vessels	bioreactor conditions	pH	COID893209	RESULTS	arg1
f43ed11eddc40218fca36709361a15ee	35470430	PMC9541590	pilot scale in 30 L bioreactor	scale	pilot scale	vessel or process parameter or production scale	scale	COID586187	ABSTRACT	arg0
51d196e75de450acf084ab972fe43f28	35470430	PMC9541590	A high cell density perfusion process	process	A high cell density perfusion process	cell culture parameters	high cell density	COID283414	ABSTRACT	arg1
39360e5c7e9f60c5300d1c2b9935bbb2	35470430	PMC9541590	A high cell density perfusion process	process	A high cell density perfusion process	process mode	perfusion	COID329168	ABSTRACT	arg1
6e8370bf19202411ed2988ad79159b74	35470430	PMC9541590	the production of acid-sensitive monoclonal antibodies, prone to aggregate at low pH, on pilot scale	production	the production	monoclonal antibody	monoclonal antibodies	COID242255	ABSTRACT	arg0
e4fb14fd8e0bdc71b55dcec6b09cb54a	35470430	PMC9541590	integrated continuous bioprocess (ICB) designed for the production of acid-sensitive monoclonal antibodies, prone to aggregate at low pH, on pilot scale	bioprocess	integrated continuous bioprocess	vessel or process parameter or production scale	scale	COID586187	ABSTRACT	arg1
5f3639329ecf02ada8de77356cece8b4	35470430	PMC9541590	integrated continuous bioprocess (ICB) designed for the production of acid-sensitive monoclonal antibodies, prone to aggregate at low pH, on pilot scale	bioprocess	integrated continuous bioprocess	bioreactor conditions	pH	COID893209	ABSTRACT	arg1
6ace33b16786377f63bf1d04011a64c3	35470430	PMC9541590	the production of acid-sensitive monoclonal antibodies, prone to aggregate at low pH, on pilot scale	production	the production	vessel or process parameter or production scale	scale	COID586187	ABSTRACT	arg0
ea9a6059abd501d873538da9c63e96a7	35470430	PMC9541590	integrated continuous bioprocess (ICB) designed for the production of acid-sensitive monoclonal antibodies, prone to aggregate at low pH, on pilot scale	bioprocess	integrated continuous bioprocess	monoclonal antibody	monoclonal antibodies	COID242255	ABSTRACT	arg1
0a93c46c38c961cadc6a2732c94de3a2	35470430	PMC9541590	the production of acid-sensitive monoclonal antibodies, prone to aggregate at low pH, on pilot scale	production	the production	bioreactor conditions	pH	COID893209	ABSTRACT	arg0
e126b41f196d7084d564ba12fd3f7f1e	35470430	PMC9541590	perfusion mode	mode	perfusion mode	process mode	perfusion	COID329168	RESULTS	arg0
500ea1d844ef88460468c234f43d8cf1	35470430	PMC9541590	high cell density seed bioreactors	bioreactors	high cell density seed bioreactors	cell culture parameters	high cell density	COID283414	RESULTS	arg1
364439fd12b2782ef51cb255346edd25	35470430	PMC9541590	high cell density seed bioreactors	bioreactors	high cell density seed bioreactors	vessel or process parameter or production scale	bioreactors	COID345693	RESULTS	arg1
ab5c8264a1a2f4baf90252ec596c6a5f	35470430	PMC9541590	commercial media	media	commercial media	media characteristics	media	COID913636	RESULTS	arg0
952d6b88621da6ce95d70009d86e296e	35470430	PMC9541590	the formation of high lactate concentration in the culture (Y. Zhang et al., )	formation	the formation	by-product or waste	lactate	COID250920	RESULTS	arg1
9116c00428e223a7d30ec6ad24fa4138	35737825	PMC9235890	higher cell densities	densities	higher cell densities	cell culture parameters	cell densities	COID283414	ABSTRACT	arg1
74e6954107791d74fa790d596e189bff	35737825	PMC9235890	DR cell lines	lines	DR cell lines	cell line	cell lines	COID702829	RESULTS	arg0
057654b1b1c7347670e307dbef5ee340	35737825	PMC9235890	approximately 1 mM higher ammonium concentrations	concentrations	approximately 1 mM higher ammonium concentrations	culture condition	ammonium	COID714150	RESULTS	arg1
f93d4a99b0717118af81779b7a08aecf	37456731	PMC10349264	the small-scale trials showing decreased growth in the last repetitions	trials	the small-scale trials	vessel or process parameter or production scale	scale	COID586187	RESULTS	arg0
bddb1794cc74d15b8960d4b0006e52c6	37456731	PMC10349264	decreased growth in the last repetitions	growth	decreased growth	cell culture parameters	growth	COID203666	RESULTS	arg1
796c5e55c13eeb9ec1cb129c638b36eb	37456731	PMC10349264	a fed batch operation	operation	a fed batch operation	process mode	fed batch	COID529446	RESULTS	arg0
2f1d7e70ce6b3aaa2db4ee10908687a8	37456731	PMC10349264	perfusion cultures	cultures	perfusion cultures	process mode	perfusion cultures	COID368508	RESULTS	arg0
6d1a17cc3cdfd0b5d500fa0ff9170c93	37456731	PMC10349264	the cell culture	culture	the cell culture	cell culture parameters	cell culture	COID293414	RESULTS	arg0
68170a106a764b484a9813186c95cb8e	37456731	PMC10349264	a high cell viability of over 93%	viability	a high cell viability	cell culture parameters	cell viability	COID547964	RESULTS	arg1
9ac004d27c99e055415dc6af7e95cfe1	37456731	PMC10349264	time	time	time	process parameters or process control	time	COID742277	RESULTS	arg0
f1bc746f1655d9495c91b12bf2ad1aea	37456731	PMC10349264	the qP values	values	the qP values	flux rate	qP	COID599783	RESULTS	arg1
708f1df40506da01bcc7c77c6d9f83fd	37731040	PMC10511539	the weakened CDC functions	functions	the weakened CDC functions	process condition	functions	COID532355	RESULTS	arg0
04eb5354c486a0e809d9d4944033418f	37731040	PMC10511539	the expression of MANII gene in the high-expressing cGNTIII pools	expression	the expression	genotype	gene	COID185502	RESULTS	arg1
c1195da474b09830784e2ec15f06f332	37731040	PMC10511539	the weakened CDC functions	functions	the weakened CDC functions	clinical outcomes	CDC	COID455860	RESULTS	arg0
ab18a39428436c876963d2d12a3ee806	37731040	PMC10511539	antibodies carrying non-fucosylated glycans	antibodies	antibodies	antibody	antibodies	COID278523	RESULTS	arg0
7de271cd125ef8afa5df026786641f77	37731040	PMC10511539	significantly higher ADCC potency	potency	significantly higher ADCC potency	clinical outcomes	potency	COID969445	RESULTS	arg1
84ab88b20c2c519e2c56f7b7ae371928	37731040	PMC10511539	significantly higher ADCC potency	potency	significantly higher ADCC potency	clinical outcomes	ADCC	COID386333	RESULTS	arg1
6817becc811525a945bc27022b9dcf0b	37731040	PMC10511539	significantly higher ADCC potency	potency	significantly higher ADCC potency	clinical outcomes	potency	COID969445	RESULTS	arg0
ecb1ef7a1f110f18d4ef2a629dabd6c4	37731040	PMC10511539	antibodies carrying non-fucosylated glycans	antibodies	antibodies	antibody	antibodies	COID278523	RESULTS	arg1
2a92bc1ac2dc240be641cf072a02221e	37731040	PMC10511539	significantly higher ADCC potency	potency	significantly higher ADCC potency	clinical outcomes	ADCC	COID386333	RESULTS	arg0
1d50ebdb526f17a0f0d5beb5fa408ddb	37731040	PMC10511539	the high-expressing cGNTIII pools	pools	the high-expressing cGNTIII pools	genotype	cGNTIII	COID316428	RESULTS	arg0
b5a03fbb06ee44f3c135f3404eafb3b4	37731040	PMC10511539	the highest non-fucosylation induction (72%)	non-fucosylation	the highest non-fucosylation induction	glycosylation	fucosylation	COID810570	RESULTS	arg1
1198b473f6ac91e08152b9f1ee9b38a5	37731040	PMC10511539	the role of Fc galactosylation in	role	the role	product quality profile	Fc galactosylation	COID097777	RESULTS	arg0
15092c75ac2518ad4cdb6ce0ab34a031	37731040	PMC10511539	CDC activation	activation	CDC activation	clinical outcomes	CDC	COID455860	RESULTS	arg1
fd5186f8b1bec1bae00064cbda012f66	37731040	PMC10511539	a high proportion of non-fucosylated IgG1	proportion	a high proportion	antibody	IgG1	COID713543	RESULTS	arg0
6fd36a2ee0e04886a41a6c8a0693ada9	37731040	PMC10511539	ADCC functions	functions	ADCC functions	process parameters or process control	ADCC functions	COID107267	RESULTS	arg1
